Tissue and cell type-associated traits map for all cell types in [Madissoon_2020_spleen] . Due to the large number of UKBB panel traits, this figure shows the non-UKBB traits with a CSEA p (chi2) < 1e-05 as default, and users can change it to 1e-04, 1e-06. For each cell type and trait association pair (shown as an edge in the figure), there may be multiple trait-associated-gene (TAG) sets, each defined at a different threshold. The pair with the minimum p-value is shown in the figure, with the p-value showing along each edge. The number of edges in the figure is thus less than (or equal to) the number of entries in the table below. Users could further select to only show the association for those ‘tissue-specfic cell types’ defined from ontology analysis.

---

Table. List of Tissue-cell type associated traits pairs for [Madissoon_2020_spleen]. If the network above is too complicated, the users could obtain the association information from the table at bottom. Because each trait might have multiple TAG sets defined at different thresholds, multiple rows for each cell type and trait pair with different "TAG Set Threshold" and " CSEA p (chi2)" (the last two columns). Users could identify the most significant association by sorting “CSAE p (chi2)” column.

Cell type	Trait name	Trait full name	Panel	Author	Year	Cases*	Controls	TAG Set Threshold	CSEA p (chi2)
T CD8 MAIT	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	2.92e-3
T CD8 MAIT	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	1.00e-2	2.53e-2
NK CD160pos	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	1.99e-2
NK FCGR3Apos	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	1.21e-3
NK FCGR3Apos	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	1.00e-2	2.53e-2
T CD8 gd	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	1.03e-4
T CD8 gd	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	1.00e-2	4.19e-2
DC plasmacytoid	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	3.82e-2
Plasmablast	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	1.40e-2
Neutrophil	2 Hour Glucose	2-Hour Glucose	ETC	Saxena	2010	NA	15234	5.00e-2	2.78e-2
B naive	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	2.83e-3
T CD4 fh	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	3.00e-2
T cell dividing	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	4.89e-2
B Hypermutation	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	5.43e-3
B Hypermutation	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-2	3.94e-3
Plasmablast	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	2.83e-3
Plasmablast	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-2	1.49e-2
CD34 progenitor	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	5.00e-2	3.85e-2
CD34 progenitor	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-4	3.60e-2
NK dividing	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-2	9.78e-3
NK dividing	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-3	9.18e-3
NK dividing	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-4	3.60e-2
Plasma IgM	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-2	8.65e-4
Plasma IgM	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-3	4.71e-3
Plasma IgM	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-5	2.90e-2
Plasma IgG	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-2	6.28e-3
Plasma IgG	ADHD	Attention Deficit Hyperactivity Disorder	ETC	Demontis	2017	19099	34194	1.00e-3	3.06e-2
T CD8 MAIT	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	4.25e-6
NK CD160pos	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	3.03e-5
NK CD160pos	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	7.26e-3
T CD8 activated	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	5.62e-5
NK FCGR3Apos	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	1.60e-5
NK FCGR3Apos	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	3.37e-3
T CD4 fh	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	5.62e-5
T CD4 fh	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	2.87e-2
T CD8 CTL	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	9.41e-4
T CD4 reg	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	2.55e-3
T CD4 reg	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	2.51e-4
T CD4 naive	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	3.16e-2
T CD4 conv	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	2.55e-3
T CD4 conv	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	3.37e-3
Monocyte	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	3.16e-2
T CD8 gd	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	2.55e-3
DC 1	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	5.00e-2	3.16e-2
Plasma IgG	ADHD	Attention Deficit Hyperactivity Disorder	MTC	Middeldorp	2016	NA	17666	1.00e-2	2.87e-2
T CD8 MAIT	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	2.77e-2
NK FCGR3Apos	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	2.77e-2
NK dividing	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	2.77e-2
NK dividing	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	4.03e-2
DC 2	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	1.38e-2
DC 2	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	4.03e-2
DC plasmacytoid	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	6.48e-3
DC plasmacytoid	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	2.29e-2
Plasmablast	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	2.77e-2
DC activated	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	5.00e-2	3.82e-2
DC activated	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	1.54e-3
DC activated	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-3	2.11e-2
NK CD160pos	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	4.03e-2
T CD8 gd	Age At Death	Age At Death	MTC	Pilling	2016	NA	45627	1.00e-2	4.03e-2
T CD8 MAIT	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	3.74e-3
T CD8 MAIT	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	1.18e-4
T cell dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	8.18e-4
T cell dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	4.40e-2
T cell dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-5	1.12e-2
T CD8 CTL	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	2.26e-2
T CD8 CTL	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	3.34e-2
NK dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	2.67e-6
NK dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	7.00e-4
NK dividing	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-3	4.56e-2
B Hypermutation	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	2.26e-2
Plasmablast	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	2.99e-4
Plasmablast	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	3.41e-3
CD34 progenitor	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	5.00e-2	8.48e-3
T CD8 activated	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	6.98e-3
T CD4 reg	Age At Menarche	Age At Menarche	ETC	Perry	2014	NA	182413	1.00e-2	2.34e-3
T CD8 MAIT	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	1.12e-2
T cell dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	8.40e-4
T cell dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-2	3.08e-2
T cell dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-3	1.44e-3
T cell dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-4	9.45e-4
B mature	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	1.94e-2
NK dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	4.57e-3
NK dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-3	2.55e-3
NK dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-4	4.52e-4
NK dividing	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-5	3.41e-2
T CD8 gd	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	4.12e-2
B Hypermutation	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	5.00e-2	2.39e-3
B Hypermutation	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-2	1.07e-2
B Hypermutation	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-3	4.41e-3
B Hypermutation	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-4	1.91e-3
Plasmablast	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-2	4.23e-2
Plasmablast	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-3	4.25e-4
Plasmablast	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-4	9.45e-4
Plasmablast	Age At Menopause	Age At Menopause	ETC	Day	2015	NA	2545	1.00e-5	1.87e-2
NK CD160pos	Aggression	Aggression	MTC	Pappa	2015	NA	15668	5.00e-2	4.02e-2
Monocyte	Aggression	Aggression	MTC	Pappa	2015	NA	15668	5.00e-2	1.31e-2
DC 2	Aggression	Aggression	MTC	Pappa	2015	NA	15668	5.00e-2	1.31e-2
CD34 progenitor	Aggression	Aggression	MTC	Pappa	2015	NA	15668	5.00e-2	1.94e-2
CD34 progenitor	Aggression	Aggression	MTC	Pappa	2015	NA	15668	1.00e-3	7.15e-3
DC 1	Aggression	Aggression	MTC	Pappa	2015	NA	15668	1.00e-3	3.41e-2
T CD8 MAIT	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	5.14e-10
T CD8 MAIT	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	4.03e-9
T CD8 MAIT	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	5.57e-11
T CD8 MAIT	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.99e-9
T CD8 MAIT	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.91e-7
NK CD160pos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	3.29e-4
NK CD160pos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	7.50e-3
NK CD160pos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.51e-2
NK CD160pos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	3.57e-2
NK CD160pos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	4.75e-2
T CD8 activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	5.89e-7
T CD8 activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	6.71e-6
T CD8 activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	8.20e-6
T CD8 activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	4.35e-5
T CD8 activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.29e-6
B naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	2.17e-3
B naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	7.50e-3
B naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	7.23e-4
B naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	8.69e-5
B naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.67e-3
NK FCGR3Apos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	9.06e-8
NK FCGR3Apos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	7.31e-5
NK FCGR3Apos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	4.56e-3
NK FCGR3Apos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	5.67e-3
NK FCGR3Apos	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	5.83e-3
T CD4 fh	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	3.73e-7
T CD4 fh	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	2.70e-7
T CD4 fh	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.52e-5
T CD4 fh	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.02e-5
T CD4 fh	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.83e-5
T cell dividing	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	8.74e-4
T cell dividing	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	1.86e-2
T cell dividing	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.51e-2
B mature	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	5.20e-6
B mature	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	1.80e-5
B mature	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	2.77e-5
B mature	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.70e-4
B mature	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.67e-3
T CD8 CTL	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	9.23e-7
T CD8 CTL	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	2.90e-5
T CD8 CTL	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.52e-5
T CD8 CTL	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	4.35e-5
T CD8 CTL	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.83e-5
T CD4 reg	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	9.10e-12
T CD4 reg	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	2.12e-9
T CD4 reg	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	3.42e-9
T CD4 reg	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.29e-8
T CD4 reg	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	5.02e-7
T CD4 naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	5.58e-5
T CD4 naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	9.02e-4
T CD4 naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.03e-2
T CD4 naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	3.57e-2
T CD4 naive	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	2.96e-2
T CD4 conv	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	3.83e-5
T CD4 conv	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	4.63e-5
T CD4 conv	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	2.60e-4
T CD4 conv	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.02e-5
T CD4 conv	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	2.00e-4
Monocyte	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	1.76e-2
NK dividing	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	1.09e-2
B T doublet	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	4.59e-4
B T doublet	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	1.76e-4
B T doublet	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	4.37e-4
B T doublet	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.94e-3
B T doublet	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	5.83e-3
DC 2	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	8.50e-3
DC 2	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	2.95e-3
DC 2	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	5.67e-3
DC 2	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	8.48e-4
Macrophage	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	6.56e-3
Macrophage	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	1.78e-2
ILC	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	2.60e-5
ILC	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	2.70e-4
ILC	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.03e-2
ILC	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	3.57e-2
T CD8 gd	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	3.83e-5
T CD8 gd	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	2.73e-3
T CD8 gd	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	6.92e-3
T CD8 gd	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	3.36e-3
T CD8 gd	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	3.17e-3
DC 1	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	1.19e-3
DC 1	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	1.39e-2
DC 1	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	1.88e-3
DC 1	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.09e-3
DC 1	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	4.18e-4
Plasma IgG	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	2.76e-2
DC plasmacytoid	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	3.29e-4
Plasmablast	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	5.58e-5
DC activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	5.00e-2	1.19e-3
DC activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-2	1.91e-3
DC activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-3	4.97e-5
DC activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-4	1.70e-4
DC activated	Allergies	Allergies	MTC	Ferreira	2017	NA	180709	1.00e-5	8.48e-4
T cell dividing	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	2.18e-4
B mature	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	6.77e-3
B mature	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	1.46e-2
B mature	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-4	1.55e-2
B mature	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-5	7.33e-3
T CD8 CTL	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	3.05e-2
Monocyte	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	5.64e-5
Monocyte	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-2	2.77e-3
Monocyte	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	4.27e-2
Monocyte	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-5	3.47e-2
NK dividing	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	4.84e-3
DC 2	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	5.64e-5
DC 2	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-2	5.74e-4
DC 2	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	2.18e-3
DC 2	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-4	6.69e-4
DC 2	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-5	4.36e-4
Macrophage	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	5.06e-4
Macrophage	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-2	1.82e-4
Macrophage	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	8.04e-3
Macrophage	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-4	2.70e-4
Macrophage	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-5	4.92e-5
DC 1	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	1.40e-4
DC 1	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-2	1.69e-2
B Hypermutation	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	1.65e-3
DC plasmacytoid	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	7.59e-4
DC activated	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	5.00e-2	3.42e-3
DC activated	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-2	9.91e-4
DC activated	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	1.08e-3
DC activated	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-4	2.70e-4
DC activated	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-5	1.52e-5
T CD8 MAIT	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	4.27e-2
B naive	Alzheimers	Alzheimer's Disease	MTC	Jansen	2019	71880	383378	1.00e-3	4.27e-2
B naive	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	4.72e-2
B naive	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	4.66e-2
T cell dividing	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	4.31e-3
Monocyte	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	4.38e-4
Monocyte	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	8.44e-3
Monocyte	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	2.73e-2
Monocyte	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	3.65e-3
Monocyte	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.67e-3
NK dividing	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	4.31e-3
DC 2	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	1.20e-4
DC 2	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	1.09e-4
DC 2	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	3.61e-3
DC 2	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	4.46e-5
DC 2	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.21e-4
Macrophage	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	1.20e-4
Macrophage	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	3.24e-3
Macrophage	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	3.16e-4
Macrophage	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	1.48e-4
Macrophage	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.25e-6
DC 1	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	7.60e-5
DC 1	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	5.73e-5
DC 1	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	9.21e-3
DC 1	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.67e-3
B Hypermutation	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	1.87e-4
Platelet	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	2.78e-2
DC plasmacytoid	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	3.03e-3
DC plasmacytoid	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	1.09e-4
DC plasmacytoid	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	4.66e-2
DC plasmacytoid	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	4.09e-2
Plasmablast	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	6.05e-3
Plasmablast	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	4.85e-2
DC activated	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	2.10e-2
DC activated	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	3.66e-4
DC activated	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	3.16e-4
DC activated	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	1.48e-4
DC activated	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	2.87e-5
CD34 progenitor	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	5.00e-2	4.72e-2
CD34 progenitor	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	1.94e-3
CD34 progenitor	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.57e-2
T CD8 MAIT	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	4.38e-2
B mature	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-2	5.28e-3
B mature	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-3	1.46e-2
B mature	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	4.66e-2
B mature	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	1.57e-2
Neutrophil	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-4	4.66e-2
Neutrophil	Alzheimers	Alzheimer's Disease	ETC	Lambert	2013	17008	37154	1.00e-5	4.09e-2
T CD8 MAIT	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	5.00e-2	7.12e-3
T CD8 activated	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	5.00e-2	1.48e-2
T CD4 reg	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	5.00e-2	1.48e-2
Monocyte	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	5.00e-2	2.11e-3
Monocyte	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	1.00e-2	3.95e-2
DC plasmacytoid	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	5.00e-2	8.70e-4
DC plasmacytoid	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	1.00e-2	3.95e-2
NK FCGR3Apos	Amyotrophic Lateral Sclerosis	Amyotrophic Lateral Sclerosis	MTC	van-Rheenen	2016	12577	23475	1.00e-3	2.11e-2
T CD8 MAIT	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	3.12e-2
B naive	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	4.30e-2
T cell dividing	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	4.30e-2
T CD4 reg	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	3.12e-2
T CD4 reg	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-2	5.15e-3
B Hypermutation	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	3.22e-3
CD34 progenitor	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	5.00e-2	4.90e-3
CD34 progenitor	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-2	5.27e-4
NK FCGR3Apos	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-2	1.01e-2
T CD4 conv	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-2	1.90e-2
DC plasmacytoid	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-2	1.18e-3
Platelet	Anorexia Nervosa	Anorexia Nervosa	MTC	Boraska	2014	2907	14860	1.00e-3	2.38e-2
T CD8 MAIT	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	1.25e-2
T CD8 MAIT	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	9.01e-4
T CD8 MAIT	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-4	4.92e-3
B naive	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	1.25e-2
B mature	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	3.91e-3
Monocyte	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	8.62e-3
B T doublet	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	1.78e-2
B T doublet	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	1.88e-3
DC 2	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	4.68e-2
DC 1	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	1.25e-2
DC 1	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	4.07e-2
Platelet	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	5.00e-2	4.15e-4
T CD8 activated	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	2.39e-2
T CD4 fh	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	7.25e-3
T CD4 fh	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-4	2.58e-2
T cell dividing	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	2.39e-2
T cell dividing	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-4	4.92e-3
T CD8 CTL	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	2.39e-2
T CD4 naive	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	4.17e-4
T CD4 conv	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	2.39e-2
B Hypermutation	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	4.07e-2
Plasmablast	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-2	7.25e-3
T CD4 reg	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-3	1.41e-2
T CD4 reg	Anorexia Nervosa	Anorexia Nervosa	MTC	Duncan	2017	3495	10982	1.00e-4	7.48e-4
T CD8 MAIT	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	2.91e-5
T CD8 MAIT	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	1.09e-4
T CD8 MAIT	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	9.74e-6
T CD8 MAIT	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	4.26e-5
T CD8 MAIT	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	8.67e-5
NK CD160pos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	2.49e-4
NK CD160pos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	9.57e-3
T CD8 activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	3.70e-4
T CD8 activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	9.56e-4
T CD8 activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.94e-3
T CD8 activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.47e-2
T CD8 activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.55e-2
B naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	7.98e-4
B naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	1.57e-3
B naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.94e-3
B naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	7.37e-3
B naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.52e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	2.49e-4
NK FCGR3Apos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	6.27e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	7.22e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	7.37e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.55e-2
T CD4 fh	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.65e-3
T CD4 fh	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	6.27e-3
T CD4 fh	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.60e-2
T CD4 fh	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	2.80e-2
T cell dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.14e-2
B mature	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	7.98e-4
B mature	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	3.34e-4
B mature	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	5.26e-4
B mature	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.59e-3
B mature	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	7.03e-4
T CD8 CTL	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.65e-3
T CD8 CTL	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	6.27e-3
T CD8 CTL	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	1.06e-3
T CD8 CTL	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.59e-3
T CD8 CTL	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	2.25e-2
T CD4 reg	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	7.15e-6
T CD4 reg	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	4.03e-3
T CD4 reg	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	1.28e-2
T CD4 reg	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	3.51e-3
T CD4 naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	8.48e-3
T CD4 naive	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	4.28e-2
T CD4 conv	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.14e-2
T CD4 conv	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	4.28e-2
NK dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.15e-3
NK dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	1.57e-3
NK dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	4.01e-6
NK dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.55e-5
NK dividing	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	7.03e-4
B T doublet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	5.46e-4
B T doublet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	1.57e-3
B T doublet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.60e-2
B T doublet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	2.80e-2
B T doublet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	1.84e-3
Macrophage	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.14e-2
ILC	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	3.28e-3
DC 1	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	3.37e-2
DC 1	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.60e-2
DC 1	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.59e-3
DC 1	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	7.03e-4
DC plasmacytoid	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	8.48e-3
Plasmablast	Asthma	Asthma	MTC	Demenais	2017	19954	107715	5.00e-2	1.14e-2
Plasmablast	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.55e-2
Plasma IgG	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-2	4.28e-2
T CD8 gd	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	3.60e-2
Platelet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	2.08e-3
Platelet	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	1.47e-2
DC activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-3	7.22e-3
DC activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-4	3.51e-3
DC activated	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.52e-3
DC 2	Asthma	Asthma	MTC	Demenais	2017	19954	107715	1.00e-5	4.55e-2
T CD8 MAIT	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	6.89e-4
T CD8 MAIT	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	4.51e-4
T CD8 MAIT	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	5.83e-4
T CD8 MAIT	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	1.41e-2
T CD8 MAIT	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
T CD8 activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	1.65e-3
T CD8 activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	4.51e-4
T CD8 activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	4.12e-3
T CD8 activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.39e-3
T CD8 activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	9.50e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	4.07e-2
NK FCGR3Apos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	1.70e-2
NK FCGR3Apos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	9.90e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.39e-3
NK FCGR3Apos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	2.12e-3
T CD8 CTL	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	1.02e-4
T CD8 CTL	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	1.71e-3
T CD8 CTL	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	1.60e-3
T CD8 CTL	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.02e-2
T CD4 reg	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	7.92e-3
T CD4 reg	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	3.18e-3
T CD4 reg	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	1.60e-3
T CD4 reg	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.02e-2
NK dividing	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	3.72e-3
NK dividing	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	3.18e-3
NK dividing	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	2.22e-2
DC 2	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	1.13e-2
DC 2	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	2.78e-2
DC 2	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.02e-2
DC 2	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
Platelet	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	3.02e-2
DC plasmacytoid	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	5.00e-2	2.21e-2
B T doublet	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	4.41e-2
B T doublet	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	9.90e-3
B T doublet	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.39e-3
B T doublet	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	9.50e-3
Macrophage	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	4.41e-2
Macrophage	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	2.22e-2
Macrophage	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.02e-2
Macrophage	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
DC activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-2	1.70e-2
DC activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	4.62e-2
DC activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.02e-2
DC activated	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
NK CD160pos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	1.60e-3
NK CD160pos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-4	4.39e-3
NK CD160pos	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
B naive	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	4.62e-2
DC 1	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-3	2.22e-2
B mature	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
ILC	Asthma	Asthma	MTC	Moffatt	2010	10365	16110	1.00e-5	3.59e-2
T CD8 MAIT	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	2.49e-2
T CD8 activated	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	5.81e-3
T CD8 activated	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-5	3.87e-2
NK FCGR3Apos	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	3.02e-3
NK FCGR3Apos	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-2	1.39e-2
T CD4 fh	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	3.23e-2
T cell dividing	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	1.90e-2
T CD4 reg	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	5.81e-3
T CD4 reg	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-2	2.09e-2
T CD4 naive	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	3.23e-2
NK dividing	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	2.47e-5
B Hypermutation	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	1.50e-3
Plasmablast	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	5.00e-2	3.23e-2
Plasmablast	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-3	2.69e-2
Plasma IgM	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-5	3.87e-2
Plasma IgG	BIP	Bipolar Disorder	MTC	Psychiatric-Genomics-Consortium	2012	7481	9250	1.00e-5	3.87e-2
NK CD160pos	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	4.54e-2
T cell dividing	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	9.52e-6
T cell dividing	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	9.69e-3
T CD4 reg	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	1.82e-2
NK dividing	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	5.47e-4
NK dividing	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	2.70e-2
B Hypermutation	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	8.54e-4
B Hypermutation	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	5.53e-3
B Hypermutation	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-3	3.15e-2
Plasmablast	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	9.23e-3
Plasmablast	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	3.06e-3
CD34 progenitor	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	5.00e-2	2.51e-2
CD34 progenitor	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	9.69e-3
T CD4 fh	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	4.30e-2
Plasma IgM	Birth Length	Birth Length	MTC	van-der-Valk	2014	NA	28238	1.00e-2	1.64e-2
T CD8 MAIT	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	3.55e-4
T CD8 activated	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	5.62e-4
NK FCGR3Apos	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	4.61e-2
T CD8 CTL	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	1.71e-5
T CD8 CTL	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	3.03e-2
T CD8 CTL	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-3	3.81e-2
T CD4 reg	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	4.61e-2
Monocyte	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	9.42e-3
DC 2	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	4.61e-2
Macrophage	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	9.42e-3
T CD8 gd	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	4.52e-3
T CD8 gd	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-4	4.37e-2
DC 1	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	1.33e-2
DC 1	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-4	4.37e-2
B Hypermutation	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	1.33e-2
B Hypermutation	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	3.03e-2
DC plasmacytoid	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	9.42e-3
Plasmablast	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	5.00e-2	4.52e-3
Plasmablast	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	1.93e-3
Plasmablast	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-3	1.71e-2
T cell dividing	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	1.86e-2
T cell dividing	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-3	1.71e-2
Plasma IgM	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	1.86e-2
Plasma IgG	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-2	1.86e-2
Plasma IgG	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-3	3.81e-2
B mature	Birth Weight	Birth Weight	MTC	Horikoshi	2013	NA	26836	1.00e-4	1.23e-2
NK FCGR3Apos	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	1.37e-2
T cell dividing	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	4.44e-4
NK dividing	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	2.54e-5
Macrophage	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	3.40e-3
Macrophage	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	3.32e-2
Macrophage	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-4	1.39e-2
T CD8 gd	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	3.41e-2
T CD8 gd	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	3.32e-2
T CD8 gd	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-3	2.91e-2
T CD8 gd	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-4	3.34e-2
DC 1	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	1.56e-3
Plasma IgM	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	1.88e-2
B Hypermutation	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	1.68e-6
B Hypermutation	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	4.95e-2
Plasma IgG	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	1.04e-3
Plasma IgG	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	8.54e-3
Platelet	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	3.41e-2
Platelet	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	4.95e-2
DC plasmacytoid	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	4.92e-3
DC plasmacytoid	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	4.95e-2
Plasmablast	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	8.89e-6
Plasmablast	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	5.16e-3
CD34 progenitor	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	4.44e-4
CD34 progenitor	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-2	1.49e-4
CD34 progenitor	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-4	5.32e-3
Neutrophil	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	5.00e-2	3.41e-2
Neutrophil	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-3	2.91e-2
Monocyte	Blood Pressure	Blood Pressure	MTC	Ehret	2011	NA	69395	1.00e-3	2.91e-2
NK FCGR3Apos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	2.31e-2
NK FCGR3Apos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-3	2.86e-2
NK FCGR3Apos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-4	2.96e-2
NK FCGR3Apos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-5	2.30e-2
T CD8 CTL	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	4.11e-2
NK dividing	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	2.42e-4
NK dividing	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	7.97e-3
NK dividing	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-3	1.33e-2
NK dividing	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-5	2.30e-2
DC 1	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	2.98e-3
DC 1	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	3.25e-2
DC 1	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-3	2.86e-2
DC 1	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-5	2.30e-2
B Hypermutation	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	3.10e-2
Plasmablast	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	2.31e-2
Plasmablast	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	1.31e-2
DC activated	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	5.00e-2	4.11e-2
NK CD160pos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	4.91e-2
NK CD160pos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-3	2.86e-2
NK CD160pos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-4	9.71e-3
NK CD160pos	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-5	2.30e-2
Plasma IgM	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	3.25e-2
CD34 progenitor	BMI Childhood	BMI Childhood	MTC	Felix	2015	NA	34744	1.00e-2	2.09e-2
T cell dividing	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	5.00e-2	1.20e-2
B Hypermutation	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	5.00e-2	1.62e-2
B Hypermutation	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-2	1.64e-2
Plasmablast	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	5.00e-2	6.33e-3
Plasmablast	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-2	3.55e-2
NK FCGR3Apos	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-2	2.44e-2
NK FCGR3Apos	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-3	9.04e-3
CD34 progenitor	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-2	1.64e-2
CD34 progenitor	BMI	Body Mass Index	MTC	Speliotes	2010	NA	123865	1.00e-3	1.67e-2
T CD4 fh	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	1.15e-2
T cell dividing	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	1.15e-2
T CD4 naive	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	3.29e-2
NK dividing	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	3.29e-2
B Hypermutation	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	1.15e-2
Plasmablast	BMI	Body Mass Index	MTC	Wood	2016	29925	89763	5.00e-2	1.83e-3
T CD4 reg	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	1.34e-2
T CD4 reg	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-3	1.56e-2
DC 2	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	1.20e-4
Macrophage	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	2.07e-4
Macrophage	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-2	8.92e-3
DC 1	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	2.78e-2
Plasma IgM	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	1.34e-2
Plasma IgG	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	1.94e-2
DC plasmacytoid	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	1.34e-2
DC activated	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	5.00e-2	2.78e-2
T cell dividing	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-2	1.75e-2
T CD4 naive	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-2	3.27e-2
T CD8 CTL	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-3	3.26e-3
T CD4 conv	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-3	1.56e-2
T CD8 gd	BMI	Body Mass Index	MTC	Yang	2012	NA	133154	1.00e-3	1.56e-2
T cell dividing	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	5.76e-3
NK dividing	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	5.76e-3
Macrophage	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	3.28e-4
Macrophage	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-4	2.11e-2
Macrophage	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-5	3.38e-2
DC 1	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	5.76e-3
Plasma IgM	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	4.17e-2
Plasma IgG	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	3.35e-2
DC plasmacytoid	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	1.66e-2
Plasmablast	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	5.76e-3
CD34 progenitor	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-3	3.23e-3
CD34 progenitor	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-4	1.54e-4
CD34 progenitor	Bone Mineral Density Estimated	Bone Mineral Density Estimated	MTC	Kemp	2017	NA	142487	1.00e-5	9.66e-5
B naive	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	3.29e-3
B naive	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.39e-2
NK FCGR3Apos	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	3.75e-2
T CD4 fh	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	1.22e-2
T CD4 fh	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.39e-2
B mature	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	1.22e-2
T CD8 CTL	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	6.47e-3
T CD4 reg	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	2.18e-2
T CD4 reg	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.39e-2
T CD4 naive	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	7.43e-4
T CD4 conv	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	4.82e-2
Monocyte	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	1.64e-2
Monocyte	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	1.52e-3
NK dividing	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	2.88e-2
B T doublet	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	1.37e-5
B T doublet	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.51e-3
DC 2	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	6.47e-3
DC 2	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	7.48e-3
Macrophage	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	3.75e-2
DC 1	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	3.29e-3
DC 1	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.51e-3
DC activated	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	5.00e-2	3.29e-3
DC activated	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	8.53e-4
T CD8 MAIT	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.39e-2
T cell dividing	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	4.39e-2
Neutrophil	Bone Mineral Density	Bone Mineral Density	MTC	Styrkarsdottir	2008	4657	207514	1.00e-2	1.52e-3
B mature	Breast Cancer	Breast Cancer	MTC	Hunter	2007	NA	1145	5.00e-2	2.56e-3
T CD8 MAIT	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	3.44e-3
B naive	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	3.50e-2
NK FCGR3Apos	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	3.44e-3
T cell dividing	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	2.49e-2
T CD8 CTL	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	4.84e-2
Monocyte	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	2.20e-3
Monocyte	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
ILC	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	5.29e-3
ILC	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
B Hypermutation	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	1.73e-2
DC activated	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	5.00e-2	1.19e-2
T CD4 conv	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
NK dividing	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
NK dividing	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-3	2.30e-2
Macrophage	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
CD34 progenitor	Cerebral White Matter Hyperintensity	Cerebral White Matter Hyperintensity	MTC	Traylor	2016	NA	3670	1.00e-2	4.71e-2
T CD8 MAIT	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	3.26e-2
NK CD160pos	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	2.73e-3
NK CD160pos	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	1.25e-3
T CD8 activated	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	1.54e-2
B naive	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	1.54e-2
B mature	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	3.58e-4
T CD8 CTL	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	3.26e-2
T CD4 reg	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	1.54e-2
T CD4 reg	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	3.79e-2
Monocyte	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	3.58e-4
Monocyte	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	2.72e-3
DC 2	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	1.54e-2
DC 2	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	3.79e-2
T CD8 gd	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	4.60e-2
T CD8 gd	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	5.63e-3
DC 1	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	1.54e-2
DC plasmacytoid	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	3.26e-2
Neutrophil	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	5.00e-2	6.75e-3
Neutrophil	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-2	3.79e-2
Plasma IgG	Clozapine Induced Agranulocytosis	Clozapine Induced Agranulocytosis	ETC	Goldstein	2014	161	1196	1.00e-3	2.30e-2
T CD8 MAIT	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	1.92e-2
T cell dividing	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	2.70e-3
T CD4 reg	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	9.20e-3
NK dividing	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	1.34e-2
DC 2	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	4.13e-3
DC 2	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-3	3.77e-2
Macrophage	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	1.74e-3
Macrophage	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	1.32e-2
Macrophage	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-3	3.77e-2
ILC	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	3.74e-2
DC 1	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	6.84e-4
DC 1	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	4.35e-2
DC 1	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-3	3.16e-3
B Hypermutation	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	6.21e-3
Plasma IgG	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	3.74e-2
Plasma IgG	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-3	3.77e-2
DC plasmacytoid	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	2.70e-3
DC plasmacytoid	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	2.45e-2
DC plasmacytoid	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-3	3.77e-2
Plasmablast	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	5.00e-2	1.10e-3
B naive	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	1.32e-2
B mature	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	1.32e-2
Neutrophil	Cognitive Performance	Cognitive Performance	MTC	Rietveld	2014	NA	106736	1.00e-2	6.78e-3
T CD8 MAIT	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.86e-2
T CD8 MAIT	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	4.53e-2
T CD8 activated	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	4.73e-2
T CD4 fh	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.86e-2
T CD4 fh	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	2.39e-3
T cell dividing	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	2.58e-2
B mature	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	4.73e-2
T CD4 reg	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	6.38e-3
T CD4 reg	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	1.57e-2
T CD4 naive	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.86e-2
T CD4 naive	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	2.12e-5
T CD4 conv	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	4.73e-2
T CD4 conv	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	8.70e-3
Monocyte	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.86e-2
Monocyte	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	8.70e-3
Macrophage	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	5.03e-4
Macrophage	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	1.17e-4
Macrophage	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-3	8.33e-3
Macrophage	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-4	3.23e-3
Plasma IgG	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.32e-2
Plasma IgG	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	4.65e-3
Plasma IgG	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-3	2.27e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.32e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	2.72e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-3	2.27e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-4	1.89e-2
Plasmablast	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.32e-2
CD34 progenitor	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	5.00e-2	1.86e-2
CD34 progenitor	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	2.72e-2
CD34 progenitor	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-3	8.33e-3
Plasma IgM	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-2	2.72e-2
Platelet	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-3	8.37e-4
Platelet	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-4	3.23e-3
B Hypermutation	CAD	Coronary Artery Disease	MTC	C4D	2011	64762	22233	1.00e-4	1.89e-2
Monocyte	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	1.31e-2
Macrophage	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	1.09e-4
Macrophage	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	3.65e-3
Macrophage	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-3	5.42e-3
Macrophage	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-4	1.65e-3
Macrophage	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-5	1.10e-3
ILC	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	3.66e-2
B Hypermutation	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	1.72e-2
Platelet	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	2.87e-2
Platelet	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	1.18e-2
Plasmablast	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	5.00e-2	1.31e-2
Plasmablast	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	2.39e-2
NK CD160pos	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	3.32e-2
B naive	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	4.53e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	2.39e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-3	3.79e-2
CD34 progenitor	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-2	4.53e-2
DC 2	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-4	1.38e-2
DC 2	CAD	Coronary Artery Disease	MTC	Nelson	2017	18467	45264	1.00e-5	6.90e-3
B mature	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	2.68e-2
T CD4 reg	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	4.61e-2
Monocyte	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	2.01e-2
NK dividing	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	4.61e-2
Macrophage	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	1.91e-3
Macrophage	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-2	4.49e-4
Macrophage	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-3	1.68e-3
Macrophage	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-4	8.37e-4
Macrophage	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-5	4.91e-2
ILC	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	2.68e-2
B Hypermutation	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	1.09e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	5.00e-2	4.61e-2
DC plasmacytoid	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-4	8.33e-3
Plasma IgM	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-2	2.48e-3
Plasma IgM	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-3	3.11e-2
Plasma IgG	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-2	6.87e-3
Plasma IgG	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-3	3.11e-2
Plasmablast	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-2	3.95e-2
B naive	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-3	3.11e-2
DC 2	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-3	8.03e-3
DC 2	CAD	Coronary Artery Disease	MTC	Schunkert	2011	22233	64762	1.00e-4	8.33e-3
T CD8 MAIT	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	2.92e-11
T CD8 MAIT	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	9.20e-8
T CD8 MAIT	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.73e-5
T CD8 MAIT	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	8.63e-6
T CD8 MAIT	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	2.08e-4
NK CD160pos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.78e-6
NK CD160pos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	4.98e-5
NK CD160pos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.28e-3
NK CD160pos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	1.57e-3
NK CD160pos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	2.75e-2
T CD8 activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.40e-8
T CD8 activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.04e-5
T CD8 activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	1.94e-3
T CD8 activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	5.33e-3
B naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	4.38e-4
B naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	3.38e-4
B naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.28e-3
B naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.53e-5
B naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	4.70e-4
NK FCGR3Apos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	3.05e-10
NK FCGR3Apos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.73e-7
NK FCGR3Apos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	1.94e-3
NK FCGR3Apos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	4.11e-4
NK FCGR3Apos	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	1.02e-3
T CD4 fh	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	6.74e-3
T CD4 fh	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	2.14e-4
T CD4 fh	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	3.24e-3
T CD4 fh	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	5.33e-3
T CD4 fh	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	4.68e-2
B mature	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	9.99e-6
B mature	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	5.99e-6
B mature	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.73e-5
B mature	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.53e-5
B mature	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	1.02e-3
T CD8 CTL	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	9.56e-11
T CD8 CTL	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	4.83e-8
T CD8 CTL	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	2.96e-5
T CD8 CTL	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.53e-5
T CD8 CTL	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	4.70e-4
T CD4 reg	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	4.97e-5
T CD4 reg	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	3.38e-4
T CD4 reg	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	6.52e-4
T CD4 reg	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.36e-3
Monocyte	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	6.74e-3
Monocyte	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	8.36e-3
Monocyte	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	4.38e-2
NK dividing	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.45e-2
DC 2	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	7.29e-5
DC 2	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	4.98e-5
DC 2	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.28e-3
DC 2	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.36e-3
DC 2	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	8.33e-3
Macrophage	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.60e-3
Macrophage	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.18e-2
Macrophage	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	8.44e-3
Macrophage	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	9.36e-3
T CD8 gd	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.06e-4
T CD8 gd	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	2.77e-3
T CD8 gd	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	8.44e-3
DC 1	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.17e-3
DC 1	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.77e-5
DC 1	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	5.73e-5
DC 1	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	4.40e-5
DC 1	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	4.70e-4
DC plasmacytoid	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	1.17e-3
DC plasmacytoid	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.18e-2
DC activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	2.26e-5
DC activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.93e-6
DC activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	1.14e-3
DC activated	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	1.59e-2
CD34 progenitor	CD	Crohn's disease	MTC	Franke	2010	6333	15056	5.00e-2	8.78e-3
B T doublet	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-2	1.18e-2
B T doublet	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	8.44e-3
B T doublet	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	8.15e-4
B T doublet	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-5	1.54e-2
T CD4 conv	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-3	2.01e-2
T CD4 naive	CD	Crohn's disease	MTC	Franke	2010	6333	15056	1.00e-4	1.59e-2
T CD8 CTL	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	6.75e-3
T CD8 CTL	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	1.62e-2
T CD4 reg	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	1.80e-4
T CD4 reg	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	2.27e-5
Monocyte	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	4.53e-3
NK dividing	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	1.43e-2
NK dividing	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	1.62e-2
NK dividing	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-3	4.17e-2
NK dividing	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-4	8.35e-4
NK dividing	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-5	4.38e-4
DC 2	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	9.89e-3
Macrophage	CD	Crohn's disease	MTC	Lee	2017	1762	972	5.00e-2	2.83e-2
Macrophage	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	4.66e-2
Macrophage	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-3	1.81e-2
T CD8 MAIT	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	2.81e-2
T CD8 MAIT	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-3	4.17e-2
T CD8 gd	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-2	4.66e-2
Platelet	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-3	7.20e-3
CD34 progenitor	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-3	1.81e-2
CD34 progenitor	CD	Crohn's disease	MTC	Lee	2017	1762	972	1.00e-4	1.55e-2
T CD8 MAIT	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	1.86e-2
B naive	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	5.83e-3
B naive	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	1.37e-2
B naive	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	1.51e-2
B naive	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	1.05e-2
NK FCGR3Apos	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	6.83e-5
NK FCGR3Apos	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	1.37e-2
T cell dividing	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	1.86e-2
B mature	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	3.07e-3
B mature	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	1.37e-2
B mature	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	1.51e-2
B mature	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	1.05e-2
T CD8 CTL	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	7.54e-4
T CD8 CTL	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	2.02e-2
NK dividing	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	2.37e-4
DC 1	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	4.25e-3
DC 1	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	1.51e-2
DC 1	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	2.77e-3
B Hypermutation	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	3.13e-2
DC plasmacytoid	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	1.86e-2
Plasmablast	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	5.00e-2	1.06e-2
Plasmablast	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	1.51e-2
T CD4 reg	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	2.02e-2
T CD4 reg	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-3	1.49e-2
Macrophage	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-2	2.02e-2
Plasma IgM	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-3	2.65e-2
Plasma IgM	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	3.43e-2
Plasma IgM	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	1.05e-2
Plasma IgG	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-3	2.65e-2
Plasma IgG	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	3.43e-2
Plasma IgG	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	1.05e-2
DC activated	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-3	4.54e-2
DC activated	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	1.51e-2
DC activated	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	2.77e-3
DC 2	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-4	3.43e-2
DC 2	Cross Disorder Brain	Cross Disorder Brain	MTC	PGC	2013	33332	27888	1.00e-5	2.77e-3
NK FCGR3Apos	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	5.00e-2	3.39e-2
B mature	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	5.00e-2	6.58e-3
Macrophage	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	5.00e-2	2.51e-2
Platelet	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	5.00e-2	1.83e-2
Platelet	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-2	6.35e-3
CD34 progenitor	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	5.00e-2	9.39e-3
DC activated	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-2	4.89e-2
NK dividing	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-4	2.03e-2
ILC	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-4	2.03e-2
Plasma IgM	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-4	2.03e-2
Plasma IgG	Depressive Symptoms	Depressive Symptoms	ETC	Okbay	2016	122210	58835	1.00e-4	2.03e-2
T cell dividing	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	1.09e-3
T cell dividing	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-2	8.15e-3
DC 2	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	2.87e-2
DC 2	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-2	2.94e-2
DC 2	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-3	1.94e-2
Macrophage	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	4.23e-3
Macrophage	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-3	5.11e-3
B Hypermutation	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	2.87e-2
B Hypermutation	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-2	2.94e-2
Plasmablast	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	6.42e-3
B naive	Extraversion	Extraversion	MTC	De-Moor	2012	NA	17375	1.00e-2	2.94e-2
T cell dividing	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	5.00e-2	1.09e-3
T cell dividing	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-2	8.15e-3
DC 2	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	5.00e-2	2.87e-2
DC 2	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-2	2.94e-2
DC 2	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-3	1.94e-2
Macrophage	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	5.00e-2	4.23e-3
Macrophage	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-3	5.11e-3
B Hypermutation	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	5.00e-2	2.87e-2
B Hypermutation	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-2	2.94e-2
Plasmablast	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	5.00e-2	6.42e-3
B naive	Extraversion	Extraversion	MTC	van-den-Berg	2016	NA	63030	1.00e-2	2.94e-2
NK FCGR3Apos	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	1.14e-2
NK FCGR3Apos	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-2	1.43e-2
T cell dividing	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	3.25e-3
T cell dividing	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-2	4.65e-2
NK dividing	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	7.87e-4
NK dividing	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-2	7.43e-3
NK dividing	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-3	1.69e-2
DC 2	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	1.68e-2
B Hypermutation	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	1.28e-3
B Hypermutation	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-2	7.43e-3
Plasmablast	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	5.00e-2	1.28e-3
Plasmablast	Fasting Proinsulin	Fasting Proinsulin	MTC	Strawbridge	2011	NA	16378	1.00e-2	1.43e-2
NK FCGR3Apos	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	3.00e-2
T CD4 reg	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	2.13e-2
Monocyte	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	2.13e-2
NK dividing	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	3.00e-2
DC 2	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	4.15e-2
DC 2	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-3	1.17e-2
ILC	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	4.15e-2
ILC	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-2	1.22e-2
DC 1	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	4.15e-2
DC 1	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-3	3.77e-2
B Hypermutation	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	4.15e-2
Plasma IgG	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	3.00e-2
Plasma IgG	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-2	3.87e-2
DC plasmacytoid	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	4.56e-4
Plasmablast	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	5.00e-2	1.49e-2
Plasma IgM	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-2	2.22e-2
Macrophage	Gait Speed	Gait Speed	MTC	Ben-Avraham	2017	NA	31478	1.00e-3	3.77e-2
T CD8 activated	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	1.53e-2
T cell dividing	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	1.78e-4
T cell dividing	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	1.18e-4
B mature	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	4.23e-2
T CD4 reg	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	4.23e-2
NK dividing	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	2.99e-4
NK dividing	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	3.17e-3
NK dividing	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-3	1.98e-2
T CD8 gd	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	3.07e-2
DC 1	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	4.78e-3
DC 1	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	2.36e-2
DC 1	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-3	6.58e-3
B Hypermutation	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	7.17e-3
DC plasmacytoid	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	3.14e-3
DC plasmacytoid	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	1.27e-2
DC plasmacytoid	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-3	1.98e-2
Plasmablast	Gout	Gout	MTC	Kottgen	2013	2115	67259	5.00e-2	1.05e-5
Plasmablast	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	2.85e-4
ILC	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	2.36e-2
Platelet	Gout	Gout	MTC	Kottgen	2013	2115	67259	1.00e-2	2.36e-2
NK CD160pos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	2.51e-4
NK CD160pos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	4.36e-4
NK CD160pos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-3	6.68e-4
T CD8 activated	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	8.05e-3
NK FCGR3Apos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	1.16e-2
NK FCGR3Apos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	2.30e-2
NK FCGR3Apos	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-3	2.32e-2
T cell dividing	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	3.17e-2
T CD8 CTL	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	4.30e-2
T CD8 CTL	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	3.89e-2
Monocyte	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	8.05e-3
Monocyte	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	2.30e-2
NK dividing	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	4.08e-4
NK dividing	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	2.30e-2
NK dividing	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-3	7.94e-3
DC 2	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	3.70e-3
DC 2	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	2.30e-2
Macrophage	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	1.03e-3
T CD8 gd	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	5.50e-3
T CD8 gd	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	2.30e-2
DC 1	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	4.30e-2
DC 1	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	3.89e-2
B Hypermutation	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	2.51e-4
Platelet	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	3.70e-3
DC plasmacytoid	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	3.17e-2
Plasmablast	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	4.30e-2
DC activated	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	5.00e-2	1.03e-3
DC activated	Head Circumference	Head Circumference	MTC	Taal	2012	NA	10768	1.00e-2	3.75e-3
T CD8 MAIT	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	8.60e-3
NK CD160pos	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	3.99e-3
NK CD160pos	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	2.87e-2
NK CD160pos	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	2.17e-2
NK CD160pos	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	1.98e-2
NK FCGR3Apos	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	5.19e-3
T cell dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	9.21e-8
T cell dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	3.89e-5
T cell dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	1.53e-3
T cell dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	3.88e-3
T cell dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	7.48e-3
NK dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	1.05e-5
NK dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	9.12e-4
NK dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	1.53e-3
NK dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	3.88e-3
NK dividing	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	7.48e-3
Plasma IgM	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	5.19e-3
Plasma IgM	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	1.53e-2
Plasma IgM	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	9.93e-4
Plasma IgM	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	2.17e-2
Plasma IgM	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	4.69e-2
B Hypermutation	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	2.32e-7
B Hypermutation	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	1.02e-5
B Hypermutation	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	9.31e-5
B Hypermutation	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	8.63e-4
B Hypermutation	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	3.09e-2
Plasma IgG	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	1.94e-4
Plasma IgG	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	1.82e-3
Plasma IgG	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	4.02e-4
Plasma IgG	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	4.52e-2
Plasma IgG	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	3.09e-2
Plasmablast	Height	Height	MTC	Lango-Allen	2010	NA	133653	5.00e-2	2.32e-7
Plasmablast	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-2	2.03e-4
Plasmablast	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	5.56e-5
Plasmablast	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	1.45e-3
Plasmablast	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-5	2.54e-3
ILC	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	2.87e-2
Platelet	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-3	2.09e-2
Platelet	Height	Height	MTC	Lango-Allen	2010	NA	133653	1.00e-4	4.52e-2
B naive	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.74e-2
B naive	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	2.97e-4
B naive	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	3.05e-3
B naive	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	4.63e-2
T cell dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.31e-8
T cell dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	7.11e-3
T cell dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	3.47e-2
T cell dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	5.40e-3
T cell dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	1.17e-2
B mature	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	3.03e-4
B mature	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	3.13e-5
B mature	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	4.36e-4
B mature	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	4.63e-2
T CD4 reg	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	3.29e-2
Monocyte	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.74e-2
NK dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	3.73e-7
NK dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	2.97e-4
NK dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	3.05e-3
NK dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	9.26e-5
NK dividing	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	3.60e-4
DC 2	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.24e-2
Macrophage	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.82e-3
DC 1	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	2.41e-2
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	4.09e-3
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	4.63e-2
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	4.91e-2
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	4.31e-6
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	4.63e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	7.63e-4
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	2.04e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	1.65e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	1.68e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	4.91e-2
Platelet	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	8.70e-3
Platelet	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	7.11e-3
Platelet	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	3.05e-3
Platelet	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	3.98e-4
Platelet	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	1.17e-2
DC plasmacytoid	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.24e-2
Plasmablast	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	5.00e-2	1.96e-7
Plasmablast	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-2	7.11e-3
Plasmablast	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-3	1.19e-3
Plasmablast	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-4	1.96e-5
Plasmablast	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	1.17e-2
Neutrophil	Hemoglobin A1c	Hemoglobin A1c	ETC	Soranzo	2010	NA	46368	1.00e-5	4.91e-2
NK CD160pos	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	3.43e-3
NK CD160pos	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-2	4.53e-2
T cell dividing	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	2.30e-3
B mature	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	1.47e-2
NK dividing	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	1.47e-2
NK dividing	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-3	4.64e-2
DC 2	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	4.98e-2
DC 1	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	2.56e-4
Plasma IgM	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	1.47e-2
B Hypermutation	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	9.66e-5
B Hypermutation	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-2	1.75e-2
Plasma IgG	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	1.47e-2
DC plasmacytoid	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	3.75e-2
DC plasmacytoid	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-3	4.64e-2
DC plasmacytoid	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-4	1.56e-2
Plasmablast	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	2.03e-5
Plasmablast	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-2	1.04e-2
Plasmablast	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-3	4.64e-2
CD34 progenitor	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	5.00e-2	4.08e-4
CD34 progenitor	Insomnia	Insomnia	MTC	Hammerschlag	2017	12863	40776	1.00e-2	3.31e-3
B naive	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	1.46e-2
B naive	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	5.29e-3
B naive	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	1.12e-3
B naive	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	2.43e-2
B mature	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	3.98e-2
B mature	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	3.45e-2
B mature	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	2.16e-2
B mature	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	4.54e-2
B mature	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-5	4.82e-2
Monocyte	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	2.46e-2
Monocyte	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	5.29e-3
Monocyte	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	1.28e-2
Monocyte	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	5.91e-3
NK dividing	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	4.64e-3
NK dividing	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	2.46e-2
Macrophage	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	8.40e-3
Macrophage	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	4.76e-2
B Hypermutation	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	1.46e-2
B Hypermutation	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	2.46e-2
Plasmablast	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	6.23e-4
Plasmablast	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	5.29e-3
CD34 progenitor	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	5.00e-2	2.46e-3
CD34 progenitor	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	1.86e-4
CD34 progenitor	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	4.03e-3
CD34 progenitor	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	4.54e-2
DC 1	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-2	1.72e-2
DC 1	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	1.28e-2
DC 1	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	1.23e-2
Platelet	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	2.16e-2
Platelet	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-4	4.54e-2
Neutrophil	Intelligence	Intelligence	MTC	Sniekers	2017	NA	78308	1.00e-3	2.16e-2
T CD8 MAIT	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	8.43e-3
T CD4 fh	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	8.43e-3
T CD8 CTL	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	4.05e-2
T CD4 reg	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	8.43e-3
DC 1	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	2.82e-2
Plasma IgM	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	5.41e-3
Plasma IgM	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	1.00e-2	7.87e-3
Plasma IgG	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	1.92e-2
Plasma IgG	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	1.00e-2	3.60e-3
DC plasmacytoid	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	4.05e-2
DC activated	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	5.00e-2	4.05e-2
T CD8 activated	Internalizing Problems	Internalizing Problems	ETC	Benke	2014	NA	4596	1.00e-3	1.79e-2
Plasmablast	Longevity	Longevity	MTC	Broer	2015	6036	3757	5.00e-2	3.65e-2
Unknown	Longevity	Longevity	MTC	Broer	2015	6036	3757	1.00e-2	3.11e-2
Unknown	Longevity	Longevity	MTC	Broer	2015	6036	3757	1.00e-3	1.94e-2
T CD8 MAIT	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	2.53e-2
T CD8 activated	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	1.17e-3
T CD8 activated	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-2	1.03e-2
NK FCGR3Apos	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	7.28e-3
T CD4 fh	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	3.35e-2
T CD4 fh	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-2	1.68e-2
T CD4 reg	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	1.39e-2
T CD4 reg	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-2	6.17e-3
Monocyte	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	3.35e-2
Monocyte	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-2	4.07e-2
DC plasmacytoid	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	5.00e-2	1.89e-2
T CD4 naive	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-2	3.60e-3
Plasmablast	MDD	Major Depressive Disorder	MTC	McMahon	2010	6686	9068	1.00e-4	3.97e-2
Monocyte	MDD	Major Depressive Disorder	MTC	PGC	2013	9240	9519	5.00e-2	2.20e-2
DC 2	MDD	Major Depressive Disorder	MTC	PGC	2013	9240	9519	5.00e-2	3.38e-3
Macrophage	MDD	Major Depressive Disorder	MTC	PGC	2013	9240	9519	5.00e-2	4.17e-2
DC activated	MDD	Major Depressive Disorder	MTC	PGC	2013	9240	9519	5.00e-2	5.71e-4
DC activated	MDD	Major Depressive Disorder	MTC	PGC	2013	9240	9519	1.00e-2	2.00e-2
T CD8 MAIT	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	5.00e-2	4.28e-2
T CD8 MAIT	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-2	4.55e-2
T CD4 reg	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	5.00e-2	3.32e-2
NK dividing	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	5.00e-2	1.44e-3
NK dividing	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-2	2.14e-2
NK dividing	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-3	2.86e-3
NK dividing	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-4	1.11e-2
NK dividing	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-5	1.50e-3
B Hypermutation	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	5.00e-2	2.55e-2
Plasmablast	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	5.00e-2	2.94e-3
Platelet	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-2	1.42e-2
Platelet	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-3	2.51e-4
CD34 progenitor	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-2	3.67e-3
CD34 progenitor	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-3	5.90e-3
CD34 progenitor	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-4	1.11e-2
Plasma IgM	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-5	3.83e-2
Plasma IgG	MDD	Major Depressive Disorder	ETC	Wray	2018	16823	25632	1.00e-5	3.83e-2
T CD8 MAIT	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	4.34e-2
T CD8 MAIT	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	1.51e-2
T CD8 MAIT	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	4.65e-2
B naive	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	1.61e-3
B naive	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	2.09e-2
B naive	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	2.72e-2
B naive	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-5	2.80e-2
NK FCGR3Apos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	9.81e-3
NK FCGR3Apos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	1.54e-4
NK FCGR3Apos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	1.00e-3
NK FCGR3Apos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	1.17e-4
NK FCGR3Apos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-5	1.47e-2
T cell dividing	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	1.61e-3
T cell dividing	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	2.87e-2
B mature	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	1.67e-2
NK dividing	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	4.14e-3
NK dividing	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	4.65e-2
NK dividing	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	4.53e-2
DC 1	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	3.47e-2
B Hypermutation	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	3.05e-3
DC plasmacytoid	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	5.57e-3
DC plasmacytoid	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	6.36e-4
Plasmablast	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	2.15e-2
CD34 progenitor	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	5.00e-2	3.47e-2
NK CD160pos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	6.36e-4
NK CD160pos	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	4.53e-2
T CD8 CTL	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	2.09e-2
T CD8 CTL	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	5.08e-3
T CD4 naive	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	2.09e-2
T CD8 gd	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-2	2.87e-2
T CD8 gd	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	3.14e-2
T CD8 gd	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	2.72e-2
T CD8 activated	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-3	2.07e-2
Neutrophil	Male Pattern Baldness	Male Pattern Baldness	MTC	Hagenaars	2017	NA	52874	1.00e-4	4.53e-2
T CD8 MAIT	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	9.13e-5
T CD8 MAIT	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	1.71e-3
T CD8 MAIT	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	1.82e-4
T CD8 MAIT	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	1.92e-4
T CD8 MAIT	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	4.09e-4
T CD8 activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	1.34e-3
NK FCGR3Apos	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.17e-3
NK FCGR3Apos	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	3.34e-2
T CD4 fh	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	3.77e-2
B mature	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.76e-5
B mature	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	1.71e-3
B mature	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	6.05e-4
B mature	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	1.92e-4
B mature	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	8.70e-5
T CD8 CTL	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	8.26e-3
T CD8 CTL	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	2.47e-2
T CD8 CTL	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	1.39e-2
T CD8 CTL	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	8.71e-3
T CD8 CTL	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	6.42e-3
T CD4 reg	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	4.82e-4
NK dividing	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.65e-2
NK dividing	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	2.47e-2
DC 2	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.65e-2
DC 2	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	1.87e-3
DC 2	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	2.70e-3
DC 2	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	1.72e-3
Plasma IgM	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.65e-2
Plasma IgM	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	7.08e-3
B Hypermutation	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	2.65e-2
B Hypermutation	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	7.08e-3
DC plasmacytoid	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	3.77e-2
DC plasmacytoid	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	3.34e-2
DC plasmacytoid	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	2.11e-2
Plasmablast	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	1.34e-3
Plasmablast	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	6.12e-5
DC activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	5.00e-2	1.83e-2
DC activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	4.31e-2
DC activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	6.05e-4
DC activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	2.70e-3
DC activated	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	4.09e-4
Macrophage	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	7.08e-3
Macrophage	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	5.32e-3
Macrophage	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	8.71e-3
Macrophage	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	6.42e-3
DC 1	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	3.55e-3
DC 1	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	3.20e-6
DC 1	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	3.24e-7
DC 1	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	6.49e-8
Plasma IgG	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-2	3.55e-3
B naive	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-3	5.32e-3
B naive	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-4	7.56e-4
B naive	MS	Multiple Sclerosis	MTC	Hafler	2007	931	2431	1.00e-5	4.09e-4
NK FCGR3Apos	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	4.51e-2
T CD4 fh	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	2.29e-2
T cell dividing	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.10e-3
T cell dividing	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	3.41e-2
Monocyte	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.10e-3
NK dividing	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.23e-3
NK dividing	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	1.87e-2
DC 2	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.59e-2
DC 1	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.58e-4
B Hypermutation	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.10e-3
DC plasmacytoid	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	2.29e-2
Plasmablast	Neuroticism	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.23e-3
B naive	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	1.21e-2
B naive	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-3	3.37e-3
B naive	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-4	3.77e-3
B naive	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-5	4.08e-2
T cell dividing	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	4.75e-4
B mature	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	1.21e-2
B mature	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-4	6.10e-3
B mature	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-5	9.35e-3
NK dividing	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	2.69e-3
DC 1	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	4.27e-2
B Hypermutation	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	1.21e-2
Plasmablast	Neuroticism	Neuroticism	MTC	Luciano	2017	NA	329821	1.00e-2	4.36e-5
T CD8 MAIT	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	1.72e-2
T cell dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	1.30e-2
T cell dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-2	2.79e-2
Monocyte	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	1.72e-2
NK dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	2.80e-3
NK dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-2	1.32e-2
NK dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-3	5.33e-3
NK dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-4	1.79e-2
NK dividing	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-5	1.95e-3
Macrophage	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	4.72e-2
DC 1	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	2.25e-2
Plasma IgM	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	1.30e-2
Plasma IgG	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	2.91e-2
Plasmablast	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	2.14e-4
Plasmablast	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	1.00e-2	1.94e-2
CD34 progenitor	Neuroticism Symptoms	Neuroticism Symptoms	ETC	Okbay	2016	NA	170911	5.00e-2	2.25e-2
NK CD160pos	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	6.56e-3
NK CD160pos	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	8.83e-3
T cell dividing	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	2.04e-2
NK dividing	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	4.34e-3
NK dividing	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	2.50e-3
T CD8 gd	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	2.04e-2
T CD8 gd	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	4.44e-2
DC 1	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	4.00e-2
B Hypermutation	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	2.89e-2
Plasma IgG	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	1.42e-2
Plasma IgG	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	2.50e-3
Platelet	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	4.34e-3
Plasmablast	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	2.04e-2
Plasmablast	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	1.57e-2
CD34 progenitor	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	5.00e-2	1.42e-2
CD34 progenitor	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-4	3.23e-2
Plasma IgM	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-2	2.50e-3
B naive	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-4	3.23e-2
B mature	Obesity Childhood	Obesity Childhood	MTC	Bradfield	2012	5530	8318	1.00e-4	3.23e-2
T cell dividing	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	2.33e-3
B mature	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	4.46e-2
B mature	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	1.00e-2	1.70e-3
Monocyte	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	4.46e-2
NK dividing	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	5.36e-3
B Hypermutation	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	2.33e-3
DC plasmacytoid	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	3.56e-3
Plasmablast	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	5.00e-2	1.50e-3
B T doublet	Obsessive Compulsive Disorder	Obsessive Compulsive Disorder	ETC	Arnold	2017	2688	7037	1.00e-2	3.83e-2
T CD8 MAIT	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	2.09e-2
T CD8 activated	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	2.09e-2
B naive	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	1.54e-2
B naive	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-2	1.00e-2
B naive	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-3	4.36e-2
T cell dividing	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	3.69e-2
T CD4 reg	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	5.74e-3
Monocyte	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	1.54e-2
Monocyte	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-2	3.85e-2
DC 2	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	1.12e-2
Macrophage	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	1.91e-3
Macrophage	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-2	2.53e-2
Macrophage	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-4	1.55e-2
DC 1	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	2.79e-3
Platelet	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	5.00e-2	2.09e-2
DC plasmacytoid	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-3	2.14e-2
CD34 progenitor	Offspring Birth Weight	Offspring Birth Weight	MTC	Beaumont	2018	NA	68258	1.00e-4	1.55e-2
T CD8 MAIT	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	4.92e-2
T CD8 MAIT	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	3.66e-2
B naive	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	1.81e-3
B naive	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	2.00e-3
Monocyte	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	2.64e-2
Monocyte	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	2.00e-3
Monocyte	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.44e-2
Macrophage	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	1.89e-2
Macrophage	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	3.84e-3
Macrophage	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.21e-4
Macrophage	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-4	8.39e-3
DC plasmacytoid	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	3.63e-2
DC plasmacytoid	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	1.24e-3
DC plasmacytoid	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-4	4.63e-4
DC plasmacytoid	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-5	1.59e-2
CD34 progenitor	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	5.00e-2	2.77e-4
CD34 progenitor	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	3.84e-3
CD34 progenitor	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	8.62e-3
T CD8 activated	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	3.66e-2
B mature	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	2.20e-2
B mature	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.44e-2
DC 2	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-2	3.66e-2
DC 2	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.44e-2
DC 2	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-4	2.11e-3
T CD8 CTL	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.44e-2
Unknown	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-3	4.44e-2
DC activated	Parkinsons	Parkinson's Disease	MTC	Pankratz	2012	4238	4239	1.00e-4	8.39e-3
NK CD160pos	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	3.42e-2
B naive	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	3.42e-2
B naive	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-2	1.01e-2
B mature	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	2.46e-2
T CD8 CTL	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	8.23e-3
T CD8 CTL	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-3	4.81e-2
NK dividing	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	3.65e-3
DC 1	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	2.46e-2
Plasma IgM	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	4.69e-2
Plasma IgG	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	3.65e-3
Plasmablast	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	3.42e-2
CD34 progenitor	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	5.00e-2	1.20e-2
T CD8 activated	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-3	4.81e-2
B T doublet	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-3	4.81e-2
Macrophage	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-3	1.59e-2
T CD8 gd	Partial Epilepsy	Partial Epilepsy	MTC	Kasperaviciute	2010	3445	6935	1.00e-3	1.59e-2
T CD8 MAIT	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	7.12e-7
T CD8 MAIT	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	1.33e-3
T CD8 MAIT	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	8.12e-3
T CD8 MAIT	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	6.17e-3
T CD8 MAIT	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	5.63e-3
T CD8 activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	6.04e-6
T CD8 activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	5.78e-3
B naive	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	2.52e-2
B naive	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	1.33e-3
B naive	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	1.51e-4
B naive	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.13e-4
B naive	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.72e-3
NK FCGR3Apos	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	4.30e-2
NK FCGR3Apos	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	4.40e-2
T CD4 fh	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	8.84e-4
T cell dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	6.00e-9
T cell dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	2.55e-4
T cell dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	6.46e-4
T cell dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.11e-3
T cell dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	1.11e-2
B mature	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	2.59e-4
B mature	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	1.41e-4
B mature	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	3.13e-5
B mature	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	5.60e-5
B mature	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.35e-4
T CD8 CTL	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	2.73e-3
T CD8 CTL	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	3.62e-3
T CD8 CTL	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	2.37e-2
T CD8 CTL	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.74e-2
T CD8 CTL	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.10e-2
T CD4 reg	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	6.87e-5
T CD4 reg	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	2.08e-2
T CD4 reg	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	8.12e-3
T CD4 reg	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	2.14e-2
Monocyte	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.31e-2
NK dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	6.00e-9
NK dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	1.10e-5
NK dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	2.39e-6
NK dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	8.66e-6
NK dividing	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	1.78e-6
B T doublet	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	1.90e-2
DC 2	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	1.89e-3
DC 2	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	2.55e-4
DC 2	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	1.28e-3
DC 2	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	1.17e-2
Macrophage	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	5.45e-3
Macrophage	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	9.05e-3
Macrophage	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	3.84e-2
Macrophage	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	3.79e-2
T CD8 gd	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.31e-2
DC 1	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	1.68e-4
DC 1	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	5.55e-6
DC 1	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	6.46e-4
DC 1	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.11e-3
DC 1	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	1.11e-2
Plasma IgM	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.31e-2
Plasma IgM	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	2.22e-3
Plasma IgM	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	2.37e-2
Plasma IgM	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.11e-3
Plasma IgM	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.72e-3
B Hypermutation	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.31e-2
Plasma IgG	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	7.58e-3
Plasma IgG	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	3.62e-3
Plasma IgG	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	2.44e-3
Plasma IgG	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.13e-4
Plasma IgG	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.35e-4
Plasmablast	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	2.59e-4
Plasmablast	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	1.33e-3
Plasmablast	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	3.17e-4
Plasmablast	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.13e-4
Plasmablast	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	5.55e-4
DC activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.88e-3
DC activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-2	2.55e-4
DC activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-3	2.44e-3
DC activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	3.13e-4
DC activated	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	5.55e-4
CD34 progenitor	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	5.00e-2	3.31e-2
Platelet	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-4	2.14e-2
Platelet	Primary Sclerosing Cholangitis	Primary Sclerosing Cholangitis	MTC	Ji	2017	2871	12019	1.00e-5	2.10e-2
T CD8 MAIT	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	2.92e-2
T CD8 activated	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	2.92e-2
T CD4 fh	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	4.62e-3
B mature	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	2.92e-2
Monocyte	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	2.92e-2
NK dividing	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	4.36e-2
Macrophage	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	5.00e-2	4.36e-2
T cell dividing	Prostate Cancer	Prostate Cancer	MTC	Yeager	2007	1172	1157	1.00e-2	2.79e-2
T CD8 MAIT	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	9.96e-5
T CD8 MAIT	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	3.51e-3
T CD8 MAIT	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	9.13e-3
T CD8 MAIT	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	4.23e-3
NK FCGR3Apos	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	1.38e-3
NK FCGR3Apos	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	3.29e-2
T cell dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	3.34e-7
T cell dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	1.09e-7
T cell dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	4.93e-5
T cell dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	1.90e-3
B mature	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	1.19e-2
B mature	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	2.29e-2
B mature	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	1.26e-2
T CD8 CTL	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	2.94e-2
T CD4 reg	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	3.63e-2
T CD4 reg	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	1.54e-2
NK dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	1.03e-5
NK dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	8.86e-7
NK dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	6.68e-6
NK dividing	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	2.66e-5
DC 2	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	5.60e-3
DC 2	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	1.54e-2
DC 2	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	1.26e-2
DC 2	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	3.29e-2
DC 1	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	3.34e-7
DC 1	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	6.25e-6
DC 1	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	1.25e-4
DC 1	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	2.42e-2
Plasma IgM	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	1.90e-2
Plasma IgM	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	8.77e-3
Plasma IgM	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	1.71e-2
Plasma IgM	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	2.42e-2
B Hypermutation	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	4.81e-5
B Hypermutation	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	1.34e-4
B Hypermutation	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	1.26e-2
B Hypermutation	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	4.40e-2
Plasma IgG	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	2.47e-3
Plasma IgG	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	3.51e-3
Plasma IgG	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	9.13e-3
Plasma IgG	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	1.26e-2
Platelet	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	2.47e-3
Platelet	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	3.51e-3
Platelet	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	2.29e-2
Platelet	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	8.87e-3
DC plasmacytoid	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	2.47e-3
DC plasmacytoid	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	2.96e-4
DC plasmacytoid	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	1.96e-4
DC plasmacytoid	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	2.86e-3
Plasmablast	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	1.27e-6
Plasmablast	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	3.60e-8
Plasmablast	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	4.93e-5
Plasmablast	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	3.27e-4
DC activated	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-2	4.29e-3
DC activated	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-3	1.54e-2
Macrophage	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-4	2.29e-2
Macrophage	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	4.40e-2
B naive	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	4.40e-2
Unknown	Red Blood Cell Distribution Width	Red Blood Cell Distribution Width	MTC	Pilling	2017	NA	116666	1.00e-5	3.29e-2
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	2.20e-5
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.73e-6
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	3.77e-8
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	8.91e-7
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	4.98e-5
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	3.76e-2
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.26e-3
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	5.55e-4
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.43e-2
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	5.72e-4
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	7.62e-6
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	2.62e-6
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	1.88e-4
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	6.52e-3
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	5.92e-5
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	3.99e-4
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	2.49e-4
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.69e-3
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	1.10e-3
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.30e-3
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	2.16e-3
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	9.42e-3
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	4.91e-2
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	5.94e-3
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	1.73e-2
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.14e-2
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	4.97e-2
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	3.63e-5
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.55e-5
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	2.62e-6
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.52e-5
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	4.85e-6
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	5.92e-5
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	3.10e-5
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	3.35e-7
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	1.88e-4
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	2.76e-3
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.50e-6
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.26e-8
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	3.77e-8
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	8.63e-6
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	4.15e-4
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.56e-2
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	5.94e-3
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	9.42e-3
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.56e-2
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.49e-2
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	2.47e-3
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	5.91e-3
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	2.84e-2
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	1.49e-2
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	2.82e-3
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	3.62e-3
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	9.42e-3
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	5.91e-3
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	8.19e-3
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	9.42e-3
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.69e-3
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	1.10e-3
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	2.12e-2
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	7.15e-4
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	4.93e-3
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	4.54e-2
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	1.93e-3
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	7.15e-4
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	2.49e-4
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.52e-5
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	1.59e-5
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	5.00e-2	2.84e-2
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	6.06e-5
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	6.97e-6
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.18e-8
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	2.58e-8
Plasma IgG	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-2	3.41e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-3	3.04e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	2.43e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-5	6.52e-3
DC plasmacytoid	Rheumatoid Arthritis	Rheumatoid Arthritis	ETC	Stahl	2010	5539	20169	1.00e-4	4.54e-2
T CD8 activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	2.67e-3
T CD8 activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	5.56e-3
NK FCGR3Apos	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	9.25e-5
NK FCGR3Apos	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.24e-2
B mature	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	9.25e-3
B mature	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	3.62e-3
B mature	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	1.24e-2
T CD8 CTL	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	1.35e-3
T CD8 CTL	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	2.59e-2
Monocyte	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	2.74e-2
Monocyte	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	3.63e-2
DC 2	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	1.62e-2
DC 2	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	3.28e-4
DC 2	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	2.09e-3
DC 2	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	5.65e-4
DC 2	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	6.59e-6
Macrophage	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	1.35e-3
Macrophage	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.93e-4
Macrophage	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	4.00e-3
Macrophage	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	1.46e-3
Macrophage	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	4.38e-3
T CD8 gd	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	1.23e-2
DC 1	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	9.25e-3
DC 1	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.46e-3
DC 1	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	1.05e-3
DC 1	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	1.77e-2
DC 1	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	1.24e-2
Platelet	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	2.74e-2
Platelet	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.24e-2
DC plasmacytoid	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	3.70e-3
DC plasmacytoid	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	3.62e-3
DC plasmacytoid	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	4.00e-3
DC plasmacytoid	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	1.46e-3
DC plasmacytoid	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	4.17e-4
DC activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	5.00e-2	2.12e-2
DC activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.46e-3
DC activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	2.43e-4
DC activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	2.36e-5
DC activated	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	4.17e-4
B naive	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	2.59e-2
B naive	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	3.60e-2
B naive	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	3.17e-2
T CD4 reg	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	1.81e-2
NK dividing	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-2	8.38e-3
NK dividing	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	1.05e-3
T cell dividing	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	3.77e-2
CD34 progenitor	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	4.00e-3
CD34 progenitor	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-4	1.77e-2
CD34 progenitor	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-5	3.17e-2
Neutrophil	Self Rated Health	Self Rated Health	MTC	Harris	2016	NA	111749	1.00e-3	1.32e-2
T CD8 MAIT	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	2.70e-2
T CD8 MAIT	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	4.81e-2
T cell dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	5.64e-4
T cell dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	1.13e-2
T cell dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	7.28e-4
T cell dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-4	4.37e-2
T cell dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-5	4.56e-3
NK dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	3.57e-8
NK dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	2.54e-4
NK dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	1.26e-7
NK dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-4	1.48e-5
NK dividing	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-5	3.44e-5
Plasma IgM	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	8.78e-3
B Hypermutation	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	3.82e-4
B Hypermutation	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	7.48e-3
B Hypermutation	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	7.28e-4
B Hypermutation	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-4	2.43e-2
B Hypermutation	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-5	2.16e-2
Plasma IgG	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	3.39e-3
Plasma IgG	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	4.81e-2
Plasma IgG	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	2.83e-2
Plasma IgG	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-4	2.43e-2
Plasma IgG	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-5	4.27e-2
DC plasmacytoid	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	3.82e-4
DC plasmacytoid	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	2.42e-2
Plasmablast	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	1.12e-4
Plasmablast	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	2.42e-2
Plasmablast	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	1.68e-2
Plasmablast	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-4	4.37e-2
Plasmablast	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-5	4.27e-2
DC activated	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	5.00e-2	2.42e-3
DC 2	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	3.44e-2
DC 2	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	2.83e-2
Platelet	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-2	3.44e-2
Platelet	Serum Urate	Serum Urate	MTC	Kottgen	2013	NA	110347	1.00e-3	4.60e-2
Monocyte	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	5.00e-2	3.98e-7
Monocyte	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-2	1.66e-3
Monocyte	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-3	1.04e-5
DC 2	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	5.00e-2	8.67e-3
DC 2	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-2	1.71e-2
DC 2	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-3	8.33e-5
Macrophage	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	5.00e-2	1.34e-3
Macrophage	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-2	3.32e-2
Macrophage	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-3	3.26e-3
DC plasmacytoid	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	5.00e-2	3.55e-3
DC plasmacytoid	Sleep Duration BMI Adjusted	Sleep Duration BMI Adjusted	MTC	Marinelli	2016	NA	10554	1.00e-3	3.26e-3
Monocyte	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	5.00e-2	3.55e-6
Monocyte	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-2	4.49e-6
Monocyte	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-3	1.04e-5
Macrophage	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	5.00e-2	3.48e-3
Macrophage	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-2	7.37e-4
Macrophage	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-3	3.26e-3
DC plasmacytoid	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	5.00e-2	3.94e-2
DC plasmacytoid	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-3	3.26e-3
DC 2	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-2	4.03e-3
DC 2	Sleep Duration	Sleep Duration	MTC	Marinelli	2016	NA	10554	1.00e-3	8.33e-5
T cell dividing	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	5.00e-2	1.45e-2
NK dividing	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	5.00e-2	7.44e-3
NK dividing	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-2	4.89e-3
NK dividing	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-3	5.71e-3
NK dividing	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-4	1.96e-3
B Hypermutation	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	5.00e-2	5.23e-3
B Hypermutation	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-2	2.24e-2
T CD4 fh	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-2	3.51e-2
T CD4 fh	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-3	3.25e-2
T CD4 naive	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-2	3.51e-2
ILC	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-2	2.24e-2
ILC	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-3	1.42e-2
ILC	Subjective Well Being	Subjective Well Being	ETC	Okbay	2016	NA	298420	1.00e-4	7.15e-3
T CD4 fh	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	1.30e-2
B mature	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	3.92e-2
T CD4 reg	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	3.64e-3
T CD4 reg	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-2	4.34e-2
T CD4 naive	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	3.92e-2
T CD4 conv	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	1.91e-2
Monocyte	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	5.67e-3
Macrophage	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	1.42e-3
DC 1	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	8.67e-3
Platelet	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	2.30e-3
DC activated	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	5.00e-2	8.63e-4
T CD8 activated	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-2	2.25e-2
T CD8 CTL	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-2	2.25e-2
T CD8 gd	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-2	4.34e-2
DC plasmacytoid	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-2	1.10e-2
B naive	Tetralogy Of Fallot	Tetralogy Of Fallot	MTC	Cordell	2013	835	5159	1.00e-3	2.57e-3
T cell dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	5.90e-4
T cell dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-2	4.82e-3
T cell dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-3	4.05e-2
B mature	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	3.25e-2
Monocyte	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	2.48e-2
NK dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	5.90e-4
NK dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-2	2.90e-3
NK dividing	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-3	5.03e-3
DC 2	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	1.87e-3
B Hypermutation	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	4.21e-2
B Hypermutation	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-2	4.28e-2
B Hypermutation	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-3	4.05e-2
Platelet	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	4.21e-2
DC plasmacytoid	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	5.00e-2	5.37e-3
T CD8 gd	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-2	4.28e-2
CD34 progenitor	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-3	4.05e-2
CD34 progenitor	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-4	1.54e-2
CD34 progenitor	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-5	2.59e-2
Unknown	Tiredness	Tiredness	MTC	Deary	2018	NA	108976	1.00e-4	3.82e-2
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	1.22e-2
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.02e-2
T CD4 reg	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	4.12e-4
DC 2	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	3.99e-2
Macrophage	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	1.07e-4
Macrophage	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	3.97e-4
Macrophage	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	3.01e-2
DC 1	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	8.83e-3
DC 1	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	1.25e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	1.68e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	7.54e-3
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	6.09e-3
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	1.41e-2
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	4.42e-3
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	7.54e-3
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.02e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	8.83e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	4.42e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	6.09e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.39e-3
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	6.32e-4
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	3.97e-4
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	2.48e-3
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.39e-3
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	5.00e-2	2.11e-3
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.02e-2
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-5	1.59e-2
B naive	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-2	3.17e-2
B naive	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	3.01e-2
NK dividing	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-3	3.01e-2
NK dividing	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.39e-3
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes	ETC	Morris	2012	12171	56862	1.00e-4	4.02e-2
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	3.48e-2
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	3.48e-2
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	7.62e-3
NK dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	2.37e-3
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	1.30e-2
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	5.00e-2	2.17e-2
ILC	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	1.00e-2	2.15e-2
DC 1	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	1.00e-2	2.15e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	1.00e-2	2.15e-2
DC activated	Type 2 Diabetes	Type 2 Diabetes	MTC	Wood	2016	4040	113735	1.00e-2	7.24e-3
T CD8 MAIT	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	8.47e-6
T CD8 MAIT	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	9.97e-5
T CD8 MAIT	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	4.81e-3
T CD8 MAIT	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	7.74e-4
NK CD160pos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	4.10e-4
NK CD160pos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	3.39e-3
NK CD160pos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	2.01e-2
T CD8 activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	4.40e-5
T CD8 activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	9.97e-5
T CD8 activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	7.94e-3
T CD8 activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	5.96e-3
NK FCGR3Apos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	2.26e-6
NK FCGR3Apos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	2.14e-5
NK FCGR3Apos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	2.84e-3
NK FCGR3Apos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	7.74e-4
NK FCGR3Apos	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	4.92e-3
T CD4 fh	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	6.73e-3
T CD4 fh	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	7.14e-3
T CD4 fh	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	7.94e-3
T cell dividing	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.89e-2
T cell dividing	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	2.01e-2
B mature	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	2.01e-4
B mature	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	3.39e-3
B mature	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	4.81e-3
B mature	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.58e-3
B mature	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	9.82e-4
T CD8 CTL	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	2.26e-6
T CD8 CTL	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	1.27e-6
T CD8 CTL	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	7.27e-5
T CD8 CTL	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	3.13e-5
T CD8 CTL	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	4.92e-3
T CD4 reg	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.39e-4
T CD4 reg	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	1.52e-3
T CD4 reg	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	1.28e-2
T CD4 reg	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.09e-2
T CD4 conv	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.48e-2
T CD4 conv	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	7.14e-3
Monocyte	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	2.85e-3
Monocyte	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	4.59e-2
Monocyte	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.93e-2
NK dividing	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.48e-2
NK dividing	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	3.62e-2
NK dividing	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	3.08e-2
DC 2	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	4.40e-5
DC 2	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	1.02e-2
DC 2	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	9.20e-4
DC 2	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.30e-5
DC 2	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	6.16e-5
Macrophage	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	3.50e-7
Macrophage	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	3.08e-2
Macrophage	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.67e-4
Macrophage	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	9.82e-4
ILC	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.12e-3
ILC	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	1.28e-2
T CD8 gd	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	2.85e-3
T CD8 gd	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	7.14e-3
T CD8 gd	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	1.28e-2
T CD8 gd	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	3.13e-3
T CD8 gd	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	2.02e-2
DC 1	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.39e-4
DC 1	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	6.47e-4
DC 1	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	4.81e-3
DC 1	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.30e-5
DC 1	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	2.24e-5
DC plasmacytoid	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	6.73e-3
DC plasmacytoid	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	4.80e-2
DC plasmacytoid	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	3.29e-2
DC plasmacytoid	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	3.78e-2
DC activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	1.31e-7
DC activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-2	2.28e-3
DC activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	7.27e-5
DC activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	2.01e-6
DC activated	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	6.16e-5
CD34 progenitor	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	5.00e-2	8.81e-3
CD34 progenitor	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	3.78e-2
B naive	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-3	4.59e-2
B naive	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-4	1.09e-2
B naive	UC	Ulcerative Colitis	MTC	Anderson	2011	6687	19718	1.00e-5	2.02e-2
Monocyte	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	3.75e-3
Monocyte	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-3	2.58e-2
NK dividing	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	2.97e-2
DC 2	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	9.11e-3
DC 2	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-2	2.72e-2
DC 2	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-3	2.58e-2
Macrophage	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	1.38e-2
B Hypermutation	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	2.34e-3
DC plasmacytoid	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	2.34e-3
DC plasmacytoid	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-2	2.72e-2
DC plasmacytoid	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-3	2.58e-2
Neutrophil	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	5.00e-2	4.24e-2
Plasma IgM	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-3	4.92e-3
Plasma IgG	Visual Refractive Error	Visual Refractive Error	MTC	Stambolian	2013	NA	7280	1.00e-3	4.92e-3
T cell dividing	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	1.46e-4
T cell dividing	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	1.11e-3
T cell dividing	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-3	8.32e-3
B mature	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	7.48e-3
B mature	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	4.61e-2
NK dividing	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	1.13e-2
NK dividing	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	8.53e-3
DC 2	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	1.67e-2
DC 2	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-4	3.46e-2
DC 1	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	1.96e-3
B Hypermutation	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	7.48e-3
B Hypermutation	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	1.11e-3
B Hypermutation	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-3	2.05e-2
B Hypermutation	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-4	3.46e-2
Plasmablast	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	7.31e-4
Plasmablast	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	4.49e-3
Plasmablast	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-3	2.05e-2
CD34 progenitor	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	5.00e-2	1.67e-2
B naive	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	4.61e-2
B naive	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-4	3.46e-2
B naive	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-5	2.58e-2
Monocyte	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-2	2.74e-2
Monocyte	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-4	3.46e-2
ILC	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-4	3.46e-2
ILC	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-5	2.58e-2
NK CD160pos	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-5	2.58e-2
T CD8 activated	Vitamin D	Vitamin D	MTC	Manousaki	2017	NA	42274	1.00e-5	2.58e-2
T CD8 MAIT	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	1.46e-3
T CD8 MAIT	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	1.27e-3
B naive	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	3.25e-2
B naive	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-4	2.30e-2
B naive	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-5	3.41e-2
T CD4 fh	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	4.30e-2
T cell dividing	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	1.79e-2
B mature	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	2.43e-2
B mature	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	2.86e-2
B mature	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-5	3.41e-2
ILC	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	1.79e-2
ILC	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	3.99e-3
ILC	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-3	2.16e-2
DC 1	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	1.46e-3
DC 1	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	3.99e-3
DC 1	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-3	4.56e-3
DC 1	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-4	2.30e-2
Plasma IgM	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	6.61e-3
B Hypermutation	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	9.33e-3
Plasma IgG	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	6.61e-3
DC plasmacytoid	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	5.00e-2	6.61e-3
DC plasmacytoid	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-5	3.41e-2
T CD8 activated	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	2.86e-2
T CD8 CTL	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-2	4.37e-2
Macrophage	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-3	4.27e-2
Macrophage	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-5	3.41e-2
DC 2	Waist Hip Ratio Adjusted For BMI	Waist Hip Ratio Adjusted For BMI	MTC	Heid	2010	NA	77167	1.00e-5	3.41e-2
T CD8 MAIT	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	3.09e-2
T CD8 activated	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	9.02e-3
T CD4 fh	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	3.56e-3
B mature	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	4.33e-4
T CD8 CTL	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	4.46e-2
T CD8 CTL	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	1.00e-2	9.85e-3
Monocyte	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	9.02e-3
B T doublet	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	2.09e-2
DC 2	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	3.09e-2
Macrophage	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	1.39e-2
ILC	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	4.46e-2
Neutrophil	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	5.00e-2	4.46e-2
DC activated	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	1.00e-2	4.24e-3
DC activated	Warfarin maintenance dose	Warfarin maintenance dose	MTC	Cooper	2008	NA	181	1.00e-3	4.37e-2
T CD8 MAIT	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	5.00e-2	3.07e-2
T CD8 activated	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	5.00e-2	3.07e-2
T CD4 reg	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	5.00e-2	9.58e-3
T CD4 reg	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	1.00e-2	2.14e-2
Monocyte	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	5.00e-2	9.58e-3
Monocyte	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	1.00e-2	5.03e-3
ILC	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	5.00e-2	3.07e-2
ILC	Albuminuria	Microalbuminuria	MTC	Boger	2011	NA	31580	1.00e-2	4.05e-2
Monocyte	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	3.99e-2
DC 2	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	3.99e-2
DC 1	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	5.82e-3
DC plasmacytoid	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	2.82e-2
DC activated	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	1.46e-3
DC activated	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	1.00e-2	4.54e-2
CD34 progenitor	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	5.00e-2	1.80e-4
T cell dividing	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Boger	2011	NA	31580	1.00e-2	5.68e-4
ILC	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	5.00e-2	2.44e-2
ILC	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-2	3.19e-3
ILC	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-3	8.49e-3
T CD4 reg	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-2	3.11e-2
T CD4 reg	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-3	8.49e-3
DC 1	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-2	3.11e-2
DC 1	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-3	8.49e-3
CD34 progenitor	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-2	7.23e-3
CD34 progenitor	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-3	8.49e-3
Macrophage	Albuminuria	Microalbuminuria	MTC	Teumer	2016	NA	54116	1.00e-3	8.49e-3
T CD4 fh	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	4.93e-2
T cell dividing	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	2.51e-4
B mature	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	4.03e-3
T CD4 reg	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	4.93e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	4.93e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	3.62e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-3	2.26e-4
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-4	3.23e-3
T CD4 conv	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	1.08e-3
T CD4 conv	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	2.96e-3
NK dividing	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	2.62e-2
B T doublet	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	1.86e-2
Macrophage	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	2.64e-3
Macrophage	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	5.91e-3
ILC	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	2.62e-2
DC 1	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	4.93e-2
B Hypermutation	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	2.51e-4
B Hypermutation	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	2.96e-3
Plasmablast	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	1.70e-3
DC activated	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	5.00e-2	8.94e-3
DC activated	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	5.91e-3
B naive	Albuminuria	Urinary Albumin to Creatinine Ratio	MTC	Teumer	2016	NA	54450	1.00e-2	1.13e-2
T cell dividing	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	1.34e-2
Monocyte	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	3.24e-2
DC 2	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	5.00e-3
Macrophage	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	3.24e-2
Plasma IgM	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	4.84e-2
Plasma IgG	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	5.00e-2	3.24e-2
NK CD160pos	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	1.00e-2	2.46e-2
B mature	Albuminuria	Urinary Albumin to Creatinine Ratio In Diabetics	MTC	Teumer	2016	NA	5825	1.00e-2	2.46e-2
B mature	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	2.35e-2
T CD4 reg	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	3.29e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	3.29e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	4.60e-2
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-3	3.15e-3
T CD4 naive	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-4	3.87e-2
T CD4 conv	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	1.65e-2
T CD4 conv	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	4.60e-2
T CD4 conv	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-3	3.20e-2
Macrophage	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	2.18e-3
Macrophage	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	4.60e-2
DC 1	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	7.72e-3
B Hypermutation	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	1.14e-2
B Hypermutation	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	8.82e-4
Plasmablast	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	1.14e-2
DC activated	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	5.00e-2	1.38e-3
T cell dividing	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	2.65e-2
ILC	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-2	2.65e-2
T CD8 MAIT	Albuminuria	Urinary Albumin to Creatinine Ratio In Nondiabetics	MTC	Teumer	2016	NA	46051	1.00e-3	3.20e-2
DC 1	Alcohol Consumption	Alcohol Consumption All Continuous	MTC	Schumann	2016	NA	70460	5.00e-2	3.18e-2
Plasma IgM	Alcohol Consumption	Alcohol Consumption All Continuous	MTC	Schumann	2016	NA	70460	5.00e-2	4.30e-2
Platelet	Alcohol Consumption	Alcohol Consumption All Continuous	MTC	Schumann	2016	NA	70460	5.00e-2	3.18e-2
Plasmablast	Alcohol Consumption	Alcohol Consumption All Continuous	MTC	Schumann	2016	NA	70460	5.00e-2	2.31e-2
Monocyte	Alcohol Consumption	Alcohol Consumption All Continuous	MTC	Schumann	2016	NA	70460	1.00e-2	2.66e-2
DC 1	Alcohol Consumption	Alcohol Consumption All Dichotomous	MTC	Schumann	2016	NA	74711	5.00e-2	1.46e-2
DC 1	Alcohol Consumption	Alcohol Consumption All Dichotomous	MTC	Schumann	2016	NA	74711	1.00e-2	1.02e-2
DC plasmacytoid	Alcohol Consumption	Alcohol Consumption All Dichotomous	MTC	Schumann	2016	NA	74711	5.00e-2	4.64e-2
T CD8 MAIT	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	4.84e-2
NK FCGR3Apos	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	4.84e-2
T CD4 fh	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	5.42e-3
T CD4 fh	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	2.13e-2
T CD4 reg	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	1.21e-2
DC 1	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	1.93e-4
DC 1	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	5.92e-3
B Hypermutation	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	4.84e-2
B Hypermutation	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	1.15e-2
Plasma IgG	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	3.51e-2
Plasma IgG	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	5.92e-3
Plasma IgG	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-3	9.87e-4
Plasmablast	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	8.16e-3
Plasmablast	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	1.38e-3
DC activated	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	5.00e-2	2.50e-2
NK dividing	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	2.92e-3
Plasma IgM	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-2	2.13e-2
Plasma IgM	Alcohol Consumption	Alcohol Consumption Men Continuous	MTC	Schumann	2016	NA	27560	1.00e-3	4.47e-3
T cell dividing	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	5.00e-2	1.36e-4
T cell dividing	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	1.00e-2	3.47e-2
NK dividing	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	5.00e-2	9.46e-3
B Hypermutation	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	5.00e-2	3.25e-2
Plasmablast	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	5.00e-2	4.70e-2
T CD8 CTL	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	1.00e-2	3.47e-2
DC activated	Alcohol Consumption	Alcohol Consumption Men Dichotomous	MTC	Schumann	2016	NA	26991	1.00e-2	1.65e-2
T CD8 MAIT	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	3.52e-4
NK CD160pos	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	3.90e-2
T CD8 activated	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	1.34e-2
T CD8 activated	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-2	2.85e-2
T CD8 activated	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-3	2.30e-2
B naive	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	1.94e-2
B naive	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-2	4.96e-2
B naive	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-3	2.30e-2
NK FCGR3Apos	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	1.57e-3
B mature	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	3.90e-3
T CD8 CTL	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	5.90e-4
T CD8 CTL	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-3	2.30e-2
T CD4 conv	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	5.99e-3
DC 1	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	5.00e-2	2.78e-2
T CD4 naive	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-2	2.85e-2
Platelet	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-2	8.13e-3
Platelet	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-3	7.15e-3
T CD4 reg	Alcohol Consumption	Alcohol Consumption Women Continuous	MTC	Schumann	2016	NA	42900	1.00e-3	2.30e-2
Macrophage	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	5.00e-2	1.10e-2
Macrophage	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	1.00e-2	2.76e-2
Macrophage	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	1.00e-3	4.92e-3
ILC	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	5.00e-2	2.39e-2
DC plasmacytoid	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	5.00e-2	4.09e-4
DC plasmacytoid	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	1.00e-2	1.42e-2
Plasmablast	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	5.00e-2	2.39e-2
CD34 progenitor	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	1.00e-2	6.90e-3
T CD8 CTL	Alcohol Consumption	Alcohol Consumption Women Dichotomous	MTC	Schumann	2016	NA	47720	1.00e-3	2.58e-2
T CD8 MAIT	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	8.46e-3
NK CD160pos	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	8.46e-3
T CD8 activated	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	4.85e-2
NK FCGR3Apos	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	2.42e-3
T cell dividing	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	1.24e-2
T cell dividing	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	1.00e-2	3.77e-2
T CD8 CTL	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	1.79e-2
T CD4 conv	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	1.79e-2
Monocyte	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	9.70e-4
NK dividing	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	3.64e-4
NK dividing	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	1.00e-2	3.77e-2
DC 2	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	2.54e-2
Macrophage	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	5.67e-3
ILC	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	2.42e-3
B Hypermutation	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	5.00e-2	8.46e-3
B Hypermutation	Alzheimers Protein Levels	Amyloid Beta 1 42	MTC	Ramirez	2014	NA	363	1.00e-2	1.15e-2
NK FCGR3Apos	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	1.32e-4
T cell dividing	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	4.93e-2
T CD4 reg	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	8.66e-3
T CD4 conv	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	8.66e-3
Monocyte	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	3.60e-2
NK dividing	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	1.27e-2
ILC	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	5.81e-3
T CD8 gd	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	1.27e-2
B Hypermutation	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	4.93e-2
DC plasmacytoid	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	5.00e-2	3.60e-2
DC plasmacytoid	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	1.00e-2	3.95e-2
B mature	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	1.00e-2	3.95e-2
DC 1	Alzheimers Protein Levels	Phosphorylated Tau Position 181	MTC	Ramirez	2014	NA	363	1.00e-2	2.31e-2
Plasmablast	Anthropometric Extremes	Extreme BMI	MTC	Berndt	2013	7962	8106	1.00e-4	4.37e-2
CD34 progenitor	Anthropometric Extremes	Extreme BMI	MTC	Berndt	2013	7962	8106	1.00e-4	1.23e-2
T CD8 MAIT	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	4.30e-2
NK CD160pos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	4.39e-4
NK CD160pos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-2	1.48e-3
NK CD160pos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	5.43e-4
NK CD160pos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-4	4.60e-4
NK CD160pos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-5	2.51e-4
NK FCGR3Apos	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	9.18e-4
T cell dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	3.87e-6
T cell dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-2	1.48e-3
T cell dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	3.49e-2
NK dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	3.83e-5
NK dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-2	3.46e-3
NK dividing	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	1.44e-2
B Hypermutation	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	5.25e-7
B Hypermutation	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-2	3.46e-3
B Hypermutation	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	2.28e-2
B Hypermutation	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-4	4.02e-2
Plasmablast	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	9.96e-6
Plasmablast	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-2	2.21e-2
Plasmablast	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-4	1.36e-2
Plasmablast	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-5	2.87e-2
CD34 progenitor	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	5.00e-2	1.57e-2
CD34 progenitor	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	3.49e-2
Platelet	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-3	2.28e-2
Plasma IgG	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-4	4.02e-2
ILC	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-5	2.87e-2
T CD8 gd	Anthropometric Extremes	Extreme Height	MTC	Berndt	2013	8097	8099	1.00e-5	2.87e-2
B mature	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	3.35e-2
T CD4 reg	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	4.66e-2
DC 2	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	2.37e-2
Macrophage	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	1.12e-2
Macrophage	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	1.00e-3	3.20e-2
DC 1	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	4.90e-3
DC activated	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	1.64e-2
CD34 progenitor	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	5.00e-2	3.16e-3
CD34 progenitor	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	1.00e-2	7.34e-3
T CD8 gd	Anthropometric Extremes	Extreme Waist Hip Ratio	MTC	Berndt	2013	4774	5481	1.00e-3	1.07e-2
T CD8 MAIT	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	5.00e-2	3.08e-2
NK CD160pos	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	5.00e-2	4.01e-2
NK dividing	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	5.00e-2	4.01e-2
Macrophage	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	5.00e-2	4.01e-2
CD34 progenitor	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	5.00e-2	3.08e-2
CD34 progenitor	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	1.00e-2	2.96e-2
T cell dividing	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	1.00e-2	4.28e-2
Platelet	Anthropometric Extremes	Obesity Class 1	MTC	Berndt	2013	32858	65840	1.00e-5	2.30e-2
T cell dividing	Anthropometric Extremes	Obesity Class 2	MTC	Berndt	2013	9889	65840	5.00e-2	3.93e-2
T cell dividing	Anthropometric Extremes	Obesity Class 2	MTC	Berndt	2013	9889	65840	1.00e-3	4.27e-2
NK dividing	Anthropometric Extremes	Obesity Class 2	MTC	Berndt	2013	9889	65840	5.00e-2	2.14e-2
DC plasmacytoid	Anthropometric Extremes	Obesity Class 2	MTC	Berndt	2013	9889	65840	5.00e-2	1.64e-3
CD34 progenitor	Anthropometric Extremes	Obesity Class 2	MTC	Berndt	2013	9889	65840	5.00e-2	5.37e-3
T CD8 MAIT	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	8.49e-3
T CD8 MAIT	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	1.00e-2	4.27e-3
NK FCGR3Apos	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	2.49e-2
NK FCGR3Apos	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	1.00e-2	2.54e-2
T cell dividing	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	4.69e-2
NK dividing	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	3.44e-2
DC 2	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	3.44e-2
ILC	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	4.69e-2
DC 1	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	2.49e-2
B Hypermutation	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	5.00e-2	1.23e-2
T CD8 CTL	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	1.00e-2	2.54e-2
T CD4 reg	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	1.00e-2	4.27e-2
Platelet	Anthropometric Extremes	Obesity Class 3	MTC	Berndt	2013	2896	65840	1.00e-3	2.96e-2
T CD4 fh	Anthropometric Extremes	Overweight	MTC	Berndt	2013	93015	65840	5.00e-2	3.56e-2
T cell dividing	Anthropometric Extremes	Overweight	MTC	Berndt	2013	93015	65840	5.00e-2	4.68e-2
T CD4 reg	Anthropometric Extremes	Overweight	MTC	Berndt	2013	93015	65840	5.00e-2	3.56e-2
Macrophage	Anthropometric Extremes	Overweight	MTC	Berndt	2013	93015	65840	5.00e-2	1.05e-2
Macrophage	Anthropometric Extremes	Overweight	MTC	Berndt	2013	93015	65840	1.00e-2	7.28e-3
B Hypermutation	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	5.00e-2	9.55e-3
B Hypermutation	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-2	3.01e-2
Plasmablast	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	5.00e-2	6.48e-3
T cell dividing	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-2	3.01e-2
T cell dividing	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-3	1.49e-2
T CD4 fh	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-3	3.54e-2
Macrophage	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-3	3.54e-2
Macrophage	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-4	3.16e-2
B naive	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-4	3.16e-2
B mature	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-4	3.16e-2
CD34 progenitor	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-4	9.41e-3
CD34 progenitor	Anthropometrics Sex Stratified	Body Mass Index Men	MTC	Randall	2013	60586	60856	1.00e-5	3.88e-3
NK FCGR3Apos	Anthropometrics Sex Stratified	Body Mass Index Women	MTC	Randall	2013	NA	73137	5.00e-2	3.61e-2
B mature	Anthropometrics Sex Stratified	Body Mass Index Women	MTC	Randall	2013	NA	73137	5.00e-2	1.04e-3
B mature	Anthropometrics Sex Stratified	Body Mass Index Women	MTC	Randall	2013	NA	73137	1.00e-2	4.19e-2
Plasmablast	Anthropometrics Sex Stratified	Body Mass Index Women	MTC	Randall	2013	NA	73137	5.00e-2	4.93e-2
CD34 progenitor	Anthropometrics Sex Stratified	Body Mass Index Women	MTC	Randall	2013	NA	73137	5.00e-2	3.61e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	3.41e-2
T cell dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	8.42e-7
T cell dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	8.68e-6
T cell dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-3	1.45e-2
T cell dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-4	2.65e-2
NK dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	1.84e-3
NK dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	2.55e-4
NK dividing	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-4	1.46e-2
Plasma IgM	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	2.58e-3
Plasma IgM	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	4.23e-3
B Hypermutation	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	1.53e-5
B Hypermutation	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	8.80e-5
B Hypermutation	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-3	3.69e-2
Plasma IgG	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	1.33e-4
Plasma IgG	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	1.12e-3
Plasmablast	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	5.00e-2	9.68e-6
Plasmablast	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	1.58e-5
Plasmablast	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-3	1.45e-2
Plasmablast	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-4	7.73e-3
DC 1	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-2	3.87e-2
NK CD160pos	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-3	2.35e-2
NK CD160pos	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-4	1.46e-2
NK CD160pos	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-5	1.16e-3
CD34 progenitor	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-4	1.46e-2
CD34 progenitor	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-5	2.85e-2
Platelet	Anthropometrics Sex Stratified	Height Men	MTC	Randall	2013	NA	60856	1.00e-5	2.85e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	2.16e-2
T cell dividing	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	2.56e-4
NK dividing	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	2.14e-3
NK dividing	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	7.26e-3
Plasma IgM	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	7.71e-4
Plasma IgM	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	3.34e-3
Plasma IgM	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-3	3.76e-2
Plasma IgM	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-5	4.38e-2
B Hypermutation	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	2.26e-6
B Hypermutation	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	1.45e-3
B Hypermutation	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-3	2.46e-2
B Hypermutation	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-4	2.46e-2
Plasma IgG	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	1.17e-4
Plasma IgG	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	3.34e-3
Plasma IgG	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-3	3.76e-2
Plasma IgG	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-5	2.39e-2
DC plasmacytoid	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	1.28e-2
Plasmablast	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	5.00e-2	5.19e-5
Plasmablast	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	2.30e-4
Plasmablast	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-3	3.76e-2
Plasmablast	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-5	4.38e-2
NK CD160pos	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	1.49e-2
NK CD160pos	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-3	5.90e-3
NK CD160pos	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-4	1.02e-3
NK CD160pos	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-5	1.23e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-2	3.89e-2
ILC	Anthropometrics Sex Stratified	Height Women	MTC	Randall	2013	NA	73137	1.00e-4	4.14e-2
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	5.00e-2	1.58e-2
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	1.00e-2	3.21e-3
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	5.00e-2	1.10e-2
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	1.00e-2	3.21e-3
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	1.00e-2	1.86e-2
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	1.00e-3	3.34e-2
Neutrophil	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	34942	1.00e-4	1.51e-3
T CD8 MAIT	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	2.62e-2
NK CD160pos	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	2.97e-3
NK CD160pos	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	4.03e-3
NK CD160pos	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	3.78e-4
NK CD160pos	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-4	8.33e-5
B naive	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	1.35e-2
NK dividing	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	1.96e-3
NK dividing	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	5.60e-4
NK dividing	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	1.17e-3
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	4.43e-3
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	5.60e-4
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	8.93e-3
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-4	1.56e-2
B Hypermutation	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	2.97e-3
B Hypermutation	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	4.89e-2
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	2.97e-3
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	4.03e-3
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	2.18e-2
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	5.00e-2	9.44e-3
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	2.15e-3
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	2.18e-2
T cell dividing	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-2	1.28e-2
T cell dividing	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	3.36e-3
Platelet	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-3	8.93e-3
ILC	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-4	1.56e-2
T CD8 gd	Anthropometrics Sex Stratified	Hip Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	43316	1.00e-4	5.68e-4
T CD8 MAIT	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	3.85e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-2	5.62e-3
NK FCGR3Apos	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	3.85e-2
Monocyte	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	9.16e-3
DC 1	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	6.12e-3
DC 1	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-2	3.36e-2
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	1.95e-2
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-2	5.62e-3
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-3	7.24e-3
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	1.65e-3
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-2	2.85e-3
CD34 progenitor	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	5.00e-2	1.35e-2
T CD4 reg	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-2	5.62e-3
Macrophage	Anthropometrics Sex Stratified	Hip Circumference Men	MTC	Randall	2013	NA	34942	1.00e-3	2.15e-2
B naive	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	5.91e-3
B naive	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	1.00e-2	2.46e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	2.57e-3
T CD4 fh	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	3.56e-2
B mature	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	5.91e-3
B mature	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	1.00e-2	4.14e-2
NK dividing	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	8.74e-3
NK dividing	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	1.00e-2	2.46e-2
Plasma IgM	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	3.56e-2
B Hypermutation	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	3.56e-2
B Hypermutation	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	1.00e-2	4.09e-3
Plasma IgG	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	2.57e-2
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	5.00e-2	6.54e-4
Plasmablast	Anthropometrics Sex Stratified	Hip Circumference Women	MTC	Randall	2013	NA	43316	1.00e-2	2.46e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	3.32e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	1.27e-2
NK CD160pos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	1.65e-2
NK CD160pos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	3.42e-3
NK CD160pos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-3	5.45e-4
T CD8 activated	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	5.04e-3
T CD8 activated	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	1.27e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	2.36e-2
T CD8 CTL	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	2.36e-2
NK dividing	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	4.60e-2
Macrophage	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	5.04e-3
T CD8 gd	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	1.65e-2
T CD8 gd	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	2.30e-2
T CD8 gd	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-3	2.42e-3
Plasma IgM	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	4.60e-2
Plasma IgG	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	4.60e-2
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	5.00e-2	4.95e-4
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	4.00e-2
T CD4 reg	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	2.30e-2
ILC	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Men	MTC	Randall	2013	NA	36231	1.00e-2	4.00e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	3.96e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	1.00e-2	3.78e-2
NK CD160pos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	2.10e-2
NK CD160pos	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	1.00e-2	3.78e-2
Plasma IgM	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	7.23e-3
Plasma IgG	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	2.10e-2
DC plasmacytoid	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	1.41e-3
DC plasmacytoid	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	1.00e-2	1.26e-2
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	2.91e-2
DC activated	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	2.10e-2
CD34 progenitor	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	5.00e-2	3.96e-2
T CD4 fh	Anthropometrics Sex Stratified	Waist Circumference Adjusted For BMI Women	MTC	Randall	2013	NA	45192	1.00e-2	3.78e-2
T cell dividing	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	1.02e-4
NK dividing	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	1.02e-4
NK dividing	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	1.00e-2	4.35e-2
B Hypermutation	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	1.83e-4
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	1.56e-3
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	1.00e-2	4.35e-2
CD34 progenitor	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	1.48e-2
CD34 progenitor	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	1.00e-3	9.71e-3
Neutrophil	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	5.00e-2	2.19e-2
Macrophage	Anthropometrics Sex Stratified	Waist Circumference Men	MTC	Randall	2013	NA	36231	1.00e-4	4.37e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	1.59e-2
NK dividing	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	1.08e-2
Plasma IgM	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	3.31e-2
B Hypermutation	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	2.32e-2
Plasma IgG	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	1.59e-2
Plasmablast	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	5.00e-2	4.08e-4
B mature	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	1.00e-2	3.27e-2
DC 1	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	1.00e-2	3.27e-2
DC 1	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	1.00e-3	8.33e-3
T CD4 fh	Anthropometrics Sex Stratified	Waist Circumference Women	MTC	Randall	2013	NA	45192	1.00e-3	8.33e-3
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.16e-4
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	1.00e-2	2.25e-2
T CD8 activated	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	7.41e-3
B naive	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.14e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	3.66e-2
B mature	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	2.53e-2
T CD8 CTL	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	6.38e-4
T CD4 reg	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	3.66e-2
T CD4 conv	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	3.68e-4
T CD4 conv	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	1.00e-2	2.25e-2
B T doublet	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.72e-2
ILC	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.08e-3
ILC	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	1.00e-2	4.34e-2
DC 1	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.14e-2
Plasma IgM	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	2.53e-2
Plasma IgG	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	1.72e-2
DC plasmacytoid	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	5.00e-2	4.72e-3
T CD4 fh	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Men	MTC	Randall	2013	NA	34629	1.00e-3	1.55e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	4.23e-2
Monocyte	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	7.30e-3
DC 2	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	4.89e-3
Macrophage	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	3.08e-2
ILC	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	4.23e-2
DC 1	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	2.09e-3
CD34 progenitor	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	5.00e-2	2.20e-2
B naive	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	1.00e-3	3.05e-3
B naive	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	1.00e-4	1.56e-2
Unknown	Anthropometrics Sex Stratified	Waist Hip Ratio Adjusted For BMI Women	MTC	Randall	2013	NA	42969	1.00e-4	1.56e-2
B naive	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	7.25e-3
T cell dividing	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	1.18e-4
B mature	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	4.63e-3
NK dividing	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	6.37e-4
DC 1	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	4.63e-3
DC 1	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	1.00e-2	3.60e-2
B Hypermutation	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	6.37e-4
DC plasmacytoid	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	3.54e-2
Plasmablast	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	7.25e-3
CD34 progenitor	Anthropometrics Sex Stratified	Waist Hip Ratio Men	MTC	Randall	2013	NA	34629	5.00e-2	2.46e-2
NK dividing	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	5.00e-2	1.92e-2
DC 2	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	5.00e-2	5.84e-3
Macrophage	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	5.00e-2	1.92e-2
DC 1	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	5.00e-2	1.94e-4
B Hypermutation	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	5.00e-2	8.85e-3
T CD4 reg	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	1.00e-2	1.92e-2
B naive	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	1.00e-3	1.54e-2
T CD4 fh	Anthropometrics Sex Stratified	Waist Hip Ratio Women	MTC	Randall	2013	NA	42969	1.00e-3	4.32e-2
T cell dividing	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	1.33e-5
T cell dividing	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	2.02e-2
T cell dividing	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-3	3.43e-3
T cell dividing	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-4	3.17e-2
Monocyte	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	2.39e-2
NK dividing	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	4.24e-2
ILC	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	4.24e-2
B Hypermutation	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	3.74e-5
B Hypermutation	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	3.09e-4
B Hypermutation	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-3	2.62e-2
Plasmablast	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	4.00e-4
Plasmablast	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	5.66e-4
Plasmablast	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-3	2.62e-2
CD34 progenitor	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	5.00e-2	1.76e-2
CD34 progenitor	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	1.30e-2
CD34 progenitor	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-4	1.24e-2
CD34 progenitor	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-5	1.55e-2
DC 1	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	2.02e-2
Unknown	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-2	3.05e-2
NK CD160pos	Anthropometrics Sex Stratified	Weight Men	MTC	Randall	2013	NA	60856	1.00e-3	2.62e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	2.15e-2
T CD8 MAIT	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	4.20e-2
NK CD160pos	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	7.36e-4
NK CD160pos	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	1.14e-2
NK FCGR3Apos	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	5.51e-3
NK FCGR3Apos	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	1.42e-3
T cell dividing	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	5.51e-3
T CD8 gd	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	2.92e-2
DC 1	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	2.15e-2
B Hypermutation	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	3.92e-2
B Hypermutation	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	2.79e-2
DC plasmacytoid	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	1.56e-2
DC plasmacytoid	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	4.20e-2
Plasmablast	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	5.51e-3
CD34 progenitor	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	5.00e-2	2.15e-2
B naive	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	4.20e-2
T CD8 CTL	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-2	2.79e-2
NK dividing	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-4	4.30e-2
Plasma IgG	Anthropometrics Sex Stratified	Weight Women	MTC	Randall	2013	NA	73137	1.00e-5	2.38e-2
B naive	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	5.00e-2	5.71e-3
T cell dividing	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	5.00e-2	2.94e-2
B mature	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	5.00e-2	3.61e-3
NK FCGR3Apos	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	1.00e-3	4.37e-2
Monocyte	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	1.00e-3	4.37e-2
DC plasmacytoid	Anxiety	Anxiety Continuous	ETC	Otowa	2016	NA	18186	1.00e-3	4.37e-2
NK CD160pos	Anxiety	Anxiety Dichotomous	MTC	Otowa	2016	7016	14745	5.00e-2	4.00e-3
T cell dividing	Anxiety	Anxiety Dichotomous	MTC	Otowa	2016	7016	14745	5.00e-2	1.53e-2
T CD8 gd	Anxiety	Anxiety Dichotomous	MTC	Otowa	2016	7016	14745	5.00e-2	4.00e-3
Plasmablast	Anxiety	Anxiety Dichotomous	MTC	Otowa	2016	7016	14745	5.00e-2	2.30e-2
B mature	Anxiety	Anxiety Dichotomous	MTC	Otowa	2016	7016	14745	1.00e-3	2.98e-2
T cell dividing	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	7.12e-5
T cell dividing	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	7.64e-3
T cell dividing	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	2.30e-2
T CD4 reg	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	3.89e-2
T CD4 reg	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	7.64e-3
T CD4 reg	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	5.36e-3
T CD4 naive	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	3.89e-2
T CD4 naive	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.25e-2
T CD4 conv	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	1.84e-2
T CD4 conv	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	7.64e-3
NK dividing	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	8.01e-3
NK dividing	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	2.30e-2
Plasma IgM	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	3.89e-2
Plasma IgM	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	7.64e-3
B Hypermutation	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	1.23e-2
B Hypermutation	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.25e-2
Plasmablast	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	3.22e-3
Plasmablast	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.39e-3
DC activated	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	5.00e-2	1.84e-2
DC activated	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.39e-3
T CD8 MAIT	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.25e-2
T CD8 MAIT	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	1.05e-3
T CD8 activated	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.25e-2
T CD8 activated	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	2.30e-2
T CD8 CTL	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.39e-3
B T doublet	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	7.64e-3
T CD8 gd	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.25e-2
Plasma IgG	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-2	3.39e-3
NK FCGR3Apos	Aortic Valve Calcification	Aortic Valve Calcification	MTC	Thanassoulis	2013	NA	6942	1.00e-3	2.30e-2
NK CD160pos	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	3.54e-2
NK FCGR3Apos	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	2.46e-2
T cell dividing	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	4.63e-3
T cell dividing	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	1.00e-3	1.38e-2
T CD8 CTL	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	3.54e-2
T CD4 reg	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	1.67e-2
Monocyte	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	1.08e-3
NK dividing	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	6.37e-4
NK dividing	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	1.00e-3	4.80e-2
Macrophage	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	4.63e-3
B Hypermutation	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	2.46e-2
B Hypermutation	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	1.00e-3	4.80e-2
Plasmablast	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	6.37e-4
Plasmablast	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	1.00e-3	4.80e-2
CD34 progenitor	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	5.00e-2	2.46e-2
ILC	Aortic Valve Calcification	Mitral Annular Calcification	MTC	Thanassoulis	2013	NA	3795	1.00e-2	2.46e-2
Monocyte	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	5.00e-2	6.48e-3
Macrophage	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	5.00e-2	2.77e-2
B Hypermutation	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	5.00e-2	1.38e-2
Plasmablast	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	5.00e-2	3.82e-2
NK CD160pos	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	1.00e-2	3.04e-2
ILC	Autism	Autism Europeans	ETC	Psychiatric-Genomics-Consortium	2017	6197	7377	1.00e-2	3.04e-2
T CD8 MAIT	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	2.83e-3
T CD8 MAIT	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	2.53e-3
T CD8 MAIT	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	3.92e-2
T CD8 MAIT	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	3.17e-2
T CD8 MAIT	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	3.83e-2
NK CD160pos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.19e-4
NK CD160pos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	1.00e-4
NK CD160pos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	1.30e-2
NK CD160pos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	3.17e-2
T CD8 activated	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	3.99e-2
NK FCGR3Apos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	3.32e-4
NK FCGR3Apos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	1.76e-3
NK FCGR3Apos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	1.91e-2
NK FCGR3Apos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	2.02e-2
NK FCGR3Apos	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	3.83e-2
T cell dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	5.79e-5
T cell dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	2.40e-4
T cell dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	1.91e-2
B mature	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.05e-2
B mature	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	1.78e-2
T CD8 CTL	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.34e-2
T CD8 CTL	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	4.83e-2
T CD4 reg	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	4.86e-2
NK dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	4.61e-4
NK dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	2.53e-3
NK dividing	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	3.64e-3
DC 2	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	6.36e-3
Macrophage	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.86e-5
Macrophage	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	1.32e-2
Macrophage	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	3.17e-2
Macrophage	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	3.83e-2
ILC	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.05e-2
DC 1	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	4.61e-4
Plasma IgM	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	2.83e-3
B Hypermutation	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	2.74e-5
B Hypermutation	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	3.65e-4
B Hypermutation	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	3.64e-3
B Hypermutation	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	2.23e-2
Plasma IgG	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	3.32e-4
Plasma IgG	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	3.11e-2
Plasma IgG	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	3.92e-2
DC plasmacytoid	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	1.34e-2
Plasmablast	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	8.70e-4
Plasmablast	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	2.40e-4
Plasmablast	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	3.02e-4
Plasmablast	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	4.83e-2
Plasmablast	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	3.83e-2
CD34 progenitor	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	5.00e-2	2.12e-2
CD34 progenitor	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-2	1.78e-2
CD34 progenitor	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	2.30e-3
CD34 progenitor	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	4.42e-3
CD34 progenitor	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-5	1.70e-3
B naive	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	2.76e-2
T CD8 gd	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-3	1.30e-2
T CD8 gd	Birth Weight	Birth Weight European	ETC	Horikoshi	2016	NA	133903	1.00e-4	1.40e-3
T CD8 MAIT	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.16e-2
DC 2	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.35e-2
DC 2	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	5.11e-3
DC 2	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	3.41e-2
Macrophage	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.25e-8
Macrophage	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.36e-4
ILC	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.35e-2
DC plasmacytoid	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.16e-2
DC plasmacytoid	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.23e-3
DC plasmacytoid	Blood Cells	Basophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	3.41e-2
T CD8 MAIT	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.86e-3
T CD8 MAIT	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	3.66e-2
NK CD160pos	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	6.59e-3
NK FCGR3Apos	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.44e-4
NK FCGR3Apos	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.02e-2
T CD4 fh	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	6.59e-3
T CD4 fh	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.02e-2
T cell dividing	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.86e-3
T CD8 CTL	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	6.59e-3
T CD8 CTL	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.02e-2
T CD4 reg	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.11e-3
T CD4 naive	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.78e-3
T CD4 conv	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.45e-2
ILC	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.33e-3
T CD8 gd	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.33e-3
DC plasmacytoid	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	6.59e-3
CD34 progenitor	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.02e-2
CD34 progenitor	Blood Cells	Eosinophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	1.92e-2
T CD8 MAIT	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	7.08e-3
B naive	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	4.67e-3
T cell dividing	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	1.54e-2
T cell dividing	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	2.52e-3
T cell dividing	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-3	4.91e-2
B mature	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	7.08e-3
B mature	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	4.07e-2
T CD8 CTL	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	4.67e-3
T CD8 CTL	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	1.12e-2
T CD4 reg	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	7.45e-4
T CD4 reg	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	1.12e-2
Monocyte	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	4.36e-2
DC 2	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	5.00e-2	1.06e-2
T CD8 activated	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	4.07e-2
Macrophage	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	4.07e-2
B Hypermutation	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-2	2.20e-2
B Hypermutation	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-3	4.91e-2
NK CD160pos	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-3	4.91e-2
NK dividing	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-3	4.91e-2
Plasmablast	Blood Cells	Hematocrit	MTC	Ferreira	2009	NA	6015	1.00e-3	4.91e-2
T CD8 MAIT	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.07e-6
T CD8 MAIT	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.85e-3
T CD8 MAIT	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	1.17e-2
NK CD160pos	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.89e-3
T CD8 activated	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.76e-3
T CD8 activated	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
NK FCGR3Apos	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.42e-7
NK FCGR3Apos	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	3.40e-4
T CD8 CTL	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	6.63e-3
T CD8 CTL	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.89e-3
T CD4 reg	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.41e-2
T CD4 reg	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
NK dividing	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.01e-2
NK dividing	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
NK dividing	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	4.58e-3
NK dividing	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-4	1.29e-2
NK dividing	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-5	3.37e-3
Macrophage	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.89e-2
T CD8 gd	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.01e-2
DC 1	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.41e-2
DC 1	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-4	3.73e-2
B Hypermutation	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.41e-2
DC plasmacytoid	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.43e-3
DC plasmacytoid	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
Neutrophil	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.89e-2
B mature	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	2.76e-2
B mature	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-4	1.29e-2
DC activated	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	2.76e-2
DC activated	Blood Cells	Lymphocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-4	3.73e-2
T CD8 MAIT	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.68e-2
NK FCGR3Apos	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.68e-2
NK FCGR3Apos	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	4.50e-2
T cell dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	7.79e-3
T cell dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	7.94e-3
T cell dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-4	2.59e-2
T CD4 reg	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.41e-2
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.15e-3
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	1.38e-2
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	2.43e-3
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-4	1.26e-3
DC 2	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	5.16e-3
DC 2	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	2.55e-2
ILC	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.68e-2
DC 1	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	5.16e-3
DC plasmacytoid	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	1.68e-2
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	3.06e-4
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	7.47e-4
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	6.68e-4
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-4	6.24e-3
DC activated	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.68e-2
DC activated	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	1.38e-2
NK CD160pos	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	4.50e-2
B Hypermutation	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	2.32e-2
Plasma IgG	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	7.94e-3
Platelet	Blood Cells	Mean Corpuscular Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-4	2.59e-2
NK FCGR3Apos	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	1.51e-2
T cell dividing	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	4.58e-2
B mature	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	4.58e-2
Monocyte	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	5.75e-4
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	2.62e-3
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-2	1.87e-2
NK dividing	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-3	8.39e-3
DC 2	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	3.15e-5
DC 2	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-2	1.87e-2
DC 2	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-3	2.89e-2
Macrophage	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	1.51e-2
T CD8 gd	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	4.58e-2
T CD8 gd	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-2	1.87e-2
DC 1	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	1.61e-3
Plasma IgM	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	1.01e-2
B Hypermutation	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	2.23e-2
Plasma IgG	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	3.23e-2
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	6.56e-3
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-2	9.18e-3
Plasmablast	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-3	2.11e-3
CD34 progenitor	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	5.00e-2	2.62e-3
CD34 progenitor	Blood Cells	Mean Corpuscular Hemoglobin Concentration	MTC	Ferreira	2009	NA	6015	1.00e-2	7.88e-4
NK FCGR3Apos	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	1.10e-2
T cell dividing	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	4.24e-2
T cell dividing	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-2	2.56e-2
T cell dividing	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-3	2.28e-3
T CD4 reg	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	4.24e-2
NK dividing	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	1.10e-2
NK dividing	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-3	4.93e-2
Plasma IgG	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	2.23e-2
Plasma IgG	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-2	1.43e-2
Plasma IgG	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-3	1.97e-2
Plasma IgG	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-4	2.30e-2
Plasmablast	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	5.00e-2	3.47e-4
Plasmablast	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-2	4.19e-4
B naive	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-2	1.43e-2
Plasma IgM	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-2	2.56e-2
Plasma IgM	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-3	1.97e-2
Plasma IgM	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-4	5.36e-3
B Hypermutation	Blood Cells	Mean Erythrocyte Cell Volume	MTC	Ferreira	2009	NA	6015	1.00e-3	4.93e-2
T cell dividing	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.57e-3
B mature	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.79e-2
T CD4 reg	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	8.54e-4
NK dividing	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.68e-2
DC 2	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.54e-3
Macrophage	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.74e-4
Macrophage	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	6.48e-3
DC 1	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.12e-4
DC 1	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	7.24e-3
B Hypermutation	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.79e-2
Platelet	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.26e-2
Platelet	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.20e-2
DC plasmacytoid	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.91e-5
DC plasmacytoid	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.20e-2
CD34 progenitor	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	8.45e-3
Neutrophil	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.86e-2
Neutrophil	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.36e-2
T CD8 MAIT	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.36e-2
T CD4 naive	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.20e-2
T CD4 conv	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.20e-2
Monocyte	Blood Cells	Monocyte Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	3.17e-3
B naive	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.84e-3
B naive	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	5.63e-3
T cell dividing	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.84e-3
B mature	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.90e-2
Monocyte	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.43e-3
NK dividing	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.84e-3
NK dividing	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	3.79e-2
DC 2	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.53e-3
Macrophage	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.43e-3
DC 1	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.41e-4
DC 1	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.11e-2
B Hypermutation	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.15e-4
DC plasmacytoid	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.72e-2
DC plasmacytoid	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	5.63e-3
DC plasmacytoid	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	2.62e-2
DC activated	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.72e-2
Platelet	Blood Cells	Neutrophil Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.10e-2
T cell dividing	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.30e-2
T cell dividing	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.75e-2
T CD4 reg	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.15e-2
T CD4 reg	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.52e-2
Monocyte	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.27e-3
Monocyte	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.10e-3
DC 2	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.25e-3
DC 2	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.75e-2
Macrophage	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.67e-2
DC 1	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	9.01e-4
B Hypermutation	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.53e-2
B Hypermutation	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.52e-2
DC plasmacytoid	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.53e-2
DC activated	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.38e-4
NK dividing	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.75e-2
Plasmablast	Blood Cells	Platelet Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.75e-2
T CD8 MAIT	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.11e-2
T CD8 MAIT	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	3.46e-2
T CD8 activated	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.59e-2
T CD8 CTL	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.91e-3
T CD4 reg	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.34e-2
DC 2	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.26e-3
DC 2	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.79e-3
DC activated	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.63e-2
NK CD160pos	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.79e-3
DC 1	Blood Cells	Red Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.90e-2
T CD8 MAIT	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.40e-3
T CD8 MAIT	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	3.43e-3
T CD8 activated	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.12e-2
T CD8 activated	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	2.62e-2
B naive	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.40e-3
B naive	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	4.10e-2
B mature	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	1.37e-2
B mature	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	7.08e-3
T CD8 CTL	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
T CD8 CTL	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	3.43e-3
T CD4 reg	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	4.12e-2
T CD4 reg	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	1.40e-2
Monocyte	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.91e-2
NK dividing	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
NK dividing	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	7.08e-3
NK dividing	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	3.58e-3
DC 2	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.91e-2
Macrophage	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	1.48e-3
ILC	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
Plasma IgM	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
Plasma IgG	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
Plasmablast	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	5.00e-2	2.02e-2
Plasmablast	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	4.10e-2
NK CD160pos	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	3.43e-3
NK FCGR3Apos	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	7.08e-3
T cell dividing	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-2	2.62e-2
T cell dividing	Blood Cells	Total Blood Hemoglobin	MTC	Ferreira	2009	NA	6015	1.00e-3	4.10e-2
NK FCGR3Apos	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.56e-2
B mature	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.56e-2
B mature	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.89e-3
B mature	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	2.07e-4
NK dividing	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	8.74e-3
NK dividing	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	5.41e-3
DC 2	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.43e-4
DC 2	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	2.85e-3
Macrophage	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	3.93e-3
Macrophage	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	4.30e-2
DC 1	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	4.89e-5
DC 1	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	6.99e-5
DC 1	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	4.30e-2
B Hypermutation	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.57e-3
B Hypermutation	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.89e-3
Platelet	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	2.57e-2
DC plasmacytoid	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	5.91e-3
DC plasmacytoid	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
DC plasmacytoid	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	6.67e-3
DC activated	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	1.65e-3
DC activated	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.74e-2
CD34 progenitor	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	5.00e-2	8.74e-3
CD34 progenitor	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
T CD8 MAIT	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.89e-3
T cell dividing	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	1.74e-2
Monocyte	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	9.89e-3
ILC	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-2	4.84e-2
B naive	Blood Cells	White Blood Cell Counts	MTC	Ferreira	2009	NA	6015	1.00e-3	6.67e-3
T CD8 MAIT	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	7.14e-3
T CD8 MAIT	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	3.20e-2
T CD8 activated	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	3.04e-2
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	2.63e-3
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	4.53e-3
T cell dividing	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	1.84e-3
T cell dividing	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	4.06e-4
B mature	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	5.96e-4
B mature	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	1.55e-2
Monocyte	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	2.32e-2
NK dividing	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	2.63e-3
NK dividing	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	4.06e-4
DC 2	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	3.04e-2
Macrophage	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	8.78e-4
Macrophage	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	4.30e-5
Macrophage	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-3	3.67e-6
Macrophage	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-4	5.10e-5
Macrophage	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-5	1.20e-5
T CD8 gd	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	3.92e-2
Plasma IgM	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	5.17e-3
Plasma IgM	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	4.48e-2
Plasma IgG	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	9.75e-3
Platelet	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	1.76e-2
Plasmablast	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	1.28e-3
Plasmablast	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	2.25e-2
CD34 progenitor	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	5.00e-2	3.92e-2
B Hypermutation	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-2	2.25e-2
DC activated	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-3	2.94e-3
DC activated	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-4	3.25e-2
DC activated	Blood Lipids	High Density Lipoprotein	ETC	Teslovich	2010	NA	99900	1.00e-5	4.54e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	1.03e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	1.96e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	2.56e-2
B naive	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	5.43e-3
B naive	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	2.59e-3
B naive	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	1.15e-2
B naive	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	4.45e-2
T cell dividing	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	4.15e-4
B mature	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	1.03e-2
B mature	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	2.07e-2
B mature	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	4.45e-2
T CD8 CTL	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	1.39e-2
T CD8 CTL	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	2.07e-2
T CD4 reg	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	3.20e-2
T CD4 reg	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	1.96e-2
NK dividing	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	1.85e-2
DC 2	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	5.43e-3
DC 2	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	6.52e-3
DC 2	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	7.40e-3
DC 2	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-5	2.46e-2
Macrophage	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	6.19e-4
Macrophage	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	4.08e-3
Macrophage	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	9.74e-4
Macrophage	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	3.71e-4
Macrophage	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-5	4.21e-4
T CD8 gd	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	2.75e-3
T CD8 gd	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	9.53e-3
DC 1	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	4.14e-2
DC 1	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	2.07e-2
DC 1	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	3.24e-2
B Hypermutation	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	5.43e-3
DC plasmacytoid	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	2.45e-2
DC plasmacytoid	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	4.08e-3
Plasmablast	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	1.03e-2
Plasmablast	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	1.42e-2
DC activated	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	5.00e-2	3.89e-3
DC activated	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	6.29e-3
DC activated	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-3	1.09e-4
DC activated	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	3.71e-4
DC activated	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-5	1.06e-3
Plasma IgM	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-2	1.42e-2
Monocyte	Blood Lipids	Low Density Lipoprotein	ETC	Teslovich	2010	NA	95454	1.00e-4	4.45e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	4.03e-3
T CD8 MAIT	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	1.12e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	1.18e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	2.44e-3
T CD8 MAIT	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	1.41e-2
T cell dividing	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.08e-3
T cell dividing	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	3.84e-2
Monocyte	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	1.77e-2
Monocyte	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	2.86e-2
DC 2	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	4.03e-3
DC 2	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	2.29e-2
DC 2	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	4.37e-3
DC 2	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	1.41e-2
DC 2	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	7.40e-3
Macrophage	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	4.19e-5
Macrophage	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	5.49e-4
Macrophage	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	8.21e-4
Macrophage	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	1.51e-4
Macrophage	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	1.59e-4
T CD8 gd	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.99e-2
DC 1	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	1.01e-2
DC 1	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	1.86e-2
Plasma IgG	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.99e-2
DC plasmacytoid	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.08e-3
DC plasmacytoid	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	3.19e-2
DC plasmacytoid	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	3.84e-2
Plasmablast	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.99e-2
DC activated	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	5.00e-2	2.31e-2
DC activated	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	1.12e-2
DC activated	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	2.56e-3
DC activated	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	6.46e-4
DC activated	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	1.80e-3
B naive	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	2.20e-3
B naive	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	7.26e-3
B mature	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-2	3.19e-2
B mature	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	1.18e-2
B mature	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	2.37e-2
B mature	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	1.41e-2
T CD8 CTL	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-3	4.29e-2
T CD8 CTL	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	3.84e-2
T CD4 reg	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-4	8.12e-3
T CD4 reg	Blood Lipids	Total Cholesterol	ETC	Teslovich	2010	NA	100184	1.00e-5	1.41e-2
T CD8 MAIT	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	1.78e-3
T CD8 MAIT	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	3.71e-3
T CD8 MAIT	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	2.21e-2
T CD8 MAIT	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-5	7.87e-3
B mature	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	2.36e-2
B mature	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-3	3.86e-2
B mature	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	6.19e-3
Monocyte	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	2.55e-3
Monocyte	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	1.34e-2
DC 2	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	5.10e-3
DC 2	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	2.85e-2
DC 2	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	2.21e-2
Macrophage	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	6.55e-5
Macrophage	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	5.38e-5
Macrophage	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-3	7.12e-4
Macrophage	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	4.97e-5
Macrophage	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-5	7.87e-3
DC 1	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	2.55e-3
DC 1	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	4.05e-2
DC activated	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	5.00e-2	9.74e-3
DC activated	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	1.97e-2
DC activated	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-3	1.38e-3
DC activated	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	3.07e-3
DC activated	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-5	3.18e-2
NK FCGR3Apos	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-2	2.85e-2
T CD4 reg	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-3	3.86e-2
T CD4 reg	Blood Lipids	Triglycerides	ETC	Teslovich	2010	NA	96598	1.00e-4	1.20e-2
T CD8 MAIT	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	5.64e-4
T CD8 MAIT	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.19e-2
T CD8 MAIT	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.56e-2
T CD8 MAIT	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	3.66e-2
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.66e-3
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.30e-3
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.06e-3
NK FCGR3Apos	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	3.66e-2
T cell dividing	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.11e-2
T cell dividing	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.37e-4
B mature	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.16e-4
B mature	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.30e-3
B mature	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	9.59e-3
Monocyte	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.47e-2
NK dividing	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.49e-3
NK dividing	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.16e-3
Macrophage	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.17e-3
Macrophage	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.32e-5
Macrophage	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.75e-6
Macrophage	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	8.25e-6
Macrophage	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.83e-6
Plasma IgM	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.93e-2
Plasma IgM	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.16e-3
Plasma IgG	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.22e-2
Plasma IgG	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.08e-2
Plasmablast	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	6.13e-3
Plasmablast	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	5.48e-4
CD34 progenitor	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.50e-2
Neutrophil	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.10e-2
B Hypermutation	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.04e-2
DC 2	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	3.77e-2
DC activated	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.56e-2
DC activated	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	3.84e-3
DC activated	Blood Lipids	High Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.65e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.17e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	3.42e-2
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	5.27e-3
T CD8 MAIT	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.01e-2
B naive	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.15e-3
B naive	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	4.03e-3
B naive	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.05e-4
B naive	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.74e-2
T cell dividing	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	7.90e-4
T cell dividing	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.31e-2
B mature	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	5.38e-4
B mature	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	9.00e-3
B mature	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.16e-4
B mature	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.37e-3
B mature	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	5.15e-3
T CD8 CTL	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.06e-2
T CD8 CTL	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.31e-2
T CD8 CTL	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	2.99e-2
T CD4 reg	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.06e-2
T CD4 reg	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	4.94e-2
NK dividing	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.06e-2
DC 2	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	6.34e-3
DC 2	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	8.09e-3
DC 2	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	5.27e-3
DC 2	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	3.40e-2
Macrophage	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	6.34e-3
Macrophage	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.31e-2
Macrophage	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.72e-3
Macrophage	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	3.10e-4
Macrophage	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	9.40e-5
T CD8 gd	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.60e-3
T CD8 gd	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.65e-2
DC 1	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.45e-2
DC 1	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	4.94e-2
B Hypermutation	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.30e-3
DC plasmacytoid	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	8.65e-3
DC plasmacytoid	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	4.94e-2
Plasmablast	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.48e-2
DC activated	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.60e-3
DC activated	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.68e-2
DC activated	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	2.12e-4
DC activated	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.40e-4
DC activated	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	2.27e-4
Plasma IgM	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	3.42e-2
Monocyte	Blood Lipids	Low Density Lipoprotein GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	4.94e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.06e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	2.79e-2
T CD8 MAIT	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	6.62e-3
T CD8 MAIT	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	3.94e-3
B naive	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.21e-2
B naive	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.27e-4
B naive	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.91e-3
T cell dividing	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.69e-3
B mature	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.58e-2
B mature	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.90e-3
B mature	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.91e-3
B mature	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.11e-2
B mature	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.28e-2
Monocyte	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.71e-3
Monocyte	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.87e-2
DC 2	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.69e-3
DC 2	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.29e-2
DC 2	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.22e-2
DC 2	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	3.84e-3
DC 2	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	3.94e-3
Macrophage	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.88e-6
Macrophage	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.55e-5
Macrophage	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.06e-3
Macrophage	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	8.38e-5
Macrophage	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	9.74e-6
DC 1	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	9.12e-3
DC 1	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	4.40e-2
DC 1	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.22e-2
DC plasmacytoid	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.65e-2
DC activated	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.38e-2
DC activated	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.42e-2
DC activated	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	3.01e-3
DC activated	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.19e-3
DC activated	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	5.26e-4
Plasma IgM	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.76e-2
Plasma IgG	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.76e-2
T CD4 reg	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.07e-2
T CD4 reg	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.11e-2
T CD4 reg	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	2.18e-2
T CD8 CTL	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	2.86e-2
T CD8 CTL	Blood Lipids	Total Cholesterol GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	2.18e-2
T CD8 MAIT	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.64e-3
T CD8 MAIT	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.79e-3
T CD8 MAIT	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	4.62e-2
T CD8 MAIT	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.93e-2
T CD8 MAIT	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	2.94e-2
NK FCGR3Apos	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	3.77e-2
NK FCGR3Apos	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.84e-3
T cell dividing	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	2.25e-2
T cell dividing	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	4.34e-2
B mature	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	7.04e-3
B mature	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.06e-2
B mature	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.59e-2
NK dividing	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	8.98e-4
Macrophage	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	1.86e-3
Macrophage	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.11e-3
Macrophage	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	8.23e-5
Macrophage	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	5.45e-5
Macrophage	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	2.20e-5
DC 1	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	9.56e-3
DC 1	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.50e-2
B Hypermutation	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.81e-2
DC activated	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	5.00e-2	4.81e-2
DC activated	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	1.02e-2
DC activated	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.21e-3
DC activated	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	6.55e-4
DC activated	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-5	1.87e-3
T CD4 reg	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	4.34e-2
T CD4 reg	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-3	1.89e-2
T CD4 reg	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-4	1.93e-2
Monocyte	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	2.18e-2
DC 2	Blood Lipids	Triglycerides GWAS and Metabochip	MTC	Willer	2013	NA	94595	1.00e-2	3.10e-2
B naive	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	1.62e-3
NK FCGR3Apos	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	4.07e-2
T cell dividing	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	2.52e-4
T cell dividing	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	1.31e-2
T cell dividing	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-3	4.40e-2
T cell dividing	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-4	4.01e-2
B mature	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	2.52e-4
T CD4 reg	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	3.20e-2
B T doublet	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	3.20e-2
DC 2	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	4.07e-2
DC 2	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	2.82e-2
Macrophage	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	1.45e-2
Macrophage	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	8.68e-3
Macrophage	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-3	3.93e-3
Macrophage	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-5	2.73e-2
ILC	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	1.09e-2
ILC	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	2.82e-2
ILC	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-3	1.43e-2
ILC	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-4	1.81e-2
ILC	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-5	2.73e-2
DC 1	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	3.19e-3
DC 1	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	2.81e-4
DC 1	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-3	2.56e-2
DC 1	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-5	8.79e-3
B Hypermutation	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	6.03e-3
Plasmablast	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	5.00e-2	2.29e-3
CD34 progenitor	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-2	4.02e-2
CD34 progenitor	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-3	1.43e-2
CD34 progenitor	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-4	7.54e-3
CD34 progenitor	BMI Age Stratified	BMI Men Age Over 50	MTC	Winkler	2015	NA	90988	1.00e-5	8.79e-3
B mature	BMI Age Stratified	BMI Men Age Under 50	MTC	Winkler	2015	NA	51625	5.00e-2	4.37e-2
Macrophage	BMI Age Stratified	BMI Men Age Under 50	MTC	Winkler	2015	NA	51625	5.00e-2	1.82e-2
Macrophage	BMI Age Stratified	BMI Men Age Under 50	MTC	Winkler	2015	NA	51625	1.00e-2	2.65e-2
Plasma IgM	BMI Age Stratified	BMI Men Age Under 50	MTC	Winkler	2015	NA	51625	1.00e-4	4.45e-2
T CD4 reg	BMI Age Stratified	BMI Women Age Over 50	MTC	Winkler	2015	NA	106622	5.00e-2	4.73e-2
CD34 progenitor	BMI Age Stratified	BMI Women Age Over 50	MTC	Winkler	2015	NA	106622	5.00e-2	9.11e-3
CD34 progenitor	BMI Age Stratified	BMI Women Age Over 50	MTC	Winkler	2015	NA	106622	1.00e-2	3.92e-2
NK FCGR3Apos	BMI Age Stratified	BMI Women Age Over 50	MTC	Winkler	2015	NA	106622	1.00e-2	2.74e-2
Macrophage	BMI Age Stratified	BMI Women Age Over 50	MTC	Winkler	2015	NA	106622	1.00e-5	5.75e-3
T cell dividing	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	2.52e-2
B mature	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	1.91e-2
NK dividing	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	2.52e-2
Macrophage	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	4.04e-3
B Hypermutation	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	5.64e-3
CD34 progenitor	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	5.00e-2	1.91e-2
DC plasmacytoid	BMI Age Stratified	BMI Women Age Under 50	MTC	Winkler	2015	NA	60654	1.00e-2	4.60e-2
NK dividing	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	5.00e-2	5.84e-3
NK dividing	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	1.93e-2
Platelet	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	5.00e-2	2.45e-3
DC plasmacytoid	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	5.00e-2	3.77e-2
DC plasmacytoid	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	3.64e-2
Plasmablast	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	5.00e-2	8.79e-3
T CD8 MAIT	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	1.93e-2
T CD8 activated	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	3.64e-2
T CD8 CTL	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	3.64e-2
T CD8 CTL	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-3	2.89e-2
DC activated	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-2	3.64e-2
T CD4 fh	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-3	2.89e-2
Macrophage	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-3	8.39e-3
T CD8 gd	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Men Under 50	MTC	Winkler	2015	NA	43776	1.00e-3	2.89e-2
T cell dividing	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	5.00e-2	3.76e-2
B mature	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	5.00e-2	1.98e-2
DC 1	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	5.00e-2	9.84e-3
Plasma IgM	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	5.00e-2	2.75e-2
Plasma IgG	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	5.00e-2	1.98e-2
Monocyte	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	1.00e-2	1.32e-2
CD34 progenitor	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	1.00e-2	3.77e-2
DC activated	BMI Age Stratified	Waist Hip Ratio Adjusted For BMI Women Under 50	MTC	Winkler	2015	NA	50526	1.00e-3	1.34e-2
T cell dividing	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	5.19e-4
T cell dividing	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-2	1.72e-2
B mature	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	2.59e-2
NK dividing	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	9.14e-3
NK dividing	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-2	2.37e-2
B Hypermutation	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	1.57e-2
Plasmablast	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	3.61e-4
Plasmablast	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-2	1.22e-2
CD34 progenitor	BMI	BMI European	ETC	Locke	2015	NA	234069	5.00e-2	3.28e-2
CD34 progenitor	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-3	1.46e-3
CD34 progenitor	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-4	1.43e-2
NK FCGR3Apos	BMI	BMI European	ETC	Locke	2015	NA	234069	1.00e-3	2.94e-2
T cell dividing	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	1.53e-2
T cell dividing	BMI	BMI European Men	MTC	Locke	2015	NA	104666	1.00e-2	1.03e-2
DC 1	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	2.67e-2
Plasma IgM	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	2.67e-2
Plasma IgG	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	2.03e-2
Plasmablast	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	2.14e-4
Plasmablast	BMI	BMI European Men	MTC	Locke	2015	NA	104666	1.00e-2	1.03e-2
CD34 progenitor	BMI	BMI European Men	MTC	Locke	2015	NA	104666	5.00e-2	4.46e-2
NK FCGR3Apos	BMI	BMI European Men	MTC	Locke	2015	NA	104666	1.00e-2	4.73e-2
Macrophage	BMI	BMI European Men	MTC	Locke	2015	NA	104666	1.00e-5	2.91e-2
T cell dividing	BMI	BMI European Women	MTC	Locke	2015	NA	132115	5.00e-2	5.40e-4
T cell dividing	BMI	BMI European Women	MTC	Locke	2015	NA	132115	1.00e-2	4.73e-2
B mature	BMI	BMI European Women	MTC	Locke	2015	NA	132115	5.00e-2	2.24e-2
NK dividing	BMI	BMI European Women	MTC	Locke	2015	NA	132115	5.00e-2	9.26e-3
NK dividing	BMI	BMI European Women	MTC	Locke	2015	NA	132115	1.00e-2	3.33e-2
NK dividing	BMI	BMI European Women	MTC	Locke	2015	NA	132115	1.00e-5	3.15e-2
B Hypermutation	BMI	BMI European Women	MTC	Locke	2015	NA	132115	5.00e-2	4.89e-2
Plasmablast	BMI	BMI European Women	MTC	Locke	2015	NA	132115	5.00e-2	4.89e-2
CD34 progenitor	BMI	BMI European Women	MTC	Locke	2015	NA	132115	1.00e-2	9.78e-4
CD34 progenitor	BMI	BMI European Women	MTC	Locke	2015	NA	132115	1.00e-3	1.57e-2
T cell dividing	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	9.55e-4
T cell dividing	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	1.73e-2
T CD4 reg	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	3.29e-2
NK dividing	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.35e-4
B Hypermutation	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	7.78e-3
Plasmablast	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	2.86e-3
Plasmablast	BMI Physical Activity Interaction	BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	1.14e-2
T cell dividing	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	8.70e-3
T cell dividing	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.08e-2
NK dividing	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.66e-2
NK dividing	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.08e-2
B Hypermutation	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	9.86e-4
T CD8 MAIT	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	2.96e-2
T CD8 CTL	BMI Physical Activity Interaction	BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	2.96e-2
T cell dividing	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	6.95e-5
T cell dividing	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	4.09e-2
NK dividing	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.67e-3
CD34 progenitor	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	2.60e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	1.77e-2
B naive	BMI Physical Activity Interaction	BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.60e-2
T cell dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.01e-3
T CD4 reg	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	3.04e-2
NK dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.80e-2
B Hypermutation	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	2.88e-3
Plasmablast	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.44e-3
T CD8 MAIT	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.96e-2
T CD8 MAIT	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.84e-2
T cell dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.10e-3
T cell dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.78e-2
B mature	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.56e-3
T CD4 reg	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.05e-2
Monocyte	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.10e-3
B Hypermutation	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	7.37e-3
Plasmablast	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.05e-2
Plasmablast	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.40e-2
Plasmablast	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.51e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.04e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.30e-2
DC 1	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.84e-2
DC 1	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.30e-2
Macrophage	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-4	1.92e-2
Macrophage	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-5	1.56e-2
T cell dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.92e-4
T cell dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	7.94e-3
NK dividing	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.55e-2
B Hypermutation	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.39e-2
Plasmablast	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.39e-2
B naive	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-3	4.69e-2
Macrophage	BMI Physical Activity Interaction	BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-5	7.46e-3
Macrophage	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	7.63e-3
Macrophage	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-4	2.22e-2
B naive	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	5.90e-3
T cell dividing	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	1.16e-2
B mature	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	1.16e-2
B Hypermutation	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	2.19e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	3.92e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-3	3.46e-2
T CD8 MAIT	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-4	2.22e-2
Neutrophil	BMI Physical Activity Interaction	BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-4	2.22e-2
B naive	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.82e-2
B naive	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.41e-2
T cell dividing	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.73e-2
B mature	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.92e-3
B mature	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	3.85e-3
Monocyte	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.92e-3
Monocyte	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	3.85e-3
NK dividing	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.98e-2
DC 1	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.77e-3
DC 1	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	3.85e-3
B Hypermutation	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.98e-2
CD34 progenitor	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.82e-2
T CD4 naive	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.41e-2
B T doublet	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.10e-2
DC 2	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.10e-2
Plasma IgM	BMI Physical Activity Interaction	BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.10e-2
T cell dividing	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.14e-2
Macrophage	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.10e-2
DC 1	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.14e-2
Plasma IgM	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.10e-2
B mature	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	1.96e-2
B Hypermutation	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.84e-2
DC plasmacytoid	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.84e-2
DC activated	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.84e-2
B naive	BMI Physical Activity Interaction	BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.87e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	1.48e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	5.96e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	2.44e-3
T CD8 activated	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.43e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	2.00e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	2.08e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	3.90e-2
T CD8 CTL	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	8.20e-3
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	2.64e-2
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	2.08e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	1.02e-3
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	9.34e-3
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	6.94e-4
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	6.09e-3
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	2.21e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	1.02e-3
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	5.36e-4
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	1.20e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	1.29e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	1.12e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	4.26e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	3.73e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.67e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-4	1.26e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	1.29e-2
NK FCGR3Apos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	4.26e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	3.00e-2
Monocyte	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	3.73e-2
Neutrophil	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	3.73e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.89e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.93e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.54e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.45e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	6.58e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-4	9.50e-3
B naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.44e-2
B naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.58e-2
B naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.61e-2
NK FCGR3Apos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.38e-2
NK FCGR3Apos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.93e-2
T cell dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.52e-3
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	7.16e-3
Monocyte	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.38e-2
Monocyte	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.20e-2
B T doublet	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.44e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.54e-2
Platelet	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	7.16e-3
Platelet	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.58e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.07e-6
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.37e-3
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.65e-3
T CD4 naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.93e-2
T CD4 naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.61e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	3.01e-2
T CD4 fh	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.62e-2
T CD4 fh	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-4	3.59e-2
T CD8 CTL	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.61e-2
T CD4 conv	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	2.49e-3
T CD4 conv	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-4	3.59e-2
Macrophage	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.61e-2
T CD8 gd	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.62e-2
T CD8 gd	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-4	3.59e-2
DC activated	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	6.58e-3
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.76e-2
Macrophage	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.51e-2
Macrophage	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	4.27e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	8.36e-5
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	7.61e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	2.16e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.07e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	2.94e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.07e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.07e-2
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-5	1.00e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-5	4.37e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-5	4.37e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-5	4.37e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	6.20e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	3.56e-4
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	4.38e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.22e-3
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	8.51e-3
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	5.20e-3
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.91e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	1.81e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	2.71e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.11e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	2.57e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	4.38e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	1.11e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	3.59e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	9.32e-3
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	2.87e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-5	1.44e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	3.17e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	1.37e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	8.58e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	1.53e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	5.20e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-5	1.44e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	1.25e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	8.51e-3
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	2.71e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.63e-3
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	2.86e-3
T cell dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.79e-3
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.63e-3
Macrophage	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.67e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.51e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.72e-2
ILC	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.40e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.76e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.20e-3
Platelet	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	7.93e-4
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.91e-8
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	3.09e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.34e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.79e-3
B naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.72e-2
B naive	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.40e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	2.86e-3
T CD8 activated	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.40e-2
NK FCGR3Apos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.93e-2
T CD8 CTL	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.09e-4
T CD8 gd	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.40e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.54e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.07e-5
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-3	8.66e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	4.93e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.50e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.97e-2
Macrophage	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	4.93e-2
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	4.93e-2
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-5	3.23e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	1.20e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	2.62e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	4.88e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	3.17e-3
B Hypermutation	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	3.77e-2
B Hypermutation	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-3	1.94e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	5.03e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	2.62e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	1.41e-2
T CD8 activated	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	4.88e-2
T CD8 gd	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	1.41e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.79e-2
B mature	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.11e-2
Monocyte	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.79e-2
NK dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.79e-2
NK dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.46e-2
DC 2	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	6.75e-3
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.25e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.79e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.79e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.25e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	7.03e-4
NK CD160pos	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.46e-2
T cell dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.46e-2
T cell dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-3	2.38e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.20e-2
Monocyte	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.18e-2
NK dividing	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.58e-2
DC 1	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.42e-3
B Hypermutation	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.58e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	2.18e-2
Plasmablast	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-3	6.60e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.20e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Circumference Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-3	6.60e-3
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	8.61e-3
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	3.57e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	4.17e-2
NK CD160pos	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	8.61e-3
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.34e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	3.57e-2
DC 2	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.34e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	1.22e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	3.97e-3
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-4	4.09e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	4.45e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	7.67e-4
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	3.43e-4
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	2.04e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-4	1.57e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	2.74e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	5.00e-2	4.88e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-2	1.68e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	9.30e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-4	1.57e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-5	4.45e-2
T CD8 activated	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	4.17e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	2.04e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-3	4.17e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European	MTC	GIANT	2017	NA	234069	1.00e-4	4.09e-2
T cell dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.36e-3
T cell dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.94e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.77e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.98e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.52e-4
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.67e-5
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.77e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.94e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.33e-2
B Hypermutation	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	8.27e-3
B Hypermutation	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.98e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.77e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.94e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.65e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.71e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.78e-3
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.67e-2
NK dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.67e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.13e-3
DC activated	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.94e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.86e-2
T CD8 activated	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.86e-2
B naive	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.86e-2
B naive	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.71e-3
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.64e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.38e-3
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.64e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.11e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	1.59e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.86e-2
DC activated	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.95e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	5.00e-2	5.71e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	6.62e-3
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	4.89e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.47e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-4	2.73e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Active European Women	MTC	GIANT	2017	NA	132115	1.00e-2	4.89e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	3.47e-3
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	6.69e-3
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	2.37e-3
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	3.98e-3
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	4.03e-3
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	2.59e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	5.00e-2	2.92e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	7.18e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	1.79e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-2	2.73e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	4.03e-3
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-5	4.02e-2
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-3	1.79e-2
T CD8 activated	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	2.63e-2
T CD4 conv	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	2.63e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	1.05e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European	MTC	GIANT	2017	NA	234069	1.00e-4	1.05e-2
T cell dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.77e-3
T cell dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.41e-2
T CD8 CTL	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.49e-2
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	8.19e-5
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.70e-6
ILC	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	4.91e-3
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.52e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.02e-3
B Hypermutation	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.52e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	4.77e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.50e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	1.02e-3
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.50e-3
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.14e-2
T CD4 reg	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.46e-2
NK dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.14e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.14e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.14e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	3.83e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Men	MTC	GIANT	2017	NA	104666	1.00e-3	1.45e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.05e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	1.25e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	5.32e-3
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	1.99e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.66e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.53e-2
Plasma IgM	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.13e-2
Plasma IgG	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	7.54e-3
Plasma IgG	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-4	1.13e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.66e-2
Platelet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.09e-2
Plasmablast	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.46e-2
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	5.00e-2	7.72e-4
CD34 progenitor	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-2	3.09e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Adjusted For Physical Activity European Women	MTC	GIANT	2017	NA	132115	1.00e-3	3.53e-2
B mature	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	1.38e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	1.38e-2
DC plasmacytoid	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	4.95e-2
Plasmablast	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	5.52e-3
Neutrophil	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	5.00e-2	2.12e-2
DC 2	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European	MTC	GIANT	2017	NA	234069	1.00e-2	5.12e-3
T CD8 MAIT	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	9.19e-3
Monocyte	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	1.88e-5
DC 2	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.54e-3
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	2.34e-2
B Hypermutation	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	5.54e-3
Plasmablast	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	5.00e-2	3.58e-2
B T doublet	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	4.89e-2
Neutrophil	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Men	MTC	GIANT	2017	NA	104666	1.00e-2	2.28e-2
T cell dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.21e-2
NK dividing	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	3.21e-2
DC 1	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	4.66e-2
Plasmablast	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	5.00e-2	1.42e-2
DC 2	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	1.10e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-2	4.75e-2
Macrophage	BMI Physical Activity Interaction	Waist Hip Ratio Adjusted For BMI Inactive European Women	MTC	GIANT	2017	NA	132115	1.00e-3	4.37e-2
T cell dividing	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	5.00e-2	2.34e-3
T cell dividing	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	1.00e-5	4.84e-2
NK dividing	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	5.00e-2	1.73e-2
NK dividing	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	1.00e-5	2.34e-2
B Hypermutation	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	5.00e-2	1.73e-2
Plasmablast	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	5.00e-2	1.40e-4
NK FCGR3Apos	BMI Smoking Adjusted	BMI Smoking Adjusted European	MTC	GIANT	2017	NA	234069	1.00e-3	1.33e-2
T CD8 MAIT	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.08e-2
T CD4 fh	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.32e-3
T cell dividing	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.32e-3
T cell dividing	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-2	1.28e-2
T CD4 reg	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.79e-3
B Hypermutation	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	3.98e-3
B Hypermutation	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-2	1.28e-2
B Hypermutation	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.53e-2
B Hypermutation	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-5	4.80e-2
Plasmablast	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.62e-2
Plasmablast	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-5	4.80e-2
B naive	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-2	4.59e-2
DC 1	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-2	3.08e-2
CD34 progenitor	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-2	2.01e-2
CD34 progenitor	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-3	1.79e-2
CD34 progenitor	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-5	4.80e-2
NK dividing	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.53e-2
Macrophage	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-4	2.51e-2
Macrophage	BMI Smoking Adjusted	BMI Smoking Adjusted Men European	MTC	GIANT	2017	NA	104666	1.00e-5	1.38e-2
NK dividing	BMI Smoking Adjusted	BMI Smoking Adjusted Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.66e-2
NK dividing	BMI Smoking Adjusted	BMI Smoking Adjusted Women European	MTC	GIANT	2017	NA	132115	1.00e-2	4.76e-2
NK FCGR3Apos	BMI Smoking Adjusted	BMI Smoking Adjusted Women European	MTC	GIANT	2017	NA	132115	1.00e-3	3.64e-2
Macrophage	BMI Smoking Adjusted	BMI Smoking Adjusted Women European	MTC	GIANT	2017	NA	132115	1.00e-5	3.46e-2
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	4.25e-2
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	7.71e-3
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	7.83e-3
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	1.65e-2
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	1.42e-2
B mature	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	1.26e-2
B mature	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	1.11e-2
B mature	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	3.33e-2
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	7.28e-3
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	3.53e-3
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	1.31e-2
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	3.05e-2
B Hypermutation	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	1.26e-2
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	4.25e-2
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	3.33e-2
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	8.53e-3
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	5.96e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	5.46e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	6.17e-4
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	2.22e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	1.31e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	8.53e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	5.96e-3
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	2.12e-2
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	1.98e-3
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	5.96e-3
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	3.83e-4
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	8.48e-4
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	3.15e-3
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	8.28e-4
NK CD160pos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	1.46e-2
NK FCGR3Apos	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	6.10e-3
T cell dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	3.89e-5
T cell dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	2.00e-2
T cell dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	1.46e-2
NK dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	8.36e-3
NK dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	8.89e-3
NK dividing	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	1.46e-2
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.64e-2
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	2.00e-2
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	7.42e-3
B Hypermutation	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.01e-2
B Hypermutation	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	2.00e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.52e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	8.89e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	2.79e-2
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.56e-3
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	2.80e-4
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.16e-4
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	3.15e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	4.16e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	1.46e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	2.73e-2
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	7.42e-3
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	1.06e-2
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-5	2.90e-3
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.61e-3
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	9.32e-3
ILC	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	4.97e-2
DC 1	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	1.65e-2
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.58e-2
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	2.49e-2
Plasma IgM	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	4.14e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.68e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	1.22e-3
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	4.54e-2
Plasmablast	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	4.14e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	9.32e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	2.49e-2
B mature	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	4.97e-2
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	2.49e-2
Plasma IgG	BMI Smoking Adjusted	Waist Circumference Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	2.46e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	2.43e-6
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	1.03e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	4.68e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	3.38e-2
T CD8 activated	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	1.65e-3
T CD8 activated	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	4.73e-2
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	2.69e-2
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	3.38e-2
NK FCGR3Apos	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	1.17e-2
NK FCGR3Apos	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	2.30e-2
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	3.30e-3
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	1.03e-2
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	1.54e-2
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	1.59e-3
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	1.56e-3
T CD8 CTL	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	3.30e-3
T CD8 CTL	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	1.63e-3
T CD4 reg	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	1.56e-2
T CD4 reg	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	3.33e-2
Monocyte	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	3.48e-2
DC 2	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	3.48e-2
DC 2	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	4.78e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	5.00e-2	3.63e-4
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	2.66e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	4.68e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	6.02e-4
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	1.56e-3
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	6.70e-3
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	1.54e-2
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	6.02e-4
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	3.26e-5
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	2.30e-2
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	2.08e-4
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	9.30e-3
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	4.78e-3
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	4.73e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-4	4.17e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-5	1.33e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-2	1.56e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking European	MTC	GIANT	2017	NA	234069	1.00e-3	1.54e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.98e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	4.10e-2
T CD8 activated	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	4.94e-2
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.42e-2
NK FCGR3Apos	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.42e-2
T CD8 CTL	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.73e-2
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	4.94e-2
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	4.10e-2
B Hypermutation	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	4.94e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	2.16e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	4.10e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	5.00e-2	1.42e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	1.81e-4
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	8.74e-3
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.83e-2
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	4.10e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	3.97e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-3	3.83e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-4	4.10e-2
DC activated	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Men European	MTC	GIANT	2017	NA	104666	1.00e-2	1.50e-2
T CD8 MAIT	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	2.63e-3
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	5.22e-3
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	2.32e-2
B naive	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	4.96e-2
NK FCGR3Apos	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	5.22e-3
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	9.91e-3
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	1.85e-2
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	3.25e-4
B mature	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	1.74e-3
DC 2	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.72e-3
DC 2	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	9.09e-3
DC 2	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	4.96e-2
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	1.83e-3
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	1.57e-2
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	4.43e-3
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	1.07e-3
Macrophage	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	4.55e-4
T CD8 gd	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	4.05e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.89e-4
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	2.38e-2
DC 1	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	9.30e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	3.13e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	1.39e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	1.85e-2
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	9.09e-3
DC plasmacytoid	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	1.83e-2
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	5.00e-2	9.91e-3
CD34 progenitor	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	3.50e-2
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-2	3.53e-2
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-3	1.85e-2
ILC	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-4	9.09e-3
B T doublet	BMI Smoking Adjusted	Waist Hip Ratio Adjusted BMI Adjusted Smoking Women European	MTC	GIANT	2017	NA	132115	1.00e-5	4.96e-2
NK dividing	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	4.52e-2
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	2.55e-2
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	3.36e-3
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	1.00e-2	3.25e-2
DC 1	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	1.74e-4
Plasmablast	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	4.52e-2
DC activated	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	5.00e-2	3.42e-2
DC activated	Bone Mineral Density	Femoral Neck Bone Mineral Density All	MTC	Estrada	2012	NA	32961	1.00e-2	4.57e-3
NK CD160pos	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	3.99e-2
Monocyte	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	2.74e-3
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	2.03e-2
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	2.74e-3
DC 1	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	4.23e-3
CD34 progenitor	Bone Mineral Density	Femoral Neck Bone Mineral Density Men	MTC	Estrada	2012	NA	32961	5.00e-2	2.74e-3
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	5.00e-2	1.11e-3
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	1.00e-2	3.29e-2
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	5.00e-2	1.11e-3
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	1.00e-2	1.09e-2
DC 1	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	5.00e-2	4.60e-2
B Hypermutation	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	5.00e-2	3.40e-2
T CD8 MAIT	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	1.00e-2	1.93e-2
DC activated	Bone Mineral Density	Femoral Neck Bone Mineral Density Women	MTC	Estrada	2012	NA	32961	1.00e-2	1.09e-2
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	5.00e-2	2.23e-2
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-2	1.27e-2
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-3	2.11e-2
NK dividing	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	5.00e-2	8.57e-4
NK dividing	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-2	2.00e-2
NK dividing	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-3	1.07e-2
DC 1	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	5.00e-2	1.19e-2
B Hypermutation	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	5.00e-2	1.64e-2
DC activated	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	5.00e-2	1.64e-2
T CD8 MAIT	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-3	3.92e-2
NK FCGR3Apos	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-3	1.07e-2
B mature	Bone Mineral Density	Lumbar Spine Bone Mineral Density All	MTC	Estrada	2012	NA	31800	1.00e-4	2.17e-2
T CD8 MAIT	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	3.22e-3
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	2.09e-3
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	1.00e-2	6.11e-4
NK CD160pos	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	1.00e-3	9.52e-3
T CD8 activated	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	8.37e-4
B mature	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	2.20e-2
T CD8 CTL	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	1.07e-2
T CD8 CTL	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	1.00e-2	3.02e-2
T CD4 reg	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	1.11e-4
T CD4 reg	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	1.00e-3	2.70e-2
Monocyte	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	1.55e-2
T CD8 gd	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	2.20e-2
Plasma IgM	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	2.20e-2
Plasma IgG	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	1.55e-2
CD34 progenitor	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	5.00e-2	1.07e-2
Macrophage	Bone Mineral Density	Lumbar Spine Bone Mineral Density Men	MTC	Estrada	2012	NA	31800	1.00e-3	2.70e-2
NK dividing	Bone Mineral Density	Lumbar Spine Bone Mineral Density Women	MTC	Estrada	2012	NA	31800	5.00e-2	1.90e-2
DC 1	Bone Mineral Density	Lumbar Spine Bone Mineral Density Women	MTC	Estrada	2012	NA	31800	5.00e-2	1.90e-2
DC activated	Bone Mineral Density	Lumbar Spine Bone Mineral Density Women	MTC	Estrada	2012	NA	31800	5.00e-2	3.50e-2
ILC	Bone Mineral Density	Lumbar Spine Bone Mineral Density Women	MTC	Estrada	2012	NA	31800	1.00e-5	1.38e-2
DC 2	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 15 to 30	MTC	Medina-Gomez	2018	NA	4180	5.00e-2	1.30e-3
Macrophage	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 15 to 30	MTC	Medina-Gomez	2018	NA	4180	5.00e-2	1.79e-2
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 15 to 30	MTC	Medina-Gomez	2018	NA	4180	5.00e-2	2.60e-2
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 15 to 30	MTC	Medina-Gomez	2018	NA	4180	1.00e-2	4.85e-2
T CD4 naive	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	3.10e-2
T CD4 naive	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-2	1.86e-2
Monocyte	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	1.10e-2
NK dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	1.25e-4
Macrophage	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	2.21e-3
T CD8 gd	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	3.10e-2
DC 1	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	3.39e-3
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	5.10e-3
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-2	1.59e-3
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-4	3.77e-2
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	9.04e-4
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-2	1.59e-3
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-3	3.74e-2
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-4	1.17e-2
DC plasmacytoid	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	2.13e-9
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	7.36e-5
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	1.00e-2	1.59e-3
DC activated	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	1.43e-3
CD34 progenitor	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 30 to 45	MTC	Medina-Gomez	2018	NA	10062	5.00e-2	7.55e-3
T CD8 MAIT	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	4.91e-3
T CD8 MAIT	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	1.22e-3
NK CD160pos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	4.91e-3
NK CD160pos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	5.68e-3
NK CD160pos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-3	1.16e-2
T CD8 activated	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	1.70e-3
T CD8 activated	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	5.68e-3
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	9.40e-3
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	2.14e-4
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-3	1.16e-2
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-4	2.54e-2
T CD8 CTL	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	6.21e-5
T CD8 CTL	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	3.90e-4
NK dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	3.01e-2
T CD8 gd	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	3.55e-4
T CD8 gd	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	3.48e-3
DC 1	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	5.00e-2	1.28e-2
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	3.23e-2
DC plasmacytoid	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	4.71e-2
DC activated	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 45 to 60	MTC	Medina-Gomez	2018	NA	18805	1.00e-2	2.17e-2
T CD8 MAIT	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	4.66e-2
NK CD160pos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	3.57e-2
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	1.26e-3
T cell dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	3.57e-2
T cell dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	1.00e-3	4.22e-2
Monocyte	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	7.81e-3
NK dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	7.81e-3
ILC	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	2.70e-2
ILC	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	1.00e-2	2.64e-3
DC 1	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	2.70e-2
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	3.63e-4
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	1.00e-2	2.78e-2
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density 60 And More	MTC	Medina-Gomez	2018	NA	22504	5.00e-2	1.86e-3
T CD8 MAIT	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.95e-4
T CD8 MAIT	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-2	1.79e-2
NK CD160pos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	1.84e-3
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	6.96e-4
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-2	3.19e-3
NK FCGR3Apos	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-3	3.50e-2
T CD4 fh	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	1.71e-2
B mature	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
T CD8 CTL	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	2.75e-2
T CD4 naive	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	6.00e-3
T CD4 conv	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
Monocyte	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	3.44e-2
NK dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	1.33e-2
Macrophage	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
ILC	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	6.00e-3
ILC	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-2	2.43e-2
ILC	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-3	3.50e-2
T CD8 gd	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
DC 1	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	7.89e-3
Plasma IgM	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	2.75e-2
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
DC plasmacytoid	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	1.70e-4
DC plasmacytoid	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	1.00e-4	1.88e-2
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	4.28e-2
DC activated	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density All	MTC	Medina-Gomez	2018	NA	56284	5.00e-2	3.63e-5
T cell dividing	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	5.00e-2	4.83e-2
B Hypermutation	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	5.00e-2	1.16e-3
B Hypermutation	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	1.00e-2	3.18e-2
Plasma IgG	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	5.00e-2	1.86e-2
DC plasmacytoid	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	5.00e-2	6.23e-3
Plasmablast	Bone Mineral Density Lifecourse	Total Body Bone Mineral Density Under 15	MTC	Medina-Gomez	2018	NA	11807	5.00e-2	1.31e-2
T cell dividing	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	1.88e-2
B mature	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	2.56e-2
NK dividing	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	1.88e-2
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	1.51e-3
DC 2	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-3	4.69e-2
Macrophage	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	3.43e-2
DC 1	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	2.29e-5
DC 1	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-2	3.25e-2
DC plasmacytoid	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	6.90e-3
DC plasmacytoid	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-2	4.91e-2
DC activated	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	5.00e-2	1.36e-2
NK FCGR3Apos	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-2	2.73e-3
T CD4 reg	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-2	4.91e-2
T CD4 reg	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-3	5.71e-3
T CD4 reg	Bone Mineral Density	Femoral Neck Bone Mineral Density	ETC	Zheng	2015	NA	26320	1.00e-4	3.82e-2
T CD8 MAIT	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	2.66e-6
T CD8 MAIT	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	1.00e-2	2.07e-2
NK CD160pos	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	3.81e-2
T CD8 activated	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	1.88e-2
NK FCGR3Apos	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	3.38e-7
NK FCGR3Apos	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	1.00e-2	1.43e-3
T CD8 CTL	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	1.87e-4
T CD4 conv	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	2.34e-3
T CD8 gd	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	5.00e-2	1.29e-2
Platelet	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	1.00e-2	3.62e-2
CD34 progenitor	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	1.00e-2	1.13e-2
Unknown	Bone Mineral Density	Forearm Bone Mineral Density	ETC	Zheng	2015	NA	6627	1.00e-2	3.62e-2
NK dividing	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	1.91e-2
DC 2	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	3.48e-2
Macrophage	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	9.96e-3
ILC	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	1.54e-3
ILC	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	1.00e-2	2.09e-2
ILC	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	1.00e-4	4.05e-2
DC 1	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	9.96e-3
Plasma IgM	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	2.60e-2
Plasma IgG	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	3.48e-2
Platelet	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	3.48e-2
Plasmablast	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	1.91e-2
DC activated	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	3.48e-2
CD34 progenitor	Bone Mineral Density	Lumbar Spine Bone Mineral Density	MTC	Zheng	2015	NA	23699	5.00e-2	4.60e-2
T CD8 MAIT	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.39e-2
T CD8 MAIT	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	3.53e-2
T CD8 activated	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	6.27e-3
T CD8 activated	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	1.44e-3
T CD8 activated	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	5.42e-3
T CD8 activated	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	8.03e-4
NK FCGR3Apos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	3.57e-2
NK FCGR3Apos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	4.41e-3
NK FCGR3Apos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	1.21e-2
NK FCGR3Apos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	1.57e-2
T cell dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.13e-5
T cell dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	1.59e-5
T cell dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	3.26e-4
T cell dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	6.38e-3
T CD8 CTL	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.07e-2
T CD8 CTL	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	1.44e-3
T CD8 CTL	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	3.51e-2
T CD8 CTL	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	3.93e-3
T CD4 reg	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.39e-2
T CD4 reg	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	6.24e-3
T CD4 reg	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	3.51e-2
NK dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	2.95e-7
NK dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	1.59e-8
NK dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	1.08e-5
NK dividing	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	2.36e-3
B Hypermutation	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.23e-6
B Hypermutation	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	4.22e-4
B Hypermutation	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	8.91e-4
B Hypermutation	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	2.38e-2
DC plasmacytoid	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	1.39e-2
Plasmablast	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	4.74e-3
Plasmablast	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	1.65e-2
Plasmablast	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	1.75e-2
CD34 progenitor	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-2	4.74e-3
CD34 progenitor	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	1.21e-2
NK CD160pos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	4.41e-3
NK CD160pos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	8.16e-3
NK CD160pos	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	1.01e-2
T CD8 gd	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-3	4.41e-3
T CD8 gd	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	2.50e-2
T CD8 gd	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	3.53e-2
Plasma IgG	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-4	4.84e-2
Plasma IgG	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	2.38e-2
Plasma IgM	Breast Cancer	Breast Cancer	MTC	Milne	2017	14135	58126	1.00e-5	2.38e-2
T CD8 MAIT	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	6.29e-3
T CD8 MAIT	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	1.64e-2
T CD8 MAIT	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	1.35e-2
B naive	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	1.76e-2
B naive	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	5.44e-3
B naive	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	1.53e-3
B naive	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-5	3.27e-2
B mature	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	4.77e-3
B mature	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	1.19e-2
B mature	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	2.06e-2
B mature	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	5.52e-3
T CD4 reg	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	1.76e-2
DC 2	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	1.38e-2
ILC	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	3.49e-2
Plasma IgM	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	1.38e-2
Plasma IgM	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	4.47e-2
Plasma IgM	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	2.92e-2
B Hypermutation	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	4.77e-3
Plasma IgG	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	2.23e-2
Plasma IgG	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	3.07e-2
Plasma IgG	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	1.74e-2
Platelet	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	4.77e-3
Platelet	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	3.01e-2
Platelet	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	1.35e-2
Platelet	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	9.96e-3
Platelet	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-5	1.75e-2
DC plasmacytoid	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	8.23e-3
DC plasmacytoid	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	3.99e-2
Plasmablast	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	3.89e-4
Plasmablast	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	2.86e-3
Plasmablast	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	3.34e-3
Plasmablast	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	2.92e-2
DC activated	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	2.80e-2
CD34 progenitor	Cognitive Functions	College	MTC	Davies	2016	NA	111114	5.00e-2	6.28e-5
CD34 progenitor	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-2	3.99e-2
CD34 progenitor	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	2.06e-2
CD34 progenitor	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	4.73e-2
Monocyte	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-3	3.07e-2
Monocyte	Cognitive Functions	College	MTC	Davies	2016	NA	111114	1.00e-4	4.73e-2
NK CD160pos	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	4.67e-2
NK FCGR3Apos	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	4.67e-2
T cell dividing	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	6.84e-4
T cell dividing	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-2	2.69e-2
Macrophage	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	2.64e-2
Macrophage	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-3	1.59e-2
DC 1	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	4.67e-2
Plasma IgM	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	1.95e-2
Plasma IgM	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-2	4.19e-2
Plasma IgG	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	1.95e-2
Plasma IgG	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-2	1.68e-2
DC plasmacytoid	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	3.54e-2
Plasmablast	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	5.02e-3
Plasmablast	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-2	2.69e-2
Plasmablast	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	1.00e-3	3.47e-2
CD34 progenitor	Cognitive Functions	Memory	MTC	Davies	2016	NA	112067	5.00e-2	2.82e-4
T CD8 MAIT	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	4.40e-2
NK FCGR3Apos	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	4.40e-2
T CD8 CTL	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	2.23e-3
T CD4 reg	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	2.64e-2
Monocyte	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	2.64e-2
NK dividing	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	4.40e-2
DC 1	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	1.08e-3
DC 1	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-2	8.95e-4
DC 1	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-3	2.07e-2
DC 1	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	4.05e-2
Plasma IgM	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	8.36e-3
Plasma IgM	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-3	2.07e-2
Plasma IgM	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	1.66e-2
Plasma IgM	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-5	2.89e-2
Plasma IgG	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	3.43e-2
Plasma IgG	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-3	3.79e-2
Plasma IgG	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	1.66e-2
Plasma IgG	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-5	2.89e-2
Plasmablast	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	3.15e-3
Plasmablast	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-2	1.65e-2
Plasmablast	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	1.66e-2
DC activated	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	5.00e-2	1.13e-2
DC activated	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-3	2.07e-2
DC activated	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	1.66e-2
DC activated	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-5	8.39e-3
T cell dividing	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-2	2.49e-2
DC plasmacytoid	Cognitive Functions	Reaction Time	MTC	Davies	2016	NA	111483	1.00e-4	1.66e-2
B naive	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	1.19e-2
T cell dividing	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	1.19e-2
B mature	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	1.68e-3
B mature	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	4.90e-2
B mature	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-4	1.13e-2
Monocyte	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	1.58e-2
Monocyte	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-2	1.92e-2
Monocyte	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	2.10e-3
Monocyte	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-4	1.13e-2
Monocyte	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-5	4.10e-2
NK dividing	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	3.53e-2
Macrophage	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	2.48e-4
Macrophage	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-2	2.10e-3
Macrophage	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	2.10e-3
B Hypermutation	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	3.53e-2
B Hypermutation	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	4.90e-2
Platelet	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	3.53e-2
CD34 progenitor	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	2.73e-2
CD34 progenitor	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	4.30e-3
Neutrophil	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	5.00e-2	2.73e-2
DC 1	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-3	2.10e-3
DC 1	Cognitive Functions	Verbal Numeric Reasoning	MTC	Davies	2016	NA	36035	1.00e-5	4.10e-2
T cell dividing	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	8.32e-4
NK dividing	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	6.46e-3
Macrophage	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	3.88e-4
Macrophage	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	5.54e-5
Macrophage	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	2.27e-3
Macrophage	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-4	9.37e-4
Macrophage	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-5	1.48e-4
Plasma IgM	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	4.42e-2
Plasma IgM	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	4.52e-2
B Hypermutation	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	2.43e-3
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	1.18e-2
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	2.31e-2
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	3.38e-2
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-5	4.66e-2
DC plasmacytoid	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	2.69e-2
DC plasmacytoid	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	1.61e-2
DC plasmacytoid	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	3.38e-2
DC plasmacytoid	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-5	4.66e-2
Plasmablast	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	2.43e-3
Plasmablast	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	7.43e-3
CD34 progenitor	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	6.46e-3
CD34 progenitor	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-5	4.66e-2
Platelet	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	4.91e-3
ILC	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	2.10e-2
DC 2	Coronary Artery Disease	Coronary Artery Disease Additive Model	MTC	Nikpay	2015	42096	99121	1.00e-5	2.15e-2
B naive	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	2.53e-2
B naive	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	4.37e-2
Monocyte	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	3.60e-3
Monocyte	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	2.14e-4
Monocyte	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	4.37e-2
Monocyte	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-4	2.58e-2
Macrophage	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	1.16e-3
Macrophage	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	9.30e-3
Plasmablast	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	5.00e-2	1.61e-2
Plasmablast	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	2.04e-2
Plasma IgM	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	4.17e-2
Plasma IgM	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	4.37e-2
Plasma IgM	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-4	4.92e-3
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-2	9.30e-3
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-3	1.23e-2
Plasma IgG	Coronary Artery Disease	Coronary Artery Disease Recessive Model	MTC	Nikpay	2015	42096	99121	1.00e-4	4.92e-3
NK CD160pos	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	4.92e-2
T CD8 activated	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	3.83e-2
NK dividing	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	2.24e-2
Macrophage	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	7.89e-4
Macrophage	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	7.79e-4
Macrophage	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-3	1.27e-4
Macrophage	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-4	3.37e-6
Macrophage	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-5	9.22e-5
ILC	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	6.73e-3
ILC	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	1.32e-2
DC 1	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	2.95e-2
Plasma IgM	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	1.69e-3
Plasma IgM	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	1.97e-2
B Hypermutation	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	2.24e-2
Plasma IgG	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	3.53e-4
Plasma IgG	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	8.65e-3
Platelet	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	4.92e-2
Platelet	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	2.88e-2
Platelet	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-3	3.62e-2
DC plasmacytoid	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	2.42e-3
DC plasmacytoid	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	3.51e-3
Plasmablast	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	6.23e-5
Plasmablast	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	1.97e-2
CD34 progenitor	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	5.00e-2	3.53e-4
CD34 progenitor	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-2	1.97e-2
CD34 progenitor	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-4	4.66e-2
CD34 progenitor	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-5	1.34e-2
Monocyte	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-4	2.15e-2
Monocyte	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-5	3.58e-2
DC 2	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-4	2.15e-2
DC 2	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-5	3.58e-2
DC activated	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-4	4.66e-2
B naive	Coronary Artery Disease	Myocardial Infarction Additive Model	MTC	Nikpay	2015	27509	99121	1.00e-5	3.58e-2
B Hypermutation	Diarrhoeal Disease	Diarrhea Age 1	MTC	Bustamante	2016	2693	3065	5.00e-2	2.28e-2
NK CD160pos	Diarrhoeal Disease	Diarrhea Age 1	MTC	Bustamante	2016	2693	3065	1.00e-2	4.83e-2
T CD8 CTL	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	5.00e-2	2.91e-2
T CD8 CTL	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	1.00e-2	4.27e-2
DC 2	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	5.00e-2	2.48e-4
DC 1	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	5.00e-2	1.32e-2
DC 1	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	1.00e-2	4.27e-2
CD34 progenitor	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	5.00e-2	1.32e-2
T CD8 MAIT	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	1.00e-3	2.98e-2
T CD8 gd	Diarrhoeal Disease	Diarrhea Age 2	MTC	Bustamante	2016	2855	2753	1.00e-3	2.98e-2
B naive	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	5.00e-2	4.77e-2
B naive	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	1.00e-2	3.18e-2
B mature	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	5.00e-2	2.95e-4
T CD4 reg	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	5.00e-2	2.28e-2
Neutrophil	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	5.00e-2	2.28e-2
B Hypermutation	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 1	MTC	Bustamante	2016	1339	5064	1.00e-2	3.18e-2
T CD8 MAIT	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	2.23e-2
T cell dividing	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	8.65e-4
T cell dividing	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	1.00e-2	4.37e-2
T cell dividing	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	1.00e-3	1.59e-2
T CD8 CTL	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	9.78e-3
T CD8 CTL	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	1.00e-3	4.81e-2
T CD4 reg	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	6.28e-3
NK dividing	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	2.23e-2
DC 1	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	9.78e-3
B Hypermutation	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	5.00e-2	2.43e-3
B Hypermutation	Diarrhoeal Disease	Diarrhea Doctor Diagnosed Age 2	MTC	Bustamante	2016	990	5243	1.00e-2	2.33e-2
T CD8 MAIT	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	3.67e-2
B naive	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	8.85e-3
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	3.67e-2
Monocyte	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	4.53e-5
DC 2	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	2.55e-3
Macrophage	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	1.86e-2
DC 1	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	1.03e-3
DC activated	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	5.00e-2	3.67e-2
Plasma IgG	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-2	4.06e-2
Plasma IgG	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-3	2.96e-2
Plasmablast	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-2	4.06e-2
Plasmablast	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-3	2.96e-2
CD34 progenitor	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-2	4.06e-2
NK CD160pos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-3	2.96e-2
T CD4 reg	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-3	2.96e-2
DC plasmacytoid	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight All	MTC	Chu	2017	NA	7324	1.00e-3	2.96e-2
B naive	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	1.12e-3
B mature	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	6.95e-3
T CD4 reg	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	3.20e-2
T CD4 reg	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	1.00e-3	1.08e-2
Monocyte	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	7.74e-5
DC 2	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	1.05e-2
Macrophage	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	4.48e-2
DC activated	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	3.20e-2
CD34 progenitor	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	5.00e-2	1.82e-3
Plasma IgM	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	1.00e-3	1.08e-2
Plasma IgG	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Men	MTC	Chu	2017	NA	3640	1.00e-3	3.97e-2
T CD8 activated	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	4.92e-2
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	4.92e-2
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	1.00e-2	1.69e-2
T cell dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	2.40e-2
T CD8 CTL	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	1.08e-2
NK dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	2.82e-3
NK dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	1.00e-2	3.35e-3
T CD8 gd	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	1.63e-2
B Hypermutation	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	3.47e-2
Plasmablast	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	5.00e-2	2.40e-2
NK CD160pos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	1.00e-2	1.69e-2
T CD4 reg	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Adjusted For Height Weight Women	MTC	Chu	2017	NA	3684	1.00e-3	2.98e-2
B naive	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	5.00e-2	2.30e-2
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	5.00e-2	3.27e-2
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	4.54e-2
DC 1	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	5.00e-2	4.57e-2
DC 1	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-3	2.90e-2
T CD8 MAIT	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	4.54e-2
NK dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	1.23e-2
B Hypermutation	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	2.43e-2
Plasma IgG	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	4.54e-2
DC activated	Ectopic Fat Traits	Pericardial Adipose Tissue Volume All	MTC	Chu	2017	NA	7324	1.00e-2	4.54e-2
B naive	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	5.00e-2	1.33e-3
B naive	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	1.00e-3	3.97e-2
B mature	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	5.00e-2	8.46e-3
Monocyte	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	5.00e-2	5.48e-3
DC 1	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	5.00e-2	3.48e-3
CD34 progenitor	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Men	MTC	Chu	2017	NA	3640	5.00e-2	1.28e-2
T CD8 activated	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	5.00e-2	3.62e-2
NK FCGR3Apos	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	5.00e-2	1.14e-2
T CD8 CTL	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	5.00e-2	3.62e-2
NK dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	5.00e-2	1.11e-3
NK dividing	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	1.00e-2	1.04e-4
B Hypermutation	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	5.00e-2	2.51e-2
B Hypermutation	Ectopic Fat Traits	Pericardial Adipose Tissue Volume Women	MTC	Chu	2017	NA	3684	1.00e-2	1.55e-2
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	4.08e-2
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	2.80e-4
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	5.63e-3
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	1.67e-4
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	3.79e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-3	2.38e-2
B T doublet	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	2.10e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	2.10e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	5.63e-3
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-3	6.60e-3
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	1.92e-3
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	1.11e-2
T CD8 gd	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	4.08e-2
Plasma IgG	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	2.10e-2
DC activated	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	5.00e-2	4.08e-2
DC activated	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	2.10e-2
NK CD160pos	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	3.79e-2
T CD4 naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14668	1.00e-2	3.79e-2
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	5.00e-2	1.83e-2
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-2	2.43e-2
NK CD160pos	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	5.00e-2	8.41e-3
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	5.00e-2	1.44e-3
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-2	2.43e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	5.00e-2	3.61e-3
T CD4 naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	5.00e-2	1.83e-2
Neutrophil	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-2	4.37e-2
Monocyte	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-3	4.81e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-3	4.57e-3
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-3	4.81e-2
DC plasmacytoid	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-3	1.59e-2
Plasmablast	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7050	1.00e-3	4.81e-2
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	4.23e-3
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-2	1.46e-2
T cell dividing	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	2.87e-2
T cell dividing	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-2	4.85e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	2.74e-3
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-2	3.16e-4
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	3.23e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	9.59e-3
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	3.23e-2
Plasma IgG	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	1.41e-2
DC plasmacytoid	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	9.59e-3
Plasmablast	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	2.87e-2
DC activated	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	5.00e-2	4.23e-3
Unknown	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-2	2.73e-2
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	3.23e-2
T CD8 CTL	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	3.23e-2
T CD4 reg	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	8.30e-3
T CD4 conv	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	1.79e-3
Platelet	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7618	1.00e-3	3.23e-2
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	9.06e-3
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-2	1.34e-2
NK CD160pos	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	1.90e-2
NK CD160pos	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-2	4.53e-2
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	1.32e-2
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-2	6.58e-4
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	2.69e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-2	4.53e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-3	4.80e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	4.03e-3
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	6.54e-4
Plasma IgG	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	1.90e-2
DC activated	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	5.00e-2	1.90e-2
T CD4 naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14668	1.00e-2	6.76e-3
T CD8 MAIT	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	4.19e-2
NK CD160pos	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	2.78e-3
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	2.78e-3
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	1.00e-2	3.66e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	6.68e-4
T CD4 naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	2.11e-2
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	4.19e-2
CD34 progenitor	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	5.00e-2	1.46e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7050	1.00e-3	4.81e-2
B naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	3.29e-3
T cell dividing	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	1.12e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	2.33e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	1.00e-2	1.56e-2
B mature	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	1.00e-3	2.30e-2
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	7.58e-3
DC 2	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	1.00e-2	4.96e-2
Macrophage	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	1.63e-2
DC 1	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	7.58e-3
Plasma IgM	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	3.28e-2
Plasma IgG	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	5.03e-3
DC plasmacytoid	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	1.63e-2
Plasmablast	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	1.12e-2
DC activated	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	8.28e-4
Unknown	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	5.00e-2	2.33e-2
T CD4 naive	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	1.00e-2	4.96e-2
T CD4 conv	Ectopic Fat Traits	Ratio Of Visceral To Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7618	1.00e-3	2.30e-2
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	1.52e-3
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	6.65e-4
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	5.75e-3
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	2.60e-2
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	3.07e-3
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	1.92e-2
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	5.69e-3
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	8.55e-3
T CD4 reg	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	8.55e-3
T CD4 reg	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	1.20e-2
Monocyte	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	5.69e-3
Monocyte	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	1.20e-2
DC 2	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	1.26e-2
DC 2	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	2.21e-2
DC 1	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	9.44e-4
B Hypermutation	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	8.55e-3
DC plasmacytoid	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	1.52e-3
DC plasmacytoid	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	1.51e-3
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	5.78e-4
Neutrophil	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	5.00e-2	1.26e-2
NK FCGR3Apos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	3.90e-2
NK FCGR3Apos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	5.75e-3
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-2	3.07e-3
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	1.92e-2
Plasma IgM	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	1.51e-3
Plasma IgG	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation All	MTC	Chu	2017	NA	11398	1.00e-3	5.75e-3
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	1.14e-3
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	1.81e-4
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	1.30e-4
NK FCGR3Apos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	9.75e-3
T CD4 fh	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	9.75e-3
T CD4 fh	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	1.52e-2
T CD4 fh	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	3.46e-2
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	6.56e-3
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	2.00e-3
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	3.46e-2
T CD4 reg	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	2.04e-2
T CD4 conv	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	2.04e-2
T CD4 conv	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	2.75e-2
T CD4 conv	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	3.46e-2
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	5.00e-2	6.56e-3
T CD4 naive	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	2.00e-3
T CD4 naive	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	1.05e-2
Monocyte	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	4.10e-3
NK dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	4.75e-2
DC 2	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	8.08e-3
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	2.75e-2
Plasmablast	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-2	2.75e-2
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	3.46e-2
ILC	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Men	MTC	Chu	2017	NA	5699	1.00e-3	3.46e-2
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	5.00e-2	4.68e-2
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-2	3.93e-2
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-3	3.88e-3
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	5.00e-2	7.79e-3
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	5.00e-2	4.68e-2
DC 1	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	5.00e-2	5.16e-3
DC 1	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-2	2.15e-2
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	5.00e-2	3.39e-2
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-2	3.93e-2
T CD8 gd	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-2	2.15e-2
T CD8 gd	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-3	1.79e-2
DC plasmacytoid	Ectopic Fat Traits	Subcutaneous Adipose Tissue Attenuation Women	MTC	Chu	2017	NA	5699	1.00e-2	2.15e-2
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	1.76e-3
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	1.00e-2	7.08e-3
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	1.39e-2
B naive	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	2.00e-2
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	1.39e-2
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	1.00e-2	4.31e-2
B mature	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	2.83e-2
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	2.83e-2
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	1.00e-2	2.47e-2
ILC	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	2.00e-2
ILC	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	1.00e-2	2.47e-2
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	5.00e-2	1.76e-3
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume All	MTC	Chu	2017	NA	14780	1.00e-3	2.62e-2
T CD8 MAIT	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	2.11e-3
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	2.60e-2
T CD8 activated	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	3.70e-2
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	8.80e-5
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	1.79e-2
NK dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	8.06e-3
DC 2	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	3.70e-2
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	1.79e-2
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	5.00e-2	7.86e-4
Plasma IgM	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	1.00e-2	1.78e-3
Plasma IgG	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	1.00e-2	3.98e-3
Plasmablast	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	1.00e-2	3.24e-2
B mature	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Men	MTC	Chu	2017	NA	7381	1.00e-3	4.58e-3
NK CD160pos	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	2.98e-2
T CD8 CTL	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	2.98e-2
T CD4 reg	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	6.45e-3
Macrophage	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	2.09e-2
DC 1	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	4.18e-2
B Hypermutation	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	4.18e-2
CD34 progenitor	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	5.00e-2	1.69e-3
T cell dividing	Ectopic Fat Traits	Subcutaneous Adipose Tissue Volume Women	MTC	Chu	2017	NA	7399	1.00e-3	2.38e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	3.06e-2
Monocyte	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	1.11e-2
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	9.38e-6
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	5.26e-3
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	2.33e-3
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	1.00e-2	2.42e-2
DC plasmacytoid	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	1.59e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	5.00e-2	1.52e-3
NK FCGR3Apos	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation All	MTC	Chu	2017	NA	11478	1.00e-2	4.00e-2
T CD8 MAIT	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	3.08e-2
T CD8 MAIT	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	1.00e-2	4.85e-2
NK CD160pos	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	3.08e-2
T CD4 reg	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	2.18e-2
T CD4 reg	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	1.00e-2	2.73e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	4.28e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	1.00e-2	2.73e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	1.51e-2
Platelet	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	1.51e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	5.00e-2	2.77e-5
DC plasmacytoid	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Men	MTC	Chu	2017	NA	5749	1.00e-2	3.61e-3
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	4.31e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	1.37e-3
Monocyte	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	5.33e-4
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	1.15e-4
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	3.30e-3
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-2	1.11e-2
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	2.14e-3
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-2	2.00e-2
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	8.61e-4
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-2	3.47e-2
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-3	4.02e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	5.00e-2	2.25e-2
Plasma IgG	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-2	2.00e-2
Plasma IgG	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-3	4.02e-2
Plasma IgM	Ectopic Fat Traits	Visceral Adipose Tissue Attenutation Women	MTC	Chu	2017	NA	5729	1.00e-3	4.02e-2
T CD8 MAIT	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	4.45e-2
NK CD160pos	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	3.28e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	8.18e-3
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-2	9.18e-3
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-3	2.96e-2
NK FCGR3Apos	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	8.18e-3
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	3.97e-4
T CD4 reg	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	3.28e-2
Monocyte	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	1.19e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	4.45e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	2.37e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	3.28e-2
Neutrophil	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	5.00e-2	1.19e-2
Neutrophil	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-2	3.06e-2
B T doublet	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-2	3.06e-2
B T doublet	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-3	9.71e-3
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI All	MTC	Chu	2017	NA	14863	1.00e-3	2.96e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7432	5.00e-2	4.30e-2
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Men	MTC	Chu	2017	NA	7432	5.00e-2	3.11e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	2.21e-3
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	1.17e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	5.27e-4
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	2.36e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	1.17e-2
Monocyte	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-3
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.16e-4
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	2.36e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	1.39e-3
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	1.27e-2
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-3
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	6.48e-3
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	1.17e-2
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-4	2.98e-2
Plasma IgG	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-2
Platelet	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-2
DC plasmacytoid	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-2
DC plasmacytoid	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	4.20e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	5.00e-2	3.45e-3
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-2	4.20e-2
T CD4 fh	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	3.77e-2
T CD4 conv	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	3.16e-3
B T doublet	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	3.16e-3
ILC	Ectopic Fat Traits	Visceral Adipose Tissue Volume Adjusted For BMI Women	MTC	Chu	2017	NA	7431	1.00e-3	3.77e-2
NK CD160pos	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	1.78e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	2.50e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	2.65e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-3	3.46e-2
NK FCGR3Apos	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	3.91e-3
T cell dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	2.50e-2
T cell dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	4.54e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	2.50e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-3	1.05e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	5.85e-3
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	1.49e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	3.45e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	4.12e-3
T CD8 gd	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	4.68e-2
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	1.07e-3
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	2.50e-2
Unknown	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	5.00e-2	1.25e-2
Monocyte	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	7.99e-3
DC 2	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	4.54e-2
Neutrophil	Ectopic Fat Traits	Visceral Adipose Tissue Volume All	MTC	Chu	2017	NA	14863	1.00e-2	1.49e-2
NK FCGR3Apos	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	2.67e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	8.61e-3
T CD4 reg	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	3.70e-3
T CD4 reg	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	1.00e-2	2.64e-2
T CD4 naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	5.70e-3
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	5.70e-3
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	1.00e-2	6.56e-3
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	5.00e-2	8.61e-3
T cell dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	1.00e-2	4.89e-2
NK dividing	Ectopic Fat Traits	Visceral Adipose Tissue Volume Men	MTC	Chu	2017	NA	7432	1.00e-2	4.89e-2
B naive	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	1.51e-2
NK FCGR3Apos	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	3.08e-2
B mature	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	3.08e-2
Macrophage	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	1.03e-2
ILC	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	2.18e-2
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	1.03e-2
DC 1	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	1.00e-3	4.47e-3
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	4.56e-3
Plasmablast	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	1.00e-2	4.07e-2
DC activated	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	3.08e-2
CD34 progenitor	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	5.00e-2	1.03e-2
B Hypermutation	Ectopic Fat Traits	Visceral Adipose Tissue Volume Women	MTC	Chu	2017	NA	7431	1.00e-3	1.74e-2
B naive	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	1.11e-2
B naive	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	8.92e-3
B naive	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-4	1.64e-3
B naive	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-5	4.20e-4
T cell dividing	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	4.95e-2
T cell dividing	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	2.55e-2
B mature	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	2.47e-3
B mature	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	2.55e-2
B mature	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-4	1.64e-3
B mature	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-5	1.99e-2
T CD4 reg	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	3.95e-2
Macrophage	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	4.95e-2
DC 1	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	3.95e-2
DC 1	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	8.92e-3
B Hypermutation	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	1.11e-2
B Hypermutation	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	1.83e-2
Platelet	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	4.95e-2
Platelet	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-5	1.99e-2
CD34 progenitor	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-2	1.90e-2
CD34 progenitor	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	6.09e-3
CD34 progenitor	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-4	4.45e-2
CD34 progenitor	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-5	1.99e-2
DC 2	Educational Attainment	Education Years All	ETC	Okbay	2016	NA	293723	1.00e-3	3.51e-2
NK CD160pos	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	5.00e-2	7.99e-3
NK CD160pos	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.00e-2
B naive	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	5.00e-2	5.99e-3
B naive	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-2	7.33e-3
B naive	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-3	5.33e-3
B naive	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-4	2.92e-4
B naive	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-5	7.36e-4
B Hypermutation	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	5.00e-2	3.73e-2
B Hypermutation	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-2	4.10e-2
NK dividing	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.00e-2
CD34 progenitor	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-2	1.53e-2
CD34 progenitor	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-3	2.62e-2
Platelet	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-3	5.33e-3
Platelet	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-5	1.59e-2
B mature	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-4	3.46e-2
B mature	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-5	2.22e-3
DC 2	Educational Attainment	Education Years Men	MTC	Okbay	2016	0	293723 men and women	1.00e-5	1.59e-2
B naive	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	4.57e-2
B naive	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	1.64e-2
B naive	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-3	5.86e-3
B naive	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-4	9.95e-4
B naive	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-5	1.79e-2
T cell dividing	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	1.19e-3
T cell dividing	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	5.98e-3
B mature	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	1.16e-2
B mature	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	4.16e-3
B mature	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-3	3.37e-4
B mature	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-4	1.87e-4
B mature	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-5	1.79e-2
NK dividing	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	5.24e-3
NK dividing	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.01e-2
DC 2	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	3.71e-2
DC 1	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	2.97e-3
Plasma IgM	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	2.99e-2
Plasma IgM	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.01e-2
B Hypermutation	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	5.05e-5
B Hypermutation	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.99e-2
Platelet	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	6.88e-3
Platelet	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-4	1.69e-2
DC plasmacytoid	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	3.71e-2
DC plasmacytoid	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	3.01e-2
Plasmablast	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	1.55e-4
Plasmablast	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	1.19e-2
CD34 progenitor	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	5.00e-2	8.66e-4
CD34 progenitor	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-2	1.64e-2
CD34 progenitor	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-3	1.14e-3
CD34 progenitor	Educational Attainment	Education Years Women	MTC	Okbay	2016	0	293723 men and women	1.00e-4	8.88e-3
T CD8 MAIT	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	1.08e-3
T cell dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	2.62e-4
T CD4 reg	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	3.89e-3
Monocyte	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	2.43e-2
Monocyte	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	7.74e-3
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	5.79e-3
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	4.40e-2
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	9.50e-3
DC 2	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	4.52e-2
Macrophage	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	1.74e-2
Macrophage	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	1.93e-2
Macrophage	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	9.50e-3
Plasma IgM	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	2.43e-2
Plasma IgM	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	3.59e-2
Plasma IgM	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-5	1.59e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	4.52e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	4.40e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	3.59e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-5	1.59e-2
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	5.00e-2	2.58e-3
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-2	3.61e-2
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	1.93e-2
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	3.59e-2
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-5	1.59e-2
NK FCGR3Apos	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-3	4.40e-2
DC 1	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	3.59e-2
DC activated	Estimated Glomerular Filtration Rate	Chronic Kidney Disease	ETC	Pattaro	2016	12385	104780	1.00e-4	3.59e-2
T CD4 fh	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	5.00e-2	4.15e-2
T cell dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	5.00e-2	8.37e-3
T CD4 reg	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	5.00e-2	1.94e-2
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	5.00e-2	4.15e-2
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	1.00e-3	3.87e-2
T CD8 activated	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	1.00e-2	3.31e-2
T CD8 activated	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	1.00e-3	3.87e-2
T CD8 MAIT	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	1.00e-3	3.87e-2
B naive	Estimated Glomerular Filtration Rate	Chronic Kidney Disease With Diabetes	MTC	Pattaro	2016	NA	11522	1.00e-3	3.87e-2
NK CD160pos	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	2.61e-2
B naive	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	7.27e-3
B naive	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	3.95e-2
T cell dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	1.19e-3
T cell dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	2.33e-3
T cell dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-3	4.28e-2
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	9.74e-5
NK dividing	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	2.33e-3
Macrophage	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	1.60e-2
Plasma IgM	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	4.11e-3
B Hypermutation	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	2.24e-3
B Hypermutation	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	7.51e-3
Plasma IgG	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	7.27e-3
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	5.00e-2	1.27e-5
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	3.32e-6
Plasmablast	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-3	3.71e-3
CD34 progenitor	Estimated Glomerular Filtration Rate	Chronic Kidney Disease Without Diabetes	MTC	Pattaro	2016	NA	118448	1.00e-2	3.95e-2
T CD8 MAIT	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	1.32e-3
NK CD160pos	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	3.22e-4
T CD8 activated	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	6.86e-5
NK FCGR3Apos	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	5.24e-4
T cell dividing	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	8.39e-4
T cell dividing	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	3.45e-2
T CD8 CTL	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	3.22e-4
T CD4 reg	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	3.98e-5
NK dividing	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	1.55e-7
NK dividing	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	3.45e-2
DC 2	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	3.96e-2
DC 2	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	1.19e-2
T CD8 gd	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	1.47e-2
DC 1	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	1.02e-2
DC 1	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	1.19e-2
Plasma IgM	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	7.01e-3
Plasma IgM	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	3.45e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	2.08e-2
DC plasmacytoid	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	2.08e-2
DC plasmacytoid	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	1.19e-2
Plasmablast	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	5.00e-2	1.95e-4
Plasmablast	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	3.45e-2
Macrophage	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-2	9.14e-4
Monocyte	Estimated Glomerular Filtration Rate	Cystatin C	MTC	Pattaro	2016	NA	32834	1.00e-4	2.03e-2
T CD8 MAIT	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	2.32e-2
T CD8 MAIT	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	1.30e-2
NK CD160pos	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	4.89e-3
B naive	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	4.89e-3
B naive	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	2.47e-2
NK FCGR3Apos	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	2.32e-2
NK FCGR3Apos	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-5	4.09e-2
T cell dividing	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	1.30e-6
T cell dividing	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	1.81e-5
B mature	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	1.11e-2
T CD4 reg	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	1.83e-2
NK dividing	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	1.30e-6
NK dividing	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	1.40e-4
Macrophage	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	3.65e-2
Macrophage	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	2.47e-2
B Hypermutation	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	4.07e-5
B Hypermutation	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	3.61e-4
Plasmablast	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	1.80e-5
Plasmablast	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	8.62e-8
Plasmablast	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-3	1.73e-3
CD34 progenitor	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	5.00e-2	3.65e-2
CD34 progenitor	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	3.34e-2
Plasma IgG	Estimated Glomerular Filtration Rate	Serum Creatinine	MTC	Pattaro	2016	NA	133413	1.00e-2	4.45e-2
Macrophage	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	5.00e-2	2.65e-3
B Hypermutation	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	5.00e-2	4.39e-2
Platelet	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	5.00e-2	1.21e-2
Platelet	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	1.00e-2	4.02e-2
T CD8 activated	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	1.00e-3	2.58e-2
NK FCGR3Apos	Estimated Glomerular Filtration Rate	Serum Creatinine African Americans Only	MTC	Pattaro	2016	NA	133413	1.00e-3	2.58e-2
T CD8 MAIT	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	4.23e-2
B naive	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	6.45e-5
B mature	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	3.22e-3
T CD4 naive	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	1.55e-2
T CD4 naive	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
DC 2	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	1.07e-2
DC 1	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	7.30e-3
B Hypermutation	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	3.08e-2
Platelet	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	7.30e-3
Platelet	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	1.00e-2	3.61e-3
DC plasmacytoid	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	5.00e-2	3.15e-4
DC plasmacytoid	Facial Shape	Mod1	MTC	Claes	2018	NA	2329	1.00e-2	1.67e-3
T CD8 CTL	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	5.00e-2	2.96e-2
T CD8 CTL	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	6.03e-3
DC 1	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	5.00e-2	2.07e-2
Platelet	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	5.00e-2	1.42e-2
DC plasmacytoid	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	5.00e-2	9.53e-3
Plasmablast	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	5.00e-2	4.16e-2
T CD8 MAIT	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	1.28e-2
T CD8 activated	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	2.58e-2
T CD4 fh	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	1.28e-2
T CD4 reg	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	1.28e-2
T CD4 naive	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	2.58e-2
T CD4 conv	Facial Shape	Mod10	MTC	Claes	2018	NA	2329	1.00e-2	1.13e-3
NK dividing	Facial Shape	Mod11	MTC	Claes	2018	NA	2329	5.00e-2	4.36e-2
Macrophage	Facial Shape	Mod11	MTC	Claes	2018	NA	2329	5.00e-2	4.36e-2
DC activated	Facial Shape	Mod11	MTC	Claes	2018	NA	2329	5.00e-2	3.14e-2
NK CD160pos	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	2.60e-2
T CD8 activated	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	3.50e-3
T cell dividing	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	2.60e-2
T CD4 reg	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	5.41e-3
NK dividing	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	8.23e-3
DC 2	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	1.80e-2
T CD8 gd	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	1.80e-2
DC 1	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	2.60e-2
DC 1	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	1.00e-2	1.78e-3
CD34 progenitor	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	5.00e-2	2.60e-2
Plasma IgM	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	1.00e-2	3.98e-3
Plasma IgG	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	1.00e-2	8.43e-3
DC activated	Facial Shape	Mod12	MTC	Claes	2018	NA	2329	1.00e-2	1.70e-2
T CD8 MAIT	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	9.82e-3
T CD8 MAIT	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	1.00e-2	6.72e-3
T CD4 fh	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	2.19e-2
T CD4 reg	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	1.56e-3
T CD4 naive	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	3.16e-2
Monocyte	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	4.49e-2
DC 2	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	4.49e-2
DC 1	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	4.49e-2
B Hypermutation	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	3.16e-2
Platelet	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	5.00e-2	1.48e-2
Platelet	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	1.00e-2	2.81e-2
T cell dividing	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	1.00e-2	2.81e-2
ILC	Facial Shape	Mod13	MTC	Claes	2018	NA	2329	1.00e-2	2.81e-2
B mature	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	5.00e-2	4.37e-2
T CD8 gd	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	5.00e-2	2.15e-2
DC plasmacytoid	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	5.00e-2	6.43e-3
DC plasmacytoid	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
T CD8 MAIT	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	9.97e-3
T CD8 MAIT	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
T CD8 activated	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	9.97e-3
T CD8 activated	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
T CD8 CTL	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	2.06e-2
T CD4 reg	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
T CD4 naive	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	2.06e-2
ILC	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-2	9.97e-3
NK CD160pos	Facial Shape	Mod14	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
T CD8 MAIT	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	1.86e-2
T CD8 MAIT	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-2	2.64e-2
T CD4 fh	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	1.86e-2
T CD8 CTL	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	3.30e-4
T CD8 CTL	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-2	1.35e-2
T CD4 reg	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	1.86e-2
T CD4 naive	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	3.70e-3
T CD4 naive	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-2	1.35e-2
Platelet	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	5.00e-2	1.86e-2
Platelet	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
T CD8 activated	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-2	1.35e-2
NK CD160pos	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-3	8.30e-3
DC 2	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
DC 1	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
CD34 progenitor	Facial Shape	Mod15	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
Macrophage	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	5.00e-2	2.07e-3
Macrophage	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	1.00e-2	3.90e-3
Plasma IgM	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	5.00e-2	4.98e-2
B Hypermutation	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	5.00e-2	1.74e-2
Plasma IgG	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	5.00e-2	3.58e-2
CD34 progenitor	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	5.00e-2	4.65e-4
CD34 progenitor	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	1.00e-2	3.90e-3
DC plasmacytoid	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	1.00e-2	1.61e-2
B naive	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	1.00e-3	1.56e-2
B mature	Facial Shape	Mod16	MTC	Claes	2018	NA	2329	1.00e-3	3.26e-3
T CD8 MAIT	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	9.81e-3
T CD8 activated	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	1.47e-2
T CD8 activated	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-2	8.51e-3
T CD8 CTL	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	3.13e-2
T CD8 CTL	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-3	8.30e-3
NK dividing	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	4.43e-2
T CD8 gd	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	3.13e-2
T CD8 gd	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-2	1.63e-3
CD34 progenitor	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	5.00e-2	3.13e-2
CD34 progenitor	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
DC activated	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-2	3.53e-2
DC activated	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-3	8.30e-3
B mature	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
T CD4 reg	Facial Shape	Mod17	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
T CD4 fh	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	2.14e-2
T CD4 fh	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-2	1.96e-2
Monocyte	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	2.90e-5
DC 2	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	3.11e-4
DC 2	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-3	1.89e-2
Macrophage	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	2.48e-3
B Hypermutation	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	9.58e-3
DC plasmacytoid	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	3.96e-3
DC activated	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	1.45e-2
Neutrophil	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	5.00e-2	4.41e-2
NK CD160pos	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-2	9.17e-3
T CD8 CTL	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-2	9.17e-3
T CD8 CTL	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-3	1.89e-2
T CD4 reg	Facial Shape	Mod18	MTC	Claes	2018	NA	2329	1.00e-2	1.96e-2
B naive	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	5.00e-2	9.56e-3
T CD8 CTL	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	5.00e-2	4.52e-2
ILC	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	5.00e-2	8.63e-4
ILC	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	1.00e-2	2.61e-4
ILC	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	1.00e-3	3.41e-2
DC 1	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	5.00e-2	4.52e-2
Platelet	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	5.00e-2	1.45e-2
T CD4 reg	Facial Shape	Mod19	MTC	Claes	2018	NA	2329	1.00e-2	1.18e-2
T CD8 MAIT	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	4.12e-2
T CD8 activated	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	4.21e-3
T CD8 activated	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-2	1.02e-3
T CD8 activated	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-3	1.79e-2
T CD4 fh	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	2.95e-2
T CD8 CTL	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	4.12e-2
T CD8 CTL	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-2	4.21e-2
T CD4 reg	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	2.07e-2
T CD4 reg	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-2	5.31e-3
Monocyte	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	4.12e-2
T CD8 gd	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	5.00e-2	9.68e-3
T CD8 gd	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-3	1.79e-2
NK CD160pos	Facial Shape	Mod2	MTC	Claes	2018	NA	2329	1.00e-3	7.02e-4
NK FCGR3Apos	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	5.00e-2	1.28e-2
T cell dividing	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	5.00e-2	3.75e-2
T CD8 CTL	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	5.00e-2	1.86e-2
T CD8 CTL	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-2	3.15e-3
Platelet	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	5.00e-2	3.75e-2
CD34 progenitor	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	5.00e-2	3.75e-2
T CD8 MAIT	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-2	4.71e-2
T CD8 activated	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-2	2.59e-2
T CD8 activated	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
T CD8 gd	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-2	1.35e-2
T CD8 gd	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
NK CD160pos	Facial Shape	Mod20	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
Macrophage	Facial Shape	Mod21	MTC	Claes	2018	NA	2329	5.00e-2	4.66e-2
DC 1	Facial Shape	Mod21	MTC	Claes	2018	NA	2329	5.00e-2	4.59e-4
DC plasmacytoid	Facial Shape	Mod21	MTC	Claes	2018	NA	2329	5.00e-2	2.37e-2
DC activated	Facial Shape	Mod21	MTC	Claes	2018	NA	2329	5.00e-2	1.12e-2
NK FCGR3Apos	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	1.70e-2
T cell dividing	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	1.70e-2
B mature	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	3.43e-2
T CD8 CTL	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	2.44e-2
NK dividing	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	2.44e-2
B Hypermutation	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	5.00e-2	7.81e-3
T CD8 MAIT	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	1.00e-2	3.03e-2
T CD8 MAIT	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	1.00e-3	3.97e-2
NK CD160pos	Facial Shape	Mod22	MTC	Claes	2018	NA	2329	1.00e-3	3.97e-2
T cell dividing	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	5.00e-2	1.08e-2
T cell dividing	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	1.00e-3	8.49e-3
NK dividing	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	5.00e-2	6.87e-4
NK dividing	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	1.00e-3	3.87e-2
B Hypermutation	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	5.00e-2	1.08e-2
B Hypermutation	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	1.00e-3	3.87e-2
DC plasmacytoid	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	5.00e-2	1.08e-2
DC plasmacytoid	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	1.00e-2	4.37e-2
Neutrophil	Facial Shape	Mod23	MTC	Claes	2018	NA	2329	5.00e-2	3.31e-2
T CD8 MAIT	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	4.51e-2
T cell dividing	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	2.22e-2
NK dividing	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	4.51e-2
DC 1	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	2.22e-2
DC 1	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	1.00e-2	1.55e-2
Plasmablast	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	3.19e-2
Plasmablast	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
CD34 progenitor	Facial Shape	Mod24	MTC	Claes	2018	NA	2329	5.00e-2	6.58e-3
T CD8 MAIT	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	2.00e-2
NK CD160pos	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	2.00e-2
NK CD160pos	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	1.00e-2	2.82e-3
T CD4 fh	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	4.07e-2
T CD4 reg	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	3.84e-3
T CD4 reg	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	1.00e-2	2.85e-2
DC 2	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	2.88e-2
T CD8 gd	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	5.00e-2	2.88e-2
T CD8 gd	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	1.00e-2	2.85e-2
Platelet	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	1.00e-2	2.85e-2
T CD4 naive	Facial Shape	Mod25	MTC	Claes	2018	NA	2329	1.00e-3	2.22e-2
T CD4 fh	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	1.28e-2
T CD4 fh	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	1.00e-2	3.69e-2
T CD4 reg	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	3.48e-3
Monocyte	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	1.33e-3
DC 2	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	1.33e-3
DC 2	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	1.00e-2	4.06e-3
Macrophage	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	1.90e-2
DC 1	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	3.94e-2
Plasma IgM	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	3.94e-2
Platelet	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	8.46e-3
Platelet	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	1.00e-2	3.69e-2
DC activated	Facial Shape	Mod26	MTC	Claes	2018	NA	2329	5.00e-2	2.77e-2
T CD8 MAIT	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	5.00e-2	1.79e-2
T CD8 MAIT	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	1.00e-2	1.96e-2
T CD4 fh	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	5.00e-2	1.21e-2
T CD4 fh	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	1.00e-2	3.84e-2
T CD8 CTL	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	5.00e-2	3.70e-2
Macrophage	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	1.00e-2	3.84e-2
ILC	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	1.00e-2	3.84e-2
DC 1	Facial Shape	Mod27	MTC	Claes	2018	NA	2329	1.00e-2	3.84e-2
T CD8 CTL	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	5.00e-2	1.90e-2
NK dividing	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	5.00e-2	3.86e-2
DC plasmacytoid	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	5.00e-2	8.66e-3
T CD8 MAIT	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-2	4.05e-2
NK CD160pos	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-2	1.07e-2
T CD4 reg	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-2	4.05e-2
ILC	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-2	2.14e-2
ILC	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-3	2.58e-2
T CD8 gd	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-2	2.14e-2
T CD4 naive	Facial Shape	Mod28	MTC	Claes	2018	NA	2329	1.00e-3	2.58e-2
Plasmablast	Facial Shape	Mod29	MTC	Claes	2018	NA	2329	5.00e-2	4.97e-2
T cell dividing	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	1.41e-2
NK dividing	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	3.89e-2
DC 1	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	7.55e-4
Plasma IgM	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	1.41e-2
B Hypermutation	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	2.01e-2
Plasma IgG	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	3.89e-2
Platelet	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	6.63e-3
DC plasmacytoid	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	1.41e-2
Plasmablast	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	1.41e-2
CD34 progenitor	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	5.00e-2	2.01e-2
NK CD160pos	Facial Shape	Mod3	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
B naive	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	5.00e-2	4.67e-2
B naive	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	1.00e-2	4.51e-2
NK dividing	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	5.00e-2	4.67e-2
B Hypermutation	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	5.00e-2	3.45e-4
B Hypermutation	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	1.00e-2	2.36e-2
Plasmablast	Facial Shape	Mod30	MTC	Claes	2018	NA	2329	5.00e-2	2.28e-2
T CD8 MAIT	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	3.57e-2
T CD8 MAIT	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	1.00e-3	1.30e-2
T CD4 fh	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	1.21e-2
DC 2	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	2.54e-2
DC 1	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	2.54e-2
Platelet	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	8.19e-3
DC activated	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	5.00e-2	1.21e-2
T CD8 CTL	Facial Shape	Mod31	MTC	Claes	2018	NA	2329	1.00e-3	1.30e-2
Monocyte	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	5.00e-2	9.37e-4
Monocyte	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-2	1.06e-2
Macrophage	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	5.00e-2	1.85e-5
Macrophage	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-2	1.24e-3
DC plasmacytoid	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	5.00e-2	2.85e-2
DC plasmacytoid	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-2	1.97e-2
DC activated	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	5.00e-2	2.85e-2
DC activated	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-2	1.97e-2
CD34 progenitor	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	5.00e-2	1.35e-2
CD34 progenitor	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-2	1.97e-2
Plasma IgM	Facial Shape	Mod32	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-2
NK CD160pos	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	4.20e-2
B naive	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	2.97e-2
B naive	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	1.00e-2	3.50e-2
B naive	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	1.00e-3	1.55e-2
NK FCGR3Apos	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	4.20e-2
B mature	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	9.34e-3
Macrophage	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	9.34e-3
DC plasmacytoid	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	2.06e-2
CD34 progenitor	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	5.00e-2	2.47e-3
CD34 progenitor	Facial Shape	Mod33	MTC	Claes	2018	NA	2329	1.00e-2	2.01e-3
B naive	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	6.77e-3
NK dividing	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	2.79e-3
ILC	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	6.77e-3
DC 1	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	1.07e-3
Plasma IgM	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	4.47e-2
B Hypermutation	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	3.18e-2
Platelet	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	6.45e-4
DC plasmacytoid	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	4.47e-2
DC activated	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	2.22e-2
CD34 progenitor	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	5.00e-2	6.77e-3
CD34 progenitor	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	1.00e-2	3.18e-2
CD34 progenitor	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	1.00e-3	7.22e-3
Neutrophil	Facial Shape	Mod34	MTC	Claes	2018	NA	2329	1.00e-2	3.18e-2
B naive	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	5.00e-2	2.15e-2
NK dividing	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	5.00e-2	2.15e-2
DC 1	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	5.00e-2	6.43e-3
Platelet	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	5.00e-2	3.09e-2
DC activated	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	5.00e-2	9.86e-4
Plasma IgM	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	1.00e-2	4.34e-2
Plasma IgG	Facial Shape	Mod35	MTC	Claes	2018	NA	2329	1.00e-2	4.34e-2
T CD8 MAIT	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	4.18e-2
T CD8 MAIT	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	5.78e-3
NK FCGR3Apos	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.94e-2
T CD4 fh	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	4.18e-2
T cell dividing	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.94e-2
T CD8 CTL	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	5.93e-3
T CD4 conv	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.94e-2
T CD4 conv	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	1.30e-2
Monocyte	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	1.37e-2
NK dividing	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	1.37e-2
DC 2	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	8.77e-4
DC 2	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	1.30e-2
Macrophage	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	4.18e-2
DC 1	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	8.77e-4
DC 1	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	2.74e-2
B Hypermutation	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	7.92e-6
DC plasmacytoid	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	1.46e-3
Plasmablast	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.03e-2
CD34 progenitor	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.94e-2
Neutrophil	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	5.00e-2	2.03e-2
Plasma IgM	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	1.30e-2
Plasma IgG	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	5.78e-3
DC activated	Facial Shape	Mod36	MTC	Claes	2018	NA	2329	1.00e-2	5.78e-3
B naive	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	1.03e-2
B mature	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	3.26e-2
Monocyte	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	2.26e-2
DC 2	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	1.54e-2
ILC	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	4.60e-2
B Hypermutation	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	2.26e-2
DC plasmacytoid	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	2.26e-2
CD34 progenitor	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	5.00e-2	2.26e-2
T CD4 fh	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	1.00e-2	3.02e-3
B T doublet	Facial Shape	Mod37	MTC	Claes	2018	NA	2329	1.00e-2	1.41e-2
B naive	Facial Shape	Mod38	MTC	Claes	2018	NA	2329	5.00e-2	1.46e-2
Monocyte	Facial Shape	Mod38	MTC	Claes	2018	NA	2329	5.00e-2	4.58e-2
DC plasmacytoid	Facial Shape	Mod38	MTC	Claes	2018	NA	2329	5.00e-2	4.58e-2
ILC	Facial Shape	Mod38	MTC	Claes	2018	NA	2329	1.00e-2	1.87e-2
ILC	Facial Shape	Mod38	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
B naive	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	5.00e-2	5.71e-3
T CD4 reg	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	5.00e-2	4.21e-2
B Hypermutation	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	5.00e-2	1.35e-2
CD34 progenitor	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	5.00e-2	2.01e-2
CD34 progenitor	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	1.00e-2	6.91e-3
ILC	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	1.00e-2	3.14e-2
ILC	Facial Shape	Mod39	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
NK CD160pos	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	4.88e-2
Monocyte	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	1.93e-3
DC 2	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	2.46e-4
Macrophage	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	1.93e-3
T CD8 gd	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	2.44e-2
DC 1	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	2.44e-2
B Hypermutation	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	3.49e-2
CD34 progenitor	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	5.00e-2	1.19e-3
T CD4 reg	Facial Shape	Mod4	MTC	Claes	2018	NA	2329	1.00e-2	1.79e-2
T cell dividing	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	5.00e-2	3.64e-3
T cell dividing	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	4.51e-3
T CD8 CTL	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	5.00e-2	2.76e-2
T CD8 CTL	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	3.74e-2
T CD4 reg	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	5.00e-2	3.92e-2
T CD4 reg	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	4.51e-3
T CD4 reg	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-3	2.59e-2
Platelet	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	5.00e-2	3.92e-2
T CD8 MAIT	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	3.74e-2
T CD8 activated	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	9.65e-3
T CD8 activated	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-3	6.24e-3
T CD4 fh	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	9.65e-3
T CD4 conv	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	1.96e-2
NK dividing	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	3.74e-2
B Hypermutation	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-2	3.74e-2
NK CD160pos	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-3	2.16e-4
Macrophage	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-3	2.59e-2
T CD8 gd	Facial Shape	Mod40	MTC	Claes	2018	NA	2329	1.00e-3	6.24e-3
NK FCGR3Apos	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	5.00e-2	3.67e-3
NK dividing	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	5.00e-2	5.83e-3
Macrophage	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	5.00e-2	3.03e-2
B Hypermutation	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	5.00e-2	1.39e-2
B Hypermutation	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
DC plasmacytoid	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	5.00e-2	1.39e-2
T CD8 CTL	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
Plasma IgM	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
Plasma IgG	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	1.00e-2	4.00e-2
Plasmablast	Facial Shape	Mod41	MTC	Claes	2018	NA	2329	1.00e-2	4.56e-3
NK CD160pos	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	1.71e-2
T CD8 CTL	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	7.83e-3
T CD4 reg	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	2.46e-2
T CD8 gd	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	1.71e-2
DC 1	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	1.71e-2
B Hypermutation	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	4.83e-2
B Hypermutation	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	1.00e-2	1.75e-2
Platelet	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	2.46e-2
DC plasmacytoid	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	4.89e-4
DC plasmacytoid	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	1.00e-2	4.32e-3
DC activated	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	3.33e-3
CD34 progenitor	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	5.00e-2	7.83e-3
T cell dividing	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	1.00e-2	3.27e-2
NK dividing	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	1.00e-2	1.75e-2
Plasmablast	Facial Shape	Mod42	MTC	Claes	2018	NA	2329	1.00e-2	1.75e-2
T CD4 reg	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	5.00e-2	2.85e-2
T CD4 naive	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	5.00e-2	1.35e-2
DC 1	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	5.00e-2	1.98e-2
DC 1	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	1.00e-2	2.33e-2
DC plasmacytoid	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	5.00e-2	9.08e-3
DC activated	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	5.00e-2	2.85e-2
Plasma IgM	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	1.00e-2	1.17e-2
Plasma IgG	Facial Shape	Mod43	MTC	Claes	2018	NA	2329	1.00e-2	2.33e-2
T CD8 activated	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	5.00e-2	3.70e-2
T cell dividing	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	5.00e-2	2.64e-2
T CD4 reg	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	5.00e-2	8.58e-3
B Hypermutation	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	5.00e-2	2.64e-2
T CD8 MAIT	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	1.00e-3	2.38e-2
B naive	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	1.00e-3	2.38e-2
Plasma IgM	Facial Shape	Mod44	MTC	Claes	2018	NA	2329	1.00e-3	2.38e-2
B naive	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	2.54e-2
T cell dividing	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	3.57e-2
T cell dividing	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	4.37e-2
B mature	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	8.19e-3
Monocyte	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	3.53e-3
Monocyte	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	2.43e-2
NK dividing	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	4.92e-2
Macrophage	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	5.42e-3
Macrophage	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	4.37e-2
DC 1	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	5.42e-3
DC 1	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	1.41e-3
DC 1	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-3	3.97e-2
B Hypermutation	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	8.19e-3
DC plasmacytoid	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	3.57e-2
DC plasmacytoid	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	2.43e-2
CD34 progenitor	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	5.00e-2	4.92e-2
CD34 progenitor	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	2.43e-2
DC 2	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	6.44e-3
ILC	Facial Shape	Mod45	MTC	Claes	2018	NA	2329	1.00e-2	6.44e-3
NK dividing	Facial Shape	Mod46	MTC	Claes	2018	NA	2329	5.00e-2	1.48e-2
DC 1	Facial Shape	Mod46	MTC	Claes	2018	NA	2329	5.00e-2	6.61e-3
DC plasmacytoid	Facial Shape	Mod46	MTC	Claes	2018	NA	2329	1.00e-2	7.47e-3
Unknown	Facial Shape	Mod46	MTC	Claes	2018	NA	2329	1.00e-3	2.30e-2
NK CD160pos	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	1.20e-2
T cell dividing	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	1.75e-2
NK dividing	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	1.75e-4
B Hypermutation	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	1.20e-2
Plasmablast	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	3.55e-2
Neutrophil	Facial Shape	Mod47	MTC	Claes	2018	NA	2329	5.00e-2	5.29e-3
NK dividing	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	5.00e-2	1.41e-2
DC 1	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	5.00e-2	8.83e-4
DC 1	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	1.00e-2	4.69e-2
B Hypermutation	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	5.00e-2	1.47e-3
DC plasmacytoid	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	5.00e-2	2.09e-2
DC plasmacytoid	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	1.00e-2	2.46e-2
CD34 progenitor	Facial Shape	Mod48	MTC	Claes	2018	NA	2329	5.00e-2	4.32e-2
Plasma IgM	Facial Shape	Mod49	MTC	Claes	2018	NA	2329	5.00e-2	2.77e-2
Neutrophil	Facial Shape	Mod49	MTC	Claes	2018	NA	2329	5.00e-2	1.90e-2
T cell dividing	Facial Shape	Mod49	MTC	Claes	2018	NA	2329	1.00e-2	1.55e-2
NK FCGR3Apos	Facial Shape	Mod5	MTC	Claes	2018	NA	2329	5.00e-2	4.08e-2
NK dividing	Facial Shape	Mod5	MTC	Claes	2018	NA	2329	5.00e-2	1.47e-2
Platelet	Facial Shape	Mod5	MTC	Claes	2018	NA	2329	5.00e-2	4.08e-2
T CD8 CTL	Facial Shape	Mod5	MTC	Claes	2018	NA	2329	1.00e-2	3.39e-2
T CD8 activated	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	1.11e-2
T CD4 fh	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	1.65e-2
T CD4 reg	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	1.11e-2
T CD4 conv	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	7.29e-3
DC 2	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	2.41e-2
Macrophage	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	2.98e-3
T CD8 gd	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	4.86e-2
CD34 progenitor	Facial Shape	Mod50	MTC	Claes	2018	NA	2329	5.00e-2	4.86e-2
T CD8 activated	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	2.27e-2
T cell dividing	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	6.94e-3
B mature	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	1.56e-2
T CD4 reg	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	2.87e-3
NK dividing	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	3.25e-2
T CD8 gd	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	4.55e-2
Plasma IgM	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	2.27e-2
B Hypermutation	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	1.05e-2
Plasmablast	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	5.00e-2	4.08e-5
T CD8 CTL	Facial Shape	Mod51	MTC	Claes	2018	NA	2329	1.00e-2	1.55e-2
Monocyte	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	5.00e-2	2.63e-2
Monocyte	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	1.00e-2	3.29e-2
DC 2	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	5.00e-2	4.76e-3
DC 1	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	5.00e-2	7.53e-3
DC plasmacytoid	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	5.00e-2	4.76e-3
T CD8 MAIT	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	1.00e-3	1.89e-2
T CD8 CTL	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	1.00e-3	1.89e-2
B T doublet	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	1.00e-3	3.23e-3
T CD8 gd	Facial Shape	Mod52	MTC	Claes	2018	NA	2329	1.00e-3	1.89e-2
Platelet	Facial Shape	Mod53	MTC	Claes	2018	NA	2329	5.00e-2	1.18e-2
Platelet	Facial Shape	Mod53	MTC	Claes	2018	NA	2329	1.00e-2	2.85e-2
CD34 progenitor	Facial Shape	Mod53	MTC	Claes	2018	NA	2329	5.00e-2	4.65e-4
Neutrophil	Facial Shape	Mod53	MTC	Claes	2018	NA	2329	5.00e-2	4.98e-2
T CD4 fh	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	5.00e-2	1.58e-2
T CD4 fh	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	7.15e-3
T CD4 reg	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	5.00e-2	1.58e-2
B T doublet	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-2	2.29e-2
DC 1	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-2	2.29e-2
DC 1	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	3.41e-2
NK CD160pos	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	7.15e-3
NK FCGR3Apos	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	7.15e-3
T CD8 CTL	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	7.15e-3
T CD4 naive	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	7.15e-3
T CD4 conv	Facial Shape	Mod54	MTC	Claes	2018	NA	2329	1.00e-3	3.41e-2
T CD8 MAIT	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	5.17e-5
NK CD160pos	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	1.53e-2
T CD8 activated	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	2.27e-2
NK FCGR3Apos	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	3.30e-2
T CD4 fh	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	1.53e-2
T cell dividing	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	6.49e-3
B mature	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	3.30e-2
T CD8 CTL	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	2.27e-2
T CD4 reg	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	1.01e-2
T CD4 conv	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	4.70e-2
T CD4 conv	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	1.00e-3	4.80e-2
NK dividing	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	9.21e-4
B Hypermutation	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	1.53e-2
B Hypermutation	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	1.00e-2	2.69e-2
Platelet	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	4.70e-2
Neutrophil	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	5.00e-2	3.30e-2
DC 1	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	1.00e-3	4.80e-2
DC activated	Facial Shape	Mod55	MTC	Claes	2018	NA	2329	1.00e-3	4.80e-2
T CD8 gd	Facial Shape	Mod56	MTC	Claes	2018	NA	2329	5.00e-2	3.97e-2
T CD8 MAIT	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	3.63e-5
T CD8 MAIT	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	1.00e-2	5.36e-3
T CD8 activated	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	2.13e-2
T CD4 naive	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	2.13e-2
NK dividing	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	4.16e-3
NK dividing	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	1.00e-2	2.02e-2
NK dividing	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	1.00e-3	4.10e-2
T CD8 gd	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	6.44e-3
DC plasmacytoid	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	5.00e-2	3.57e-4
DC plasmacytoid	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	1.00e-2	1.07e-2
ILC	Facial Shape	Mod57	MTC	Claes	2018	NA	2329	1.00e-2	1.07e-2
T CD8 MAIT	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	8.25e-3
T CD4 fh	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	5.40e-3
T cell dividing	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	5.40e-3
T CD4 reg	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	8.25e-3
T CD4 reg	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	1.00e-2	4.38e-2
T CD4 naive	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	1.24e-2
T CD4 naive	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	1.00e-2	4.38e-2
T CD4 conv	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	4.96e-4
DC plasmacytoid	Facial Shape	Mod58	MTC	Claes	2018	NA	2329	5.00e-2	3.72e-2
Plasma IgM	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	5.00e-2	4.94e-2
B Hypermutation	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	5.00e-2	3.50e-2
Plasma IgG	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	5.00e-2	4.94e-2
Plasmablast	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	5.00e-2	2.94e-3
ILC	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	1.00e-2	3.39e-2
T CD8 activated	Facial Shape	Mod59	MTC	Claes	2018	NA	2329	1.00e-3	3.41e-2
T cell dividing	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	5.00e-2	7.67e-3
T cell dividing	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	1.00e-2	5.91e-3
NK dividing	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	5.00e-2	4.90e-2
NK dividing	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	1.00e-2	2.43e-2
DC 2	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	5.00e-2	2.01e-3
DC 1	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	5.00e-2	1.15e-2
DC 1	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	1.00e-2	1.23e-2
Neutrophil	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	5.00e-2	4.90e-2
DC plasmacytoid	Facial Shape	Mod6	MTC	Claes	2018	NA	2329	1.00e-2	2.43e-2
B naive	Facial Shape	Mod60	MTC	Claes	2018	NA	2329	5.00e-2	4.22e-3
B mature	Facial Shape	Mod60	MTC	Claes	2018	NA	2329	5.00e-2	1.56e-2
T CD8 gd	Facial Shape	Mod60	MTC	Claes	2018	NA	2329	5.00e-2	3.37e-2
DC 1	Facial Shape	Mod60	MTC	Claes	2018	NA	2329	1.00e-2	3.76e-2
B naive	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	1.25e-2
T cell dividing	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	8.24e-3
NK dividing	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	3.92e-2
T CD8 gd	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	1.25e-2
B Hypermutation	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	2.52e-4
B Hypermutation	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	1.00e-2	2.19e-3
Plasmablast	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	5.00e-2	3.92e-2
CD34 progenitor	Facial Shape	Mod61	MTC	Claes	2018	NA	2329	1.00e-2	2.37e-2
T CD8 MAIT	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	1.99e-3
T CD8 MAIT	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-2	3.02e-3
T CD8 MAIT	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
NK CD160pos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	1.99e-3
NK CD160pos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-2	2.81e-2
NK CD160pos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
T CD8 activated	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	1.22e-3
T CD8 activated	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-2	1.41e-2
T CD8 activated	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	3.60e-4
NK FCGR3Apos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	1.16e-2
NK FCGR3Apos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-2	2.81e-2
NK FCGR3Apos	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
T CD4 fh	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	3.18e-3
T CD8 CTL	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	1.72e-2
T CD8 CTL	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
T CD4 reg	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	4.97e-2
T CD4 naive	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	4.98e-3
T CD4 conv	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	4.97e-2
ILC	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	3.56e-2
T CD8 gd	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	5.00e-2	4.98e-3
T CD8 gd	Facial Shape	Mod62	MTC	Claes	2018	NA	2329	1.00e-3	4.91e-2
B naive	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	5.00e-2	1.13e-2
T CD4 fh	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	5.00e-2	4.81e-2
T cell dividing	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	5.00e-2	4.81e-2
T cell dividing	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	1.00e-2	3.37e-2
B mature	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	5.00e-2	1.67e-2
DC 1	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	5.00e-2	1.67e-2
T CD4 reg	Facial Shape	Mod63	MTC	Claes	2018	NA	2329	1.00e-3	2.58e-2
T CD8 MAIT	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	1.50e-2
T CD8 MAIT	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-2	4.88e-2
T CD8 MAIT	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-3	2.12e-3
T CD8 activated	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	6.77e-3
T CD8 activated	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-2	2.69e-2
B naive	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	2.84e-3
T CD4 fh	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	3.10e-2
T CD8 CTL	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	3.10e-2
T CD8 CTL	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-2	7.02e-3
T CD4 reg	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	4.34e-2
T CD4 naive	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	1.50e-2
T CD4 naive	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-3	9.50e-3
DC 1	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	2.37e-4
DC activated	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	5.00e-2	3.10e-2
T CD8 gd	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-2	1.41e-2
NK CD160pos	Facial Shape	Mod7	MTC	Claes	2018	NA	2329	1.00e-3	3.59e-2
Monocyte	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	5.00e-2	2.72e-2
Monocyte	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	2.10e-2
DC 2	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	5.00e-2	1.31e-2
DC 2	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	3.79e-2
Macrophage	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	5.00e-2	8.82e-3
Macrophage	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	5.63e-3
CD34 progenitor	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	5.00e-2	8.82e-3
CD34 progenitor	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	2.72e-3
CD34 progenitor	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
B mature	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	3.79e-2
ILC	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	3.79e-2
DC plasmacytoid	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-2	5.63e-3
DC plasmacytoid	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
T CD4 reg	Facial Shape	Mod8	MTC	Claes	2018	NA	2329	1.00e-3	4.37e-2
B naive	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	4.26e-2
B mature	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	4.26e-2
Monocyte	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	2.08e-2
DC 2	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	2.08e-2
DC 2	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-2	2.04e-2
DC 2	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-3	3.88e-3
Macrophage	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	4.26e-2
B Hypermutation	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	6.09e-3
B Hypermutation	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-2	2.04e-2
DC plasmacytoid	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	5.00e-2	2.08e-2
T CD4 fh	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-2	2.04e-2
T CD4 reg	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-2	1.01e-2
DC 1	Facial Shape	Mod9	MTC	Claes	2018	NA	2329	1.00e-3	1.79e-2
Monocyte	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.45e-2
DC 2	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	1.05e-4
DC 2	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	1.91e-2
DC 2	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-3	2.33e-3
DC 2	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-4	1.83e-2
DC 1	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.45e-2
Platelet	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.77e-3
Platelet	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	1.91e-2
Platelet	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-3	1.20e-2
DC activated	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	1.34e-2
Neutrophil	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	9.94e-4
Neutrophil	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	7.48e-3
T CD8 CTL	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	2.93e-2
B Hypermutation	Forced Expiratory Volume	Forced Expiratory Volume	MTC	Soler-Artigas	2015	NA	38199	1.00e-4	4.64e-2
T CD8 MAIT	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	2.86e-7
T CD8 activated	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.68e-2
NK FCGR3Apos	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	3.51e-2
T cell dividing	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.68e-2
B mature	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.68e-2
T CD8 CTL	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	6.71e-3
T CD4 reg	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	2.28e-4
T CD4 conv	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	1.36e-2
Macrophage	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	1.36e-2
Macrophage	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-4	2.30e-2
Macrophage	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-5	8.49e-3
ILC	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	6.71e-3
T CD8 gd	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	3.51e-2
DC 1	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.68e-2
DC plasmacytoid	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.62e-3
CD34 progenitor	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.68e-2
CD34 progenitor	Forced Expiratory Volume	Forced Expiratory Volume Over Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	2.86e-2
T CD8 MAIT	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	3.58e-2
T cell dividing	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	3.58e-3
T CD8 CTL	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	3.58e-2
T CD8 CTL	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-3	1.84e-2
T CD8 CTL	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-5	2.58e-2
NK dividing	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	1.10e-3
DC 2	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	7.39e-3
DC 2	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	2.65e-2
DC 1	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	2.68e-2
Platelet	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	7.39e-3
Platelet	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	1.13e-3
Platelet	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-3	3.81e-2
Platelet	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-4	1.92e-2
Plasmablast	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	5.00e-2	4.72e-2
CD34 progenitor	Forced Expiratory Volume	Forced Vital Capacity	MTC	Soler-Artigas	2015	NA	38199	1.00e-2	1.03e-2
B mature	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	3.79e-2
Monocyte	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	9.11e-3
NK dividing	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	1.34e-2
Macrophage	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	3.79e-2
T CD8 gd	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	1.92e-2
T CD8 gd	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	1.00e-2	9.35e-3
T CD8 gd	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	1.00e-3	7.22e-3
B Hypermutation	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	5.00e-2	3.79e-2
NK FCGR3Apos	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	1.00e-3	2.90e-2
T CD4 reg	Gestational Weight Gain	Early Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	7704	1.00e-3	7.22e-3
B naive	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	5.00e-2	2.50e-3
B naive	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	1.00e-2	7.78e-3
B naive	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	1.00e-3	4.37e-2
B mature	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	5.00e-2	3.34e-4
B mature	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	1.00e-2	1.77e-3
B Hypermutation	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	5.00e-2	4.15e-2
B Hypermutation	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	1.00e-2	2.83e-2
Plasmablast	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	5.00e-2	2.94e-2
Plasmablast	Gestational Weight Gain	Early Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	8559	1.00e-2	2.83e-2
T cell dividing	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	4.20e-2
T CD8 CTL	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	4.20e-2
T CD4 reg	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	1.14e-3
T CD4 reg	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	1.00e-2	4.07e-2
Monocyte	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	1.14e-3
DC 2	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	2.13e-2
Macrophage	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	1.48e-2
DC 1	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	6.75e-3
CD34 progenitor	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	4.20e-2
Neutrophil	Gestational Weight Gain	Late Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	8641	5.00e-2	4.20e-2
NK CD160pos	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	4.53e-2
NK FCGR3Apos	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	1.44e-3
NK dividing	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	3.47e-3
NK dividing	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	1.00e-2	4.71e-3
DC 2	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	4.53e-2
Macrophage	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	3.30e-2
B Hypermutation	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	2.37e-2
B Hypermutation	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	1.00e-2	1.71e-2
DC plasmacytoid	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	1.67e-2
Plasmablast	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	5.00e-2	3.30e-2
Plasmablast	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	1.00e-2	3.06e-2
T cell dividing	Gestational Weight Gain	Late Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	7681	1.00e-2	1.71e-2
T cell dividing	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	5.00e-2	6.54e-3
NK dividing	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	5.00e-2	6.54e-3
Unknown	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	5.00e-2	6.54e-3
T CD8 activated	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-2	2.73e-2
T CD8 CTL	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-2	4.85e-2
T CD4 reg	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-2	4.85e-2
T CD4 conv	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-2	4.85e-2
B mature	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-3	2.03e-2
T CD4 naive	Gestational Weight Gain	Total Gestational Weight Gain Maternal Variants	MTC	Warrington	2017	NA	16434	1.00e-3	2.03e-2
DC 2	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	1.86e-2
DC 1	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	1.86e-2
Plasma IgM	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	5.12e-4
B Hypermutation	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	9.91e-5
B Hypermutation	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	6.56e-3
Plasma IgG	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	8.54e-4
Platelet	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	3.79e-2
DC plasmacytoid	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	2.68e-2
DC plasmacytoid	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	4.89e-2
Plasmablast	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	5.00e-2	1.74e-4
Plasmablast	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	4.89e-2
NK CD160pos	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	1.35e-2
NK dividing	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	2.64e-2
Neutrophil	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-2	4.89e-2
T CD4 fh	Gestational Weight Gain	Total Gestational Weight Gain Offspring Variants	MTC	Warrington	2017	NA	10555	1.00e-3	2.22e-2
B mature	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.38e-2
DC activated	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.12e-2
Macrophage	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.64e-2
Platelet	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	1.00e-2	4.89e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	1.00e-2	4.89e-2
T CD4 reg	Glucose Stimulated Insulin Secretion	AUC Insulin	MTC	Prokopenko	2014	NA	10837	1.00e-3	1.74e-2
B mature	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.82e-3
Macrophage	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.40e-2
DC plasmacytoid	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.41e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	1.00e-2	3.27e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.75e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.91e-2
DC activated	Glucose Stimulated Insulin Secretion	AUC Insulin Over AUC Glucose	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.91e-2
DC 1	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.73e-2
Plasma IgM	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.89e-3
Plasma IgM	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	6.44e-3
Plasma IgG	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.89e-3
Plasma IgG	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	6.44e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.98e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	4.37e-2
Plasmablast	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.23e-3
Plasmablast	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	6.44e-3
Plasmablast	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.10e-2
B mature	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	3.09e-3
Macrophage	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	6.44e-3
B Hypermutation	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.43e-2
B Hypermutation	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.10e-2
DC activated	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	4.37e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	Corrected Insulin Response	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.28e-2
T CD8 MAIT	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	6.11e-3
NK FCGR3Apos	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	9.34e-3
NK FCGR3Apos	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	3.53e-2
T CD8 CTL	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.06e-2
T CD8 CTL	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.02e-2
Monocyte	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	9.34e-3
Macrophage	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.23e-4
Macrophage	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.45e-3
DC 1	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.40e-2
DC 1	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.02e-2
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.62e-6
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.94e-2
DC activated	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.40e-2
DC activated	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.12e-3
B mature	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.94e-2
Plasmablast	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	3.53e-2
Plasmablast	Glucose Stimulated Insulin Secretion	Disposition Index	MTC	Prokopenko	2014	NA	10837	1.00e-3	1.55e-2
T cell dividing	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.70e-2
NK dividing	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	4.90e-2
B Hypermutation	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.01e-3
B Hypermutation	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.37e-2
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.20e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.67e-3
Plasmablast	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.15e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.01e-3
CD34 progenitor	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.18e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	Incremental Insulin At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.37e-2
T cell dividing	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	8.26e-3
B mature	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	5.39e-3
B mature	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.71e-2
NK dividing	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.77e-2
DC 2	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.77e-2
Macrophage	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.83e-2
B Hypermutation	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.17e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	8.26e-3
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.66e-3
Plasmablast	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	5.00e-2	5.39e-3
CD34 progenitor	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-2	1.71e-2
NK FCGR3Apos	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-3	2.03e-2
Platelet	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes	MTC	Prokopenko	2014	NA	10837	1.00e-3	2.03e-2
NK FCGR3Apos	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.60e-2
Plasma IgM	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	5.28e-3
B Hypermutation	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.69e-4
Plasma IgG	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.76e-2
Plasma IgG	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.11e-2
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	8.20e-4
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.11e-2
DC plasmacytoid	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-3	2.12e-3
Plasmablast	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.91e-4
Plasmablast	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.11e-2
CD34 progenitor	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	5.00e-2	8.04e-3
B mature	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-2	3.92e-2
B mature	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-3	4.03e-4
DC 2	Glucose Stimulated Insulin Secretion	Insulin Response At 30 Minutes Corrected For BMI	MTC	Prokopenko	2014	NA	10837	1.00e-3	3.59e-2
Monocyte	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.57e-2
Monocyte	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	5.78e-3
NK dividing	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	7.63e-3
DC 2	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.17e-2
DC 2	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	5.78e-3
Macrophage	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.75e-2
DC 1	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	3.69e-2
Platelet	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	2.57e-2
Platelet	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	9.51e-4
Platelet	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-3	2.48e-3
Neutrophil	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	5.00e-2	1.17e-2
DC activated	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-2	2.74e-2
DC activated	Glucose Stimulated Insulin Secretion	Insulin Sensitivity Index	MTC	Prokopenko	2014	NA	10837	1.00e-3	2.48e-3
NK CD160pos	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	1.61e-2
NK FCGR3Apos	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	3.93e-2
T CD4 fh	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	3.93e-2
T cell dividing	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	1.16e-2
T CD4 reg	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	1.61e-2
NK dividing	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	2.96e-2
DC 1	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	2.20e-2
DC 1	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	6.38e-4
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	2.79e-3
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	2.53e-2
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-3	2.58e-2
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-4	9.79e-3
B Hypermutation	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	1.16e-2
B Hypermutation	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	2.53e-2
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	8.31e-3
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	2.53e-2
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-3	2.58e-2
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-4	1.18e-3
DC plasmacytoid	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	1.61e-2
Plasmablast	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	5.30e-5
Plasmablast	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	3.60e-3
Plasmablast	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-3	2.58e-2
Plasmablast	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-4	9.79e-3
DC activated	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	5.00e-2	8.31e-3
DC activated	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-2	6.09e-3
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Glucose	MTC	Manning	2012	NA	58074	1.00e-3	4.87e-2
T CD4 fh	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	3.65e-2
T CD4 reg	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	1.16e-2
T CD4 naive	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	4.93e-3
T CD4 naive	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	4.87e-2
T CD4 conv	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	1.93e-3
T CD4 conv	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	6.03e-3
DC 2	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	1.16e-2
B Hypermutation	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	1.74e-2
B Hypermutation	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	4.87e-2
DC activated	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	2.54e-2
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	5.00e-2	3.11e-3
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	2.58e-2
T cell dividing	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	2.58e-2
T cell dividing	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-3	4.91e-2
DC plasmacytoid	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	4.87e-2
Plasmablast	Glycemic Traits BMI Corrected	Fasting Glucose Interaction With BMI	MTC	Manning	2012	NA	58074	1.00e-2	2.58e-2
T CD8 MAIT	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	6.28e-3
T CD8 MAIT	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	2.13e-2
NK CD160pos	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.29e-2
NK CD160pos	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	2.22e-3
NK CD160pos	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	1.78e-2
NK CD160pos	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-4	2.73e-3
T CD4 fh	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	9.06e-3
T cell dividing	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.81e-2
T cell dividing	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	2.13e-2
T CD4 reg	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.21e-4
T CD4 reg	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	7.33e-3
T CD4 naive	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.81e-2
Monocyte	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	2.50e-2
Monocyte	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	4.30e-2
NK dividing	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	4.56e-2
NK dividing	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	2.22e-3
NK dividing	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	4.30e-2
ILC	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.81e-2
ILC	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	3.46e-2
ILC	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	6.67e-3
ILC	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-4	2.73e-3
T CD8 gd	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	9.06e-3
DC 1	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	1.81e-2
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	5.00e-2	4.28e-3
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-2	7.33e-3
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	2.28e-3
CD34 progenitor	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-4	6.39e-5
Macrophage	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-3	4.30e-2
Macrophage	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-4	1.35e-2
DC 2	Glycemic Traits BMI Corrected	Fasting Insulin	MTC	Manning	2012	NA	51750	1.00e-4	1.35e-2
T cell dividing	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	9.55e-3
T CD8 CTL	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	3.00e-2
NK dividing	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	1.42e-2
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	4.22e-2
Plasma IgM	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-2	2.33e-2
B Hypermutation	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	9.55e-3
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	1.42e-2
Plasma IgG	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-2	4.37e-2
Plasmablast	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	5.00e-2	1.60e-3
Plasmablast	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-2	4.37e-2
T CD8 MAIT	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-2	2.33e-2
T CD4 conv	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-2	4.37e-2
Monocyte	Glycemic Traits BMI Corrected	Fasting Insulin Interaction With BMI	MTC	Manning	2012	NA	51750	1.00e-3	1.79e-2
NK CD160pos	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	4.36e-2
NK CD160pos	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-3	2.28e-2
T cell dividing	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.70e-2
NK dividing	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	8.42e-3
DC 2	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	4.36e-2
Macrophage	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.70e-2
ILC	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.70e-2
B Hypermutation	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.73e-4
DC plasmacytoid	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.21e-2
Plasmablast	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	3.23e-2
Plasmablast	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-2	2.33e-2
Plasmablast	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-3	4.89e-2
CD34 progenitor	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	5.00e-2	1.22e-5
CD34 progenitor	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-2	1.33e-3
Plasma IgM	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-2	1.40e-2
Plasma IgM	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-3	4.89e-2
Plasma IgM	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-4	3.16e-3
Plasma IgM	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-5	2.30e-2
Plasma IgG	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-2	1.40e-2
Plasma IgG	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-4	1.17e-2
Plasma IgG	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-5	2.30e-2
DC activated	Glycemic Traits	Fasting Glucose	ETC	Dupuis	2010	NA	46186	1.00e-3	4.89e-2
NK CD160pos	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	1.27e-3
NK CD160pos	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	1.00e-2	5.39e-4
T cell dividing	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	1.96e-3
B mature	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	1.27e-3
Monocyte	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	1.27e-3
NK dividing	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	6.62e-3
NK dividing	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	1.00e-2	8.37e-3
Macrophage	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	2.71e-2
B Hypermutation	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	2.98e-3
CD34 progenitor	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	5.00e-2	1.27e-3
CD34 progenitor	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	1.00e-2	2.49e-4
T CD4 fh	Glycemic Traits	Fasting Insulin	ETC	Dupuis	2010	NA	38238	1.00e-2	4.40e-2
NK CD160pos	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	2.65e-2
T cell dividing	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	1.31e-2
B mature	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	9.00e-3
B mature	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-2	3.06e-2
T CD4 reg	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	4.03e-3
Monocyte	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	2.63e-3
NK dividing	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	6.07e-3
ILC	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	1.88e-2
Plasma IgM	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	2.65e-2
Plasma IgM	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-4	1.35e-2
B Hypermutation	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	1.88e-2
Platelet	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	6.07e-3
Plasmablast	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	1.69e-3
Plasmablast	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-2	3.06e-2
Plasmablast	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-3	1.54e-2
Plasmablast	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-4	2.73e-3
CD34 progenitor	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	5.00e-2	2.77e-5
CD34 progenitor	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-2	2.18e-4
CD34 progenitor	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-3	1.54e-2
T CD8 activated	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-2	3.06e-2
DC activated	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-3	1.54e-2
Plasma IgG	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-4	1.35e-2
Neutrophil	Glycemic Traits	HOMA B	MTC	Dupuis	2010	NA	36466	1.00e-4	1.35e-2
NK CD160pos	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	5.00e-2	4.71e-3
NK CD160pos	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-2	1.09e-3
T cell dividing	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	5.00e-2	1.45e-2
B mature	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	5.00e-2	4.71e-3
B mature	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-2	4.07e-2
B Hypermutation	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	5.00e-2	1.45e-2
B Hypermutation	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-2	2.44e-2
CD34 progenitor	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	5.00e-2	4.71e-3
CD34 progenitor	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-2	1.09e-3
NK dividing	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-2	1.41e-2
NK dividing	Glycemic Traits	HOMA IR	MTC	Dupuis	2010	NA	37037	1.00e-3	2.15e-2
T CD8 MAIT	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	3.04e-2
T CD8 MAIT	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	1.16e-2
NK CD160pos	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	7.14e-3
NK CD160pos	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	3.65e-2
NK CD160pos	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	3.55e-2
NK FCGR3Apos	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	3.92e-2
T cell dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	2.63e-3
T cell dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	3.65e-2
T cell dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	2.13e-2
T cell dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	4.06e-3
T cell dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.58e-3
B mature	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	3.04e-2
B mature	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	7.65e-3
B mature	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	6.85e-3
NK dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	8.78e-4
NK dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	1.16e-2
NK dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	4.65e-4
NK dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	9.84e-5
NK dividing	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.58e-3
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	1.84e-3
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	3.65e-2
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	3.55e-2
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	1.87e-2
B Hypermutation	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	2.41e-2
Platelet	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	2.32e-2
Platelet	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	6.85e-3
Platelet	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	7.02e-4
Platelet	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.80e-4
Plasmablast	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	5.00e-2	3.71e-3
Plasmablast	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-2	7.00e-4
Plasmablast	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	2.18e-4
Plasmablast	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	1.13e-5
Plasmablast	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.60e-5
DC 1	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	2.13e-2
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	1.23e-2
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	4.06e-3
Plasma IgM	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.05e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	3.55e-2
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	8.98e-3
Plasma IgG	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-5	1.05e-2
DC plasmacytoid	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-3	1.91e-3
DC plasmacytoid	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	8.98e-3
CD34 progenitor	Hemoglobin A1c	Hemoglobin A1c European	MTC	Wheeler	2017	NA	159940	1.00e-4	3.69e-2
T CD8 MAIT	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	2.16e-8
T CD8 MAIT	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	2.58e-7
T CD8 MAIT	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	7.47e-6
T CD8 MAIT	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	8.68e-5
T CD8 MAIT	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	7.36e-4
NK CD160pos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.50e-4
NK CD160pos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	1.34e-4
NK CD160pos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.32e-2
NK CD160pos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	3.49e-2
T CD8 activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.25e-8
T CD8 activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	4.85e-5
T CD8 activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	2.96e-5
T CD8 activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	2.51e-3
B naive	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.02e-4
B naive	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	2.86e-5
B naive	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.94e-3
B naive	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	1.34e-2
B naive	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	3.19e-2
NK FCGR3Apos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	4.89e-7
NK FCGR3Apos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	4.85e-5
NK FCGR3Apos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.32e-2
NK FCGR3Apos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	4.52e-3
NK FCGR3Apos	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	1.87e-2
T CD4 fh	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.29e-3
T CD4 fh	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	3.08e-3
T CD4 fh	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.14e-3
B mature	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.28e-5
B mature	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	1.35e-7
B mature	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	7.47e-6
B mature	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	1.80e-4
B mature	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	1.51e-3
T CD8 CTL	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	4.07e-9
T CD8 CTL	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	9.04e-7
T CD8 CTL	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.50e-5
T CD8 CTL	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	3.63e-4
T CD8 CTL	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	3.00e-3
T CD4 reg	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	3.18e-4
T CD4 reg	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	5.59e-4
T CD4 reg	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	5.28e-3
T CD4 reg	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	3.49e-2
Monocyte	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	8.11e-3
Monocyte	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	3.00e-2
B T doublet	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	4.58e-4
B T doublet	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	1.35e-3
B T doublet	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.32e-2
DC 2	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	6.83e-5
DC 2	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	1.66e-5
DC 2	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	5.28e-3
DC 2	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	3.49e-2
Macrophage	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	8.11e-3
Macrophage	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	4.70e-2
Macrophage	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	2.01e-2
T CD8 gd	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.29e-3
T CD8 gd	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	9.53e-3
T CD8 gd	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	5.28e-3
T CD8 gd	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	1.36e-3
DC 1	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	2.47e-3
DC 1	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	5.39e-6
DC 1	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	7.47e-6
DC 1	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-4	7.11e-4
DC 1	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	1.51e-3
Plasma IgM	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	3.70e-2
DC plasmacytoid	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.07e-2
DC plasmacytoid	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	4.70e-2
Plasmablast	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	4.62e-2
DC activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	1.07e-2
DC activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	3.52e-4
DC activated	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.94e-3
CD34 progenitor	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	5.00e-2	2.31e-2
CD34 progenitor	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	4.70e-2
CD34 progenitor	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-5	1.05e-2
T CD4 conv	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-2	1.88e-2
T CD4 conv	Inflammatory Bowel Disease European	Crohn's disease	ETC	Liu	2015	5956	14927	1.00e-3	1.32e-2
T CD8 MAIT	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	2.21e-10
T CD8 MAIT	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.15e-5
T CD8 MAIT	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	2.25e-6
T CD8 MAIT	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	2.96e-5
T CD8 MAIT	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	3.73e-4
NK CD160pos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	2.10e-7
NK CD160pos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	1.34e-2
NK CD160pos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	5.95e-3
NK CD160pos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	7.34e-3
NK CD160pos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	4.95e-3
T CD8 activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	4.82e-8
T CD8 activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.20e-4
T CD8 activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	1.01e-4
T CD8 activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	8.08e-4
T CD8 activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	4.95e-3
B naive	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	2.47e-4
B naive	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.48e-3
B naive	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	2.94e-2
B naive	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	8.74e-3
NK FCGR3Apos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	7.93e-8
NK FCGR3Apos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	6.84e-6
NK FCGR3Apos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	1.63e-5
NK FCGR3Apos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	1.42e-5
NK FCGR3Apos	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	7.63e-6
T CD4 fh	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	4.90e-4
T CD4 fh	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	2.45e-2
T CD4 fh	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	5.34e-4
T CD4 fh	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	2.94e-2
T cell dividing	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	1.56e-2
B mature	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	3.38e-7
B mature	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	7.61e-7
B mature	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	1.79e-4
B mature	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	2.96e-5
B mature	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	7.63e-6
T CD8 CTL	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	1.15e-11
T CD8 CTL	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	1.34e-6
T CD8 CTL	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	5.59e-5
T CD8 CTL	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	1.19e-4
T CD8 CTL	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	3.94e-5
T CD4 reg	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	3.27e-6
T CD4 reg	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	1.92e-5
T CD4 reg	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	3.04e-5
T CD4 reg	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	4.37e-4
T CD4 reg	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	2.48e-2
Monocyte	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	8.32e-5
Monocyte	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.25e-2
Monocyte	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	3.97e-2
DC 2	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	7.68e-6
DC 2	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	1.31e-4
DC 2	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	5.59e-5
DC 2	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	4.37e-4
DC 2	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	1.44e-3
Macrophage	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	6.82e-4
Macrophage	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	1.82e-2
Macrophage	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	4.12e-2
ILC	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	9.48e-3
ILC	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.25e-2
ILC	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	2.91e-2
T CD8 gd	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	3.49e-4
T CD8 gd	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	3.25e-2
T CD8 gd	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	1.48e-3
T CD8 gd	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	1.20e-2
T CD8 gd	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	2.72e-3
DC 1	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	3.88e-5
DC 1	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	8.25e-5
DC 1	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	8.98e-4
DC 1	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	2.56e-3
DC 1	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	7.45e-4
DC plasmacytoid	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	4.90e-4
DC activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	9.43e-4
DC activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	4.90e-4
DC activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-3	8.98e-4
DC activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	1.20e-2
DC activated	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	8.74e-3
CD34 progenitor	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	5.00e-2	1.76e-3
CD34 progenitor	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-2	4.97e-3
CD34 progenitor	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-4	4.42e-2
CD34 progenitor	Inflammatory Bowel Disease European	Inflammatory Bowel Disease	ETC	Liu	2015	12882	21770	1.00e-5	1.50e-2
T CD8 MAIT	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	7.29e-7
T CD8 MAIT	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	6.81e-4
T CD8 MAIT	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	6.07e-5
T CD8 MAIT	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	3.26e-4
T CD8 MAIT	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.65e-2
NK CD160pos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	2.11e-4
NK CD160pos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.07e-3
NK CD160pos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	4.07e-3
NK CD160pos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	4.14e-2
T CD8 activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	6.50e-5
T CD8 activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.07e-3
T CD8 activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	4.07e-3
T CD8 activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.33e-3
B naive	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	2.94e-2
B naive	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.65e-2
NK FCGR3Apos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	4.87e-6
NK FCGR3Apos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	2.66e-4
NK FCGR3Apos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	1.19e-4
NK FCGR3Apos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	3.26e-4
NK FCGR3Apos	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.98e-3
T CD4 fh	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	9.00e-4
T CD4 fh	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	3.13e-2
T cell dividing	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	1.76e-3
T cell dividing	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	3.13e-2
B mature	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	4.87e-6
B mature	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.07e-3
B mature	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	2.65e-2
B mature	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	6.70e-4
B mature	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	6.26e-5
T CD8 CTL	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	1.92e-6
T CD8 CTL	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	9.82e-5
T CD8 CTL	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	7.73e-4
T CD8 CTL	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	3.26e-4
T CD8 CTL	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.98e-3
T CD4 reg	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	1.85e-5
T CD4 reg	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.63e-4
T CD4 reg	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	4.07e-3
T CD4 reg	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.51e-2
T CD4 reg	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	8.53e-3
T CD4 conv	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	2.31e-2
Monocyte	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	3.32e-3
Monocyte	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.64e-2
NK dividing	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	2.94e-2
B T doublet	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	1.80e-2
DC 2	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	3.08e-4
DC 2	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	6.81e-4
DC 2	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	2.40e-3
DC 2	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	6.70e-4
DC 2	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	8.88e-4
Macrophage	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	2.31e-2
Macrophage	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	2.28e-2
Macrophage	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	1.72e-2
Macrophage	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.51e-2
Macrophage	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	4.20e-3
ILC	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	1.26e-3
ILC	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.63e-4
ILC	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	2.65e-2
T CD8 gd	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	3.32e-3
T CD8 gd	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	2.65e-2
T CD8 gd	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.33e-3
T CD8 gd	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.65e-2
DC 1	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	6.50e-5
DC 1	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	1.07e-3
DC 1	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	4.07e-3
DC 1	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.53e-4
DC 1	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	2.38e-5
DC plasmacytoid	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	3.32e-3
DC activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	5.00e-2	7.66e-6
DC activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-2	5.84e-5
DC activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	4.07e-3
DC activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	1.53e-4
DC activated	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	1.58e-4
CD34 progenitor	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-3	3.98e-2
CD34 progenitor	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-4	2.55e-2
CD34 progenitor	Inflammatory Bowel Disease European	Ulcerative Colitis	ETC	Liu	2015	6968	20464	1.00e-5	3.83e-4
T cell dividing	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	2.36e-3
T cell dividing	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	1.00e-2	2.91e-2
B mature	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	2.36e-3
Plasma IgM	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	2.36e-3
B Hypermutation	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	5.54e-4
B Hypermutation	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	1.00e-2	2.91e-2
Plasma IgG	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	2.67e-2
Plasmablast	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	5.00e-2	1.28e-2
Neutrophil	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	1.00e-2	2.91e-2
Monocyte	Insulin Secretion	Acute Insulin Response	MTC	Wood	2017	NA	2087	1.00e-3	4.02e-2
T cell dividing	Insulin Secretion	Acute Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	1.58e-2
B Hypermutation	Insulin Secretion	Acute Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	7.12e-3
CD34 progenitor	Insulin Secretion	Acute Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	3.27e-2
T cell dividing	Insulin Secretion	Acute Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	2.25e-2
T cell dividing	Insulin Secretion	Acute Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2087	1.00e-2	3.92e-2
B Hypermutation	Insulin Secretion	Acute Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	4.53e-3
B Hypermutation	Insulin Secretion	Acute Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2087	1.00e-2	2.19e-2
Plasmablast	Insulin Secretion	Acute Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2087	5.00e-2	2.25e-2
NK dividing	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	5.00e-2	1.79e-3
Plasma IgM	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	5.00e-2	6.53e-4
Plasma IgM	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	1.00e-2	2.64e-2
B Hypermutation	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	5.00e-2	2.36e-2
B Hypermutation	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	1.00e-2	2.64e-2
Plasma IgG	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	5.00e-2	2.89e-3
Plasma IgG	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	1.00e-2	4.89e-2
Plasmablast	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	5.00e-2	4.58e-3
Plasmablast	Insulin Secretion	Disposition Index	MTC	Wood	2017	NA	2042	1.00e-2	1.35e-2
T CD8 MAIT	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	4.62e-2
T CD8 activated	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	2.29e-2
NK FCGR3Apos	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	4.62e-2
T CD8 CTL	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	2.29e-2
NK dividing	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	2.84e-3
T CD8 gd	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	4.48e-3
Plasma IgM	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	3.29e-2
Plasmablast	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	5.00e-2	1.57e-2
Plasmablast	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	1.00e-2	4.71e-2
B Hypermutation	Insulin Secretion	Disposition Index Adjusted For BMI	MTC	Wood	2017	NA	2042	1.00e-2	6.22e-3
T CD8 MAIT	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	1.45e-2
T CD8 MAIT	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	8.21e-3
T CD8 activated	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	3.17e-2
T CD8 activated	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	3.57e-3
NK FCGR3Apos	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	9.56e-3
NK FCGR3Apos	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	1.77e-2
T CD4 fh	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	3.17e-2
T CD4 fh	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	1.77e-2
T cell dividing	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	4.52e-2
T CD4 reg	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	8.63e-4
T CD4 reg	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	1.77e-2
NK dividing	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	1.45e-3
B T doublet	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	3.17e-2
B T doublet	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	3.60e-2
DC 2	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	9.56e-3
T CD8 gd	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	1.45e-2
DC 1	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	2.40e-3
B Hypermutation	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	2.40e-3
Plasmablast	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	5.00e-2	6.15e-3
T CD8 CTL	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	3.60e-2
ILC	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-2	3.57e-3
ILC	Insulin Secretion	Insulin Secretion Rate	MTC	Wood	2017	NA	527	1.00e-3	2.03e-2
T CD8 MAIT	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.08e-2
T CD8 MAIT	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-2	3.92e-2
T CD8 activated	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.64e-2
T CD8 activated	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-2	1.96e-2
NK FCGR3Apos	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.64e-2
T CD4 fh	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.64e-2
T cell dividing	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.08e-2
T cell dividing	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-2	1.96e-2
T CD4 reg	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.70e-3
T CD4 reg	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-2	3.92e-2
NK dividing	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	2.78e-3
B T doublet	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	3.51e-2
DC 2	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	7.03e-3
Macrophage	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	4.99e-2
T CD8 gd	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.64e-2
DC 1	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	7.03e-3
Plasma IgM	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	3.51e-2
B Hypermutation	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	7.03e-3
Plasmablast	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	5.00e-2	1.70e-3
ILC	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-2	9.17e-3
ILC	Insulin Secretion	Insulin Secretion Rate Adjusted For BMI	MTC	Wood	2017	NA	527	1.00e-3	2.59e-2
T cell dividing	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	1.42e-5
B mature	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	2.60e-2
B mature	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	1.00e-2	2.95e-2
Monocyte	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	3.70e-2
NK dividing	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	3.36e-3
DC 1	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	2.60e-2
B Hypermutation	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	4.83e-7
B Hypermutation	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	1.00e-2	1.62e-2
Plasmablast	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	2.11e-3
CD34 progenitor	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	2.60e-2
Neutrophil	Insulin Secretion	Peak Insulin Response	MTC	Wood	2017	NA	2159	5.00e-2	1.21e-2
B mature	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	3.88e-2
B mature	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	2.47e-2
B Hypermutation	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	9.26e-4
B Hypermutation	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	7.08e-3
Plasmablast	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	8.85e-3
T cell dividing	Insulin Secretion	Peak Insulin Response Adjusted For BMI And Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	1.35e-2
T cell dividing	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	4.52e-4
T cell dividing	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	2.85e-2
NK dividing	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	1.19e-2
B Hypermutation	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	2.55e-5
B Hypermutation	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	4.06e-3
Plasmablast	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	5.00e-2	1.19e-2
B mature	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-2	4.06e-3
B T doublet	Insulin Secretion	Peak Insulin Response Adjusted For Insulin Sensitivity	MTC	Wood	2017	NA	2159	1.00e-3	2.38e-2
T CD8 MAIT	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	5.00e-2	2.57e-3
T CD8 MAIT	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-3	1.00e-2
T CD8 activated	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	5.00e-2	1.99e-2
T CD8 activated	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-2	2.19e-2
T CD4 fh	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	5.00e-2	3.64e-4
T CD4 fh	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-2	2.19e-2
T CD4 fh	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-3	4.37e-2
T CD8 CTL	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	5.00e-2	2.83e-2
Macrophage	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-2	5.90e-3
T CD8 gd	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-2	2.19e-2
Plasmablast	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-2	5.90e-3
NK CD160pos	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-3	4.37e-2
T CD4 naive	Insulin Sensitivity Index	Model 1	MTC	Walford	2016	NA	16753	1.00e-3	4.37e-2
T CD8 MAIT	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	3.57e-2
T CD8 activated	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	5.42e-3
NK FCGR3Apos	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	3.57e-2
T CD4 fh	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	8.19e-3
T CD4 fh	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-2	3.62e-2
T CD4 reg	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	2.54e-2
T CD4 naive	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	4.92e-2
T CD4 naive	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-2	3.62e-2
T CD4 naive	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-3	3.16e-2
NK dividing	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	2.54e-2
Macrophage	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	3.57e-2
DC 1	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	3.57e-2
B Hypermutation	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	1.21e-2
Platelet	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	4.92e-2
DC plasmacytoid	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	1.77e-2
DC plasmacytoid	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-2	1.13e-2
Plasmablast	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	5.00e-2	1.21e-2
Plasmablast	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-2	3.62e-2
B naive	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-2	2.07e-2
Plasma IgG	Insulin Sensitivity Index	Model 2	MTC	Walford	2016	NA	16753	1.00e-3	9.41e-3
T CD8 MAIT	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	2.04e-2
B naive	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	2.04e-2
T CD4 fh	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	1.00e-2
T CD4 fh	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-2	1.94e-2
T cell dividing	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	4.62e-3
T cell dividing	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-2	1.94e-2
Monocyte	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	1.44e-2
Monocyte	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-3	3.20e-2
NK dividing	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	4.62e-3
ILC	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	6.86e-3
B Hypermutation	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	1.29e-3
B Hypermutation	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-2	1.49e-3
Platelet	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	1.13e-4
Platelet	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-2	3.00e-3
DC plasmacytoid	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	3.89e-2
Plasmablast	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	5.00e-2	8.16e-4
Plasmablast	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-2	5.80e-3
NK FCGR3Apos	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-3	3.20e-2
DC activated	Insulin Sensitivity Index	Model 3	MTC	Walford	2016	NA	16753	1.00e-3	3.20e-2
T CD8 activated	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	4.77e-2
B naive	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	1.61e-2
T CD4 reg	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	2.89e-3
T CD4 reg	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	1.00e-2	4.54e-2
Macrophage	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	4.77e-2
Macrophage	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	1.00e-2	1.29e-2
ILC	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	2.36e-2
DC 1	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	7.10e-3
B Hypermutation	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	7.10e-3
Plasmablast	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	4.58e-3
DC activated	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	1.08e-2
CD34 progenitor	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	5.00e-2	2.36e-2
CD34 progenitor	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	1.00e-2	1.29e-2
T CD4 naive	Intracerebral Hemorrhage	All ICH	MTC	Woo	2014	1545	1481	1.00e-2	4.54e-2
T cell dividing	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	5.00e-2	1.39e-2
T CD4 reg	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	5.00e-2	4.46e-2
Macrophage	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	5.00e-2	2.09e-2
B Hypermutation	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	5.00e-2	3.56e-3
B Hypermutation	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	1.00e-2	1.37e-2
CD34 progenitor	Intracerebral Hemorrhage	Lobar ICH	MTC	Woo	2014	664	1481	5.00e-2	1.39e-2
T CD4 reg	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	2.54e-4
T CD4 reg	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	2.01e-3
Monocyte	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	3.56e-2
Macrophage	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	3.56e-2
DC 1	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	1.22e-3
DC 1	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	3.50e-2
Plasma IgM	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	4.97e-2
Plasma IgG	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	1.16e-2
Platelet	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	2.49e-2
DC plasmacytoid	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	4.97e-2
Plasmablast	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	1.99e-3
Plasmablast	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	9.30e-3
DC activated	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	1.72e-2
DC activated	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	1.85e-2
CD34 progenitor	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	7.67e-3
Neutrophil	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	5.00e-2	2.49e-2
T CD4 fh	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	1.85e-2
B Hypermutation	Intracerebral Hemorrhage	Nonlobar ICH	MTC	Woo	2014	881	1481	1.00e-2	3.50e-2
T CD8 MAIT	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	4.93e-2
T CD4 fh	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	8.66e-3
T CD8 CTL	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	4.93e-2
T CD4 reg	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	5.81e-3
T CD4 reg	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	2.47e-2
T CD4 conv	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	1.83e-2
T CD4 conv	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	2.47e-2
Monocyte	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	4.93e-2
NK dividing	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	3.60e-2
NK dividing	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	7.34e-3
DC 2	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	1.27e-2
DC 2	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	2.47e-2
ILC	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	1.83e-2
ILC	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	1.38e-2
Plasma IgM	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	1.27e-2
Plasma IgG	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	4.93e-2
DC plasmacytoid	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	4.93e-2
DC plasmacytoid	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	4.26e-2
Plasmablast	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	5.00e-2	1.83e-2
T cell dividing	Ischaemic Stroke	All Stroke	MTC	Traylor	2012	10210	12285	1.00e-2	7.34e-3
NK CD160pos	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.91e-2
B naive	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	3.64e-3
T cell dividing	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	2.76e-2
T CD8 CTL	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	5.67e-3
Monocyte	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.30e-2
NK dividing	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.42e-3
NK dividing	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	1.00e-2	2.33e-2
DC 1	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.30e-2
Plasma IgM	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.91e-2
B Hypermutation	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	3.64e-3
B Hypermutation	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	1.00e-2	1.17e-2
Plasma IgG	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	8.67e-3
Platelet	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.91e-2
Plasmablast	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	5.00e-2	1.30e-2
Plasmablast	Ischaemic Stroke	Cardioembolic Stroke	MTC	Traylor	2012	1715	12285	1.00e-2	2.33e-2
T CD8 MAIT	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.52e-5
T CD8 activated	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	7.23e-4
T CD8 activated	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	1.00e-2	2.20e-2
NK FCGR3Apos	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	4.56e-3
T CD4 fh	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.03e-2
T CD4 fh	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	1.00e-2	4.07e-2
T cell dividing	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	3.08e-2
T CD8 CTL	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.03e-2
T CD8 CTL	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	1.00e-2	2.52e-3
T CD4 reg	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.03e-2
T CD4 conv	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.88e-3
Monocyte	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	6.92e-3
DC 2	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	1.51e-2
Macrophage	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	2.18e-2
DC activated	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	5.00e-2	2.18e-2
Plasma IgM	Ischaemic Stroke	Large Vessel Disease	MTC	Traylor	2012	1877	12285	1.00e-2	4.07e-2
Monocyte	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	3.09e-2
NK dividing	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	4.46e-2
DC 2	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	5.73e-3
DC 2	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	1.00e-2	1.70e-2
Macrophage	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	4.33e-4
Macrophage	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	1.00e-2	8.07e-3
B Hypermutation	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	3.09e-2
DC plasmacytoid	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	1.39e-2
Plasmablast	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	3.09e-2
DC activated	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	1.39e-2
CD34 progenitor	Kidney Function	CKDi	MTC	Gorski	2015	NA	45530	5.00e-2	2.09e-2
T CD8 MAIT	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	2.87e-2
NK CD160pos	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	2.02e-3
B naive	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	4.15e-2
Macrophage	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	8.37e-3
Macrophage	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	3.89e-2
B Hypermutation	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	4.15e-2
Plasmablast	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	2.87e-2
DC activated	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	8.37e-3
DC activated	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	3.89e-2
CD34 progenitor	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	5.00e-2	8.37e-3
CD34 progenitor	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	3.89e-2
CD34 progenitor	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-3	3.23e-2
NK FCGR3Apos	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	3.89e-2
NK FCGR3Apos	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-3	3.23e-2
T CD8 CTL	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	3.89e-2
T CD8 gd	Kidney Function	CKDi25	MTC	Gorski	2015	NA	45530	1.00e-2	1.01e-2
T CD8 MAIT	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	5.31e-3
T CD8 activated	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	1.25e-2
B naive	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	2.74e-2
T cell dividing	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	7.51e-4
T CD4 conv	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	2.74e-2
NK dividing	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	1.87e-2
Macrophage	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	3.35e-3
T CD8 gd	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	3.92e-2
DC 1	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	3.92e-2
Plasma IgM	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	8.24e-3
Plasma IgM	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	1.00e-2	9.91e-4
Plasma IgG	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	2.52e-4
Plasma IgG	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	1.00e-2	5.28e-5
Plasma IgG	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	1.00e-3	4.91e-2
DC plasmacytoid	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	1.87e-2
Plasmablast	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	5.00e-2	4.25e-5
Plasmablast	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	1.00e-2	1.16e-2
Plasmablast	Kidney Function	eGFR Decline	MTC	Gorski	2015	NA	45530	1.00e-3	4.91e-2
T cell dividing	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.64e-4
Monocyte	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.72e-3
Monocyte	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	1.02e-3
NK dividing	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.13e-2
DC 2	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.42e-2
Macrophage	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.67e-4
Macrophage	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	2.58e-3
DC 1	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.72e-3
Plasma IgM	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.13e-2
B Hypermutation	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	8.09e-4
Plasma IgG	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	9.29e-3
Plasmablast	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.64e-4
DC activated	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.13e-2
CD34 progenitor	Kidney Function	eGFR Decline With Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.13e-2
T CD8 MAIT	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.50e-3
T CD8 activated	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.06e-3
B naive	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.33e-2
T CD4 fh	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.33e-2
T cell dividing	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.53e-2
NK dividing	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.00e-2
Macrophage	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.77e-2
Macrophage	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-3	3.41e-2
T CD8 gd	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.00e-2
DC 1	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	3.33e-2
Plasma IgM	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.77e-2
Plasma IgM	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	5.11e-3
Plasma IgM	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-3	3.41e-2
Plasma IgG	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	8.94e-4
Plasma IgG	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	9.26e-4
Plasma IgG	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-3	3.41e-2
Plasmablast	Kidney Function	eGFR Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	2.95e-4
B naive	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	2.96e-2
T cell dividing	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	3.36e-3
T cell dividing	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	1.00e-2	9.30e-3
T CD4 reg	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	4.28e-2
NK dividing	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	4.28e-2
DC 1	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	8.55e-3
B Hypermutation	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	1.21e-3
DC plasmacytoid	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	8.55e-3
DC activated	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	2.96e-2
CD34 progenitor	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	5.00e-2	8.55e-3
CD34 progenitor	Kidney Function	Rapid Decline	MTC	Gorski	2015	NA	45530	1.00e-2	9.30e-3
B naive	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.87e-2
T cell dividing	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.81e-3
T cell dividing	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	3.16e-2
B mature	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.07e-2
NK dividing	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.22e-2
B Hypermutation	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	6.11e-4
B Hypermutation	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-2	3.16e-2
DC plasmacytoid	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.07e-2
DC plasmacytoid	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-3	1.59e-2
DC activated	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	4.07e-2
CD34 progenitor	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	5.00e-2	1.81e-3
CD34 progenitor	Kidney Function	Rapid Decline Without Chronic Kidney Disease	MTC	Gorski	2015	NA	45530	1.00e-3	1.59e-2
T cell dividing	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	1.43e-4
T cell dividing	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	1.72e-3
NK dividing	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	1.11e-5
NK dividing	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	4.33e-4
Plasma IgM	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	8.83e-3
Plasma IgM	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	4.00e-3
B Hypermutation	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	1.87e-3
B Hypermutation	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	5.96e-3
Plasma IgG	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	1.87e-3
Plasma IgG	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	1.72e-3
Plasmablast	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	5.00e-2	1.68e-6
Plasmablast	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-2	9.54e-5
T CD4 reg	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-4	2.95e-2
T CD4 reg	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-5	8.51e-3
NK FCGR3Apos	Kidney Function	Serum Creatinine	MTC	Gorski	2017	NA	45530	1.00e-5	3.53e-2
NK CD160pos	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	2.80e-2
T cell dividing	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	2.21e-4
T cell dividing	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-2	3.39e-2
T cell dividing	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-3	4.96e-2
T CD8 CTL	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	6.21e-4
NK dividing	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	1.63e-3
Macrophage	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	6.13e-3
DC 1	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	2.29e-5
DC 1	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-3	4.96e-2
Plasma IgM	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	3.91e-2
B Hypermutation	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	3.91e-2
Plasma IgG	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	1.36e-2
Platelet	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	1.36e-2
Platelet	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-2	1.04e-2
Plasmablast	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	5.00e-2	2.29e-5
Plasmablast	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-2	3.39e-2
Plasmablast	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-3	5.96e-3
CD34 progenitor	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-2	1.29e-3
B naive	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-3	4.96e-2
Monocyte	Kidney Function	Serum Cystatine	MTC	Gorski	2017	NA	45530	1.00e-3	4.96e-2
T CD4 reg	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	1.65e-5
T CD4 reg	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
Monocyte	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	4.83e-2
Monocyte	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
Monocyte	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	2.42e-3
NK dividing	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	3.48e-2
NK dividing	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	3.16e-2
Macrophage	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	4.89e-4
Macrophage	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	1.68e-5
Macrophage	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	5.45e-4
Plasmablast	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	4.89e-4
DC activated	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	5.00e-2	3.48e-2
DC activated	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	7.74e-3
T cell dividing	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
DC 2	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
DC 2	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	2.42e-3
DC 1	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
DC 1	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	3.16e-2
Neutrophil	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-2	2.91e-2
NK FCGR3Apos	Kidney Function	Chronic Kidney Disease	MTC	Kottgen	2010	NA	67093	1.00e-3	3.16e-2
T CD8 MAIT	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	1.79e-2
T cell dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	1.89e-4
T cell dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-2	1.17e-3
T cell dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-3	1.11e-2
T cell dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-4	2.97e-2
T CD4 reg	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	1.79e-2
NK dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	2.95e-4
NK dividing	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-2	2.17e-2
Macrophage	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	1.79e-2
Macrophage	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-2	9.00e-3
Plasma IgM	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	1.79e-2
B Hypermutation	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	3.34e-3
Plasmablast	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	5.00e-2	4.60e-5
Plasmablast	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-2	1.41e-5
Plasmablast	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-3	1.11e-2
Plasmablast	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-4	2.97e-2
Plasmablast	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-5	2.30e-2
Platelet	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-2	4.76e-2
Monocyte	Kidney Function	Serum Creatinine	MTC	Kottgen	2010	NA	67093	1.00e-4	2.97e-2
B naive	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	1.38e-2
T cell dividing	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	6.27e-3
T cell dividing	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	1.00e-2	1.87e-2
T CD4 reg	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	2.67e-3
T CD4 reg	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	1.00e-2	4.62e-4
DC 2	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	1.99e-2
Macrophage	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	2.67e-3
DC 1	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	1.06e-3
DC plasmacytoid	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	9.37e-3
DC plasmacytoid	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	1.00e-2	3.41e-2
Plasmablast	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	5.00e-2	9.37e-3
Plasmablast	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	1.00e-2	3.41e-2
T CD4 conv	Kidney Function	Serum Cystatin	MTC	Kottgen	2010	NA	67093	1.00e-2	1.87e-2
NK FCGR3Apos	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	3.98e-2
T cell dividing	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	1.59e-2
NK dividing	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	8.07e-3
DC 1	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	3.98e-2
DC 1	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	1.00e-2	3.23e-4
B Hypermutation	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	2.19e-2
Plasma IgG	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	1.59e-2
Plasmablast	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	5.00e-2	1.19e-4
Plasmablast	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	1.00e-2	3.65e-2
DC 2	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	1.00e-2	3.65e-2
DC plasmacytoid	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	1.00e-2	3.65e-2
Neutrophil	Lean Body Mass	Appendicular Lean Mass	MTC	Zillikens	2017	NA	28330	1.00e-3	4.05e-2
Monocyte	Lean Body Mass	Whole Body Lean Mass	MTC	Zillikens	2017	NA	38292	5.00e-2	4.80e-2
Plasmablast	Lean Body Mass	Whole Body Lean Mass	MTC	Zillikens	2017	NA	38292	5.00e-2	6.47e-4
Plasmablast	Lean Body Mass	Whole Body Lean Mass	MTC	Zillikens	2017	NA	38292	1.00e-2	4.07e-2
DC 1	Lean Body Mass	Whole Body Lean Mass	MTC	Zillikens	2017	NA	38292	1.00e-2	2.55e-2
T CD8 MAIT	Lean Body Mass	Whole Body Lean Mass	MTC	Zillikens	2017	NA	38292	1.00e-4	2.90e-2
T CD8 activated	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	4.67e-2
T CD8 activated	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.08e-2
B mature	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	1.28e-2
B T doublet	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	2.52e-2
B T doublet	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	7.44e-6
B T doublet	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-3	7.46e-3
DC 2	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	4.16e-3
Macrophage	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	1.28e-2
DC 1	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	4.16e-3
DC 1	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	5.65e-3
DC activated	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	5.00e-2	2.52e-2
DC activated	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	3.50e-2
T CD8 MAIT	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.36e-3
NK FCGR3Apos	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.08e-2
T CD4 fh	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.19e-4
T CD8 CTL	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	2.83e-3
T CD4 reg	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.99e-2
T CD4 naive	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.36e-3
T CD4 conv	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-2	1.99e-2
B naive	Leptin	Leptin Adjusted For BMI	MTC	Kilpelainen	2016	NA	32161	1.00e-3	2.62e-2
B naive	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	2.36e-2
T CD4 fh	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	8.07e-3
B mature	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	4.73e-5
B mature	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-2	1.86e-2
B mature	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-3	8.79e-3
DC 2	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	5.46e-3
DC 2	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-2	1.86e-2
Macrophage	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	3.79e-4
DC 1	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	8.07e-3
DC 1	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-2	1.86e-2
DC plasmacytoid	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	3.27e-2
Plasmablast	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	2.36e-2
CD34 progenitor	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	5.00e-2	2.36e-2
T CD8 activated	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-2	3.25e-2
T CD4 reg	Leptin	Leptin Not Adjusted For BMI	ETC	Kilpelainen	2016	NA	32161	1.00e-2	1.86e-2
T cell dividing	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	2.92e-3
T cell dividing	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-2	3.03e-2
Monocyte	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	2.45e-4
Monocyte	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-2	1.61e-2
DC 2	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	2.92e-3
DC 2	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-2	3.90e-3
Macrophage	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	7.19e-6
Macrophage	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-2	1.30e-4
Macrophage	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-3	2.77e-3
DC 1	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	1.54e-2
B Hypermutation	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	3.16e-2
B Hypermutation	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	1.00e-3	3.46e-2
CD34 progenitor	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Activity	MTC	Suchindran	2010	NA	6668	5.00e-2	3.16e-2
NK CD160pos	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.35e-2
T cell dividing	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	5.17e-4
T cell dividing	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	3.98e-2
T CD8 CTL	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.35e-2
T CD4 reg	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	4.93e-2
NK dividing	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	5.17e-4
DC 2	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.53e-3
DC 2	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	1.96e-4
Macrophage	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	3.44e-2
Macrophage	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	3.72e-3
DC 1	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	1.62e-4
DC 1	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	1.48e-3
B Hypermutation	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	5.17e-4
B Hypermutation	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	3.98e-2
DC plasmacytoid	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.53e-3
DC plasmacytoid	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	1.48e-3
Plasmablast	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.53e-3
DC activated	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	5.00e-2	2.35e-2
DC activated	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	3.98e-2
B naive	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	3.72e-3
Monocyte	Lipoprotein Associated Phospholipase A2	Lipoprotein Associated Phospholipase A2 (LpPLA2) Mass	MTC	Suchindran	2010	NA	6668	1.00e-2	8.77e-3
Monocyte	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.68e-4
DC 2	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.64e-2
DC 2	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.98e-2
Macrophage	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.47e-5
Macrophage	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	1.35e-5
Macrophage	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	2.79e-4
Macrophage	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	4.10e-2
CD34 progenitor	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.33e-3
Neutrophil	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.32e-2
Platelet	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	1.81e-2
Platelet	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	1.30e-2
Platelet	Lipoprotein Concentrations	High Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	7.15e-3
NK CD160pos	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.87e-2
NK FCGR3Apos	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	5.04e-3
NK FCGR3Apos	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	1.75e-2
T cell dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	5.04e-3
T cell dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.53e-2
T cell dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	1.92e-2
T cell dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	3.77e-2
T cell dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
T CD4 reg	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	7.35e-3
T CD4 reg	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.53e-2
NK dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	5.04e-3
NK dividing	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	2.86e-2
DC 2	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.87e-2
DC 2	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	1.04e-2
DC 2	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
Plasma IgM	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.89e-2
Plasma IgM	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	1.92e-2
Plasma IgM	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	3.16e-3
Plasma IgM	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	8.30e-3
Plasma IgG	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.89e-2
Plasma IgG	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	4.22e-2
Plasma IgG	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	1.17e-2
Plasma IgG	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
Plasmablast	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	7.35e-3
Plasmablast	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	3.14e-3
Plasmablast	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	3.77e-2
Plasmablast	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
DC activated	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.50e-2
DC activated	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	1.78e-3
DC activated	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	1.92e-2
DC activated	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	1.17e-2
DC activated	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	1.79e-3
T CD8 CTL	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	2.86e-2
Monocyte	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.53e-2
Macrophage	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.53e-2
Macrophage	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	1.17e-2
Macrophage	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	1.79e-3
B Hypermutation	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-2	4.53e-2
B Hypermutation	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	4.22e-2
B Hypermutation	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-4	3.77e-2
B Hypermutation	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
CD34 progenitor	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-3	4.22e-2
Neutrophil	Lipoprotein Concentrations	Low Density Lipoprotein	MTC	Kathiresan	2009	NA	19840	1.00e-5	3.23e-2
T CD8 MAIT	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.65e-4
T CD8 MAIT	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	8.45e-3
T CD8 MAIT	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-4	2.43e-2
T CD8 activated	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.60e-2
NK FCGR3Apos	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.89e-2
T cell dividing	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	9.61e-3
T CD8 CTL	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	4.68e-2
T CD4 reg	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	5.77e-4
T CD4 reg	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-4	9.05e-3
T CD4 reg	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-5	1.07e-2
Monocyte	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.36e-2
Monocyte	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	2.36e-2
NK dividing	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	4.68e-2
Macrophage	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	5.77e-4
Macrophage	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	3.77e-2
Macrophage	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-3	7.23e-3
DC 1	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	6.71e-3
Plasma IgM	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	2.60e-2
B Hypermutation	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.38e-3
Plasma IgG	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.89e-2
Platelet	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.36e-2
Platelet	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	2.36e-2
Plasmablast	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.65e-4
CD34 progenitor	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	3.03e-5
CD34 progenitor	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	2.36e-2
Neutrophil	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	5.00e-2	1.36e-2
Neutrophil	Lipoprotein Concentrations	Triglycerides	MTC	Kathiresan	2009	NA	19840	1.00e-2	1.44e-2
T cell dividing	Loneliness	Case Control	MTC	Gao	2017	1632	3164	5.00e-2	3.08e-3
T CD8 CTL	Loneliness	Case Control	MTC	Gao	2017	1632	3164	5.00e-2	2.67e-2
NK dividing	Loneliness	Case Control	MTC	Gao	2017	1632	3164	5.00e-2	4.94e-3
DC 1	Loneliness	Case Control	MTC	Gao	2017	1632	3164	5.00e-2	7.77e-3
B Hypermutation	Loneliness	Case Control	MTC	Gao	2017	1632	3164	5.00e-2	1.81e-2
DC activated	Loneliness	Case Control	MTC	Gao	2017	1632	3164	1.00e-2	4.51e-2
ILC	Loneliness	Case Control	MTC	Gao	2017	1632	3164	1.00e-3	8.39e-3
T cell dividing	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	4.07e-3
Monocyte	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	4.49e-2
NK dividing	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	3.16e-2
DC 2	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	2.19e-2
DC 2	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-2	3.92e-2
Macrophage	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	4.07e-3
DC 1	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	1.56e-3
DC 1	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-2	1.07e-2
DC plasmacytoid	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	9.82e-3
DC plasmacytoid	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-2	1.07e-2
DC plasmacytoid	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-3	2.90e-2
Plasmablast	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	5.00e-2	4.49e-2
Unknown	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-2	2.11e-2
Unknown	Loneliness	Loneliness	MTC	Gao	2017	NA	6924	1.00e-3	7.22e-3
T CD8 MAIT	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	7.11e-3
T CD8 CTL	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	3.35e-2
T CD8 gd	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	3.35e-2
DC 1	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	3.35e-2
DC 1	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	1.00e-2	4.37e-2
Plasmablast	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	4.60e-3
DC activated	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	1.08e-2
CD34 progenitor	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	5.00e-2	4.70e-2
NK CD160pos	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	1.00e-2	2.33e-2
T cell dividing	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	1.00e-2	2.33e-2
Macrophage	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	1.00e-2	2.33e-2
Platelet	Longevity	Age 85 Or Greater	MTC	Deelen	2014	7729	16121	1.00e-3	2.58e-2
T CD8 MAIT	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	1.44e-2
NK FCGR3Apos	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	2.98e-2
T CD8 CTL	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	4.20e-3
T CD4 reg	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	2.69e-3
NK dividing	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	6.45e-3
NK dividing	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	1.00e-2	4.38e-2
T CD8 gd	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	4.20e-3
T CD8 gd	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	1.00e-2	2.39e-2
Plasmablast	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	5.00e-2	4.20e-3
Plasmablast	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	1.00e-2	4.38e-2
T cell dividing	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	1.00e-2	4.38e-2
B Hypermutation	Longevity	Age 90 Or Greater	MTC	Deelen	2014	5406	15112	1.00e-2	1.23e-2
T CD8 MAIT	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.82e-3
T CD8 MAIT	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	4.02e-2
NK FCGR3Apos	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.00e-2
T cell dividing	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.00e-2
B mature	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.42e-2
B mature	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.14e-2
T CD4 naive	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.89e-2
NK dividing	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.00e-2
Plasma IgM	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.89e-2
B Hypermutation	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.14e-3
Plasma IgG	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.89e-2
DC plasmacytoid	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.04e-2
Plasmablast	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.83e-5
T CD8 activated	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	4.02e-2
T CD4 reg	Lymphocyte Subsets	CD19 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	4.02e-2
T CD8 MAIT	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	5.43e-5
T CD8 activated	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	7.25e-4
NK FCGR3Apos	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.16e-3
NK FCGR3Apos	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.56e-2
T cell dividing	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.84e-3
B mature	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.00e-2
T CD8 CTL	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.16e-3
T CD4 reg	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.84e-3
NK dividing	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.60e-4
NK dividing	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.93e-3
NK dividing	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	7.24e-3
DC 2	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.81e-2
Macrophage	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.34e-3
Macrophage	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.56e-2
T CD8 gd	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.60e-4
DC 1	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.45e-4
DC 1	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	7.66e-3
B Hypermutation	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	7.25e-4
B Hypermutation	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.56e-2
B Hypermutation	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	2.15e-2
DC plasmacytoid	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.83e-3
DC plasmacytoid	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	7.66e-3
Plasmablast	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.34e-3
Plasmablast	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.56e-2
DC activated	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.84e-3
CD34 progenitor	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.34e-3
Plasma IgM	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	7.66e-3
Plasma IgG	Lymphocyte Subsets	CD3 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.43e-2
T CD8 MAIT	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	2.72e-4
T CD8 MAIT	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	4.06e-4
T CD8 MAIT	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	1.96e-4
T CD8 MAIT	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	3.93e-3
T CD8 MAIT	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	3.86e-3
NK CD160pos	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	2.90e-2
T CD8 activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	2.06e-2
T CD8 activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	3.50e-2
NK FCGR3Apos	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	9.90e-3
NK FCGR3Apos	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	3.50e-2
T cell dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	2.90e-2
B mature	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	9.90e-3
B mature	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	3.42e-3
B mature	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	6.56e-5
B mature	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	1.41e-4
B mature	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	1.30e-3
T CD8 CTL	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	6.69e-3
T CD8 CTL	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	2.07e-2
T CD8 CTL	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	3.72e-3
T CD8 CTL	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	2.46e-2
T CD4 reg	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	6.69e-3
T CD4 naive	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	4.01e-2
T CD4 conv	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	4.01e-2
Monocyte	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	1.44e-2
NK dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	1.87e-3
NK dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	1.18e-2
NK dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	8.77e-3
NK dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	1.02e-2
NK dividing	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	1.05e-2
DC 2	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	4.51e-4
DC 2	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	5.56e-4
DC 2	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	3.93e-3
DC 2	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	2.63e-2
Macrophage	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	6.69e-3
Macrophage	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	3.50e-2
Macrophage	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	5.56e-4
Macrophage	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	1.40e-3
Macrophage	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	3.86e-3
DC 1	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	7.36e-4
DC 1	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	4.06e-4
DC 1	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	1.77e-6
DC 1	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	4.60e-4
DC 1	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	1.05e-2
B Hypermutation	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	4.01e-2
DC activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	5.00e-2	6.69e-3
DC activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	4.06e-4
DC activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	2.07e-5
DC activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	4.04e-5
DC activated	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-5	1.30e-3
B naive	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	1.18e-2
B naive	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	1.48e-3
B naive	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-4	1.02e-2
DC plasmacytoid	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-2	3.50e-2
DC plasmacytoid	Lymphocyte Subsets	CD4:CD8 Ratio	MTC	Ferreira	2010	NA	2538	1.00e-3	8.77e-3
T CD8 MAIT	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.00e-4
B naive	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	5.84e-3
B naive	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	5.98e-5
B naive	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	3.66e-3
B naive	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	5.82e-3
T CD4 fh	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.31e-2
B mature	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.55e-6
B mature	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.58e-3
B mature	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	3.66e-3
B mature	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.36e-3
T CD8 CTL	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.82e-2
T CD4 reg	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	8.82e-3
B T doublet	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.00e-4
B T doublet	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.26e-3
DC 2	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.43e-3
DC 2	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.58e-3
DC 2	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.15e-3
DC 2	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.36e-3
Macrophage	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.43e-3
Macrophage	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.58e-3
Macrophage	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.06e-2
Macrophage	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.36e-3
T CD8 gd	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.90e-2
DC 1	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.01e-6
DC 1	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	4.96e-8
DC 1	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.01e-6
DC 1	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	4.91e-5
B Hypermutation	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.43e-3
B Hypermutation	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	6.45e-3
DC plasmacytoid	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.53e-3
DC plasmacytoid	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.44e-4
DC plasmacytoid	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	3.31e-4
DC plasmacytoid	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	2.75e-4
Plasmablast	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	8.82e-3
Plasmablast	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.26e-3
DC activated	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.15e-4
DC activated	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.32e-4
DC activated	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.06e-2
DC activated	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	2.15e-2
CD34 progenitor	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.31e-2
Plasma IgM	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.87e-2
Plasma IgG	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.87e-2
T CD4 naive	Lymphocyte Subsets	CD4 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	2.79e-2
NK CD160pos	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.08e-2
NK CD160pos	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	9.42e-4
NK CD160pos	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	3.02e-6
T cell dividing	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.20e-2
T CD8 CTL	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.11e-3
T CD8 CTL	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	2.30e-2
T CD4 reg	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.44e-2
Monocyte	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.44e-2
NK dividing	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.78e-4
Macrophage	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.58e-2
DC 1	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.98e-3
B Hypermutation	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.27e-2
Plasmablast	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.08e-2
NK FCGR3Apos	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	2.30e-2
T CD8 gd	Lymphocyte Subsets	CD56 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.73e-4
T CD8 MAIT	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.09e-3
T CD8 MAIT	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.05e-4
T CD8 MAIT	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.40e-2
T CD8 MAIT	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	7.20e-3
T CD8 MAIT	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	6.67e-3
T CD8 activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.83e-2
T CD8 activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.39e-2
NK FCGR3Apos	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	7.16e-4
NK FCGR3Apos	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.63e-3
T cell dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	7.16e-4
T cell dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	6.69e-3
B mature	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.51e-2
B mature	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.40e-2
B mature	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.81e-2
B mature	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	6.67e-3
T CD8 CTL	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	5.78e-5
T CD8 CTL	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	6.69e-3
NK dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.65e-4
NK dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	2.03e-5
NK dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.40e-2
NK dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	7.20e-3
NK dividing	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	2.28e-3
DC 2	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.13e-3
DC 2	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.63e-3
DC 2	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.40e-2
Macrophage	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.46e-4
Macrophage	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	3.39e-2
Macrophage	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	6.09e-3
Macrophage	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.81e-2
Macrophage	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	6.67e-3
ILC	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	6.09e-3
T CD8 gd	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	4.09e-3
T CD8 gd	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	1.19e-2
DC 1	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.29e-2
DC 1	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	3.01e-2
DC 1	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	4.30e-2
B Hypermutation	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.29e-2
Platelet	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	8.92e-3
DC plasmacytoid	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	2.71e-3
DC plasmacytoid	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-2	6.69e-3
DC activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	1.65e-4
DC activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-3	1.40e-2
DC activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-4	1.81e-2
DC activated	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	1.00e-5	1.78e-2
CD34 progenitor	Lymphocyte Subsets	CD8 Level	MTC	Ferreira	2010	NA	2538	5.00e-2	3.51e-2
Monocyte	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	2.52e-3
DC 2	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	2.74e-2
DC 2	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	4.00e-2
Macrophage	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	8.99e-3
Macrophage	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	1.27e-2
Plasma IgM	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	3.84e-2
Unknown	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	5.98e-3
DC 1	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	4.00e-2
DC activated	TB LM	Total body lean mass	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	1.27e-2
NK CD160pos	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	3.43e-2
NK FCGR3Apos	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	5.64e-3
NK FCGR3Apos	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	2.99e-2
T cell dividing	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	1.22e-2
NK dividing	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	3.74e-3
DC 2	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	3.43e-2
ILC	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	1.75e-2
B Hypermutation	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	9.92e-4
B Hypermutation	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	4.94e-2
DC plasmacytoid	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	4.69e-2
Plasmablast	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	2.47e-2
Plasmablast	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-3	2.91e-2
Plasmablast	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-4	4.92e-3
DC activated	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	5.00e-2	1.22e-2
DC activated	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	4.94e-2
DC activated	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-3	1.04e-2
B naive	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-2	4.94e-2
B naive	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-3	2.91e-2
Plasma IgM	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-4	4.92e-3
Plasma IgG	TBLH BMD	Total body less head bone mineral density	MTC	Medina-Gomez	2017	NA	10414	1.00e-4	4.92e-3
NK FCGR3Apos	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	5.00e-2	3.61e-2
Monocyte	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	5.00e-2	3.61e-2
ILC	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	5.00e-2	6.56e-3
Plasma IgM	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	5.00e-2	1.61e-2
Plasma IgG	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	5.00e-2	1.04e-2
CD34 progenitor	New Onset Diabetes	New Onset Diabetes After Drugs, European American	MTC	Chang	2018	138	414	1.00e-2	8.43e-3
B naive	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	5.00e-2	2.71e-2
NK FCGR3Apos	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	5.00e-2	1.82e-2
B mature	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	5.00e-2	1.19e-2
Platelet	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	5.00e-2	2.71e-2
Platelet	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-2	2.16e-2
Platelet	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-3	3.26e-3
CD34 progenitor	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	5.00e-2	1.80e-3
CD34 progenitor	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-2	4.56e-3
CD34 progenitor	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-3	3.26e-3
T CD4 naive	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-2	2.16e-2
NK CD160pos	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-3	1.56e-2
ILC	Personality Big5	Agreeableness	MTC	De-Moor	2012	NA	17375	1.00e-3	1.56e-2
T CD8 MAIT	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	1.75e-2
NK CD160pos	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	8.02e-3
NK CD160pos	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	1.00e-2	2.52e-2
NK FCGR3Apos	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	1.20e-2
NK FCGR3Apos	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	1.00e-2	2.52e-2
T CD4 fh	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	5.29e-3
T CD4 fh	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	1.00e-2	2.52e-2
T CD4 reg	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	4.92e-2
T CD4 naive	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	4.92e-2
T CD4 conv	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	8.02e-3
Macrophage	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	2.51e-2
Plasma IgM	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	4.92e-2
B Hypermutation	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	2.51e-2
Plasma IgG	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	3.55e-2
DC plasmacytoid	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	3.55e-2
Plasmablast	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	3.55e-2
CD34 progenitor	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	5.00e-2	3.55e-2
ILC	Personality Big5	Conscientousness	MTC	De-Moor	2012	NA	17375	1.00e-2	3.25e-3
NK FCGR3Apos	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	2.85e-2
T cell dividing	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	3.55e-3
T CD4 reg	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	1.96e-2
NK dividing	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	1.96e-2
B Hypermutation	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	4.08e-2
Plasmablast	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	8.67e-3
CD34 progenitor	Personality Big5	Extraversion	MTC	De-Moor	2012	NA	17375	5.00e-2	4.08e-2
T CD8 activated	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	6.06e-3
T CD8 activated	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	1.07e-2
NK FCGR3Apos	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.41e-2
NK FCGR3Apos	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	5.03e-3
T cell dividing	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	2.40e-3
T CD4 reg	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	9.34e-3
T CD4 reg	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	5.03e-3
T CD4 reg	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-3	8.49e-3
Monocyte	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	1.41e-2
Monocyte	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	1.07e-2
NK dividing	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	6.06e-3
DC 2	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.86e-3
Macrophage	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	2.09e-2
B Hypermutation	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.04e-2
Plasmablast	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	3.04e-2
CD34 progenitor	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	5.00e-2	2.09e-2
NK CD160pos	Personality Big5	Neuroticism	MTC	De-Moor	2012	NA	17375	1.00e-2	4.05e-2
T cell dividing	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	5.00e-2	5.23e-3
NK dividing	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	5.00e-2	1.20e-3
B Hypermutation	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	5.00e-2	4.08e-4
B Hypermutation	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	1.00e-2	2.98e-2
Plasmablast	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	5.00e-2	7.06e-4
Plasmablast	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	1.00e-3	2.58e-2
CD34 progenitor	Personality Big5	Openness To Experience	MTC	De-Moor	2012	NA	17375	5.00e-2	4.02e-2
T CD8 MAIT	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	8.49e-6
T CD8 MAIT	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	1.00e-2	1.32e-2
NK CD160pos	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	3.70e-2
NK CD160pos	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	1.00e-3	8.79e-3
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	3.41e-4
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	1.00e-2	7.40e-3
T cell dividing	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	2.72e-2
T CD8 CTL	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	8.63e-4
T CD4 reg	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	4.96e-2
NK dividing	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	1.34e-3
DC 2	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	2.72e-2
Plasma IgG	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	4.96e-2
Plasmablast	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	2.06e-3
CD34 progenitor	Pubertal Anthropometrics	Height 10 Year Females	MTC	Cousminer	2013	NA	14040	5.00e-2	3.70e-2
T CD8 MAIT	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.03e-2
T CD8 MAIT	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	2.59e-2
T CD8 MAIT	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	1.23e-2
NK CD160pos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	2.60e-3
NK CD160pos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	6.64e-4
NK CD160pos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	1.23e-2
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	9.28e-5
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	2.15e-3
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	1.23e-2
NK FCGR3Apos	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-4	4.32e-2
T cell dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	5.39e-4
T cell dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	3.72e-3
T cell dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-4	1.54e-2
T CD8 CTL	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	2.60e-3
NK dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	9.28e-5
NK dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	3.72e-3
NK dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	2.61e-2
NK dividing	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-4	1.54e-2
DC 2	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	3.38e-2
B Hypermutation	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.42e-2
B Hypermutation	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-4	1.54e-2
Platelet	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	4.42e-2
Plasmablast	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	5.39e-4
T CD4 reg	Pubertal Anthropometrics	Height 10 Year Females And 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-5	2.58e-2
T CD8 MAIT	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.64e-2
NK CD160pos	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	7.87e-5
NK FCGR3Apos	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	3.21e-2
NK FCGR3Apos	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	5.56e-4
NK FCGR3Apos	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	3.43e-2
T cell dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	8.17e-6
T cell dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	1.15e-3
T cell dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	3.43e-2
T cell dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-4	1.23e-2
T CD8 CTL	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	5.34e-3
T CD8 CTL	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	8.18e-3
T CD4 reg	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.64e-2
NK dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	2.24e-4
NK dividing	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	1.15e-3
DC 2	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	4.38e-2
DC 2	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	3.43e-2
ILC	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.15e-2
T CD8 gd	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	2.32e-2
T CD8 gd	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	4.19e-2
Plasma IgM	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	5.34e-3
Plasma IgM	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-3	1.51e-2
B Hypermutation	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	3.55e-3
B Hypermutation	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	1.00e-2	4.41e-3
Plasma IgG	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	2.32e-2
Plasmablast	Pubertal Anthropometrics	Height 12 Year Males	MTC	Cousminer	2013	NA	14040	5.00e-2	1.50e-3
CD34 progenitor	Pubertal Anthropometrics	Late Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	4.07e-2
B mature	Pubertal Anthropometrics	Late Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-3	4.81e-2
NK dividing	Pubertal Anthropometrics	Late Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-3	4.81e-2
ILC	Pubertal Anthropometrics	Late Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-3	4.81e-2
Plasmablast	Pubertal Anthropometrics	Late Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-3	4.81e-2
T CD8 CTL	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	3.84e-2
DC 2	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	2.71e-2
DC 2	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	2.64e-2
Macrophage	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	5.53e-3
Macrophage	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	2.64e-2
CD34 progenitor	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	1.27e-2
CD34 progenitor	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	1.35e-2
B mature	Pubertal Anthropometrics	Late Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	4.89e-2
NK FCGR3Apos	Pubertal Anthropometrics	Late Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	4.59e-2
B mature	Pubertal Anthropometrics	Late Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	4.59e-2
T CD4 reg	Pubertal Anthropometrics	Late Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	4.59e-2
Macrophage	Pubertal Anthropometrics	Late Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	1.11e-2
CD34 progenitor	Pubertal Anthropometrics	Late Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-2	1.58e-2
DC 2	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	2.73e-2
DC 2	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	3.53e-2
Macrophage	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	7.22e-3
Macrophage	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	2.15e-3
DC 1	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	2.73e-2
Platelet	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	2.30e-3
DC plasmacytoid	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	3.68e-2
DC plasmacytoid	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	2.16e-2
Plasmablast	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	3.68e-2
Plasmablast	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	4.03e-3
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	2.00e-2
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	1.12e-3
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-3	1.15e-3
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-4	4.01e-3
CD34 progenitor	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	5.00e-2	6.45e-4
CD34 progenitor	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	3.53e-2
T cell dividing	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	2.16e-2
NK dividing	Pubertal Anthropometrics	Total Pubertal Height Increase	MTC	Cousminer	2013	NA	10799	1.00e-2	2.15e-3
NK FCGR3Apos	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	3.74e-3
NK FCGR3Apos	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	1.68e-5
CD34 progenitor	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	5.00e-2	8.36e-3
T CD8 CTL	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-2	1.85e-2
B naive	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-3	8.39e-3
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase Females	MTC	Cousminer	2013	NA	10799	1.00e-3	2.89e-2
B mature	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	3.93e-3
B mature	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-2	1.30e-2
B mature	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-3	2.51e-2
Monocyte	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	3.56e-2
Monocyte	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-2	4.17e-2
DC 2	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	8.74e-3
DC 2	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-2	6.78e-3
Plasma IgM	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	4.85e-2
DC plasmacytoid	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	3.93e-3
Plasmablast	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	1.27e-2
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	5.91e-3
DC activated	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	1.00e-2	1.30e-2
CD34 progenitor	Pubertal Anthropometrics	Total Pubertal Height Increase Males	MTC	Cousminer	2013	NA	10799	5.00e-2	1.27e-2
DC 1	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	5.00e-2	3.51e-4
Plasma IgM	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	5.00e-2	3.56e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	5.00e-2	5.96e-5
CD34 progenitor	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-2	3.58e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-3	1.40e-2
CD34 progenitor	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-5	4.37e-2
T CD8 MAIT	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-2	3.63e-2
B naive	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-5	4.37e-2
B mature	Reproductive Behavior	Age First Birth Female	MTC	Barban	2016	NA	189656	1.00e-5	4.37e-2
T cell dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	5.00e-2	3.25e-2
T cell dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	1.80e-2
T cell dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-3	1.83e-2
NK dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	5.00e-2	1.65e-2
NK dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	2.74e-3
NK dividing	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-3	6.45e-3
B Hypermutation	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	5.00e-2	5.25e-3
B Hypermutation	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	1.80e-2
B Hypermutation	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-3	4.64e-2
CD34 progenitor	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	5.00e-2	7.82e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	1.35e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-3	4.64e-2
Platelet	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	5.33e-3
Plasmablast	Reproductive Behavior	Age First Birth Male	MTC	Barban	2016	NA	48408	1.00e-2	3.12e-2
T cell dividing	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	1.86e-2
NK dividing	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	1.41e-2
NK dividing	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-2	1.70e-2
DC 1	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	1.05e-2
Plasma IgM	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	4.03e-2
Plasmablast	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	2.43e-2
CD34 progenitor	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	5.00e-2	4.15e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-2	1.70e-2
CD34 progenitor	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-3	3.09e-3
CD34 progenitor	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-4	2.43e-2
CD34 progenitor	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-5	8.35e-4
B Hypermutation	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-2	1.14e-2
B naive	Reproductive Behavior	Age First Birth Pooled	ETC	Barban	2016	NA	238064	1.00e-4	2.43e-2
T CD4 naive	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	5.00e-2	4.81e-2
Monocyte	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	5.00e-2	4.81e-2
Monocyte	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	1.80e-2
DC 1	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	5.00e-2	2.46e-3
DC 1	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	8.38e-5
DC activated	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	5.00e-2	1.47e-2
DC activated	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	4.39e-2
NK FCGR3Apos	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	4.39e-2
T cell dividing	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	1.80e-2
T cell dividing	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-3	2.22e-2
NK dividing	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	1.80e-2
DC 2	Reproductive Behavior	Number Children Even Born Pooled	MTC	Barban	2016	NA	329139	1.00e-2	4.39e-2
T CD8 MAIT	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	4.09e-2
B naive	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	7.55e-3
B naive	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	1.00e-2	4.19e-2
T CD4 naive	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	3.45e-3
T CD4 naive	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	1.00e-2	1.46e-2
Monocyte	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	5.14e-3
DC 2	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	6.00e-4
Macrophage	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	5.14e-3
DC 1	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	3.74e-4
DC 1	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	1.00e-2	4.41e-3
CD34 progenitor	Reproductive Behavior	Number Children Ever Born Female	MTC	Barban	2016	NA	225230	5.00e-2	9.50e-4
DC 1	Reproductive Behavior	Number Children Ever Born Male	MTC	Barban	2016	NA	103909	5.00e-2	2.87e-3
Plasma IgM	Reproductive Behavior	Number Children Ever Born Male	MTC	Barban	2016	NA	103909	5.00e-2	2.27e-2
Plasmablast	Reproductive Behavior	Number Children Ever Born Male	MTC	Barban	2016	NA	103909	5.00e-2	2.27e-2
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	3.65e-5
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.23e-8
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	8.06e-9
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	8.24e-9
T CD8 MAIT	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	5.95e-10
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	3.64e-6
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	5.13e-8
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	8.06e-9
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.20e-6
T CD8 activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	5.75e-7
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.88e-7
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	2.35e-4
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	1.36e-4
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	8.78e-5
B naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.73e-4
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	5.63e-5
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	4.88e-5
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	2.64e-4
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.73e-2
NK FCGR3Apos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	7.34e-3
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	6.55e-3
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.16e-2
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	4.99e-2
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	2.88e-2
T CD4 fh	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	3.75e-3
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	4.26e-4
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	8.01e-3
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	2.88e-2
T cell dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	2.47e-2
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	4.87e-7
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.59e-5
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	3.47e-6
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	2.99e-6
B mature	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.62e-6
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.90e-4
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.43e-6
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	1.23e-7
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.20e-6
T CD8 CTL	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	6.58e-8
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.23e-6
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	5.13e-8
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	3.12e-9
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	8.24e-9
T CD4 reg	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	2.02e-9
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.03e-2
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.16e-2
T CD4 naive	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	4.26e-2
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.03e-2
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	5.44e-3
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	5.03e-3
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	3.98e-4
T CD4 conv	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.17e-5
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	3.51e-3
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	6.22e-4
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	8.39e-3
NK dividing	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	4.63e-2
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	4.82e-3
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.16e-2
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	1.67e-3
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	3.94e-5
B T doublet	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.62e-6
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	1.81e-3
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.66e-2
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	4.63e-2
DC 2	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	2.47e-2
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.63e-2
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	4.88e-5
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	7.58e-6
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.00e-2
T CD8 gd	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.38e-2
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	2.53e-3
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	8.01e-3
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	4.99e-2
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	5.61e-3
DC 1	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	3.75e-3
Plasma IgM	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	4.26e-4
Plasma IgM	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	3.22e-2
B Hypermutation	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	1.28e-3
Plasma IgG	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	1.95e-4
Plasma IgG	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	8.01e-3
Plasmablast	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	1.30e-4
Plasmablast	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	2.33e-2
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	5.00e-2	1.28e-3
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	1.41e-4
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	3.37e-5
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	4.67e-7
DC activated	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	5.75e-7
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	2.39e-3
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-3	1.36e-4
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	2.88e-2
NK CD160pos	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	2.47e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-2	2.33e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.00e-2
Macrophage	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-5	1.38e-2
DC plasmacytoid	Rheumatoid Arthritis	Rheumatoid Arthritis European	MTC	Okada	2014	14361	43923	1.00e-4	1.00e-2
T CD4 fh	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	1.32e-2
T CD4 fh	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	1.00e-2
T cell dividing	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	2.96e-2
T cell dividing	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	4.37e-2
T CD4 reg	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	2.96e-2
T CD4 reg	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	1.00e-2
Monocyte	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	3.36e-3
Macrophage	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	1.21e-3
Macrophage	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-2	1.47e-2
T CD8 gd	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	4.28e-2
DC activated	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	5.00e-2	4.28e-2
T CD4 naive	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-2	6.84e-3
T CD4 naive	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	1.00e-2
T CD4 conv	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	4.37e-2
B T doublet	Shoulder Dislocation	Shoulder Dislocation, European Or Latino	MTC	Kim	2017	662	82602	1.00e-3	4.37e-2
T CD8 activated	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	2.03e-2
T CD8 activated	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	1.00e-2	4.19e-2
B naive	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	4.08e-4
B naive	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	1.00e-2	5.57e-3
B mature	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	4.98e-2
T CD4 conv	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	1.47e-2
B T doublet	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	1.47e-2
B T doublet	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	1.00e-2	1.63e-2
B T doublet	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	1.00e-3	2.51e-3
Macrophage	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	2.03e-2
B Hypermutation	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	4.98e-2
Platelet	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	4.98e-2
CD34 progenitor	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	5.00e-2	9.97e-4
CD34 progenitor	Sleep Duration	Oversleeper	MTC	Jones	2016	NA	91306	1.00e-2	1.63e-2
T cell dividing	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	2.56e-2
B mature	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	1.87e-2
T CD4 reg	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	3.45e-2
T CD4 reg	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	1.00e-2	1.35e-2
NK dividing	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	4.58e-2
Macrophage	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	4.58e-2
Macrophage	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	1.00e-3	3.81e-2
DC 1	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	3.45e-2
B Hypermutation	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	2.56e-2
DC plasmacytoid	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	2.56e-2
Plasmablast	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	3.45e-2
Neutrophil	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	5.00e-2	4.58e-2
NK CD160pos	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	1.00e-3	3.81e-2
NK FCGR3Apos	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	1.00e-3	1.71e-2
NK FCGR3Apos	Sleep Duration	Undersleeper	MTC	Jones	2016	NA	110188	1.00e-4	7.15e-3
B naive	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	6.14e-3
T cell dividing	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	6.14e-3
T cell dividing	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	4.81e-2
B mature	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	8.47e-3
NK dividing	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	2.08e-2
NK dividing	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	1.26e-3
NK dividing	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-3	3.05e-2
Plasma IgM	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	8.47e-3
Plasma IgM	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	3.58e-3
B Hypermutation	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	6.14e-3
B Hypermutation	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	3.31e-2
Plasma IgG	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	1.52e-3
Plasma IgG	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	1.26e-3
Plasmablast	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	2.12e-5
Plasmablast	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	2.22e-4
DC activated	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	8.47e-3
CD34 progenitor	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	4.60e-2
CD34 progenitor	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-3	1.55e-2
Neutrophil	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	5.00e-2	1.56e-2
T CD4 reg	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	2.22e-2
Platelet	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-2	4.81e-2
T CD8 activated	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-4	7.94e-3
T CD8 CTL	Sleep Duration	Average Sleep Duration	MTC	Jones	2016	NA	127573	1.00e-4	7.94e-3
T CD8 MAIT	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	4.54e-2
B naive	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	2.25e-2
T cell dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	1.76e-5
T cell dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	2.36e-5
T cell dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	6.51e-4
T cell dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-4	1.40e-3
T cell dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	2.54e-2
B mature	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	4.26e-4
B mature	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	3.89e-2
B mature	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	4.52e-3
NK dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	1.22e-3
NK dividing	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	6.97e-3
T CD8 gd	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	4.54e-2
DC 1	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	4.61e-6
DC 1	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	8.46e-4
DC 1	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	2.07e-2
DC 1	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	4.52e-3
B Hypermutation	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	1.70e-3
B Hypermutation	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	1.33e-3
B Hypermutation	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	3.30e-4
B Hypermutation	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-4	6.90e-3
B Hypermutation	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	1.71e-3
Plasmablast	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	2.25e-2
Plasmablast	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	2.05e-2
Plasmablast	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	1.66e-5
Plasmablast	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-4	1.40e-3
Plasmablast	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	6.03e-4
DC activated	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	2.34e-3
CD34 progenitor	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	5.00e-2	3.21e-3
CD34 progenitor	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	6.97e-3
NK FCGR3Apos	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-2	1.45e-2
Plasma IgM	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	1.25e-2
Plasma IgM	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	2.54e-2
Plasma IgG	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-3	7.37e-3
Plasma IgG	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-4	1.42e-2
Plasma IgG	Circadian Rhythm	Sleep Chronotype	MTC	Jones	2016	NA	127898	1.00e-5	1.11e-2
T CD8 MAIT	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	1.44e-3
DC 2	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	4.53e-2
Macrophage	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	5.27e-3
ILC	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	2.37e-2
Plasma IgM	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	2.25e-3
Plasma IgG	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	3.47e-3
DC plasmacytoid	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	5.00e-2	7.86e-3
B naive	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	1.00e-2	1.02e-2
Plasmablast	Stroke (ischemic)	All Ischemic Stroke	MTC	Traylor	2017	12389	62004	1.00e-2	3.25e-2
NK FCGR3Apos	Stroke (ischemic)	Cardioembolic Stroke	MTC	Traylor	2017	2365	62004	5.00e-2	3.09e-2
NK dividing	Stroke (ischemic)	Cardioembolic Stroke	MTC	Traylor	2017	2365	62004	5.00e-2	4.14e-3
B Hypermutation	Stroke (ischemic)	Cardioembolic Stroke	MTC	Traylor	2017	2365	62004	5.00e-2	1.47e-2
DC plasmacytoid	Stroke (ischemic)	Cardioembolic Stroke	MTC	Traylor	2017	2365	62004	5.00e-2	1.47e-2
T cell dividing	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	3.01e-3
T cell dividing	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	1.87e-3
T cell dividing	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-3	2.89e-2
NK dividing	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	1.19e-3
NK dividing	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	1.59e-2
DC 2	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	1.56e-2
Macrophage	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	4.43e-2
ILC	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	7.10e-3
ILC	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	3.99e-3
B Hypermutation	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	1.52e-4
B Hypermutation	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	8.15e-3
Plasmablast	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	5.00e-2	3.18e-2
Plasmablast	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	2.94e-2
T CD8 MAIT	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	8.15e-3
NK CD160pos	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	8.15e-3
NK FCGR3Apos	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	8.15e-3
T CD8 CTL	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	1.59e-2
T CD4 reg	Stroke (ischemic)	Large Artery Stroke	MTC	Traylor	2017	2167	62004	1.00e-2	2.94e-2
NK CD160pos	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	9.11e-3
NK FCGR3Apos	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	4.12e-2
NK dividing	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	1.37e-2
NK dividing	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	1.00e-2	1.55e-2
DC 2	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	9.11e-3
Plasmablast	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	5.95e-3
CD34 progenitor	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	5.00e-2	4.12e-2
DC plasmacytoid	Stroke (ischemic)	Small Vessel Stroke	MTC	Traylor	2017	1894	62004	1.00e-2	7.47e-3
Macrophage	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	5.00e-2	1.72e-3
Macrophage	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-2	6.88e-4
Macrophage	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-3	5.36e-3
DC 1	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	5.00e-2	3.22e-2
DC 1	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-2	2.80e-2
DC 1	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-3	5.36e-3
CD34 progenitor	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	5.00e-2	3.70e-4
CD34 progenitor	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-2	1.47e-2
DC 2	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-2	2.80e-2
DC 2	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-3	5.36e-3
DC plasmacytoid	Smoking	Cigarettes Per Day	ETC	Furberg	2010	NA	38181	1.00e-2	2.80e-2
T CD4 reg	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	5.00e-2	3.85e-2
T CD4 conv	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	5.00e-2	2.76e-2
B T doublet	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	5.00e-2	3.85e-2
B T doublet	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	1.00e-2	5.22e-4
DC 1	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	5.00e-2	3.85e-2
NK CD160pos	Smoking	Current Vs Former Discrete	MTC	Furberg	2010	20619	15226	1.00e-2	2.81e-2
NK dividing	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	1.44e-2
ILC	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	2.99e-3
ILC	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	1.00e-2	5.33e-5
ILC	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	1.00e-3	1.16e-3
Platelet	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	2.87e-2
DC activated	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	9.97e-3
DC activated	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	1.00e-2	2.29e-2
CD34 progenitor	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	2.05e-2
CD34 progenitor	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	1.00e-2	1.25e-2
Unknown	Smoking	Ever Vs Never Smoked Discrete	MTC	Furberg	2010	39022	30387	5.00e-2	9.97e-3
T cell dividing	Smoking	Log Age Onset Smoking	MTC	Furberg	2010	NA	22438	5.00e-2	7.29e-3
T CD4 reg	Smoking	Log Age Onset Smoking	MTC	Furberg	2010	NA	22438	5.00e-2	6.92e-4
NK dividing	Smoking	Log Age Onset Smoking	MTC	Furberg	2010	NA	22438	5.00e-2	2.39e-2
Plasmablast	Smoking	Log Age Onset Smoking	MTC	Furberg	2010	NA	22438	5.00e-2	1.64e-2
T CD8 MAIT	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	6.00e-3
T CD8 MAIT	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-2	1.90e-2
B naive	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	1.49e-2
B naive	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-2	4.06e-2
NK FCGR3Apos	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	4.96e-4
NK FCGR3Apos	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-2	3.22e-3
T cell dividing	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	6.00e-3
B mature	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	1.11e-2
T CD4 reg	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	8.22e-3
B Hypermutation	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	3.11e-3
B Hypermutation	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-2	4.06e-2
CD34 progenitor	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	5.00e-2	8.22e-3
CD34 progenitor	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-3	4.87e-3
CD34 progenitor	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-4	3.60e-2
CD34 progenitor	Social Deprivation	Household Income	MTC	Hill	2016	NA	112005	1.00e-5	4.80e-2
T CD8 MAIT	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	4.14e-3
B naive	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	5.76e-3
B naive	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-3	7.08e-3
NK FCGR3Apos	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	1.94e-2
NK FCGR3Apos	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-2	3.21e-2
T cell dividing	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	4.14e-3
B mature	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	7.93e-3
B mature	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-2	2.16e-2
B mature	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-3	3.43e-3
T CD4 reg	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	1.99e-4
Monocyte	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	2.55e-2
Monocyte	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-4	3.60e-2
Macrophage	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	1.94e-2
B Hypermutation	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	5.76e-3
B Hypermutation	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-2	4.66e-2
DC activated	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	4.14e-3
CD34 progenitor	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	5.00e-2	1.94e-2
CD34 progenitor	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-2	2.16e-2
CD34 progenitor	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-3	7.08e-3
CD34 progenitor	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-4	3.60e-2
CD34 progenitor	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-5	2.48e-3
Plasma IgM	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-4	1.44e-2
Plasma IgG	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-4	3.60e-2
Unknown	Social Deprivation	Household Income One Person Per Household	MTC	Hill	2016	NA	112005	1.00e-5	3.97e-2
NK CD160pos	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	5.00e-2	1.81e-3
B naive	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	5.00e-2	2.30e-2
NK FCGR3Apos	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	5.00e-2	2.56e-5
B mature	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	5.00e-2	4.01e-3
B mature	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	1.00e-3	7.66e-3
DC plasmacytoid	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	5.00e-2	7.72e-4
T cell dividing	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	1.00e-2	3.53e-2
CD34 progenitor	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	1.00e-2	3.53e-2
T CD4 conv	Social Deprivation	Townsend Score	MTC	Hill	2016	NA	96900	1.00e-3	2.11e-2
B mature	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	2.51e-2
B mature	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	4.60e-2
B mature	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	2.62e-4
Monocyte	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	4.92e-2
Macrophage	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	5.05e-4
Macrophage	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	3.91e-3
Macrophage	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	1.07e-3
Macrophage	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	2.22e-2
DC 1	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	3.55e-2
DC 1	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	2.65e-2
B Hypermutation	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	1.75e-2
B Hypermutation	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	8.82e-4
Plasmablast	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	4.92e-2
Plasmablast	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	3.91e-3
Plasmablast	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	2.22e-2
DC activated	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	2.51e-2
CD34 progenitor	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	8.02e-3
CD34 progenitor	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	2.65e-2
CD34 progenitor	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	3.94e-3
CD34 progenitor	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	2.22e-2
Neutrophil	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	5.00e-2	4.92e-2
T CD8 MAIT	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	7.73e-3
T CD8 MAIT	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	3.94e-3
T CD8 MAIT	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	2.22e-2
NK CD160pos	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	2.65e-2
NK CD160pos	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	3.73e-2
T CD8 activated	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	4.60e-2
T cell dividing	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	7.73e-3
T cell dividing	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	3.73e-2
T CD8 gd	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	3.91e-3
DC plasmacytoid	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-2	4.60e-2
DC plasmacytoid	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	1.29e-2
DC plasmacytoid	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	4.01e-3
T CD8 CTL	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-3	3.73e-2
NK FCGR3Apos	Statin Efficacy	Delta HDL	MTC	Barber	2010	NA	3928	1.00e-4	4.01e-3
NK CD160pos	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.57e-2
NK CD160pos	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	8.93e-3
T CD8 activated	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.87e-3
T CD8 activated	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	9.42e-4
NK FCGR3Apos	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.64e-3
NK FCGR3Apos	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	9.42e-4
NK FCGR3Apos	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-3	4.91e-2
T CD4 fh	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	7.12e-3
T cell dividing	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.98e-3
T cell dividing	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.17e-2
T CD4 reg	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.27e-2
NK dividing	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	6.99e-6
NK dividing	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	4.41e-3
DC 2	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.87e-3
DC 2	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.17e-2
T CD8 gd	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.16e-3
T CD8 gd	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	2.09e-3
DC 1	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.57e-2
Plasma IgM	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.27e-2
B Hypermutation	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.46e-4
Plasmablast	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.45e-5
Plasmablast	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.17e-2
T CD8 MAIT	Statin Efficacy	Delta HDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	8.93e-3
Macrophage	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	1.28e-3
Macrophage	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-2	4.17e-2
ILC	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	3.26e-2
Plasma IgM	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	1.61e-2
Platelet	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	1.10e-2
Plasmablast	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	1.69e-4
Plasmablast	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-2	5.71e-5
Plasmablast	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-3	2.20e-4
Plasmablast	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-4	2.98e-2
CD34 progenitor	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	5.00e-2	1.71e-5
T cell dividing	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-3	9.52e-3
NK dividing	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-3	9.52e-3
B Hypermutation	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-3	9.52e-3
B Hypermutation	Statin Efficacy	Delta LDL	MTC	Barber	2010	NA	3928	1.00e-4	2.98e-2
T CD8 MAIT	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.94e-4
T CD8 activated	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.27e-2
T cell dividing	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.05e-2
T cell dividing	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	1.11e-2
T CD8 CTL	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.05e-2
T CD4 reg	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.56e-2
T CD4 reg	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	1.11e-2
DC 2	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.27e-2
Macrophage	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.80e-3
Macrophage	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.79e-2
DC 1	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	7.39e-5
DC 1	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	1.25e-3
B Hypermutation	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.55e-2
Platelet	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.55e-2
DC activated	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.79e-2
DC activated	Statin Efficacy	Delta LDL With Statin	MTC	Barber	2010	NA	3928	1.00e-3	1.23e-2
NK CD160pos	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	3.41e-4
NK FCGR3Apos	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	1.31e-2
T cell dividing	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	8.82e-3
B mature	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	3.80e-3
Monocyte	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	1.90e-2
NK dividing	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	2.00e-4
DC 2	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	2.72e-2
DC 2	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	1.00e-2	1.90e-2
Macrophage	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	5.72e-4
Macrophage	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	1.00e-2	5.15e-3
ILC	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	1.90e-2
ILC	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	1.00e-2	1.90e-2
B Hypermutation	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	1.31e-2
B Hypermutation	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	1.00e-2	3.40e-2
Plasmablast	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	3.80e-3
CD34 progenitor	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	5.00e-2	2.72e-2
DC 1	Statin Efficacy	Delta TC	MTC	Barber	2010	NA	3928	1.00e-2	3.40e-2
T CD8 MAIT	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.20e-2
NK CD160pos	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.04e-2
T CD8 activated	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.16e-3
NK FCGR3Apos	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	6.93e-3
T cell dividing	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.52e-2
T cell dividing	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	3.46e-2
B mature	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.35e-2
T CD8 CTL	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.55e-3
T CD8 CTL	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-2	2.15e-2
T CD4 reg	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.55e-3
NK dividing	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	4.35e-2
DC 2	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.12e-2
DC 2	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	3.46e-2
Macrophage	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.86e-3
Macrophage	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-2	3.93e-2
Macrophage	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	1.05e-2
T CD8 gd	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.16e-3
T CD8 gd	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-2	5.56e-3
DC 1	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	2.94e-3
DC 1	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-2	2.15e-2
DC 1	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	3.46e-2
B Hypermutation	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.12e-2
Plasmablast	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.04e-2
Plasmablast	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	1.05e-2
DC activated	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-2	1.12e-2
DC activated	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	3.46e-2
T CD4 naive	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	1.05e-2
Platelet	Statin Efficacy	Delta TC With Statin	MTC	Barber	2010	NA	3928	1.00e-3	3.46e-2
T cell dividing	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	4.38e-5
T cell dividing	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-3	1.45e-2
T cell dividing	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-5	4.37e-2
NK dividing	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	3.60e-2
DC 2	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	4.93e-2
DC 1	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	2.59e-2
DC 1	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-2	3.09e-2
B Hypermutation	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	5.81e-3
Plasmablast	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	1.83e-2
Plasmablast	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-3	3.83e-2
DC activated	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	5.00e-2	2.59e-2
DC activated	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-2	5.49e-3
Macrophage	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-2	1.02e-2
Macrophage	Statin Efficacy	Delta TG	MTC	Barber	2010	NA	3928	1.00e-3	4.91e-3
B mature	Statin Efficacy	Delta TG With Statin	MTC	Barber	2010	NA	3928	5.00e-2	8.45e-4
T CD8 gd	Statin Efficacy	Delta TG With Statin	MTC	Barber	2010	NA	3928	5.00e-2	3.67e-2
B Hypermutation	Statin Efficacy	Delta TG With Statin	MTC	Barber	2010	NA	3928	5.00e-2	1.38e-3
Monocyte	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	5.00e-2	6.73e-3
DC 2	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	5.00e-2	4.67e-2
DC 1	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	5.00e-2	6.73e-3
DC 1	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	1.00e-3	3.59e-2
Plasmablast	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	5.00e-2	4.67e-2
Platelet	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	1.00e-2	1.07e-2
T cell dividing	Tanner Stage	Tanner Stage All	MTC	Cousminer	2014	NA	9913	1.00e-3	9.50e-3
NK FCGR3Apos	Tanner Stage	Tanner Stage Females	MTC	Cousminer	2014	NA	6144	5.00e-2	4.18e-2
NK FCGR3Apos	Tanner Stage	Tanner Stage Females	MTC	Cousminer	2014	NA	6144	1.00e-2	8.12e-3
CD34 progenitor	Tanner Stage	Tanner Stage Females	MTC	Cousminer	2014	NA	6144	5.00e-2	2.03e-2
T CD4 naive	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	3.59e-2
Monocyte	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	2.01e-4
Monocyte	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	1.00e-2	1.35e-2
NK dividing	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	2.48e-2
Macrophage	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	7.22e-3
T CD8 gd	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	3.59e-2
Plasma IgG	Tanner Stage	Tanner Stage Males	MTC	Cousminer	2014	NA	3769	5.00e-2	2.48e-2
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	6.63e-4
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	4.28e-3
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	1.52e-4
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	3.58e-2
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	1.92e-2
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	8.81e-4
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	4.85e-3
T CD8 activated	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	2.36e-2
T CD8 activated	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	2.61e-2
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	6.90e-5
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	1.20e-3
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	1.17e-2
T CD4 fh	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	3.77e-2
T CD4 fh	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	2.84e-3
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	2.08e-6
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	2.84e-3
T cell dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	2.68e-2
B mature	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	3.77e-2
B mature	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	4.83e-2
T CD4 reg	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	3.77e-2
T CD4 reg	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	4.28e-3
Monocyte	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	3.77e-2
NK dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	1.52e-4
NK dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	2.61e-2
NK dividing	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	4.75e-2
Macrophage	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	1.42e-2
Macrophage	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	3.27e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	2.36e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	3.58e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	1.17e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	1.50e-4
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	4.85e-3
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	4.59e-5
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	4.28e-3
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	4.75e-2
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	3.27e-2
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	2.68e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	1.84e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	6.33e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	1.18e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	2.15e-5
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	6.57e-4
Platelet	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	4.71e-2
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	5.00e-2	1.52e-4
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-2	2.84e-3
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	3.94e-3
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	1.50e-4
Plasmablast	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-5	2.19e-4
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-3	6.88e-3
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes	MTC	Scott	2017	26676	132532	1.00e-4	3.27e-2
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	2.31e-3
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	1.38e-2
T CD8 MAIT	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	4.00e-2
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	4.53e-3
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	4.86e-4
NK CD160pos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	1.67e-3
T CD8 activated	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	3.41e-2
T CD8 activated	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	1.27e-2
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	2.76e-5
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	3.71e-3
NK FCGR3Apos	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	2.30e-2
T CD4 fh	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	8.50e-3
T cell dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	5.13e-7
T cell dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	4.86e-4
T cell dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	4.00e-2
T cell dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-4	3.08e-2
T cell dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-5	8.79e-3
T CD4 reg	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	8.50e-3
NK dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	2.41e-4
NK dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	1.40e-3
NK dividing	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	4.00e-2
T CD8 gd	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	4.36e-2
DC 1	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	1.53e-2
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	4.53e-3
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	2.79e-4
Plasma IgM	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-4	3.08e-2
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	4.34e-5
B Hypermutation	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	4.86e-4
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	1.13e-3
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	2.49e-5
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	2.30e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-4	3.08e-2
Plasma IgG	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-5	2.73e-2
Plasmablast	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	6.76e-5
Plasmablast	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	4.86e-4
Plasmablast	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-4	5.31e-3
Plasmablast	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-5	2.50e-3
Neutrophil	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	5.00e-2	2.02e-2
CD34 progenitor	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-2	4.29e-2
B mature	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	2.30e-2
Macrophage	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-3	1.27e-2
Macrophage	Type 2 Diabetes	Type 2 Diabetes BMI Adjusted	MTC	Scott	2017	26676	132532	1.00e-4	1.96e-3
NK CD160pos	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	2.89e-2
NK CD160pos	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	3.96e-2
NK CD160pos	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	1.71e-2
T cell dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.78e-4
T cell dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	2.17e-3
T cell dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	1.07e-2
T cell dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-4	1.99e-2
NK dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.78e-4
NK dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	4.91e-3
NK dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	6.49e-3
NK dividing	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-4	1.08e-2
Plasma IgM	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.74e-2
Plasma IgM	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	1.05e-2
Plasma IgM	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	1.07e-2
Plasma IgM	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-4	1.08e-2
B Hypermutation	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	5.54e-4
B Hypermutation	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	1.49e-2
Plasma IgG	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.74e-2
Plasma IgG	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	1.05e-2
Plasma IgG	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	1.71e-2
Plasmablast	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	5.78e-6
Plasmablast	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	1.30e-4
Plasmablast	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	6.91e-4
NK FCGR3Apos	Waist Format 1	Hip Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	4.03e-2
NK CD160pos	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.01e-2
NK CD160pos	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-2	4.16e-2
T cell dividing	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.26e-4
T cell dividing	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.35e-2
T cell dividing	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-3	4.26e-2
NK dividing	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	6.32e-4
NK dividing	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-2	5.75e-3
B Hypermutation	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	6.32e-4
B Hypermutation	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.65e-3
B Hypermutation	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-3	4.26e-2
Plasma IgG	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.36e-2
Plasmablast	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	2.81e-6
B naive	Waist Format 1	Hip Circumference Females European	MTC	Shungin	2015	NA	86570	1.00e-2	4.16e-2
NK CD160pos	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	3.17e-2
NK CD160pos	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.42e-2
NK FCGR3Apos	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.81e-2
NK FCGR3Apos	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.02e-2
T cell dividing	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	9.99e-5
T cell dividing	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	5.51e-3
NK dividing	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	6.33e-5
NK dividing	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	5.51e-3
Plasma IgM	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	8.26e-4
Plasma IgM	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	3.99e-4
Plasma IgM	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.76e-4
Plasma IgM	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-4	3.93e-3
Plasma IgM	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-5	2.73e-2
B Hypermutation	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.40e-4
B Hypermutation	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.21e-4
Plasma IgG	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.56e-3
Plasma IgG	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.21e-3
Plasma IgG	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.04e-3
Plasmablast	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	5.50e-6
Plasmablast	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.73e-5
Plasmablast	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	9.40e-4
Macrophage	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.95e-2
T CD8 MAIT	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-4	2.46e-2
T CD8 CTL	Waist Format 1	Hip Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-4	2.46e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.89e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	1.49e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	3.39e-2
T cell dividing	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	1.04e-2
T cell dividing	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	3.23e-2
T cell dividing	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-5	4.44e-2
NK dividing	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	7.63e-3
Plasmablast	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	5.00e-2	5.52e-3
NK CD160pos	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	4.61e-2
T CD4 fh	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	3.23e-2
ILC	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	4.61e-2
CD34 progenitor	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-2	9.81e-3
T CD8 CTL	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-3	3.39e-2
T CD8 CTL	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-4	4.51e-2
Macrophage	Waist Format 1	Waist Circumference European	MTC	Shungin	2015	NA	143480	1.00e-5	4.44e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.29e-2
T CD4 fh	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.76e-2
T cell dividing	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	6.62e-3
T CD4 reg	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.19e-2
NK dividing	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	2.38e-2
B Hypermutation	Waist Format 1	Waist Circumference Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.18e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.41e-2
NK FCGR3Apos	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-4	3.12e-2
T cell dividing	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.29e-4
T cell dividing	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	8.92e-3
T cell dividing	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-5	4.80e-2
NK dividing	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.97e-5
B Hypermutation	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.48e-3
Plasmablast	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.92e-4
Plasmablast	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.28e-2
Plasmablast	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	4.64e-2
Plasma IgM	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	3.14e-3
Plasma IgM	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.19e-3
Plasma IgG	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-2	3.49e-2
ILC	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-3	4.64e-2
Macrophage	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-5	4.80e-2
DC 1	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-5	1.38e-2
CD34 progenitor	Waist Format 1	Waist Circumference Males European	MTC	Shungin	2015	NA	56910	1.00e-5	4.80e-2
T CD8 MAIT	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.51e-3
T CD8 MAIT	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	2.75e-2
T CD4 fh	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.26e-2
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	6.88e-3
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	5.71e-3
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.68e-2
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	7.25e-3
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	1.04e-2
Monocyte	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.26e-2
Monocyte	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.68e-2
Monocyte	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	2.91e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	3.84e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	4.21e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	1.69e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	9.59e-4
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	4.92e-2
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	5.71e-3
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.70e-4
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	1.25e-4
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	5.98e-5
ILC	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	4.92e-2
ILC	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	2.75e-2
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	3.55e-3
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	8.88e-3
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.31e-3
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	2.90e-3
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	2.51e-4
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.21e-3
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	8.88e-3
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	3.65e-2
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	3.33e-3
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	4.92e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.68e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	3.65e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	1.04e-2
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.21e-3
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	8.05e-4
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	2.75e-2
B naive	Waist Format 1	Waist Hip Ratio Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	2.91e-2
T CD8 MAIT	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.99e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.18e-3
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.88e-3
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.72e-3
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	6.27e-3
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	5.55e-4
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	4.96e-2
Plasma IgG	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	2.28e-2
Plasma IgG	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	2.32e-2
Plasma IgG	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	3.79e-2
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.72e-3
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.88e-3
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	3.79e-2
DC plasmacytoid	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	4.96e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.99e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.43e-2
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	2.10e-2
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.99e-2
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.43e-2
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	3.79e-2
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	2.32e-2
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	2.72e-3
B naive	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	2.10e-2
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	2.10e-2
B mature	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	1.83e-2
Plasma IgM	Waist Format 1	Waist Hip Ratio Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	3.79e-2
B naive	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.40e-2
ILC	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.40e-2
ILC	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	5.61e-3
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	3.50e-5
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.73e-2
DC 1	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	7.02e-4
DC activated	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.73e-2
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.85e-3
CD34 progenitor	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.00e-2
B T doublet	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.63e-2
B T doublet	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.56e-3
B T doublet	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.79e-2
DC 2	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.79e-2
Macrophage	Waist Format 1	Waist Hip Ratio Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.79e-2
T CD8 MAIT	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	3.65e-2
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	7.74e-6
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	1.22e-3
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	3.90e-2
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	1.52e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	8.90e-5
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	7.84e-3
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	7.29e-3
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	7.89e-4
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.19e-5
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	3.27e-5
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	6.37e-4
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	1.29e-4
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	2.58e-6
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.19e-5
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	1.51e-2
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.05e-6
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	1.31e-6
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.18e-6
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	2.62e-5
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	2.58e-6
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.19e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	8.69e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	7.73e-3
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	5.60e-4
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	5.41e-5
B mature	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	4.80e-2
DC 1	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	1.51e-2
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	7.73e-3
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	5.60e-4
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	1.77e-3
Platelet	Waist Format 2	Hip Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	7.78e-3
B naive	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.45e-2
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	7.93e-4
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.04e-3
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	1.66e-2
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	4.34e-2
B mature	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.91e-2
B mature	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	4.29e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.09e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.53e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	9.69e-3
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	9.26e-4
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	1.13e-2
DC 1	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.09e-2
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	2.52e-4
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.22e-3
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	4.18e-5
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	1.65e-5
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	2.06e-6
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.73e-4
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	7.06e-3
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.23e-5
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.63e-4
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	7.96e-6
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	1.65e-5
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	2.06e-6
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.76e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.22e-3
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	9.18e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	4.85e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	8.78e-6
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	7.06e-3
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	2.99e-3
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	2.23e-3
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	2.80e-2
Platelet	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.10e-2
Platelet	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	1.10e-2
Platelet	Waist Format 2	Hip Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-5	1.13e-2
T CD8 MAIT	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.86e-2
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.77e-3
NK CD160pos	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	3.94e-2
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.52e-3
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	9.44e-4
T cell dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	1.97e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.66e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	3.94e-2
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.31e-4
NK dividing	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	4.93e-2
ILC	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.72e-2
DC 1	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.72e-2
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.24e-3
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	5.97e-5
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.06e-3
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	2.33e-3
Plasma IgM	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	2.28e-3
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.66e-2
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	5.45e-3
B Hypermutation	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	4.93e-2
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.69e-5
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.30e-6
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.07e-3
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	5.45e-3
Plasma IgG	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	1.97e-2
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	7.32e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.87e-4
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.22e-4
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.48e-5
Plasmablast	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	7.04e-3
Platelet	Waist Format 2	Hip Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	4.83e-2
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.02e-2
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	5.07e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	3.49e-4
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	5.46e-4
B mature	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.19e-2
B mature	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	7.10e-3
DC 1	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.56e-2
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.40e-3
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	3.38e-3
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	2.31e-3
B Hypermutation	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	2.02e-2
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	6.98e-4
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	3.38e-3
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	1.26e-3
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	3.30e-2
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	1.56e-2
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.74e-2
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	4.89e-2
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	3.70e-3
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	2.20e-2
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.11e-3
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	4.07e-2
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-5	9.82e-3
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	5.00e-2	1.19e-2
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	9.12e-4
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	3.08e-2
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	4.17e-2
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.74e-2
NK FCGR3Apos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	2.20e-2
NK FCGR3Apos	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-3	4.74e-2
ILC	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-2	3.05e-2
ILC	Waist Format 2	Waist Circumference Adjusted For BMI European	MTC	Shungin	2015	NA	143480	1.00e-4	2.78e-3
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	8.07e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.01e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	2.85e-2
NK FCGR3Apos	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.35e-2
T CD4 fh	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.31e-2
B mature	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	4.31e-2
T CD4 naive	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.35e-2
T CD4 conv	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.10e-2
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	3.35e-2
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	8.41e-3
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	8.53e-3
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	2.51e-3
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.96e-2
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	4.61e-2
B T doublet	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	2.85e-2
ILC	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	4.10e-2
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-2	1.94e-2
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	8.53e-3
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	6.37e-3
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-3	4.61e-2
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	2.51e-3
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI Females European	MTC	Shungin	2015	NA	86570	1.00e-4	9.21e-4
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.58e-2
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.20e-4
T CD8 MAIT	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	3.80e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.06e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.72e-5
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	3.80e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	4.01e-3
NK CD160pos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	3.16e-2
B naive	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.78e-2
B naive	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.27e-2
NK FCGR3Apos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.23e-3
NK FCGR3Apos	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	7.47e-4
T cell dividing	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	7.21e-4
B mature	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.58e-2
B mature	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	6.02e-3
B mature	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.52e-2
T CD8 CTL	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	8.62e-3
T CD8 CTL	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	7.47e-4
NK dividing	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	8.79e-5
NK dividing	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.24e-4
NK dividing	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	7.78e-3
DC 1	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.11e-2
DC 1	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	6.02e-3
Plasma IgM	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.58e-2
B Hypermutation	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.23e-3
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	8.62e-3
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.83e-2
Plasma IgG	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	2.97e-2
Platelet	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	6.26e-3
Platelet	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.91e-2
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.23e-3
DC plasmacytoid	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.31e-4
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	2.11e-4
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.30e-3
Plasmablast	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	3.37e-4
DC activated	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	8.62e-3
CD34 progenitor	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.55e-3
ILC	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.27e-2
ILC	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-4	1.15e-2
ILC	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-5	9.41e-3
Neutrophil	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.91e-2
Neutrophil	Waist Format 2	Waist Circumference Adjusted For BMI Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.83e-2
DC 1	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	5.00e-2	2.08e-2
DC 1	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-2	1.34e-3
DC 1	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-4	1.23e-2
DC 1	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-5	2.30e-2
CD34 progenitor	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	5.00e-2	1.13e-2
CD34 progenitor	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-3	3.69e-2
Macrophage	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-2	6.39e-3
Macrophage	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-3	8.98e-3
Macrophage	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-4	3.35e-2
ILC	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-3	3.69e-2
ILC	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-4	3.35e-2
Plasma IgM	Waist Format 2	Waist Hip Ratio European	MTC	Shungin	2015	NA	143480	1.00e-4	3.35e-2
DC 2	Waist Format 2	Waist Hip Ratio Females European	MTC	Shungin	2015	NA	86570	5.00e-2	1.23e-2
DC plasmacytoid	Waist Format 2	Waist Hip Ratio Females European	MTC	Shungin	2015	NA	86570	5.00e-2	6.33e-3
CD34 progenitor	Waist Format 2	Waist Hip Ratio Females European	MTC	Shungin	2015	NA	86570	5.00e-2	8.87e-3
Macrophage	Waist Format 2	Waist Hip Ratio Females European	MTC	Shungin	2015	NA	86570	1.00e-2	3.40e-2
B mature	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.30e-2
B mature	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.80e-2
ILC	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.06e-3
ILC	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.31e-3
DC 1	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	5.00e-2	4.24e-4
DC 1	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.31e-3
DC 1	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.97e-2
DC 1	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-4	9.50e-3
DC activated	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	5.00e-2	1.66e-2
CD34 progenitor	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	5.00e-2	3.18e-2
CD34 progenitor	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	1.31e-3
CD34 progenitor	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.28e-3
B naive	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.90e-2
B naive	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-3	2.97e-2
B naive	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-4	9.50e-3
T cell dividing	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	4.80e-2
T CD4 conv	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.90e-2
B T doublet	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-2	2.62e-3
NK dividing	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-3	1.15e-2
Macrophage	Waist Format 2	Waist Hip Ratio Males European	MTC	Shungin	2015	NA	56910	1.00e-4	3.59e-2
NK FCGR3Apos	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	2.60e-3
NK FCGR3Apos	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	1.85e-2
NK FCGR3Apos	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-5	1.81e-2
T cell dividing	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	3.71e-7
T cell dividing	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	2.23e-3
T CD4 reg	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	3.35e-2
T CD4 reg	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	3.28e-3
T CD4 reg	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-3	1.05e-2
T CD4 reg	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-4	6.69e-4
T CD4 naive	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	4.15e-2
T CD4 naive	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-5	4.17e-2
NK dividing	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	1.32e-4
NK dividing	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	2.51e-2
DC 1	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	2.14e-2
DC 1	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	4.45e-2
DC 1	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-3	4.29e-2
B Hypermutation	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	4.27e-5
B Hypermutation	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-2	1.34e-2
Platelet	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	7.95e-3
Platelet	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	1.00e-3	2.77e-2
Plasmablast	BIP	Bipolar disorder	ETC	Stahl	2018	20352	31358	5.00e-2	1.93e-5
B naive	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	3.84e-3
B naive	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	4.80e-4
B naive	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-4	1.22e-3
B naive	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	9.75e-3
NK FCGR3Apos	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	4.68e-2
T cell dividing	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	5.12e-3
B mature	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	1.49e-2
B mature	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	1.89e-2
B mature	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-4	7.67e-3
B mature	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	2.00e-3
T CD4 reg	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	3.78e-2
T CD4 reg	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	1.89e-2
NK dividing	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	1.49e-2
NK dividing	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	1.89e-2
NK dividing	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-4	1.99e-3
NK dividing	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	5.90e-3
DC 1	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	3.84e-3
DC 1	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	2.54e-2
DC 1	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	2.46e-2
Plasma IgM	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	1.15e-2
Plasma IgM	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	3.38e-2
Plasma IgM	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-4	4.97e-2
B Hypermutation	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	4.68e-2
Plasma IgG	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	1.15e-2
Plasmablast	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-2	6.46e-5
Plasmablast	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	3.38e-2
Plasmablast	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-4	4.97e-2
T CD8 MAIT	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-3	3.38e-2
T CD8 MAIT	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	3.76e-2
T CD4 naive	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	3.76e-2
Platelet	SCZ	Schizophrenia	ETC	Ripke	2014	32405	42221+í	1.00e-5	3.76e-2
T CD8 MAIT	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	9.96e-6
T CD8 MAIT	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.68e-5
T CD8 MAIT	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.95e-4
T CD8 MAIT	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	1.26e-5
T CD8 MAIT	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	9.96e-6
NK CD160pos	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	3.81e-5
NK CD160pos	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	8.55e-3
T CD8 activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	1.57e-5
T CD8 activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.40e-4
T CD8 activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.29e-3
T CD8 activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	3.40e-4
T CD8 activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	1.59e-4
B naive	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	5.31e-7
B naive	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.35e-4
B naive	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	3.75e-4
B naive	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	6.99e-5
B naive	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	2.60e-5
NK FCGR3Apos	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	1.46e-6
NK FCGR3Apos	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.61e-3
T CD4 fh	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	3.32e-2
T CD4 fh	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	4.84e-2
T CD4 fh	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	4.45e-2
T cell dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	4.81e-3
T cell dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.25e-2
T cell dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	3.99e-3
T cell dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	2.85e-3
T cell dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	3.73e-3
B mature	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	3.57e-9
B mature	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.41e-6
B mature	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.95e-4
B mature	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	1.57e-4
B mature	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	2.60e-5
T CD8 CTL	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	6.25e-6
T CD8 CTL	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.40e-4
T CD8 CTL	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	3.75e-4
T CD8 CTL	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	9.89e-3
T CD8 CTL	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	3.73e-3
T CD4 reg	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	4.81e-3
T CD4 reg	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	3.90e-4
T CD4 reg	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.29e-3
T CD4 reg	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	7.15e-4
T CD4 reg	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	3.71e-4
T CD4 conv	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	2.54e-3
T CD4 conv	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.50e-3
T CD4 conv	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	5.41e-3
T CD4 conv	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	1.41e-2
Monocyte	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	1.54e-2
NK dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	5.31e-7
NK dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	4.50e-6
NK dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	4.90e-5
NK dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	1.26e-5
NK dividing	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	2.60e-5
B T doublet	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	3.51e-3
B T doublet	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.02e-3
B T doublet	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	7.03e-4
B T doublet	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	7.15e-4
B T doublet	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	3.71e-4
DC 2	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	1.34e-4
DC 2	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.79e-2
DC 2	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	1.41e-2
Macrophage	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	2.59e-2
Macrophage	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.52e-2
Macrophage	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	6.75e-3
Macrophage	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	4.84e-2
Macrophage	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	1.41e-2
ILC	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	4.21e-2
ILC	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.25e-2
T CD8 gd	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	4.81e-3
T CD8 gd	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	4.77e-2
T CD8 gd	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	4.84e-2
DC 1	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	2.00e-4
DC 1	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	2.50e-3
DC 1	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.29e-3
DC 1	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	2.85e-3
DC 1	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	1.59e-4
Plasma IgM	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	8.77e-3
B Hypermutation	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	8.77e-3
Plasma IgG	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	1.17e-2
Plasma IgG	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	4.77e-2
DC plasmacytoid	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	2.00e-4
DC plasmacytoid	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	3.83e-3
DC plasmacytoid	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	1.11e-2
DC plasmacytoid	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	4.84e-2
Plasmablast	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	4.81e-3
Plasmablast	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	1.79e-2
DC activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	5.00e-2	2.00e-4
DC activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-2	4.72e-5
DC activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-3	7.79e-8
DC activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-4	1.26e-5
DC activated	T1D	Type 1 Diabetes	ETC	Bradfield	2011	9934	16956	1.00e-5	9.96e-6
B naive	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	5.00e-2	7.76e-3
T CD4 reg	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	5.00e-2	3.37e-3
T CD4 reg	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	1.00e-2	2.33e-2
T CD4 conv	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	5.00e-2	3.34e-2
T CD4 conv	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	1.00e-2	2.33e-2
T CD4 fh	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	1.00e-2	2.93e-3
T CD4 naive	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	1.00e-2	4.22e-2
B T doublet	PAN	Pancreatic Cancer	ETC	Amundadottir	2009	1771	1805	1.00e-2	1.23e-2
T CD8 MAIT	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	2.52e-2
T cell dividing	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	1.92e-2
T cell dividing	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-2	1.49e-2
T CD4 naive	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	2.52e-2
T CD8 gd	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	4.20e-2
DC 1	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	1.08e-2
DC 1	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-2	1.49e-2
DC 1	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-4	1.57e-2
B Hypermutation	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	2.99e-3
B Hypermutation	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-2	2.22e-2
CD34 progenitor	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	5.00e-2	1.92e-2
NK dividing	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-2	3.99e-3
B naive	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-3	3.79e-2
B naive	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-4	1.67e-3
B naive	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-5	4.92e-3
B mature	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-4	4.09e-2
B mature	COL	SSGAC_College	ETC	Rietveld	2013	NA	101069	1.00e-5	4.92e-3
T CD8 MAIT	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.75e-3
T CD8 MAIT	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.34e-2
T CD8 MAIT	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	3.13e-2
T CD8 MAIT	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	7.04e-3
B naive	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	2.10e-2
B naive	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	7.26e-3
B naive	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	4.07e-3
B naive	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	4.22e-2
NK FCGR3Apos	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.32e-2
T cell dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	9.87e-3
T cell dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	2.37e-2
T cell dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.20e-2
T cell dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	2.17e-2
B mature	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	4.31e-3
B mature	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	8.86e-4
B mature	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	5.92e-3
B mature	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	3.05e-2
T CD4 reg	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	4.13e-2
NK dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.28e-2
NK dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.79e-2
NK dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	8.50e-3
NK dividing	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	2.83e-4
Macrophage	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	9.87e-3
Macrophage	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.34e-2
Macrophage	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	4.18e-2
ILC	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.32e-2
DC 1	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	7.55e-3
DC 1	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	3.09e-2
Platelet	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.75e-3
Platelet	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.83e-5
Platelet	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.20e-2
Platelet	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.96e-3
DC plasmacytoid	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.27e-3
DC plasmacytoid	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	5.25e-3
DC plasmacytoid	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	4.07e-3
DC plasmacytoid	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	3.05e-2
Plasmablast	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	5.73e-3
Plasmablast	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	4.03e-4
Plasmablast	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.22e-3
Plasmablast	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	7.69e-4
DC activated	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.22e-3
Monocyte	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	7.26e-3
Monocyte	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	2.30e-2
Plasma IgM	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	2.37e-2
Plasma IgM	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	2.17e-2
Plasma IgG	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	3.09e-2
Plasma IgG	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.68e-2
Plasma IgG	HGB	Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	4.67e-3
T CD8 MAIT	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	2.16e-3
T CD8 MAIT	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.51e-3
T CD8 MAIT	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	6.67e-4
T CD8 MAIT	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	8.09e-3
NK FCGR3Apos	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.21e-3
NK FCGR3Apos	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	2.94e-3
NK FCGR3Apos	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	4.82e-3
T cell dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	3.11e-7
T cell dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.09e-5
T cell dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	2.77e-4
T cell dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.46e-3
T cell dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	4.69e-4
B mature	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	3.92e-2
T CD8 CTL	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	3.92e-2
T CD8 CTL	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	2.87e-2
T CD8 CTL	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	3.33e-3
NK dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.80e-6
NK dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.27e-5
NK dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	2.74e-7
NK dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	4.93e-7
NK dividing	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.59e-7
DC 2	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.62e-3
DC 2	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	4.05e-3
DC 1	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	2.49e-4
DC 1	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.31e-2
DC 1	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	2.51e-2
DC 1	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.72e-2
Plasma IgM	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	8.19e-3
Plasma IgM	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	4.05e-3
Plasma IgM	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	9.70e-3
Plasma IgM	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	3.03e-2
B Hypermutation	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	2.49e-4
B Hypermutation	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.57e-4
B Hypermutation	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	3.33e-3
B Hypermutation	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	3.56e-3
B Hypermutation	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.36e-3
Plasma IgG	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	2.86e-3
Plasma IgG	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	5.20e-4
Plasma IgG	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	3.33e-3
Plasma IgG	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	2.44e-2
Plasma IgG	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.39e-2
Platelet	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.38e-5
Platelet	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.64e-4
Platelet	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.75e-4
Platelet	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	2.04e-4
Platelet	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.20e-5
DC plasmacytoid	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.62e-3
DC plasmacytoid	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	2.12e-3
DC plasmacytoid	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	4.82e-3
DC plasmacytoid	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	4.69e-2
Plasmablast	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	4.30e-5
Plasmablast	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	1.17e-6
Plasmablast	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	1.47e-5
Plasmablast	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	1.21e-5
Plasmablast	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	7.22e-7
CD34 progenitor	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	5.00e-2	1.33e-2
Macrophage	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-2	3.66e-2
Macrophage	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	4.43e-2
Macrophage	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	3.41e-2
Unknown	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-3	9.70e-3
Unknown	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-4	2.44e-2
Unknown	MCHC	Mean Corpuscular Hemoglobin Concentration	ETC	Astle	2016	NA	173480	1.00e-5	1.39e-2
T CD8 MAIT	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	6.05e-6
T CD8 MAIT	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	8.80e-5
T CD8 MAIT	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	2.66e-4
T CD8 MAIT	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.05e-4
T CD8 MAIT	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.19e-4
T CD8 activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	2.58e-3
T CD8 activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	1.52e-4
T CD8 activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	2.50e-2
T CD8 activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.95e-2
T CD8 activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	3.60e-2
B naive	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	3.57e-3
B naive	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	2.82e-3
B naive	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	6.55e-5
B naive	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	5.06e-6
B naive	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.19e-4
NK FCGR3Apos	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	4.90e-3
NK FCGR3Apos	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	1.52e-4
NK FCGR3Apos	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	1.56e-2
NK FCGR3Apos	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.95e-2
T CD4 fh	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	6.33e-4
T cell dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	9.12e-4
T cell dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	9.75e-3
B mature	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	1.53e-5
B mature	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	1.57e-5
B mature	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	8.96e-8
B mature	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.18e-7
B mature	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.39e-7
T CD8 CTL	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	8.82e-5
T CD8 CTL	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	7.04e-4
T CD8 CTL	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	1.56e-2
T CD8 CTL	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	8.80e-3
T CD8 CTL	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.87e-2
T CD4 reg	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	3.75e-6
T CD4 reg	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	2.82e-3
NK dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	9.12e-4
NK dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	8.80e-5
NK dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	9.49e-3
NK dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	1.65e-2
NK dividing	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	3.60e-2
DC 2	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	4.33e-2
DC 2	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	9.77e-4
DC 2	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	4.70e-4
DC 2	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.19e-4
Macrophage	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	2.66e-2
Macrophage	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	2.04e-2
Macrophage	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	3.22e-3
Macrophage	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.21e-3
Macrophage	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.88e-3
DC 1	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	1.58e-2
DC 1	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	4.34e-3
DC 1	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	6.61e-6
DC 1	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	5.06e-6
DC 1	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	4.94e-6
B Hypermutation	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	2.58e-3
B Hypermutation	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	6.56e-3
Plasma IgG	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	2.66e-2
Plasma IgG	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	2.89e-2
Plasma IgG	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	1.56e-2
Plasmablast	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	2.66e-2
DC activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	5.00e-2	1.30e-3
DC activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	4.58e-6
DC activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	5.18e-9
DC activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	7.15e-8
DC activated	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.57e-6
Plasma IgM	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-2	2.89e-2
Plasma IgM	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-3	1.56e-2
B T doublet	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-4	2.95e-2
B T doublet	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	3.60e-2
NK CD160pos	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	3.60e-2
DC plasmacytoid	PBC	Primary Biliary Cirrhosis	ETC	Cordell	2015	2764	10475	1.00e-5	1.87e-2
T CD8 MAIT	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	1.36e-8
T CD8 MAIT	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	9.82e-5
T CD8 MAIT	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	7.31e-4
T CD8 MAIT	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	5.26e-4
T CD8 MAIT	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.97e-4
NK CD160pos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	4.61e-2
T CD8 activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	2.66e-5
T CD8 activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.98e-5
T CD8 activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	5.14e-5
T CD8 activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	5.26e-5
T CD8 activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	3.93e-3
B naive	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	2.95e-7
B naive	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.13e-5
B naive	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	1.18e-5
B naive	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	9.74e-6
B naive	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	5.61e-6
NK FCGR3Apos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	8.76e-5
NK FCGR3Apos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	8.08e-3
NK FCGR3Apos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	4.35e-2
NK FCGR3Apos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	3.60e-2
NK FCGR3Apos	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	2.47e-2
T CD4 fh	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	1.45e-2
T CD4 fh	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	4.22e-2
T cell dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	1.47e-3
T cell dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	4.22e-2
B mature	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	2.64e-10
B mature	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	2.33e-9
B mature	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	2.73e-10
B mature	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	1.24e-9
B mature	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	9.81e-10
T CD8 CTL	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	7.49e-6
T CD8 CTL	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.63e-4
T CD8 CTL	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	3.91e-4
T CD8 CTL	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	5.26e-4
T CD8 CTL	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.97e-4
T CD4 reg	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	4.84e-6
T CD4 reg	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	3.43e-5
T CD4 reg	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	2.49e-5
T CD4 reg	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	5.26e-4
T CD4 reg	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	9.49e-4
T CD4 conv	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	2.97e-2
NK dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	7.74e-7
NK dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	5.84e-5
NK dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	1.84e-2
NK dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	7.22e-3
NK dividing	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.97e-3
B T doublet	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	2.68e-4
B T doublet	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.16e-2
B T doublet	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	1.15e-2
DC 2	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	6.54e-3
DC 2	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.64e-2
DC 2	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	6.97e-3
DC 2	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	1.06e-3
DC 2	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.97e-3
Macrophage	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	5.43e-4
Macrophage	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.64e-2
Macrophage	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	6.97e-3
Macrophage	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	5.26e-4
Macrophage	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	9.49e-4
T CD8 gd	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	1.47e-3
T CD8 gd	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.07e-3
T CD8 gd	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	6.97e-3
T CD8 gd	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	3.94e-3
T CD8 gd	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	4.20e-2
DC 1	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	1.12e-2
DC 1	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	4.35e-2
DC 1	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	2.08e-3
DC 1	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	9.49e-4
B Hypermutation	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	6.54e-3
B Hypermutation	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.16e-2
B Hypermutation	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	4.35e-2
DC plasmacytoid	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	7.63e-4
DC plasmacytoid	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.64e-2
DC plasmacytoid	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	4.35e-2
DC plasmacytoid	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	2.18e-2
DC plasmacytoid	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.39e-2
Plasmablast	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	8.76e-5
Plasmablast	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	1.07e-3
Plasmablast	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	2.87e-2
DC activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	5.00e-2	7.49e-6
DC activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-2	5.84e-5
DC activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-3	3.91e-4
DC activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-4	9.74e-6
DC activated	SLE	Systemic Lupus Erythematosus	ETC	Bentham	2015	7219	15991	1.00e-5	1.44e-5
NK FCGR3Apos	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	4.23e-2
NK FCGR3Apos	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	2.65e-2
NK FCGR3Apos	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	4.74e-2
T cell dividing	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	3.42e-2
B mature	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	6.16e-3
Monocyte	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.05e-2
Monocyte	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	3.86e-3
DC 2	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	4.23e-2
DC 2	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	4.57e-2
DC 2	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	4.74e-2
DC 2	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	2.79e-2
Macrophage	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.31e-4
Macrophage	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	3.63e-4
Macrophage	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	4.74e-4
Macrophage	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	4.58e-4
ILC	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	4.23e-2
ILC	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	7.70e-3
ILC	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	3.25e-3
ILC	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	4.17e-2
DC 1	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.89e-4
DC 1	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	5.54e-4
DC 1	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	3.25e-3
DC 1	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	2.79e-2
Plasma IgM	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	8.06e-3
Plasma IgM	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	4.57e-2
B Hypermutation	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	2.18e-2
Plasma IgG	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.04e-3
Plasma IgG	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	1.98e-2
Plasma IgG	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	2.41e-2
Plasma IgG	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	4.17e-2
Platelet	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.05e-2
Platelet	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	7.70e-3
Platelet	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	5.03e-3
Platelet	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	4.17e-2
DC plasmacytoid	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	1.94e-3
DC plasmacytoid	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	1.98e-2
Plasmablast	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	5.38e-4
Plasmablast	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	3.86e-3
Plasmablast	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	1.68e-2
CD34 progenitor	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-2	3.42e-2
T CD8 gd	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-3	2.65e-2
DC activated	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-4	2.41e-2
DC activated	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	4.17e-2
T CD8 MAIT	RHR	CAD Resting Heart Rate	ETC	Eppinga	2016	NA	265046	1.00e-5	1.82e-2
T CD8 MAIT	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.39e-11
T CD8 MAIT	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	2.14e-8
T CD8 MAIT	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	1.07e-6
T CD8 MAIT	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.22e-7
T CD8 MAIT	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	6.58e-8
NK CD160pos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	4.53e-6
NK CD160pos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	1.04e-4
T CD8 activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.18e-6
T CD8 activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	1.56e-6
T CD8 activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.25e-4
T CD8 activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.91e-4
T CD8 activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.30e-4
B naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	3.31e-2
B naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.96e-2
B naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	4.55e-3
B naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	4.89e-4
NK FCGR3Apos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.37e-8
NK FCGR3Apos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	8.77e-7
NK FCGR3Apos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	3.36e-3
NK FCGR3Apos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	7.87e-3
NK FCGR3Apos	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.20e-2
T CD4 fh	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	6.84e-4
T CD4 fh	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	3.92e-5
T CD4 fh	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	5.42e-3
T CD4 fh	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.32e-2
T cell dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.18e-6
T cell dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	3.20e-2
T cell dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	8.55e-3
T cell dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	2.16e-2
T cell dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.00e-3
B mature	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	4.53e-6
B mature	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	9.21e-3
B mature	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.04e-3
B mature	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.91e-4
B mature	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	1.99e-5
T CD8 CTL	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	8.01e-9
T CD8 CTL	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	1.44e-9
T CD8 CTL	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	4.55e-6
T CD8 CTL	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	2.07e-5
T CD8 CTL	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.30e-4
T CD4 reg	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	2.31e-8
T CD4 reg	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	2.14e-8
T CD4 reg	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.25e-4
T CD4 reg	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	4.45e-5
T CD4 reg	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.30e-4
T CD4 naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	2.10e-2
T CD4 naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	3.16e-3
T CD4 naive	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	1.32e-2
T CD4 conv	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	6.84e-4
T CD4 conv	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	6.43e-5
T CD4 conv	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.04e-3
T CD4 conv	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.32e-2
T CD4 conv	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	3.66e-2
Monocyte	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.69e-4
NK dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.55e-9
NK dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	4.80e-6
NK dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	1.81e-5
NK dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	4.12e-6
NK dividing	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	1.30e-6
B T doublet	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	5.43e-5
B T doublet	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	8.77e-7
B T doublet	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	3.49e-5
B T doublet	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	7.38e-4
B T doublet	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.00e-3
DC 2	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	4.53e-6
DC 2	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	9.66e-4
DC 2	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.04e-3
DC 2	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	3.41e-2
DC 2	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	7.12e-3
Macrophage	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.07e-5
Macrophage	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	6.53e-3
Macrophage	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.96e-2
Macrophage	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	3.66e-2
ILC	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.29e-2
T CD8 gd	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	6.84e-4
T CD8 gd	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	4.11e-4
T CD8 gd	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	8.55e-3
T CD8 gd	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.32e-2
DC 1	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	6.99e-6
DC 1	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	4.57e-3
DC 1	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	5.42e-3
DC 1	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	2.16e-2
DC 1	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	7.12e-3
B Hypermutation	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	1.17e-4
B Hypermutation	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	4.28e-2
DC plasmacytoid	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	5.81e-3
DC plasmacytoid	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	9.66e-4
DC plasmacytoid	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.00e-2
Plasmablast	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	7.98e-5
Plasmablast	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	6.53e-3
Plasmablast	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	3.36e-3
Plasmablast	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	1.32e-2
Plasmablast	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	1.27e-2
DC activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	5.00e-2	3.66e-5
DC activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	8.26e-6
DC activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.06e-8
DC activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	7.45e-7
DC activated	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	8.25e-6
Plasma IgM	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	2.39e-2
Plasma IgM	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	8.55e-3
Plasma IgM	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	2.16e-2
Plasma IgM	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	2.20e-2
Plasma IgG	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-2	4.22e-2
Plasma IgG	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-3	2.04e-3
Plasma IgG	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-4	2.55e-3
Plasma IgG	T1D CA	Type1Diabetes (Childhood adiposity age < 17)	ETC	Censin	2017	5913	8828	1.00e-5	1.01e-3
T CD8 MAIT	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	4.90e-4
T CD8 MAIT	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	3.31e-2
T CD8 activated	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	2.45e-2
B naive	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	2.45e-2
NK FCGR3Apos	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	7.01e-3
NK FCGR3Apos	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-5	1.07e-2
T cell dividing	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	7.43e-4
T cell dividing	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	1.39e-2
T CD8 CTL	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	3.25e-2
T CD4 reg	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	2.41e-3
T CD4 naive	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	4.25e-2
T CD4 conv	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	7.01e-3
NK dividing	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	7.01e-3
B Hypermutation	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	2.41e-3
B Hypermutation	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	8.68e-3
B Hypermutation	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-3	3.78e-2
DC plasmacytoid	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	9.76e-3
Plasmablast	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	5.00e-2	7.01e-3
Plasmablast	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	1.39e-2
Plasmablast	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-3	2.02e-2
T CD4 fh	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	3.31e-2
Plasma IgM	EOC	Epithelial Ovarian Cancer	ETC	Phelan	2017	25509	40941	1.00e-2	4.91e-2
B naive	AUD	Alcohol Dependency	ETC	Walters	2018	11569	34999	5.00e-2	3.87e-2
B Hypermutation	AUD	Alcohol Dependency	ETC	Walters	2018	11569	34999	5.00e-2	2.71e-2
T CD8 MAIT	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	6.85e-17
T CD8 MAIT	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.96e-12
T CD8 MAIT	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	1.46e-11
T CD8 MAIT	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	2.42e-11
T CD8 MAIT	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	2.08e-10
NK CD160pos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	3.50e-10
NK CD160pos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.31e-6
NK CD160pos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	8.68e-6
NK CD160pos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	6.57e-5
NK CD160pos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	2.81e-5
T CD8 activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.82e-14
T CD8 activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	9.49e-14
T CD8 activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	1.46e-11
T CD8 activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	1.56e-8
T CD8 activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.94e-7
B naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.77e-7
B naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.66e-5
B naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	5.05e-5
B naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	4.20e-4
B naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.22e-4
NK FCGR3Apos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	3.50e-10
NK FCGR3Apos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	4.39e-8
NK FCGR3Apos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	6.73e-7
NK FCGR3Apos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	4.25e-7
NK FCGR3Apos	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	7.80e-8
T CD4 fh	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	8.95e-9
T CD4 fh	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.31e-8
T CD4 fh	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	4.69e-6
T CD4 fh	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	7.47e-4
T CD4 fh	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	2.43e-4
T cell dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	7.67e-4
T cell dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	2.50e-4
T cell dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	3.87e-2
B mature	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	4.52e-7
B mature	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	6.20e-6
B mature	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	2.49e-6
B mature	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	1.98e-6
B mature	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	7.80e-8
T CD8 CTL	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.32e-13
T CD8 CTL	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.72e-11
T CD8 CTL	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	9.22e-10
T CD8 CTL	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	2.69e-9
T CD8 CTL	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	4.44e-9
T CD4 reg	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.69e-12
T CD4 reg	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	9.49e-14
T CD4 reg	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	7.99e-11
T CD4 reg	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	4.25e-7
T CD4 reg	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.12e-6
T CD4 conv	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	5.55e-4
T CD4 conv	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	2.50e-4
T CD4 conv	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	2.55e-4
T CD4 conv	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	7.47e-4
T CD4 conv	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	5.24e-3
Monocyte	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.29e-2
Monocyte	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	2.31e-2
NK dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	7.15e-7
NK dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.02e-5
NK dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	4.24e-4
NK dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	1.30e-3
NK dividing	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	5.92e-5
B T doublet	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	9.57e-6
B T doublet	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.42e-7
B T doublet	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	2.85e-5
B T doublet	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	6.57e-5
B T doublet	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.22e-4
DC 2	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	4.65e-5
DC 2	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	3.60e-3
DC 2	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	2.76e-3
DC 2	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	1.30e-3
DC 2	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	5.24e-3
Macrophage	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	3.46e-3
Macrophage	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	5.05e-3
Macrophage	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	4.23e-3
Macrophage	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	2.22e-3
Macrophage	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	2.99e-3
T CD8 gd	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.12e-10
T CD8 gd	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	3.73e-6
T CD8 gd	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	4.24e-4
T CD8 gd	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	2.31e-4
T CD8 gd	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.66e-3
DC 1	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.43e-3
DC 1	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	3.60e-3
DC 1	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	2.76e-3
DC 1	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	1.30e-3
DC 1	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.66e-3
Plasma IgM	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.43e-3
Plasma IgM	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	3.78e-4
Plasma IgM	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	6.39e-3
Plasma IgM	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	9.59e-3
Plasma IgM	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.47e-2
B Hypermutation	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	7.67e-4
B Hypermutation	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.77e-3
Plasma IgG	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.43e-3
Plasma IgG	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	5.65e-4
Plasma IgG	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	3.38e-2
Plasma IgG	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.47e-2
DC plasmacytoid	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	4.65e-5
DC plasmacytoid	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	8.37e-4
DC plasmacytoid	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	3.87e-2
Plasmablast	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	2.01e-4
Plasmablast	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	2.54e-3
DC activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	5.00e-2	1.75e-6
DC activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	1.31e-6
DC activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	6.73e-7
DC activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	3.67e-8
DC activated	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-5	1.18e-8
T CD4 naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-2	2.54e-3
T CD4 naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-3	4.23e-3
T CD4 naive	MS	Multiple Sclerosis	ETC	Patsopoulos	2017	14802	26703	1.00e-4	4.91e-2
B naive	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	2.97e-2
B naive	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	4.22e-3
B mature	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	2.31e-2
B mature	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	1.69e-2
B mature	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	6.60e-4
NK dividing	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	1.37e-2
NK dividing	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	1.69e-2
NK dividing	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	1.73e-3
DC 1	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	1.04e-2
DC 1	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	1.99e-3
DC 1	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	1.08e-3
Plasma IgM	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	2.25e-3
Plasma IgM	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	6.17e-3
Plasma IgM	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	2.91e-2
Plasma IgG	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	7.78e-3
Plasma IgG	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	4.13e-2
Plasmablast	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-3	5.21e-5
Plasmablast	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	3.68e-4
Plasmablast	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	6.44e-3
NK FCGR3Apos	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	4.13e-2
T cell dividing	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-4	4.13e-2
T CD4 reg	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	2.91e-2
DC 2	SCZ	Schizophrenia	ETC	Pardinas	2018	40675	64643	1.00e-5	2.91e-2
T CD8 MAIT	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.01e-5
T CD8 MAIT	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.22e-5
T CD8 MAIT	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	3.09e-4
T CD8 MAIT	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	4.18e-4
T CD8 MAIT	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	1.89e-4
NK CD160pos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	7.04e-3
NK CD160pos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	3.98e-3
NK CD160pos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	3.09e-4
NK CD160pos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	4.18e-4
NK CD160pos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	9.87e-4
T CD8 activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	7.73e-8
T CD8 activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.04e-4
T CD8 activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	3.09e-4
T CD8 activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	1.45e-2
T CD8 activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	1.74e-2
B naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	5.00e-3
B naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	3.98e-3
B naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	1.08e-2
NK FCGR3Apos	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	7.04e-3
T CD4 fh	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	3.28e-4
T CD4 fh	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.22e-5
T CD4 fh	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	1.11e-6
T CD4 fh	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	4.91e-3
T CD4 fh	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	4.47e-3
B mature	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.44e-3
T CD8 CTL	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	1.13e-3
T CD8 CTL	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.10e-2
T CD8 CTL	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	2.26e-2
T CD4 reg	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	1.43e-6
T CD4 reg	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	2.55e-5
T CD4 reg	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	2.05e-3
T CD4 naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.44e-2
T CD4 naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	3.98e-3
T CD4 naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	8.18e-4
T CD4 naive	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	3.83e-2
T CD4 conv	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	5.00e-3
T CD4 conv	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	3.98e-3
T CD4 conv	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	1.11e-4
T CD4 conv	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	1.45e-2
T CD4 conv	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	4.47e-3
Monocyte	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	9.79e-3
B T doublet	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	3.51e-3
B T doublet	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	3.98e-3
B T doublet	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	2.05e-3
B T doublet	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-4	4.18e-4
B T doublet	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-5	9.87e-4
DC 2	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	1.13e-3
Macrophage	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	5.00e-3
Macrophage	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.10e-2
ILC	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.44e-3
T CD8 gd	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	1.82e-2
T CD8 gd	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	6.69e-3
T CD8 gd	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	4.84e-3
DC 1	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	5.00e-3
B Hypermutation	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	4.23e-2
DC plasmacytoid	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	3.28e-4
DC plasmacytoid	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.30e-3
DC plasmacytoid	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	1.08e-2
Plasmablast	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	3.51e-3
DC activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.01e-5
DC activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-2	1.22e-5
DC activated	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	3.77e-5
CD34 progenitor	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	5.00e-2	2.44e-3
Plasma IgG	CEL	Celiac Disease	ETC	Trynka	2011	12041	12228	1.00e-3	4.45e-2
ILC	Glycine level	Glycine levels, both male and female	ETC	Jia	2019	NA	30118	5.00e-2	9.99e-3
Neutrophil	Glycine level	Glycine levels, both male and female	ETC	Jia	2019	NA	30118	5.00e-2	2.73e-2
T CD8 MAIT	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	1.91e-2
T CD8 MAIT	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	2.05e-2
NK FCGR3Apos	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	3.29e-2
NK FCGR3Apos	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	5.57e-3
NK FCGR3Apos	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-5	2.73e-2
T cell dividing	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	5.64e-3
T cell dividing	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	2.05e-2
B mature	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	3.29e-2
T CD4 reg	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	2.86e-3
T CD4 reg	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	7.30e-4
NK dividing	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	1.39e-3
Macrophage	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	6.48e-4
Macrophage	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	2.05e-2
Macrophage	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-4	1.39e-2
Macrophage	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-5	2.50e-3
ILC	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	1.06e-2
ILC	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	3.02e-2
DC 1	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	4.04e-3
DC 1	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-5	8.79e-3
B Hypermutation	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	1.06e-2
Plasmablast	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	5.00e-2	4.25e-2
NK CD160pos	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	4.37e-2
T CD8 activated	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	4.37e-2
T CD4 fh	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	2.05e-2
T CD8 CTL	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	1.36e-2
T CD8 gd	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	1.25e-3
DC activated	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-2	3.02e-2
DC 2	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-4	1.39e-2
DC 2	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-5	2.50e-3
Neutrophil	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-4	3.34e-2
Monocyte	Handedness	Handedness, right-handed vs non-right-handed	ETC	Kovel	2019	293857	37180	1.00e-5	8.79e-3
T cell dividing	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	5.00e-2	9.90e-4
T cell dividing	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	1.00e-2	1.07e-4
NK dividing	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	5.00e-2	8.01e-3
NK dividing	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	1.00e-2	2.47e-3
Macrophage	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	5.00e-2	2.33e-2
B Hypermutation	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	5.00e-2	5.44e-3
B Hypermutation	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	1.00e-2	5.55e-4
Plasmablast	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	5.00e-2	1.55e-3
Plasmablast	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	1.00e-2	5.55e-4
DC 1	Ambidextrousness	Ambidextrousness	ETC	Kovel	2019	5324	325713	1.00e-2	3.04e-2
T CD8 MAIT	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	2.13e-3
NK CD160pos	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	1.59e-2
NK FCGR3Apos	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	4.36e-3
NK FCGR3Apos	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-4	8.33e-3
T CD4 fh	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	1.46e-3
T CD4 fh	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	3.41e-2
T CD4 fh	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-3	1.12e-2
T cell dividing	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	9.90e-4
T cell dividing	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	5.94e-3
T CD8 CTL	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	1.17e-2
T CD4 reg	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	4.26e-7
T CD4 reg	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	3.41e-2
NK dividing	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	6.63e-4
NK dividing	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	3.41e-2
Macrophage	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	3.72e-2
Macrophage	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	1.49e-2
Macrophage	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-3	2.20e-2
Macrophage	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-4	2.31e-4
Macrophage	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-5	4.47e-3
ILC	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	1.59e-2
ILC	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	3.41e-2
T CD8 gd	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	1.17e-2
DC 1	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	3.06e-3
DC 1	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-4	2.27e-2
B Hypermutation	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	2.88e-4
DC activated	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	5.00e-2	2.84e-2
DC activated	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	2.28e-2
Neutrophil	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-2	4.97e-2
DC 2	Handedness	Handedness, left-handed vs non-left-handed	ETC	Kovel	2019	31856	299181	1.00e-4	2.27e-2
T cell dividing	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	3.02e-2
NK dividing	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	6.75e-3
DC 2	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	3.02e-2
Macrophage	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	6.75e-3
Platelet	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	3.02e-2
CD34 progenitor	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	5.00e-2	1.14e-3
CD34 progenitor	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	1.00e-2	4.50e-2
DC plasmacytoid	Parkinsons	Parkinsons disease, age of onset	ETC	Blauwendraat	2019	NA	17996	1.00e-2	4.50e-2
T CD8 MAIT	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	1.62e-2
T CD4 conv	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	4.20e-3
Monocyte	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	1.99e-3
Monocyte	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-2	1.23e-2
Monocyte	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	1.36e-3
Monocyte	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-4	3.16e-2
DC 2	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	3.89e-2
DC 2	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-2	3.01e-2
DC 2	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	7.75e-3
B Hypermutation	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	5.87e-4
B Hypermutation	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-2	1.23e-2
B Hypermutation	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	3.35e-3
DC plasmacytoid	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	3.89e-2
Plasmablast	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	3.89e-2
Plasmablast	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-2	4.52e-2
Plasmablast	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	3.44e-2
DC activated	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	5.00e-2	2.94e-2
DC activated	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-2	3.01e-2
T cell dividing	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	3.44e-2
B mature	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	3.44e-2
B mature	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-4	5.45e-4
ILC	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-3	3.44e-2
ILC	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-4	9.41e-3
B naive	Active	Time to most active 10 hours	ETC	Jones	2019	NA	85670	1.00e-4	9.41e-3
T cell dividing	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	6.05e-4
T cell dividing	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-2	3.74e-2
NK dividing	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	1.82e-2
NK dividing	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-2	3.74e-2
DC 2	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	3.16e-2
T CD8 gd	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	3.82e-3
Platelet	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	1.82e-2
Platelet	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-2	7.02e-3
Plasmablast	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	1.82e-2
CD34 progenitor	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	5.00e-2	1.31e-3
CD34 progenitor	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-2	1.69e-2
Plasma IgM	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-5	2.59e-2
Plasma IgG	Sleep	Sleep efficiency	ETC	Jones	2019	NA	84810	1.00e-5	2.59e-2
T cell dividing	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	1.85e-2
T cell dividing	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	1.00e-2	4.53e-3
B mature	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	1.31e-2
B mature	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	1.00e-4	3.41e-2
NK dividing	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	6.29e-3
NK dividing	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	1.00e-2	4.53e-3
Platelet	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	3.00e-4
Platelet	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	1.00e-2	3.84e-2
Plasmablast	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	2.84e-3
CD34 progenitor	Sleep	Sleep duration variability	ETC	Jones	2019	NA	84810	5.00e-2	4.26e-3
T cell dividing	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	5.00e-2	4.62e-2
T cell dividing	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-2	9.07e-3
Platelet	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	5.00e-2	7.87e-3
DC plasmacytoid	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	5.00e-2	2.28e-2
CD34 progenitor	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	5.00e-2	2.28e-2
NK dividing	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-2	9.07e-3
Plasmablast	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-2	2.63e-2
T CD4 naive	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-3	2.70e-2
T CD4 naive	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-5	2.97e-2
B naive	Sleep	Sleep duration	ETC	Jones	2019	NA	85449	1.00e-4	2.69e-2
T CD8 MAIT	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	2.39e-2
T CD8 activated	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	1.76e-2
T CD8 CTL	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	9.21e-3
Monocyte	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	1.28e-2
Monocyte	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-3	3.43e-2
DC 2	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	2.16e-3
DC 2	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	4.50e-2
DC 1	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	2.16e-3
DC 1	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	1.77e-4
DC 1	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-3	2.26e-5
DC plasmacytoid	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	4.57e-3
DC activated	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	5.00e-2	3.92e-5
DC activated	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	1.14e-2
T cell dividing	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	4.50e-2
T CD4 reg	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	4.50e-2
CD34 progenitor	Sleep	Sleep time to midpoint	ETC	Jones	2019	NA	84810	1.00e-2	4.50e-2
T CD8 activated	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	2.95e-2
T CD8 activated	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-2	4.15e-2
T CD4 fh	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	2.95e-2
T cell dividing	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	4.84e-3
B mature	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	2.95e-2
B mature	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-2	2.82e-2
NK dividing	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	3.83e-2
T CD8 gd	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	4.84e-3
T CD8 gd	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-2	1.87e-2
B Hypermutation	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	6.73e-3
B Hypermutation	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-2	4.15e-2
DC plasmacytoid	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	6.73e-3
DC plasmacytoid	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-2	2.82e-2
DC plasmacytoid	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-3	1.55e-2
Plasmablast	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	5.00e-2	3.83e-2
Plasma IgM	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-4	3.58e-2
T CD4 naive	Sleep	Sleep time to least active 5 hours	ETC	Jones	2019	NA	85205	1.00e-5	3.87e-2
T cell dividing	Sleep	Diurnal inactivity	ETC	Jones	2019	NA	84757	5.00e-2	3.20e-3
T CD4 reg	Sleep	Diurnal inactivity	ETC	Jones	2019	NA	84757	5.00e-2	2.05e-2
CD34 progenitor	Sleep	Diurnal inactivity	ETC	Jones	2019	NA	84757	5.00e-2	3.49e-2
B naive	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	1.90e-2
NK FCGR3Apos	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	1.14e-2
T cell dividing	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	3.84e-2
B mature	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	3.69e-3
B mature	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-2	1.96e-3
B mature	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-3	2.88e-3
DC 1	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	2.42e-2
B Hypermutation	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	8.19e-5
B Hypermutation	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-2	3.58e-2
Plasmablast	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	5.25e-4
Plasmablast	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-2	2.62e-2
Plasmablast	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-3	2.51e-2
DC activated	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	3.06e-2
DC activated	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	1.00e-3	1.53e-2
CD34 progenitor	Sleep	Sleep number of episodes	ETC	Jones	2019	NA	84810	5.00e-2	3.06e-2
NK CD160pos	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	2.94e-2
NK FCGR3Apos	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	1.35e-3
T CD8 CTL	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	1.35e-3
Monocyte	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	2.94e-2
Macrophage	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	8.88e-3
T CD8 gd	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	2.94e-2
DC plasmacytoid	Facial attractiveness	Facial attractiveness, male raters	ETC	Hu	2019	NA	3928	5.00e-2	4.21e-2
T CD8 gd	Facial attractiveness	Facial attractiveness, female raters	ETC	Hu	2019	NA	3928	5.00e-2	1.76e-2
T CD8 gd	Facial attractiveness	Facial attractiveness, female raters	ETC	Hu	2019	NA	3928	1.00e-2	8.19e-4
T CD8 gd	Facial attractiveness	Facial attractiveness, female raters	ETC	Hu	2019	NA	3928	1.00e-3	7.48e-4
DC plasmacytoid	Facial attractiveness	Facial attractiveness, female raters	ETC	Hu	2019	NA	3928	5.00e-2	1.76e-2
Platelet	Facial attractiveness	Facial attractiveness, female raters	ETC	Hu	2019	NA	3928	1.00e-3	2.58e-2
B Hypermutation	Facial attractiveness	Facial attractiveness of males, male raters	ETC	Hu	2019	NA	1792	5.00e-2	8.03e-3
B Hypermutation	Facial attractiveness	Facial attractiveness of males, male raters	ETC	Hu	2019	NA	1792	1.00e-2	4.22e-2
Plasmablast	Facial attractiveness	Facial attractiveness of males, male raters	ETC	Hu	2019	NA	1792	5.00e-2	2.68e-2
B mature	Facial attractiveness	Facial attractiveness of males, male raters	ETC	Hu	2019	NA	1792	1.00e-3	5.11e-3
B naive	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	3.59e-2
NK FCGR3Apos	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	7.22e-3
T CD4 reg	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	2.48e-2
NK dividing	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	1.68e-2
ILC	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	1.68e-2
DC 1	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	2.48e-2
Platelet	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	2.48e-2
DC plasmacytoid	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	6.07e-5
DC plasmacytoid	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	1.00e-2	8.29e-3
Plasmablast	Facial attractiveness	Facial attractiveness of females, female raters	ETC	Hu	2019	NA	2062	5.00e-2	3.59e-2
T CD8 MAIT	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	5.38e-4
T CD8 MAIT	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	1.00e-2	3.19e-3
T CD4 fh	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	4.04e-3
T CD4 fh	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	1.00e-2	1.42e-2
T CD8 CTL	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	4.04e-3
T CD8 CTL	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	1.00e-2	6.90e-3
T CD4 reg	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	1.49e-2
DC 2	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	3.20e-2
ILC	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	5.00e-2	2.51e-3
T CD8 activated	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	1.00e-2	3.19e-3
T CD8 gd	Facial attractiveness	Facial attractiveness of males, female raters	ETC	Hu	2019	NA	1792	1.00e-2	5.86e-4
NK CD160pos	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	1.35e-2
B naive	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	2.03e-2
NK FCGR3Apos	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	8.85e-3
B mature	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	2.03e-2
T CD8 CTL	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	4.26e-2
T CD4 reg	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	2.97e-2
Monocyte	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	4.26e-2
Macrophage	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	5.67e-3
ILC	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	8.85e-3
ILC	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	1.00e-2	2.37e-2
DC 1	Facial attractiveness	Facial attractiveness of females, male raters	ETC	Hu	2019	NA	2062	5.00e-2	2.97e-2
T CD8 MAIT	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	6.71e-6
T CD8 MAIT	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.67e-7
T CD8 MAIT	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	2.73e-8
T CD8 MAIT	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	7.08e-8
T CD8 MAIT	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.71e-8
NK CD160pos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	2.64e-2
NK CD160pos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	2.27e-2
NK CD160pos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	2.43e-2
T CD8 activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	4.38e-7
T CD8 activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	9.05e-8
T CD8 activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	3.13e-6
T CD8 activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	9.28e-5
T CD8 activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	4.01e-5
B naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	1.77e-3
B naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	6.32e-4
B naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	9.59e-5
B naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	4.18e-4
B naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.04e-4
NK FCGR3Apos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	7.76e-5
NK FCGR3Apos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.73e-6
NK FCGR3Apos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	6.46e-6
NK FCGR3Apos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.67e-3
NK FCGR3Apos	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.28e-2
T CD4 fh	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	3.38e-4
T CD4 fh	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	4.09e-5
T CD4 fh	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	1.79e-4
T CD4 fh	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	8.48e-4
T CD4 fh	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	2.59e-4
T cell dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	2.36e-5
T cell dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.70e-4
B mature	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	5.26e-5
B mature	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	4.09e-5
B mature	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	1.79e-4
B mature	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.67e-3
B mature	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.04e-4
T CD8 CTL	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	5.26e-5
T CD8 CTL	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.35e-8
T CD8 CTL	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	3.13e-6
T CD8 CTL	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.29e-6
T CD8 CTL	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.48e-5
T CD4 reg	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	4.57e-10
T CD4 reg	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.18e-11
T CD4 reg	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	1.16e-8
T CD4 reg	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.91e-7
T CD4 reg	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.89e-7
T CD4 naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	2.41e-3
T CD4 naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	9.55e-4
T CD4 naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	1.03e-3
T CD4 naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.67e-3
T CD4 naive	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	4.37e-2
T CD4 conv	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	3.54e-5
T CD4 conv	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.70e-4
T CD4 conv	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	5.04e-5
T CD4 conv	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	4.18e-4
T CD4 conv	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	2.59e-4
NK dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	4.78e-4
NK dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	4.09e-5
NK dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	4.11e-2
NK dividing	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	1.04e-2
B T doublet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	3.38e-4
B T doublet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	5.20e-6
B T doublet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	2.59e-5
B T doublet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	5.83e-3
B T doublet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	6.44e-3
DC 2	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	5.76e-3
DC 2	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	2.27e-2
DC 2	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	2.95e-3
DC 2	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	4.18e-4
DC 2	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	6.19e-4
Macrophage	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	3.25e-3
Macrophage	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	3.03e-2
Macrophage	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	4.37e-2
ILC	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	3.30e-2
T CD8 gd	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	4.34e-6
T CD8 gd	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	4.09e-5
T CD8 gd	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	2.95e-3
T CD8 gd	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	5.83e-3
T CD8 gd	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	1.28e-2
DC 1	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	2.64e-2
DC 1	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	3.03e-2
DC 1	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	1.22e-2
DC 1	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	8.48e-4
DC 1	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	6.19e-4
B Hypermutation	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	1.64e-2
B Hypermutation	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	1.68e-2
DC plasmacytoid	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	4.10e-2
Plasmablast	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	1.77e-3
Plasmablast	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	3.03e-2
DC activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	5.00e-2	5.76e-3
DC activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	8.83e-3
DC activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-3	9.59e-5
DC activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-4	7.76e-6
DC activated	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-5	5.27e-6
Platelet	Asthma	Asthma, adult-onset	ETC	Ferreira	2019	26582	300671	1.00e-2	3.03e-2
T CD8 MAIT	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.99e-13
T CD8 MAIT	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	6.44e-11
T CD8 MAIT	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	8.79e-8
T CD8 MAIT	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.02e-8
T CD8 MAIT	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	1.37e-9
NK CD160pos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	6.21e-3
NK CD160pos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	3.58e-2
NK CD160pos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.49e-2
T CD8 activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	8.47e-7
T CD8 activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.25e-6
T CD8 activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	6.75e-5
T CD8 activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	3.42e-5
T CD8 activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	8.43e-6
B naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	2.82e-3
B naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	1.36e-3
B naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	1.89e-4
B naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	2.14e-4
B naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	1.49e-4
NK FCGR3Apos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	5.66e-8
NK FCGR3Apos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.25e-6
NK FCGR3Apos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	2.21e-6
NK FCGR3Apos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.79e-5
NK FCGR3Apos	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	1.49e-4
T CD4 fh	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.47e-5
T CD4 fh	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.84e-7
T CD4 fh	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	1.19e-6
T CD4 fh	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	4.63e-6
T CD4 fh	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	7.71e-7
T cell dividing	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	8.47e-7
T cell dividing	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	1.36e-4
T cell dividing	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	3.58e-2
B mature	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.98e-6
B mature	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	1.53e-5
B mature	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	2.28e-5
B mature	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.11e-6
B mature	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.71e-5
T CD8 CTL	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	8.15e-9
T CD8 CTL	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	5.32e-9
T CD8 CTL	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	3.32e-7
T CD8 CTL	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.15e-7
T CD8 CTL	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.61e-9
T CD4 reg	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	4.94e-9
T CD4 reg	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	3.09e-8
T CD4 reg	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	2.28e-5
T CD4 reg	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	4.63e-6
T CD4 reg	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.88e-6
T CD4 naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	4.81e-3
T CD4 naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.05e-4
T CD4 naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	2.91e-3
T CD4 naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.81e-2
T CD4 naive	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.14e-3
T CD4 conv	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.20e-3
T CD4 conv	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.42e-5
T CD4 conv	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	1.30e-5
T CD4 conv	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	3.80e-4
T CD4 conv	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	2.88e-4
NK dividing	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	9.96e-6
NK dividing	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	4.50e-4
B T doublet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	4.81e-3
B T doublet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.70e-3
B T doublet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	4.98e-4
B T doublet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.13e-3
B T doublet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	1.49e-4
DC 2	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.82e-4
DC 2	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	3.05e-4
DC 2	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	2.62e-2
DC 2	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	7.77e-3
DC 2	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	2.28e-2
Macrophage	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	2.50e-2
Macrophage	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	1.67e-2
T CD8 gd	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	7.97e-3
T CD8 gd	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.83e-2
T CD8 gd	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	1.89e-2
T CD8 gd	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.81e-2
T CD8 gd	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	8.92e-3
DC 1	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	4.83e-4
DC 1	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	2.05e-4
DC 1	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	6.43e-3
DC 1	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	4.94e-3
DC 1	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	8.92e-3
B Hypermutation	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	4.81e-3
Platelet	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	1.62e-2
DC plasmacytoid	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	2.50e-2
DC plasmacytoid	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	4.60e-2
Plasmablast	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	2.14e-3
Plasmablast	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	3.62e-2
DC activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	5.00e-2	3.51e-4
DC activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	3.68e-6
DC activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-3	3.95e-5
DC activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	2.29e-6
DC activated	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	3.88e-6
ILC	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-2	4.60e-2
ILC	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-4	1.20e-2
ILC	Asthma	Asthma, childhood-onset	ETC	Ferreira	2019	13962	300671	1.00e-5	1.44e-2
B naive	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.03e-2
B naive	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.14e-2
B naive	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-3	3.23e-2
B naive	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-4	1.72e-2
NK FCGR3Apos	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	3.80e-2
T cell dividing	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.03e-2
T cell dividing	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	2.48e-2
B mature	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.03e-2
B mature	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	1.06e-2
B mature	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-4	4.17e-2
B mature	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-5	1.36e-2
NK dividing	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	1.29e-2
NK dividing	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	5.69e-3
B Hypermutation	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	1.62e-2
Plasmablast	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.12e-3
Plasmablast	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.14e-2
CD34 progenitor	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-3	3.23e-2
CD34 progenitor	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-5	1.36e-2
T CD8 gd	Neuroticism	General factor of neuroticism	ETC	Hill	2019	NA	270059	1.00e-4	2.72e-2
T CD8 MAIT	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.23e-3
NK FCGR3Apos	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.67e-3
T cell dividing	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.29e-4
T cell dividing	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
B mature	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.73e-2
B mature	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
NK dividing	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.67e-3
NK dividing	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
DC 2	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	3.44e-2
Macrophage	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	9.90e-3
Macrophage	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	3.73e-2
T CD8 gd	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.29e-2
DC 1	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.04e-6
DC 1	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	1.33e-5
B Hypermutation	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.14e-2
DC activated	Neuroticism	Worry-vulnerability-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	1.05e-3
T CD8 MAIT	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.23e-3
NK FCGR3Apos	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.67e-3
T cell dividing	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.29e-4
T cell dividing	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
B mature	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.73e-2
B mature	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
NK dividing	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.67e-3
NK dividing	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	4.94e-2
DC 2	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	3.44e-2
Macrophage	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	9.90e-3
Macrophage	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	3.73e-2
T CD8 gd	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	4.29e-2
DC 1	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	5.04e-6
DC 1	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	1.33e-5
B Hypermutation	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	5.00e-2	2.14e-2
DC activated	Neuroticism	Anxiety-tension-special-factor-of-neuroticism	ETC	Hill	2019	NA	270059	1.00e-2	1.05e-3
T CD8 MAIT	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	2.43e-2
B naive	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	1.21e-2
B naive	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	1.20e-2
B naive	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-3	4.23e-2
B mature	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	1.84e-3
B mature	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	1.20e-2
T CD8 CTL	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	2.43e-2
T CD4 reg	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	1.21e-2
T CD4 reg	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	1.62e-2
NK dividing	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	3.02e-2
DC 2	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	3.02e-2
DC 2	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	3.71e-2
DC 1	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	2.73e-4
DC 1	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	2.06e-4
DC 1	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-3	3.41e-3
Plasma IgM	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	1.54e-2
Plasma IgM	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	2.59e-2
B Hypermutation	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	9.50e-5
B Hypermutation	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	4.78e-4
B Hypermutation	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-3	1.99e-2
Plasma IgG	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	1.54e-2
Plasma IgG	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	2.59e-2
DC plasmacytoid	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	6.59e-5
DC plasmacytoid	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	2.06e-4
DC plasmacytoid	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-3	2.08e-3
DC plasmacytoid	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	9.03e-3
DC plasmacytoid	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-5	2.19e-2
Plasmablast	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	9.46e-6
Plasmablast	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	7.15e-4
Plasmablast	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	4.17e-2
CD34 progenitor	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	5.00e-2	3.73e-2
CD34 progenitor	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	4.17e-2
CD34 progenitor	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-5	1.16e-2
Macrophage	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-2	2.16e-2
Macrophage	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-5	3.92e-2
Monocyte	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-4	2.59e-2
ILC	Na/K ratio	Urinary sodium to potassium ratio	ETC	Zanetti	2019	NA	108942	1.00e-5	2.19e-2
T CD8 MAIT	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	4.64e-3
T CD8 MAIT	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-2	1.94e-2
T CD8 MAIT	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	3.44e-2
T CD8 MAIT	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-5	3.52e-2
NK CD160pos	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	4.86e-2
T CD8 activated	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	7.88e-3
NK FCGR3Apos	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	1.98e-3
T cell dividing	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	1.30e-2
B mature	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	1.30e-2
B mature	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	2.35e-2
B mature	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-4	8.68e-3
T CD8 CTL	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	3.97e-2
NK dividing	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	7.88e-3
T CD8 gd	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	2.60e-2
T CD8 gd	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	4.93e-2
DC 1	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	4.64e-3
DC 1	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-5	3.52e-2
Platelet	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	3.22e-2
DC plasmacytoid	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	1.53e-5
DC plasmacytoid	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-2	3.17e-6
DC plasmacytoid	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	8.81e-5
DC plasmacytoid	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-4	1.53e-4
DC plasmacytoid	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-5	2.23e-3
Plasmablast	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	3.97e-2
CD34 progenitor	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	5.00e-2	1.98e-3
CD34 progenitor	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-2	1.44e-2
CD34 progenitor	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	2.53e-3
CD34 progenitor	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-4	6.70e-4
CD34 progenitor	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-5	2.23e-3
Macrophage	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-2	4.43e-2
Macrophage	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-3	8.81e-5
Macrophage	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-4	8.68e-3
Macrophage	K/C ratio	Urinary potassium to creatinine ratio	ETC	Zanetti	2019	NA	218435	1.00e-5	4.79e-3
T CD8 MAIT	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.22e-3
T CD8 MAIT	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	4.15e-3
NK CD160pos	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	4.62e-4
NK CD160pos	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	1.57e-2
T CD8 activated	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.22e-3
T CD8 activated	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	2.83e-2
T CD8 activated	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	3.98e-2
NK FCGR3Apos	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	3.73e-5
NK FCGR3Apos	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	9.03e-4
NK FCGR3Apos	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	1.82e-2
T CD4 fh	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	8.83e-3
T cell dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	1.14e-2
T cell dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	3.73e-2
T cell dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	1.19e-2
T cell dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-4	1.87e-2
T cell dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-5	3.98e-2
T CD8 CTL	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	1.13e-5
T CD8 CTL	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	9.03e-4
T CD8 CTL	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	1.82e-2
T CD4 reg	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.34e-4
T CD4 reg	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	1.57e-2
T CD4 reg	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	2.73e-2
Monocyte	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.89e-2
NK dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	1.65e-3
NK dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	8.26e-3
NK dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	7.62e-3
NK dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-4	1.05e-2
NK dividing	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-5	3.98e-2
DC 2	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	1.84e-2
T CD8 gd	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.89e-2
T CD8 gd	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	4.86e-2
DC 1	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	8.83e-3
B Hypermutation	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	8.83e-3
B Hypermutation	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-2	2.12e-2
B Hypermutation	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	3.98e-2
Platelet	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	8.83e-3
DC plasmacytoid	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	8.83e-3
Plasmablast	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.32e-2
DC activated	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	2.98e-3
CD34 progenitor	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	5.00e-2	5.20e-3
CD34 progenitor	Sleep	Sleep duration, short sleep	ETC	Dashti	2019	106192	305742	1.00e-3	2.73e-2
T CD8 MAIT	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.08e-2
T CD8 MAIT	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-4	1.54e-2
T CD8 activated	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.08e-2
T cell dividing	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.08e-2
T cell dividing	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	1.64e-3
T CD8 CTL	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	1.58e-2
T CD4 conv	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.71e-2
NK dividing	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	8.91e-3
NK dividing	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	4.51e-2
DC 2	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	1.58e-2
DC 1	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	1.24e-3
DC 1	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	3.19e-2
B Hypermutation	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	3.47e-3
B Hypermutation	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	1.64e-3
Platelet	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	6.57e-3
Platelet	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	5.92e-4
Plasmablast	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.49e-3
Plasmablast	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	1.98e-4
Plasmablast	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-4	3.82e-2
DC activated	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	1.19e-2
CD34 progenitor	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	5.00e-2	2.71e-2
CD34 progenitor	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-2	9.95e-4
CD34 progenitor	Sleep	Sleep duration, long sleep	ETC	Dashti	2019	34184	305742	1.00e-3	1.16e-2
T CD8 MAIT	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	2.77e-2
T CD8 MAIT	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-4	4.56e-2
NK CD160pos	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	4.37e-2
B naive	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	7.59e-3
B naive	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-3	2.03e-2
T cell dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	1.20e-3
T cell dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-3	7.29e-3
T cell dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-4	1.39e-2
B mature	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	3.49e-2
NK dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	3.05e-6
NK dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-3	3.78e-6
NK dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-4	1.18e-4
NK dividing	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-5	1.90e-3
B Hypermutation	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	4.25e-3
B Hypermutation	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-3	2.30e-3
Plasmablast	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	1.31e-2
Plasmablast	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-3	4.98e-2
Plasmablast	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-4	3.14e-2
DC activated	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	1.00e-2
CD34 progenitor	Sleep	Sleep duration	ETC	Dashti	2019	NA	446118	1.00e-2	1.67e-3
T cell dividing	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	1.46e-2
NK dividing	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	1.98e-2
Plasma IgM	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	1.07e-2
Plasma IgM	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-5	3.12e-2
B Hypermutation	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	1.84e-3
B Hypermutation	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-2	1.24e-2
Plasma IgG	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	1.98e-2
Plasma IgG	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-5	3.12e-2
Plasmablast	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	3.63e-4
Plasmablast	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-2	4.82e-3
Plasmablast	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-3	3.92e-2
Plasmablast	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-4	2.18e-2
Plasmablast	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	1.00e-5	1.13e-2
CD34 progenitor	Glycine level	Glycine level	ETC	Wittemans	2019	NA	80003	5.00e-2	7.70e-3
T CD8 MAIT	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.04e-7
T CD8 MAIT	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-2	4.34e-3
T CD8 MAIT	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-3	2.20e-2
T CD8 MAIT	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	1.65e-2
T CD8 activated	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	5.23e-3
NK FCGR3Apos	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.84e-3
NK FCGR3Apos	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-2	2.85e-2
NK FCGR3Apos	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-3	7.12e-3
NK FCGR3Apos	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	3.47e-2
T cell dividing	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.07e-3
T CD8 CTL	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	7.55e-4
T CD4 reg	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.05e-2
NK dividing	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	7.55e-4
NK dividing	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-2	3.94e-2
DC 2	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	5.23e-3
DC 2	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	3.47e-2
Macrophage	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.84e-3
Macrophage	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	7.33e-3
Macrophage	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-5	9.81e-3
T CD8 gd	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	3.32e-2
DC 1	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.27e-5
DC 1	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-2	1.15e-3
B Hypermutation	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.07e-3
DC plasmacytoid	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.54e-4
DC plasmacytoid	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-2	4.34e-3
DC plasmacytoid	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-3	3.66e-2
DC plasmacytoid	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	3.47e-2
Plasmablast	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	9.28e-3
DC activated	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	5.00e-2	2.84e-3
NK CD160pos	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	3.47e-2
Neutrophil	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-4	3.47e-2
B naive	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-5	2.61e-2
B mature	CTS	Carpal tunnel syndrome	ETC	Wiberg	2019	12312	389344	1.00e-5	1.04e-3
T CD4 fh	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	5.00e-2	2.43e-3
T CD4 fh	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	1.00e-2	1.83e-2
T CD4 reg	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	5.00e-2	3.84e-3
T CD4 reg	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	1.00e-2	1.83e-2
T CD4 naive	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	5.00e-2	5.97e-3
T CD4 conv	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	5.00e-2	1.36e-2
T CD4 conv	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	1.00e-2	1.83e-2
Neutrophil	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	5.00e-2	4.07e-2
T CD8 activated	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	1.00e-2	9.35e-3
B naive	MI/CF	Meconium ileus in cystic fibrosis	ETC	Gong	2019	1115	5655	1.00e-2	3.39e-2
NK CD160pos	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	7.80e-4
NK FCGR3Apos	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	1.05e-2
T cell dividing	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	3.09e-3
T cell dividing	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-3	4.77e-2
Monocyte	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	1.05e-2
Monocyte	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-4	4.73e-2
NK dividing	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	3.09e-3
NK dividing	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-3	4.77e-2
DC 1	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	1.39e-2
DC 1	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-3	5.88e-3
Plasma IgM	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	4.90e-2
B Hypermutation	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	4.26e-3
Plasmablast	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	1.12e-3
CD34 progenitor	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-2	1.39e-2
DC 2	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-3	2.53e-2
DC 2	Insomnia	Insomnia symptoms, never-rarely vs sometimes usually	ETC	Lane	2019	345022	108357	1.00e-5	3.04e-2
B naive	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	2.30e-2
NK FCGR3Apos	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	4.18e-4
T cell dividing	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	8.56e-4
B mature	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	2.30e-2
NK dividing	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	1.05e-2
DC 1	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	3.22e-3
DC 1	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-4	3.78e-3
DC 1	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-5	1.05e-2
B Hypermutation	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	1.69e-3
B Hypermutation	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-4	2.05e-2
B Hypermutation	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-5	4.29e-2
CD34 progenitor	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-3	1.69e-3
CD34 progenitor	Chronotype	Chronotype	ETC	Jones	2019	NA	449734	1.00e-4	1.50e-2
T CD8 MAIT	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	2.39e-2
NK FCGR3Apos	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	9.37e-3
NK FCGR3Apos	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-3	1.40e-2
T cell dividing	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	3.87e-4
T CD4 reg	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	4.48e-2
NK dividing	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	1.52e-2
DC 1	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	1.20e-2
DC 1	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-3	1.04e-2
DC 1	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-4	1.60e-2
DC 1	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-5	3.58e-2
B Hypermutation	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	3.26e-3
B Hypermutation	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-3	1.86e-2
Platelet	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	5.61e-3
CD34 progenitor	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-2	3.87e-4
CD34 progenitor	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-3	1.86e-2
B mature	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-3	5.59e-3
B mature	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-4	1.60e-2
B mature	Morning person	Morning person	ETC	Jones	2019	252287	150908	1.00e-5	6.64e-3
T CD8 MAIT	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	1.77e-2
NK CD160pos	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	2.51e-2
T CD4 reg	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	1.77e-2
NK dividing	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	1.77e-2
Macrophage	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	8.41e-3
ILC	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	3.49e-2
B Hypermutation	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	2.43e-3
Plasmablast	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	2.51e-2
Plasmablast	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-2	3.12e-2
CD34 progenitor	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	5.00e-2	3.71e-4
CD34 progenitor	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-2	1.00e-2
NK FCGR3Apos	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-2	1.00e-2
B mature	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-2	1.00e-2
DC plasmacytoid	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-2	2.74e-3
T CD8 activated	BMI	Normal body mass index vs thin control, adult vs thin adult	ETC	McKay	2019	6460	1471	1.00e-3	4.63e-2
NK CD160pos	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	2.92e-2
T cell dividing	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	2.92e-2
NK dividing	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	1.08e-2
DC 2	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	1.08e-2
ILC	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	3.49e-3
ILC	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	1.00e-2	2.25e-2
DC 1	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	2.92e-2
DC 1	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	1.00e-2	2.25e-2
B Hypermutation	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	2.92e-2
CD34 progenitor	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	5.00e-2	1.53e-2
CD34 progenitor	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	1.00e-2	3.70e-2
Monocyte	Obesity	Obesity, extreme obese children vs control adult	ETC	McKay	2019	1456	6460	1.00e-3	3.82e-2
NK CD160pos	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	2.78e-2
NK CD160pos	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	1.00e-4	2.62e-2
NK FCGR3Apos	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	2.04e-2
B mature	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	2.78e-2
NK dividing	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	1.05e-2
NK dividing	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	1.00e-3	1.25e-2
DC 2	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	2.04e-2
DC 1	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	4.96e-2
Platelet	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	7.37e-3
CD34 progenitor	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	5.00e-2	2.15e-5
CD34 progenitor	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	1.00e-2	3.10e-5
ILC	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	1.00e-2	4.76e-2
T CD8 gd	Obesity	Obese children vs thin adults	ETC	McKay	2019	1471	1456	1.00e-2	1.89e-2
T CD8 MAIT	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	2.60e-9
T CD8 MAIT	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.07e-6
T CD8 MAIT	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	8.76e-7
T CD8 MAIT	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	2.64e-4
T CD8 MAIT	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	3.78e-4
T CD8 activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	7.36e-7
T CD8 activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.30e-6
T CD8 activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	1.13e-3
T CD8 activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	1.79e-3
T CD8 activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	3.36e-3
B naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	2.51e-3
B naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	7.90e-5
B naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	5.25e-4
B naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	3.14e-5
B naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	3.36e-3
NK FCGR3Apos	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	3.63e-3
NK FCGR3Apos	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.17e-2
NK FCGR3Apos	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.98e-2
NK FCGR3Apos	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	4.09e-2
NK FCGR3Apos	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	2.18e-2
T CD4 fh	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.14e-5
T CD4 fh	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.59e-3
T CD4 fh	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.98e-2
T CD4 fh	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	4.89e-2
T cell dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.41e-2
T cell dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.77e-2
T cell dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	9.04e-3
T cell dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	4.09e-2
T cell dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	4.89e-2
B mature	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	7.75e-11
B mature	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.70e-10
B mature	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	2.42e-6
B mature	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	3.05e-6
B mature	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	1.17e-3
T CD8 CTL	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	4.11e-7
T CD8 CTL	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	7.90e-5
T CD8 CTL	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.18e-5
T CD8 CTL	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	9.34e-5
T CD8 CTL	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	1.17e-3
T CD4 reg	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	5.17e-5
T CD4 reg	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	5.12e-4
T CD4 reg	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	2.34e-4
T CD4 reg	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	7.07e-4
T CD4 reg	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	3.78e-4
T CD4 naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.71e-3
T CD4 naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.72e-3
T CD4 naive	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.98e-2
T CD4 conv	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	2.10e-4
T CD4 conv	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.72e-3
T CD4 conv	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	2.94e-2
NK dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.15e-3
NK dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.59e-3
NK dividing	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.71e-3
B T doublet	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	2.51e-3
B T doublet	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.72e-3
B T doublet	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.71e-3
B T doublet	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	9.69e-3
B T doublet	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	4.89e-2
DC 2	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	3.63e-3
DC 2	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.83e-2
DC 2	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	2.94e-2
DC 2	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	4.89e-2
Macrophage	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.71e-3
Macrophage	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	4.30e-3
Macrophage	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	3.36e-3
ILC	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	3.63e-3
T CD8 gd	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	6.77e-6
T CD8 gd	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	7.39e-3
DC 1	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	2.10e-4
DC 1	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	9.14e-4
DC 1	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	9.04e-3
DC 1	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	9.69e-3
DC 1	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	4.89e-2
Plasma IgM	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.92e-2
Plasma IgM	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.17e-2
B Hypermutation	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.92e-2
B Hypermutation	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	4.53e-3
DC plasmacytoid	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.15e-3
DC plasmacytoid	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.59e-3
DC plasmacytoid	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	9.04e-3
DC plasmacytoid	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	4.09e-2
DC plasmacytoid	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	2.18e-2
Plasmablast	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	3.42e-2
Plasmablast	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	2.77e-2
DC activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	5.00e-2	1.15e-3
DC activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	1.51e-4
DC activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-3	4.18e-5
DC activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-4	2.64e-4
DC activated	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-5	1.17e-3
Plasma IgG	Vitiligo	Vitiligo late onset	ETC	Jin	2019	1467	19156	1.00e-2	4.10e-2
T CD8 MAIT	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.60e-4
T CD8 MAIT	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	2.40e-3
T CD8 MAIT	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	2.33e-3
T CD8 MAIT	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	2.03e-2
T CD8 MAIT	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	9.52e-3
NK CD160pos	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.12e-2
NK CD160pos	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	2.65e-2
T CD8 activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	9.20e-4
T CD8 activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	6.75e-3
T CD8 activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	5.45e-3
T CD8 activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	4.82e-2
T CD8 activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	9.52e-3
B naive	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.82e-2
B naive	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	2.48e-2
B naive	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.81e-3
B naive	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	3.00e-3
NK FCGR3Apos	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	8.30e-3
NK FCGR3Apos	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	4.23e-4
NK FCGR3Apos	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	2.48e-2
T cell dividing	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	1.57e-2
B mature	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	4.01e-4
B mature	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	7.73e-4
B mature	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	1.48e-5
B mature	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.12e-5
B mature	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	5.15e-5
T CD8 CTL	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.01e-3
T CD8 CTL	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	6.75e-3
T CD8 CTL	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	1.31e-4
T CD8 CTL	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.81e-3
T CD8 CTL	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	3.00e-3
T CD4 reg	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.60e-4
T CD4 reg	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	3.98e-2
T CD4 reg	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	1.20e-2
Monocyte	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.82e-2
NK dividing	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	9.20e-4
NK dividing	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	1.19e-4
T CD8 gd	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	3.71e-2
T CD8 gd	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	2.70e-2
DC 1	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	4.18e-3
DC 1	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	1.19e-4
DC 1	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	4.53e-5
DC 1	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	2.03e-2
DC plasmacytoid	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.12e-2
DC plasmacytoid	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	1.38e-3
DC plasmacytoid	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	3.61e-4
DC plasmacytoid	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.81e-3
DC plasmacytoid	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	9.52e-3
DC activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	1.52e-5
DC activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	1.49e-5
DC activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	4.64e-6
DC activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	8.79e-4
DC activated	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	2.70e-2
Neutrophil	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	5.00e-2	2.92e-3
DC 2	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-2	2.65e-2
DC 2	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	5.45e-3
B T doublet	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	4.83e-2
B T doublet	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.81e-3
B T doublet	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	2.70e-2
Macrophage	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-3	4.83e-2
Macrophage	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-4	7.81e-3
Macrophage	Vitiligo	Vitiligo early onset	ETC	Jin	2019	704	9031	1.00e-5	3.00e-3
NK CD160pos	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	3.46e-2
B naive	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	5.60e-3
T cell dividing	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	3.32e-3
B mature	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	3.32e-3
B mature	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-3	4.59e-2
DC 2	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	7.20e-3
Macrophage	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	4.32e-3
Macrophage	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	4.42e-2
Macrophage	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-3	7.45e-3
DC 1	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	9.20e-3
DC 1	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	4.42e-2
Platelet	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	1.17e-2
Platelet	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	1.16e-2
DC plasmacytoid	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	7.20e-3
DC plasmacytoid	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	3.31e-3
Plasmablast	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	1.13e-4
Plasmablast	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	3.46e-2
CD34 progenitor	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	5.00e-2	5.83e-4
CD34 progenitor	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-2	1.66e-3
CD34 progenitor	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-3	2.79e-4
CD34 progenitor	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-4	9.38e-4
CD34 progenitor	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-5	6.55e-4
ILC	Body fat distribution	Body fat distribution, leg fat ratio, male	ETC	Andersen	2019	NA	116138	1.00e-3	3.31e-2
T CD8 MAIT	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	3.95e-2
B naive	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	4.79e-3
T cell dividing	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	4.81e-2
T cell dividing	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	1.51e-2
B mature	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	2.29e-4
B mature	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	1.77e-2
DC 2	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	6.23e-3
DC 2	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	4.45e-2
Macrophage	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	3.95e-2
Macrophage	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	8.19e-3
Macrophage	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	3.67e-2
DC 1	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	1.03e-2
DC 1	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	1.51e-2
DC plasmacytoid	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	4.79e-3
Plasmablast	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	1.32e-2
Plasmablast	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	4.45e-2
CD34 progenitor	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	5.00e-2	1.55e-3
CD34 progenitor	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	1.51e-2
CD34 progenitor	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	3.24e-3
CD34 progenitor	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	1.07e-2
CD34 progenitor	Body fat distribution	Body fat distribution-trunk-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-5	3.99e-3
T CD8 MAIT	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	2.49e-3
NK CD160pos	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	3.56e-2
NK FCGR3Apos	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	6.05e-3
T cell dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	3.38e-3
T cell dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-4	6.69e-3
B mature	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	1.82e-3
B mature	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-4	3.40e-3
B mature	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-5	3.13e-2
T CD4 reg	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	1.75e-2
NK dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	2.34e-4
NK dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-4	1.26e-2
DC 1	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	2.83e-2
B Hypermutation	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	2.83e-2
Platelet	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-3	4.43e-2
CD34 progenitor	Body fat distribution	Body fat distribution-arm-fat-ratio-female	ETC	Andersen	2019	NA	116138	1.00e-5	2.30e-2
T CD8 MAIT	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	4.96e-2
T CD8 MAIT	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	1.64e-2
T CD8 MAIT	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-5	2.16e-2
NK CD160pos	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	1.50e-2
NK CD160pos	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	2.26e-2
NK FCGR3Apos	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.39e-4
NK FCGR3Apos	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	7.01e-5
NK FCGR3Apos	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	1.72e-2
T CD4 reg	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.98e-2
T CD4 naive	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.98e-2
NK dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	2.49e-2
NK dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	3.70e-2
NK dividing	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-5	2.55e-3
Macrophage	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	6.57e-3
Macrophage	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	8.25e-3
Macrophage	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	4.68e-3
DC 1	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.98e-2
DC 1	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	4.68e-3
DC 1	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-5	7.87e-3
B Hypermutation	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.62e-3
B Hypermutation	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	4.12e-2
Plasma IgG	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	1.94e-2
Plasmablast	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-2	3.62e-3
T CD8 CTL	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-3	5.73e-3
T CD8 CTL	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	3.70e-2
T CD8 CTL	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-5	7.87e-3
B mature	Body fat distribution	Body fat distribution-arm-fat-ratio-male	ETC	Andersen	2019	NA	116138	1.00e-4	3.70e-2
T cell dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-2	4.57e-3
T cell dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	8.46e-4
T cell dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	2.39e-3
T cell dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	1.47e-2
NK dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-2	1.72e-3
NK dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	3.83e-5
NK dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	6.83e-3
NK dividing	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	2.50e-2
B Hypermutation	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-2	2.40e-3
B Hypermutation	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	1.34e-3
B Hypermutation	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	4.14e-4
B Hypermutation	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	2.38e-3
Plasmablast	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-2	6.21e-3
Plasmablast	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	1.34e-3
Plasmablast	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	2.20e-4
Plasmablast	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	2.50e-2
B naive	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	7.26e-3
B mature	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	7.26e-3
Plasma IgM	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-3	3.03e-2
Plasma IgM	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	2.72e-2
Plasma IgM	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	2.50e-2
Macrophage	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	4.10e-2
Macrophage	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	4.11e-2
DC plasmacytoid	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-4	2.72e-2
DC plasmacytoid	Osteoarthritis	Osteoarthritis	ETC	Tachmazidou	2019	77052	378169	1.00e-5	2.50e-2
T CD8 MAIT	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	8.44e-4
NK FCGR3Apos	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	2.49e-5
NK FCGR3Apos	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	2.17e-2
T cell dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	6.38e-3
T cell dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	3.15e-3
T cell dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	4.24e-4
T cell dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	1.07e-2
T cell dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-5	3.09e-3
Monocyte	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	1.36e-2
NK dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	1.59e-4
NK dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	3.15e-3
NK dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	7.54e-5
NK dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	6.19e-3
NK dividing	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-5	6.44e-3
Plasma IgM	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	2.70e-2
Plasma IgM	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	2.87e-2
Plasma IgM	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	1.83e-2
B Hypermutation	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	3.34e-2
B Hypermutation	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	8.72e-3
B Hypermutation	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	1.37e-4
B Hypermutation	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	1.01e-3
B Hypermutation	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-5	3.09e-3
Plasma IgG	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	4.11e-2
Plasmablast	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	5.00e-2	4.43e-4
Plasmablast	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-2	4.60e-4
Plasmablast	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	2.01e-3
Plasmablast	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	3.49e-3
Plasmablast	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-5	3.09e-3
Macrophage	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-3	3.84e-2
Macrophage	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	2.89e-2
NK CD160pos	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-4	6.19e-3
NK CD160pos	Osteoarthritis	Osteoarthritis of the hip or knee	ETC	Tachmazidou	2019	39427	378169	1.00e-5	2.43e-2
T CD8 MAIT	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	1.75e-2
Monocyte	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	9.96e-3
Monocyte	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-2	1.53e-3
Monocyte	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-3	1.19e-2
Monocyte	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-4	3.37e-3
Monocyte	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-5	2.22e-2
NK dividing	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	1.33e-2
Macrophage	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	3.95e-3
Macrophage	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-2	9.43e-4
Macrophage	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-3	2.03e-2
Macrophage	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-4	2.87e-2
Plasma IgM	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	5.44e-3
B Hypermutation	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	1.43e-3
B Hypermutation	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-2	8.82e-3
B Hypermutation	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-3	3.33e-2
B Hypermutation	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-4	1.48e-2
B Hypermutation	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-5	2.22e-2
Plasma IgG	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	1.33e-2
Plasmablast	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	2.85e-3
Plasmablast	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-2	8.82e-3
CD34 progenitor	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	5.00e-2	2.29e-2
DC plasmacytoid	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-3	3.72e-3
DC plasmacytoid	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-4	7.26e-3
DC plasmacytoid	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-5	2.22e-2
B naive	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-4	2.87e-2
B mature	Osteoarthritis	Osteoarthritis hip	ETC	Tachmazidou	2019	15704	378169	1.00e-5	4.62e-2
T CD8 MAIT	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	2.57e-4
NK CD160pos	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.12e-2
B naive	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	9.60e-3
NK FCGR3Apos	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	1.23e-2
T CD4 fh	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	2.50e-2
T cell dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	6.01e-5
T cell dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-2	1.70e-2
T cell dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	5.06e-4
T cell dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-4	1.32e-3
T cell dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-5	2.17e-4
T CD8 CTL	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	4.74e-2
T CD4 reg	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	4.31e-3
T CD4 reg	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	2.56e-2
T CD4 reg	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-4	4.57e-2
T CD4 reg	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-5	1.48e-2
T CD4 conv	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	4.74e-2
NK dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.53e-6
NK dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-2	8.91e-3
NK dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	2.60e-3
NK dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-4	9.17e-3
NK dividing	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-5	1.48e-2
Plasma IgM	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.25e-3
Plasma IgM	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-2	1.70e-2
Plasma IgM	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	1.10e-2
B Hypermutation	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.63e-4
B Hypermutation	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	3.77e-2
B Hypermutation	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-4	4.57e-2
B Hypermutation	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-5	1.48e-2
Plasma IgG	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.12e-2
Plasma IgG	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	1.69e-2
DC plasmacytoid	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	3.86e-2
Plasmablast	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	5.00e-2	5.42e-6
Plasmablast	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-2	1.41e-3
Plasmablast	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	2.81e-4
Plasmablast	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-4	4.99e-3
Plasmablast	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-5	2.93e-2
Platelet	Osteoarthritis	Knee osteoarthritis	ETC	Tachmazidou	2019	24955	376169	1.00e-3	3.77e-2
T CD8 MAIT	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	4.36e-3
B naive	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	4.82e-2
NK FCGR3Apos	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	4.36e-3
NK FCGR3Apos	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-2	2.15e-2
B mature	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	2.62e-2
T CD8 CTL	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	2.62e-2
T CD4 naive	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	1.89e-4
T CD4 naive	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-2	3.66e-2
T CD4 conv	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	2.62e-2
Monocyte	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	3.58e-2
Monocyte	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-3	2.91e-2
NK dividing	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	4.82e-2
NK dividing	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-2	3.66e-2
DC 2	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	9.34e-3
T CD8 gd	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	4.82e-2
DC 1	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	1.34e-2
DC 1	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-2	1.21e-2
Platelet	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	1.34e-2
Platelet	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-5	1.89e-2
DC activated	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	3.09e-4
CD34 progenitor	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	5.00e-2	1.34e-2
NK CD160pos	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-2	3.66e-2
T CD4 reg	Brain volume	White matter hyperintensity volume	ETC	Traylor	2019	NA	8429	1.00e-3	2.91e-2
T cell dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-2	4.65e-4
T cell dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-3	2.14e-3
T cell dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-4	7.10e-3
NK dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-2	2.39e-3
NK dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-3	6.55e-3
NK dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-4	4.77e-2
NK dividing	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-5	3.50e-2
DC 1	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-2	3.38e-2
CD34 progenitor	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-2	1.30e-2
CD34 progenitor	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-3	2.43e-2
CD34 progenitor	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-4	7.10e-3
B mature	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-3	3.26e-2
B mature	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-4	2.36e-2
B mature	Smoking	Smoking initiation ever regular vs never-regular	ETC	Liua	2019	NA	1232091	1.00e-5	3.50e-2
T cell dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	1.31e-3
T cell dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-2	8.07e-4
T cell dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-3	1.92e-2
T cell dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-4	7.77e-4
T cell dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-5	3.81e-2
NK dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	1.17e-2
NK dividing	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-2	1.28e-2
DC 1	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	4.43e-2
B Hypermutation	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	1.31e-3
B Hypermutation	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-2	3.51e-3
B Hypermutation	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-4	1.16e-2
DC plasmacytoid	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	5.45e-3
Plasmablast	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	5.00e-2	1.17e-2
T CD4 reg	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-4	2.87e-2
T CD4 reg	Alcohol consumption	Alcohol consumption, drinks-per-week	ETC	Liua	2019	NA	941280	1.00e-5	2.32e-2
T cell dividing	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	1.81e-2
T cell dividing	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	1.00e-2	1.28e-2
T CD4 reg	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	4.12e-2
NK dividing	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	7.18e-3
DC 2	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	4.12e-2
Macrophage	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	7.18e-3
DC 1	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	8.26e-4
DC plasmacytoid	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	4.12e-2
CD34 progenitor	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	5.00e-2	1.22e-3
CD34 progenitor	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	1.00e-2	2.94e-2
CD34 progenitor	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	1.00e-3	3.39e-3
CD34 progenitor	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	1.00e-4	8.23e-3
CD34 progenitor	Smoking	Smoking cessation	ETC	Liua	2019	NA	547219	1.00e-5	2.27e-2
T cell dividing	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	5.00e-2	8.32e-3
T CD4 naive	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	5.00e-2	3.58e-2
Monocyte	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	5.00e-2	1.40e-2
Monocyte	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	1.00e-2	2.60e-2
DC 1	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	5.00e-2	1.40e-2
CD34 progenitor	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	5.00e-2	4.43e-2
CD34 progenitor	Smoking	Smoking behaviour, cigarettes smoked per day	ETC	Liua	2019	NA	377334	1.00e-4	2.90e-2
T CD8 MAIT	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	1.87e-2
T CD8 MAIT	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	2.69e-3
NK FCGR3Apos	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	3.15e-2
NK FCGR3Apos	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	2.20e-2
T cell dividing	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	2.76e-5
T cell dividing	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	2.69e-3
T CD4 reg	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	2.44e-2
T CD4 reg	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	4.25e-3
Macrophage	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	1.07e-2
B Hypermutation	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	1.08e-3
Plasmablast	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	6.68e-5
Plasmablast	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	2.20e-2
Plasmablast	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-3	3.12e-2
CD34 progenitor	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	5.00e-2	3.15e-2
CD34 progenitor	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	1.67e-3
CD34 progenitor	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-3	2.96e-4
CD34 progenitor	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-4	1.89e-2
T CD8 activated	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	3.16e-2
B mature	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	3.16e-2
T CD8 CTL	Smoking	Age of smoking initiation	ETC	Liua	2019	NA	341427	1.00e-2	2.20e-2
B naive	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	4.12e-4
B naive	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	1.20e-2
B naive	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-3	2.37e-2
B naive	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-4	3.25e-2
T cell dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	2.67e-4
T cell dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	2.54e-2
B mature	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	2.97e-2
B mature	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	3.60e-2
NK dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	4.12e-4
NK dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	1.76e-2
NK dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-3	8.91e-3
NK dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-4	8.29e-4
NK dividing	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-5	6.67e-5
Macrophage	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	3.91e-2
Macrophage	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	3.60e-2
Plasmablast	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	8.70e-3
Plasmablast	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	5.28e-3
Plasmablast	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-3	3.69e-2
Plasmablast	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-4	3.25e-2
Plasmablast	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-5	1.56e-2
CD34 progenitor	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	5.00e-2	4.37e-3
CD34 progenitor	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-2	1.34e-3
CD34 progenitor	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-3	2.99e-3
CD34 progenitor	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-4	1.67e-3
CD34 progenitor	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-5	8.13e-3
Platelet	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-3	3.69e-2
Platelet	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-5	2.85e-2
B Hypermutation	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-4	3.25e-2
Plasma IgG	Depression	Depressive-symptoms	ETC	Baselmans	2019	NA	1067913	1.00e-5	4.96e-2
B naive	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	8.33e-3
B naive	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-3	2.23e-2
T cell dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	1.30e-4
T cell dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-2	4.07e-4
NK dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	3.06e-4
NK dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-2	1.45e-4
NK dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-3	1.44e-2
NK dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-4	4.64e-2
NK dividing	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-5	8.80e-3
B Hypermutation	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	3.06e-3
B Hypermutation	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-2	4.03e-3
Plasmablast	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	3.32e-5
Plasmablast	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-2	9.00e-3
Plasmablast	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-3	3.37e-2
Plasmablast	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-5	2.95e-2
CD34 progenitor	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	5.00e-2	2.05e-2
CD34 progenitor	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-3	2.23e-2
CD34 progenitor	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-4	2.91e-2
Plasma IgG	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-3	3.37e-2
Plasma IgG	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-4	4.64e-2
Plasma IgG	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-5	1.65e-2
Plasma IgM	Neuroticism	Neuroticism	ETC	Baselmans	2019	NA	523783	1.00e-5	2.95e-2
T cell dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	5.00e-2	6.28e-3
T cell dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-2	2.24e-2
NK dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	5.00e-2	3.45e-4
NK dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-2	8.29e-4
NK dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-3	5.91e-3
NK dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-4	2.82e-3
NK dividing	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-5	2.73e-3
Plasma IgG	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	5.00e-2	4.22e-2
Plasma IgG	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-2	2.24e-2
Plasma IgG	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-3	1.13e-2
Plasma IgG	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-4	2.85e-2
Plasmablast	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	5.00e-2	1.42e-2
CD34 progenitor	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	5.00e-2	2.09e-2
NK FCGR3Apos	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-3	3.62e-2
NK FCGR3Apos	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-4	2.85e-2
NK FCGR3Apos	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-5	2.03e-2
Plasma IgM	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-3	3.62e-2
ILC	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-5	4.82e-2
Platelet	Positive affect	Positive affect	ETC	Baselmans	2019	NA	410603	1.00e-5	4.82e-2
T cell dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	5.00e-2	7.40e-3
T cell dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-2	3.01e-2
NK dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	5.00e-2	9.96e-6
NK dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-2	1.14e-4
NK dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-3	4.01e-3
NK dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-4	1.07e-2
NK dividing	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-5	2.11e-3
Platelet	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	5.00e-2	4.45e-2
Plasmablast	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	5.00e-2	4.45e-2
CD34 progenitor	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	5.00e-2	1.41e-2
Plasma IgG	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-2	1.40e-2
NK FCGR3Apos	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-3	2.97e-2
B Hypermutation	Life satisfaction	Life satisfaction	ETC	Baselmans	2019	NA	80852	1.00e-5	2.89e-2
NK CD160pos	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	4.30e-2
NK CD160pos	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-3	4.52e-2
NK CD160pos	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-5	4.89e-2
NK FCGR3Apos	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	2.78e-2
T CD4 fh	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	6.17e-3
T cell dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	2.78e-2
T cell dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-3	4.52e-2
T cell dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-4	2.13e-2
T cell dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-5	1.88e-2
B mature	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	8.10e-3
NK dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	2.21e-2
NK dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-3	1.37e-2
NK dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-4	2.28e-3
NK dividing	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-5	1.14e-4
Plasmablast	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-2	1.02e-3
Plasmablast	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-3	1.54e-3
Plasmablast	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-4	8.09e-4
Plasmablast	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-5	9.75e-4
CD34 progenitor	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-3	1.88e-2
B Hypermutation	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-4	4.49e-2
B Hypermutation	Body fat	Body fat percentage	ETC	Hubel	2018	70700	85261	1.00e-5	3.09e-2
Monocyte	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	5.00e-2	4.35e-2
Macrophage	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	5.00e-2	3.03e-2
Macrophage	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	8.68e-3
DC 1	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	5.00e-2	8.08e-4
DC 1	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	6.10e-4
Platelet	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	5.00e-2	2.07e-2
Platelet	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	1.86e-2
CD34 progenitor	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	5.00e-2	3.67e-3
CD34 progenitor	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	8.68e-3
DC 2	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	1.86e-2
DC plasmacytoid	Postburn scar height	Postburn scar height	ETC	Wallace	2018	NA	665	1.00e-2	3.80e-3
T CD4 reg	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	2.91e-2
T CD4 reg	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	1.00e-2	1.86e-2
T CD4 naive	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	2.91e-2
Macrophage	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	2.91e-2
DC 1	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	1.98e-2
DC 1	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	1.00e-2	1.86e-2
Plasma IgM	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	4.18e-2
DC activated	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	8.63e-3
CD34 progenitor	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	5.00e-2	2.91e-2
CD34 progenitor	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	1.00e-2	3.76e-2
T CD8 CTL	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	1.00e-2	3.76e-2
Platelet	Postburn scar pliability	Postburn scar pliability	ETC	Wallace	2018	NA	665	1.00e-2	3.76e-2
NK CD160pos	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	5.00e-2	2.10e-2
T cell dividing	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	5.00e-2	5.67e-3
T cell dividing	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	1.00e-2	7.32e-3
NK dividing	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	5.00e-2	2.10e-2
ILC	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	5.00e-2	4.51e-2
T CD4 reg	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	1.00e-2	3.29e-2
T CD4 naive	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	1.00e-2	7.32e-3
Unknown	Erectile dysfunction	Erectile dysfunction	ETC	Bovijn	2018	6175	217630	1.00e-3	4.55e-4
T CD8 MAIT	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
T CD8 MAIT	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.64e-3
T CD8 MAIT	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-3	1.08e-3
B naive	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
B naive	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
T cell dividing	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
B mature	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
B mature	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
T CD8 CTL	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	2.62e-2
T CD8 CTL	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	2.08e-2
T CD4 reg	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
T CD4 reg	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
T CD4 reg	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-3	3.12e-2
T CD4 conv	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	8.94e-3
Monocyte	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.08e-3
NK dividing	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.86e-2
B T doublet	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.70e-3
B T doublet	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	6.31e-3
DC 2	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.03e-3
Macrophage	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	5.07e-5
Macrophage	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	6.31e-3
Macrophage	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-3	1.13e-2
ILC	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.86e-2
ILC	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	2.08e-2
T CD8 gd	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	6.05e-3
T CD8 gd	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
DC 1	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	3.62e-2
DC 1	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
B Hypermutation	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	3.62e-2
DC plasmacytoid	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	4.93e-2
DC activated	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.70e-3
DC activated	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	3.28e-3
DC activated	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-3	3.12e-2
Neutrophil	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	5.00e-2	1.08e-3
Neutrophil	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	3.55e-2
Neutrophil	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-3	3.12e-2
T CD8 activated	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	3.55e-2
NK FCGR3Apos	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	1.17e-2
CD34 progenitor	Psoriatic arthritis	Psoriatic arthritis	ETC	Aterido	2018	744	1454	1.00e-2	3.55e-2
T CD8 MAIT	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	3.50e-6
T CD8 MAIT	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	6.13e-7
T CD8 MAIT	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	4.40e-9
T CD8 MAIT	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.88e-7
T CD8 MAIT	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.82e-4
NK CD160pos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	2.71e-2
NK CD160pos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.74e-2
T CD8 activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	2.67e-4
T CD8 activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	8.95e-4
T CD8 activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	2.24e-5
T CD8 activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	4.15e-4
T CD8 activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	5.32e-3
NK FCGR3Apos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	3.50e-6
NK FCGR3Apos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	8.37e-5
NK FCGR3Apos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	1.35e-4
NK FCGR3Apos	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	4.15e-4
T CD4 fh	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	4.09e-4
T CD4 fh	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	5.10e-4
T CD4 fh	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.11e-3
T CD4 fh	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	1.44e-2
T CD4 fh	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.39e-2
T CD8 CTL	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	6.96e-5
T CD8 CTL	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	2.85e-4
T CD8 CTL	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	2.24e-5
T CD8 CTL	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	1.48e-4
T CD8 CTL	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.39e-2
T CD4 reg	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	3.83e-7
T CD4 reg	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	8.37e-5
T CD4 reg	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	7.00e-4
T CD4 reg	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	6.52e-3
T CD4 naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	6.50e-8
T CD4 naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	4.40e-5
T CD4 naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.11e-3
T CD4 conv	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.73e-4
T CD4 conv	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	4.40e-5
T CD4 conv	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	5.60e-5
T CD4 conv	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	2.76e-3
Monocyte	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	5.80e-3
B T doublet	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.37e-3
B T doublet	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	2.26e-5
B T doublet	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	1.35e-4
B T doublet	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	2.76e-3
B T doublet	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	6.05e-4
DC 2	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	2.00e-3
DC 2	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	6.83e-3
DC 2	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	2.14e-2
DC 2	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.00e-2
DC 2	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	3.34e-2
Macrophage	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.37e-3
Macrophage	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.00e-2
T CD8 gd	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.11e-2
T CD8 gd	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	2.14e-2
T CD8 gd	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.00e-2
T CD8 gd	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.39e-2
DC plasmacytoid	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.11e-2
DC plasmacytoid	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	3.66e-2
DC plasmacytoid	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.74e-2
DC plasmacytoid	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.00e-2
DC activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	5.00e-2	1.52e-2
DC activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.74e-2
DC activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	3.00e-2
DC activated	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.39e-2
DC 1	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-2	3.66e-2
DC 1	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	1.17e-2
DC 1	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	1.10e-3
DC 1	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.87e-3
B naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	6.17e-3
B naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	4.15e-4
B naive	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.82e-4
B mature	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	3.11e-3
B mature	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	1.10e-3
B mature	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	1.82e-4
NK dividing	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-3	1.17e-2
NK dividing	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-4	1.44e-2
NK dividing	Asthma	Asthma, moderate or severe	ETC	Shrine	2018	5414	21471	1.00e-5	3.34e-2
B naive	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.89e-3
B mature	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.59e-2
DC 1	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.85e-2
Platelet	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.59e-2
Platelet	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.60e-2
Plasmablast	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.08e-3
Plasmablast	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.88e-2
DC activated	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	5.00e-2	3.64e-2
DC activated	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.88e-2
NK dividing	Sleep	Sleep duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.81e-2
B naive	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	2.61e-2
NK FCGR3Apos	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	1.20e-2
T cell dividing	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	4.20e-2
T cell dividing	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-2	7.29e-3
T CD8 CTL	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	2.61e-2
T CD4 reg	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	2.61e-2
NK dividing	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	1.39e-3
NK dividing	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-2	4.58e-2
Macrophage	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	6.94e-4
ILC	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	2.70e-3
Platelet	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	6.94e-4
Platelet	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-2	1.52e-4
Platelet	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-3	3.74e-2
DC plasmacytoid	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	4.20e-2
DC plasmacytoid	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-3	2.14e-2
DC activated	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	5.00e-2	6.78e-3
B mature	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-2	2.32e-2
B Hypermutation	Physical activity	Physical activity, overall physical activity time	ETC	Doherty	2018	NA	91105	1.00e-2	4.58e-2
T cell dividing	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.37e-2
T cell dividing	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.46e-2
DC 1	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	3.08e-2
DC 1	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.46e-2
Plasma IgM	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	3.95e-2
Platelet	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.02e-2
Platelet	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.11e-2
Platelet	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.46e-2
DC plasmacytoid	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.02e-2
DC plasmacytoid	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.69e-2
Plasmablast	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.81e-2
Plasmablast	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.69e-2
Plasmablast	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.46e-2
Plasmablast	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-4	3.73e-2
T CD4 naive	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.70e-2
T CD4 naive	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	1.79e-2
T CD4 naive	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-4	1.29e-2
T CD4 naive	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-5	2.22e-2
NK dividing	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	8.73e-3
B Hypermutation	Sedentary behaviour duration	Sedentary behaviour duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.46e-2
T CD8 MAIT	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.08e-2
NK CD160pos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.01e-4
NK CD160pos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	4.74e-4
NK CD160pos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-3	1.59e-2
NK CD160pos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.59e-2
NK FCGR3Apos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.63e-4
NK FCGR3Apos	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	5.24e-3
B mature	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.01e-4
B mature	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	8.91e-3
T CD8 CTL	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.70e-2
NK dividing	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	9.40e-4
NK dividing	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.47e-2
DC 2	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.09e-3
DC 2	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	2.37e-2
DC 2	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-3	3.74e-2
Macrophage	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	6.32e-3
Macrophage	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	2.99e-3
T CD8 gd	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.70e-2
Platelet	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	6.32e-3
DC plasmacytoid	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.09e-3
DC plasmacytoid	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	2.99e-3
DC plasmacytoid	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-3	1.59e-2
DC activated	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.70e-2
DC activated	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.47e-2
T CD4 naive	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-3	1.59e-2
T CD4 naive	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.59e-2
T CD4 conv	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.59e-2
Monocyte	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.59e-2
Neutrophil	Physical activity	Physical activity, walking duration	ETC	Doherty	2018	NA	91105	1.00e-4	2.59e-2
B naive	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.22e-3
T CD4 fh	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	5.98e-3
T CD4 fh	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-3	1.78e-2
T cell dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.26e-2
T cell dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.77e-2
B mature	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.85e-3
T CD4 reg	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.34e-2
NK dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	2.34e-2
NK dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	4.82e-3
NK dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-3	4.30e-2
NK dividing	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-4	3.97e-2
Macrophage	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	1.85e-3
Macrophage	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	1.43e-3
DC 1	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	5.00e-2	4.26e-2
NK CD160pos	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.77e-2
T CD8 CTL	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.77e-2
T CD8 CTL	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-3	4.30e-2
T CD4 naive	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.77e-2
T CD4 naive	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-3	4.30e-2
T CD8 gd	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	3.77e-2
DC plasmacytoid	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-2	8.45e-3
B T doublet	Physical activity	Physical activity, moderate intensity activity duration	ETC	Doherty	2018	NA	91105	1.00e-3	4.30e-2
T cell dividing	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	ETC	Aragam	2018	1816	388326	5.00e-2	4.13e-3
B Hypermutation	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	ETC	Aragam	2018	1816	388326	5.00e-2	9.32e-3
B Hypermutation	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	ETC	Aragam	2018	1816	388326	1.00e-2	1.24e-2
T CD8 MAIT	Nonischemic cardiomyopathy	Nonischemic cardiomyopathy	ETC	Aragam	2018	1816	388326	1.00e-3	3.83e-2
Macrophage	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	5.00e-2	2.64e-2
Macrophage	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	1.00e-2	3.09e-2
B Hypermutation	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	5.00e-2	1.92e-2
T cell dividing	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	1.00e-2	4.89e-2
DC plasmacytoid	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	1.00e-2	4.89e-2
B naive	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	1.00e-3	7.49e-4
B mature	Heart failure	Heart failure	ETC	Aragam	2018	6504	387652	1.00e-3	7.66e-3
T CD8 MAIT	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	2.22e-2
T CD8 MAIT	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	1.00e-3	1.74e-2
T CD4 fh	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	2.22e-2
T CD4 fh	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	1.00e-2	3.52e-2
T cell dividing	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	1.03e-2
NK dividing	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	3.82e-4
B Hypermutation	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	3.18e-2
Plasmablast	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	5.00e-2	4.47e-2
DC activated	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	1.00e-2	3.52e-2
T CD4 naive	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	1.00e-3	1.74e-2
B T doublet	Hippocampal volume	Hippocampal tail volume	ETC	Meer	2018	NA	21297	1.00e-3	4.47e-3
Platelet	Fimbria volume	Fimbria volume	ETC	Meer	2018	NA	21297	5.00e-2	1.77e-2
T CD4 conv	Fimbria volume	Fimbria volume	ETC	Meer	2018	NA	21297	1.00e-2	3.53e-2
DC 2	Fimbria volume	Fimbria volume	ETC	Meer	2018	NA	21297	1.00e-3	3.87e-2
DC 1	Fimbria volume	Fimbria volume	ETC	Meer	2018	NA	21297	1.00e-3	3.87e-2
CD34 progenitor	Parasubiculum volume	Parasubiculum volume	ETC	Meer	2018	NA	21297	1.00e-3	2.03e-2
T cell dividing	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	5.00e-2	3.36e-3
NK dividing	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	5.00e-2	1.94e-2
DC 1	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	5.00e-2	1.29e-2
B Hypermutation	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	5.00e-2	8.41e-3
T CD4 fh	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	1.00e-2	2.48e-2
ILC	Hippocampal volume	Hippocampal fissure volume	ETC	Meer	2018	NA	21297	1.00e-2	4.83e-2
T cell dividing	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	8.65e-3
B mature	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	1.32e-2
Monocyte	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	8.65e-3
NK dividing	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	4.54e-4
DC 2	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	8.65e-3
Macrophage	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	8.65e-3
DC 1	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	8.65e-3
B Hypermutation	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	1.32e-2
Platelet	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	1.97e-2
DC plasmacytoid	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	5.00e-2	7.79e-4
DC plasmacytoid	Brain volume	Dentate gyrus molecular layer volume	ETC	Meer	2018	NA	21297	1.00e-2	4.06e-3
T cell dividing	Brain volume	Dentate gyrus granule cell layer volume	ETC	Meer	2018	NA	21297	1.00e-2	3.60e-2
NK dividing	Brain volume	Dentate gyrus granule cell layer volume	ETC	Meer	2018	NA	21297	1.00e-2	9.18e-3
B Hypermutation	Brain volume	Dentate gyrus granule cell layer volume	ETC	Meer	2018	NA	21297	1.00e-2	3.60e-2
T CD8 MAIT	Brain volume	Dentate gyrus granule cell layer volume	ETC	Meer	2018	NA	21297	1.00e-3	3.59e-2
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA4 volume	ETC	Meer	2018	NA	21297	5.00e-2	2.05e-2
Plasmablast	Hippocampal volume	Hippocampal subfield CA4 volume	ETC	Meer	2018	NA	21297	5.00e-2	4.24e-2
T CD8 MAIT	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.99e-2
T CD8 MAIT	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.20e-2
NK FCGR3Apos	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.70e-3
NK FCGR3Apos	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.20e-2
T cell dividing	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.82e-2
T cell dividing	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	3.17e-3
T CD8 gd	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	9.37e-3
Plasmablast	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.38e-2
Plasmablast	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.27e-2
T CD4 fh	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.20e-2
ILC	Hippocampal volume	Total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-4	3.87e-2
NK CD160pos	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	3.98e-2
T CD4 fh	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	9.20e-4
T CD4 fh	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-2	2.25e-2
T CD4 fh	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-3	2.98e-2
T cell dividing	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	1.15e-2
B mature	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	2.69e-2
T CD4 conv	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	2.69e-2
T CD4 conv	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-2	1.04e-2
T CD4 conv	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-3	2.98e-2
DC 2	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	1.15e-2
Macrophage	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	7.27e-3
ILC	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	7.27e-3
ILC	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-2	2.25e-2
DC 1	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	8.19e-5
Plasma IgM	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	7.27e-3
B Hypermutation	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	1.78e-2
Plasma IgG	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	7.27e-3
DC plasmacytoid	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	2.70e-3
Plasmablast	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	5.00e-2	1.15e-2
Plasmablast	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-3	2.98e-2
T CD4 naive	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-2	4.52e-3
B T doublet	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-2	2.25e-2
T CD4 reg	Hippocampal volume	Hippocampal subfield CA1 volume	ETC	Meer	2018	NA	21297	1.00e-3	2.98e-2
B naive	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	4.97e-2
NK dividing	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	2.49e-2
NK dividing	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	1.00e-2	2.27e-2
DC 1	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	1.72e-2
B Hypermutation	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	1.16e-2
B Hypermutation	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	1.00e-2	2.27e-2
DC plasmacytoid	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	4.97e-2
Plasmablast	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	4.98e-3
Plasmablast	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	1.00e-2	4.06e-2
T cell dividing	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	1.00e-2	4.06e-2
Platelet	Subiculum volume	Subiculum volume	ETC	Meer	2018	NA	21297	1.00e-2	4.06e-2
B mature	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	1.01e-2
NK dividing	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	2.25e-2
NK dividing	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	1.00e-3	1.30e-2
Platelet	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	2.25e-2
Plasmablast	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	5.00e-2	4.64e-2
Plasma IgM	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	1.00e-3	4.10e-2
Plasma IgG	Presubiculum volume	Presubiculum volume	ETC	Meer	2018	NA	21297	1.00e-3	4.10e-2
T cell dividing	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.63e-2
B mature	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	7.18e-3
DC 2	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.63e-2
CD34 progenitor	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.68e-2
CD34 progenitor	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	4.37e-2
T CD4 fh	HATA volume	HATA volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.89e-2
T cell dividing	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.42e-2
NK dividing	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
Plasma IgM	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
Plasma IgM	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.55e-2
B Hypermutation	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.08e-2
Plasma IgG	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.42e-2
Plasma IgG	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.04e-2
Platelet	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.78e-3
DC 2	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.55e-2
DC 1	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.55e-2
DC plasmacytoid	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.25e-2
Neutrophil	Fimbria volume	Fimbria volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.25e-2
T CD8 MAIT	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
NK FCGR3Apos	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.27e-2
T cell dividing	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
NK dividing	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
DC 1	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	5.53e-3
DC 1	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.15e-2
B Hypermutation	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
Platelet	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
Platelet	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.05e-2
Plasmablast	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.84e-2
DC activated	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.27e-2
ILC	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.17e-2
ILC	Hippocampal volume	Hippocampal tail volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	3.46e-2
T cell dividing	Hippocampal volume	Hippocampal fissure volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.32e-2
Monocyte	Hippocampal volume	Hippocampal fissure volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.00e-2
Plasmablast	Hippocampal volume	Hippocampal fissure volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.00e-2
ILC	Hippocampal volume	Hippocampal fissure volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	5.44e-3
T CD8 MAIT	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.58e-3
T CD8 MAIT	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.06e-2
T CD8 MAIT	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	4.10e-2
B naive	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.64e-2
NK FCGR3Apos	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.59e-3
NK FCGR3Apos	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.00e-2
T cell dividing	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	9.47e-4
B Hypermutation	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.25e-2
Platelet	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.25e-2
Plasmablast	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.52e-2
CD34 progenitor	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.52e-2
T CD4 conv	Brain volume	Dentate gyrus molecular layer volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	9.97e-3
T CD8 MAIT	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.95e-3
T CD8 MAIT	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.92e-3
B naive	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.08e-2
NK FCGR3Apos	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.63e-3
NK FCGR3Apos	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	4.92e-3
T CD4 fh	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.59e-2
T cell dividing	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.38e-4
T CD4 reg	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.14e-3
NK dividing	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.63e-3
ILC	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.63e-2
T CD8 gd	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.32e-2
B Hypermutation	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.32e-2
Platelet	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.63e-2
Plasmablast	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.08e-2
Monocyte	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.02e-2
DC 2	Brain volume	Dentate gyrus granule cell layer volume corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.02e-2
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.22e-3
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.47e-2
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	2.62e-2
NK CD160pos	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.80e-2
NK FCGR3Apos	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.38e-3
T cell dividing	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	5.09e-4
T CD4 reg	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.50e-3
NK dividing	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.50e-3
T CD8 gd	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.50e-3
B Hypermutation	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	5.41e-3
Plasmablast	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.01e-4
Monocyte	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.47e-2
DC 2	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.47e-2
ILC	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	2.80e-2
T CD4 fh	Hippocampal volume	Hippocampal subfield CA4 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	2.62e-2
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.54e-2
B naive	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.60e-2
B mature	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.20e-2
NK dividing	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.54e-2
B Hypermutation	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	5.28e-3
B Hypermutation	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	3.27e-2
DC plasmacytoid	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	8.20e-4
DC plasmacytoid	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	8.81e-4
Plasmablast	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.93e-4
Plasmablast	Hippocampal volume	Hippocampal subfield CA3 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	8.92e-3
NK FCGR3Apos	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
T CD4 fh	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
T CD4 fh	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.96e-2
T cell dividing	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	6.76e-3
T CD4 reg	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.05e-2
Monocyte	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
DC 2	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	1.61e-2
Macrophage	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	4.24e-3
ILC	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	2.40e-2
B Hypermutation	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.51e-2
Platelet	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	6.76e-3
CD34 progenitor	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	6.76e-3
CD34 progenitor	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	3.84e-2
T CD4 conv	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	9.46e-3
B T doublet	Hippocampal volume	Hippocampal subfield CA1 volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-2	1.96e-2
T cell dividing	Subiculum volume	Subiculum volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.92e-2
B Hypermutation	Subiculum volume	Subiculum volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	5.00e-2	3.92e-2
B Hypermutation	Subiculum volume	Subiculum volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	2.38e-2
T CD8 MAIT	Parasubiculum volume	Presubiculum volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	2.03e-2
T CD4 reg	Parasubiculum volume	Presubiculum volume, corrected for total hippocampal volume	ETC	Meer	2018	NA	21297	1.00e-3	2.03e-2
ILC	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	5.00e-2	1.02e-2
ILC	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	1.00e-2	6.52e-3
Plasmablast	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	5.00e-2	3.50e-2
CD34 progenitor	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	5.00e-2	7.70e-5
CD34 progenitor	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	1.00e-2	1.44e-2
T CD4 naive	HATA volume	Hippocampal amygdala transition area volume	ETC	Meer	2018	NA	21297	1.00e-3	4.58e-3
T CD8 MAIT	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	5.00e-2	4.85e-2
NK CD160pos	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	5.00e-2	3.55e-2
NK FCGR3Apos	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	5.00e-2	3.55e-2
NK dividing	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	5.00e-2	4.85e-2
B Hypermutation	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	5.00e-2	4.85e-2
B naive	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	1.00e-2	2.95e-2
Unknown	Hippocampal volume	Hippocampal subfield CA3 volume	ETC	Meer	2018	NA	21297	1.00e-2	2.95e-2
T CD8 MAIT	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	2.57e-3
T CD8 activated	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	1.69e-2
T CD8 activated	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-4	2.90e-2
T CD4 fh	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	3.23e-2
T CD8 CTL	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	1.09e-3
T CD4 reg	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	1.20e-2
Monocyte	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	2.36e-2
Monocyte	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-2	3.20e-2
T CD8 gd	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	1.20e-2
T CD8 gd	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-2	1.98e-2
T CD8 gd	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-3	2.07e-5
T CD8 gd	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-4	2.90e-2
Platelet	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	5.00e-2	3.23e-2
Platelet	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-2	3.85e-3
DC activated	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-2	1.18e-2
NK CD160pos	IHPS	Infantile hypertrophic pyloric stenosis	ETC	Fadista	2018	NA	4438	1.00e-3	2.91e-4
B naive	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	5.00e-2	1.26e-4
B naive	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-2	8.78e-3
DC 1	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	5.00e-2	3.02e-2
DC 1	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-2	2.76e-3
DC plasmacytoid	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	5.00e-2	1.47e-3
DC plasmacytoid	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-3	1.56e-2
CD34 progenitor	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	5.00e-2	4.69e-2
CD34 progenitor	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-2	3.35e-2
B Hypermutation	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-2	4.12e-3
B Hypermutation	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-3	3.88e-2
T CD8 MAIT	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-4	3.93e-2
T CD4 reg	ACR	Urinary albumin to creatinine ratio	ETC	Zanetti	2019	NA	218759	1.00e-4	3.93e-2
T CD8 MAIT	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	2.65e-5
T CD8 MAIT	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	1.13e-3
T CD8 MAIT	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	2.58e-2
T CD8 activated	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	3.17e-2
T CD8 activated	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	4.50e-2
T CD8 activated	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	3.84e-2
B naive	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	1.25e-2
T cell dividing	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	4.99e-4
T cell dividing	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	1.29e-4
T CD8 CTL	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	3.25e-3
T CD8 CTL	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	5.16e-3
T CD8 CTL	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	4.14e-3
T CD8 CTL	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-4	1.04e-2
NK dividing	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	5.70e-3
NK dividing	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	3.19e-4
T CD8 gd	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	1.59e-2
T CD8 gd	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	1.41e-2
DC 1	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	7.46e-3
DC 1	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	3.60e-3
B Hypermutation	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	3.17e-2
B Hypermutation	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	3.60e-3
DC plasmacytoid	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	2.54e-2
DC plasmacytoid	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	3.43e-2
Plasmablast	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	9.68e-3
Plasmablast	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	3.43e-2
CD34 progenitor	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	5.00e-2	3.17e-2
CD34 progenitor	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	3.84e-2
NK FCGR3Apos	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	2.58e-2
NK FCGR3Apos	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	6.77e-3
DC activated	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-2	1.02e-2
ILC	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-3	3.84e-2
Monocyte	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-4	3.22e-2
Monocyte	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-5	2.48e-2
NK CD160pos	Na/C	Urinary sodium to creatinine ratio	ETC	Zanetti	2019	NA	218450	1.00e-5	4.83e-2
T CD8 MAIT	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	4.36e-3
NK FCGR3Apos	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	2.68e-2
T cell dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	7.09e-4
T cell dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	3.98e-2
T cell dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-4	3.82e-2
B mature	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	1.52e-3
B mature	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	2.27e-2
Monocyte	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	3.48e-2
Monocyte	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	2.73e-2
NK dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	6.06e-3
NK dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	1.82e-2
NK dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	1.21e-2
NK dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-4	5.66e-3
NK dividing	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-5	5.36e-3
DC 2	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	8.35e-3
DC 2	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	1.19e-2
DC 2	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	4.06e-2
Macrophage	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	3.10e-3
Macrophage	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	2.73e-2
DC 1	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	8.35e-3
B Hypermutation	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	2.09e-4
B Hypermutation	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	4.77e-3
B Hypermutation	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	2.27e-2
Platelet	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	3.48e-2
Platelet	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	1.03e-3
Plasmablast	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	3.48e-2
CD34 progenitor	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	5.00e-2	1.04e-3
CD34 progenitor	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-2	3.32e-4
CD34 progenitor	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	4.06e-2
B naive	AUD	Alcohol-Use-Disorder	ETC	Kranzler	2019	34658	167346	1.00e-3	2.27e-2
T cell dividing	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	2.04e-2
B mature	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	2.63e-2
Monocyte	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	3.64e-3
DC 2	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	9.00e-3
Macrophage	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	4.97e-3
DC 1	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	4.97e-3
B Hypermutation	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	6.72e-3
DC plasmacytoid	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	4.25e-2
Plasmablast	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	1.35e-3
CD34 progenitor	AUDIT-C	Alcohol-Use-Disorder-Identification-Test-Consumption	ETC	Kranzler	2019	NA	200680	5.00e-2	1.90e-3
T CD8 MAIT	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	3.10e-2
T CD8 MAIT	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	9.69e-3
T CD8 MAIT	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	2.93e-2
T CD8 activated	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.10e-2
T CD8 activated	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	2.75e-2
B naive	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.10e-5
B naive	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	1.72e-4
B naive	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	1.66e-2
T CD4 fh	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	4.62e-3
T cell dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.45e-2
T cell dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	3.06e-3
T cell dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	2.75e-2
T cell dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	1.48e-2
B mature	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	2.06e-4
B mature	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	1.03e-2
B mature	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	2.75e-2
B mature	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	2.93e-2
T CD8 CTL	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	3.39e-3
T CD4 reg	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	8.34e-3
T CD4 reg	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	2.75e-2
Monocyte	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.45e-2
NK dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	9.32e-5
NK dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	4.79e-4
NK dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	1.96e-4
NK dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	9.47e-6
NK dividing	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-5	3.08e-5
Macrophage	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	2.06e-4
T CD8 gd	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	4.91e-2
DC 1	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.78e-3
B Hypermutation	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	2.47e-3
B Hypermutation	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	1.03e-2
Platelet	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	1.27e-3
Platelet	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-2	3.01e-2
Platelet	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-3	9.69e-3
CD34 progenitor	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	5.00e-2	6.24e-3
Plasma IgM	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	2.93e-2
Plasma IgG	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	1.48e-2
Plasmablast	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-4	2.93e-2
Neutrophil	Medication use	Medication use (drugs for peptic ulcer and gastro-oesophageal reflux disease)	ETC	Wu Y	2019	53,137	79,230	1.00e-5	1.05e-2
T CD8 MAIT	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	4.73e-2
T CD8 MAIT	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	2.47e-2
T CD8 MAIT	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	2.04e-2
T CD8 MAIT	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	1.01e-2
B naive	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	7.30e-3
B naive	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	5.86e-5
B naive	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	4.75e-5
B naive	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	4.00e-3
B naive	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	1.18e-3
T cell dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	6.82e-4
T cell dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	2.89e-2
B mature	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	1.98e-2
B mature	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	4.12e-3
B mature	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	2.47e-5
B mature	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	2.97e-4
B mature	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	9.40e-5
T CD8 CTL	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	4.73e-2
NK dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	3.49e-4
NK dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	8.30e-3
NK dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	2.47e-2
NK dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	4.00e-3
NK dividing	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	5.15e-3
Macrophage	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	9.48e-3
Macrophage	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	8.30e-3
Macrophage	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	1.65e-2
Macrophage	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	1.22e-2
Macrophage	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	3.40e-2
B Hypermutation	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	1.29e-3
B Hypermutation	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	8.30e-3
B Hypermutation	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	2.47e-2
B Hypermutation	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	2.04e-2
B Hypermutation	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	3.40e-2
Plasmablast	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	9.48e-3
Plasmablast	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-2	2.89e-2
CD34 progenitor	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	5.00e-2	3.11e-2
ILC	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-3	1.65e-2
ILC	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	3.29e-2
DC 1	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	1.22e-2
DC 1	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	2.27e-4
DC activated	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-4	2.04e-2
DC activated	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	1.01e-2
DC 2	Medication use	Medication use (drugs used in diabetes)	ETC	Wu Y	2019	15,272	290,641	1.00e-5	3.40e-2
T CD8 MAIT	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	1.75e-4
T cell dividing	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.40e-3
T cell dividing	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-2	2.91e-2
T cell dividing	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-4	4.64e-2
T CD4 reg	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.62e-2
T CD4 conv	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.01e-2
Monocyte	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	1.53e-2
NK dividing	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.01e-2
B T doublet	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	3.37e-2
DC 2	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.40e-3
DC 2	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-2	2.91e-2
DC 2	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-3	3.92e-2
DC 2	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-5	3.77e-2
Macrophage	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.62e-4
Macrophage	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-2	8.89e-3
Macrophage	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-3	5.19e-3
Macrophage	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-4	5.97e-4
Macrophage	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-5	1.55e-4
DC 1	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	1.26e-5
Plasmablast	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	1.15e-2
DC activated	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	5.71e-4
DC activated	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-2	2.27e-3
DC activated	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-5	3.77e-2
CD34 progenitor	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	5.00e-2	2.62e-2
T CD8 gd	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-4	4.64e-2
T CD8 gd	Medication use	Medication use (antithrombotic agents)	ETC	Wu Y	2019	67,653	85,986	1.00e-5	3.77e-2
B naive	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	2.77e-3
T CD4 fh	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	1.81e-2
B mature	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	1.81e-2
T CD4 reg	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	8.96e-3
T CD4 reg	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-2	3.88e-3
T CD4 reg	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-3	2.80e-2
DC 1	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	4.16e-3
B Hypermutation	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	4.67e-2
Plasma IgG	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	4.67e-2
DC plasmacytoid	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	1.18e-3
Plasmablast	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	6.15e-3
DC activated	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	4.67e-2
CD34 progenitor	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	5.00e-2	8.96e-3
Monocyte	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-2	3.83e-2
Monocyte	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-3	1.13e-2
DC 2	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-3	2.80e-2
Macrophage	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-3	2.80e-2
Macrophage	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-4	3.97e-2
Platelet	Medication use	Medication use (vasodilators used in cardiac diseases)	ETC	Wu Y	2019	5,546	237,113	1.00e-4	3.97e-2
B naive	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	3.11e-2
NK FCGR3Apos	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	1.69e-2
NK FCGR3Apos	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	2.88e-2
NK FCGR3Apos	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-3	6.69e-3
NK FCGR3Apos	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-4	7.22e-3
B mature	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	4.14e-2
B mature	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	4.63e-2
T CD4 reg	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	8.70e-3
T CD4 reg	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	3.04e-3
Monocyte	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	1.11e-5
Monocyte	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	2.88e-2
DC 2	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	8.59e-4
DC 2	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-4	2.90e-2
Macrophage	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	4.14e-2
ILC	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	2.31e-2
DC 1	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	1.96e-3
DC 1	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	1.73e-2
DC 1	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-4	2.90e-2
CD34 progenitor	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	5.00e-2	4.14e-2
CD34 progenitor	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	2.88e-2
CD34 progenitor	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-3	6.69e-3
CD34 progenitor	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-4	1.51e-3
T CD8 MAIT	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	2.88e-2
T CD8 CTL	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-2	4.63e-2
NK CD160pos	Medication use	Medication use (antihypertensives)	ETC	Wu Y	2019	6,431	145,949	1.00e-4	2.90e-2
T CD8 MAIT	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	2.48e-4
T CD8 MAIT	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	1.25e-4
T CD8 MAIT	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	2.11e-2
NK CD160pos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.84e-2
NK CD160pos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	9.13e-3
NK CD160pos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	3.14e-2
NK CD160pos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	3.29e-2
T CD8 activated	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	4.37e-2
B naive	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	4.03e-3
NK FCGR3Apos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	4.03e-3
NK FCGR3Apos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	1.05e-3
NK FCGR3Apos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	7.00e-4
NK FCGR3Apos	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	1.93e-2
T cell dividing	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.70e-3
B mature	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.26e-3
T CD8 CTL	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	3.56e-2
T CD8 CTL	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	3.03e-2
T CD4 reg	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	9.24e-4
T CD4 reg	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	4.65e-4
NK dividing	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.46e-2
DC 2	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	2.31e-2
DC 2	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	3.03e-2
Macrophage	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	8.92e-3
Macrophage	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	3.03e-2
ILC	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.46e-2
ILC	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	1.93e-2
ILC	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-5	2.81e-2
T CD8 gd	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	3.56e-2
T CD8 gd	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	3.27e-3
T CD8 gd	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	1.39e-2
DC 1	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.26e-3
DC 1	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	1.26e-2
DC 1	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	3.14e-2
DC 1	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	3.13e-3
DC 1	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-5	1.41e-2
Plasma IgG	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	3.56e-2
Plasma IgG	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	9.13e-3
DC plasmacytoid	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	9.24e-4
DC plasmacytoid	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	2.26e-3
DC plasmacytoid	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	8.91e-3
DC plasmacytoid	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	3.13e-3
DC plasmacytoid	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-5	5.22e-4
Plasmablast	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	5.00e-2	1.70e-3
CD34 progenitor	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-2	1.26e-2
CD34 progenitor	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-3	8.91e-3
CD34 progenitor	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	1.67e-4
CD34 progenitor	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-5	5.22e-4
DC activated	Medication use	Medication use (beta blocking agents)	ETC	Wu Y	2019	31,700	192,324	1.00e-4	1.93e-2
T CD8 MAIT	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	8.88e-7
T CD8 MAIT	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	7.75e-4
T CD8 MAIT	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	8.28e-3
NK CD160pos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	3.88e-3
NK CD160pos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	1.30e-2
NK CD160pos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	3.09e-3
NK CD160pos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	2.59e-2
B naive	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	1.06e-3
NK FCGR3Apos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	3.66e-4
NK FCGR3Apos	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	6.24e-3
T cell dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	3.66e-4
T cell dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	2.53e-2
T cell dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	1.31e-2
T cell dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	9.03e-3
B mature	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	7.52e-4
B mature	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	1.87e-3
B mature	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	3.04e-2
T CD4 reg	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	4.21e-2
NK dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	7.52e-4
NK dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	3.04e-4
NK dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	5.94e-6
NK dividing	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	1.18e-6
T CD8 gd	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	1.60e-2
B Hypermutation	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	1.16e-4
B Hypermutation	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	1.21e-3
B Hypermutation	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	3.04e-2
Plasma IgG	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	1.60e-2
Plasma IgG	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	2.53e-2
Plasma IgG	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	3.09e-3
Plasma IgG	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	1.56e-2
DC plasmacytoid	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	7.03e-3
DC plasmacytoid	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	1.87e-3
DC plasmacytoid	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	1.05e-3
DC plasmacytoid	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	4.17e-2
Plasmablast	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-2	7.52e-4
Plasmablast	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	3.04e-4
Plasmablast	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	5.95e-4
Plasmablast	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	1.45e-3
DC 1	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	4.66e-2
DC 1	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	4.47e-2
CD34 progenitor	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-3	1.82e-2
CD34 progenitor	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	3.04e-2
CD34 progenitor	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	2.59e-2
ILC	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	8.28e-3
ILC	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	1.56e-2
Plasma IgM	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-4	5.12e-3
Plasma IgM	Medication use	Medication use (diuretics)	ETC	Wu Y	2019	34,453	194,633	1.00e-5	4.17e-2
T CD8 MAIT	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	1.96e-2
T CD8 MAIT	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	5.53e-3
T CD8 MAIT	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	4.29e-2
T CD8 MAIT	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-5	4.06e-2
B naive	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	4.80e-3
B naive	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-5	2.51e-2
NK FCGR3Apos	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	1.96e-2
NK FCGR3Apos	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	1.67e-2
NK FCGR3Apos	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	4.29e-2
T cell dividing	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	4.80e-3
B mature	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	2.56e-3
NK dividing	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	1.51e-2
NK dividing	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	1.60e-3
NK dividing	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	1.96e-2
Macrophage	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	9.27e-4
Macrophage	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	2.45e-3
Macrophage	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	3.14e-3
T CD8 gd	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	3.23e-2
B Hypermutation	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	9.27e-4
B Hypermutation	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	1.17e-2
Plasma IgG	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	1.15e-2
Plasma IgG	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	1.67e-2
Plasma IgG	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	4.29e-2
DC plasmacytoid	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	1.15e-2
DC plasmacytoid	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	2.94e-2
Plasmablast	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-2	4.13e-5
Plasmablast	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-3	5.53e-3
ILC	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	4.29e-2
CD34 progenitor	Medication use	Medication use (calcium channel blockers)	ETC	Wu Y	2019	31,904	172,474	1.00e-4	2.94e-2
T CD8 MAIT	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	6.68e-5
T CD8 MAIT	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	1.07e-3
T CD8 MAIT	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	6.40e-4
T CD8 MAIT	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	1.81e-2
NK CD160pos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	1.84e-2
NK CD160pos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	3.45e-2
NK CD160pos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	1.19e-2
B naive	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	3.51e-2
B naive	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	3.45e-2
B naive	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	2.37e-2
NK FCGR3Apos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	9.58e-5
NK FCGR3Apos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	9.26e-5
NK FCGR3Apos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	2.45e-3
NK FCGR3Apos	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	7.73e-3
T cell dividing	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	9.02e-3
B mature	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	6.68e-5
B mature	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	4.39e-3
B mature	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	2.37e-2
T CD8 CTL	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	2.30e-2
NK dividing	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	5.41e-3
NK dividing	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	3.13e-3
NK dividing	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	6.40e-4
NK dividing	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	3.03e-3
Macrophage	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	3.15e-3
Macrophage	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	2.65e-2
Macrophage	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	3.28e-2
Macrophage	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	1.81e-2
T CD8 gd	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	3.15e-3
T CD8 gd	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	7.29e-4
T CD8 gd	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	2.45e-3
T CD8 gd	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	7.73e-3
DC 1	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	3.15e-3
DC 1	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	3.45e-2
B Hypermutation	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	7.18e-4
B Hypermutation	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	2.65e-2
B Hypermutation	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	3.28e-2
Plasma IgG	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	1.84e-2
Plasma IgG	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	2.69e-2
Platelet	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	4.30e-2
DC plasmacytoid	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	1.78e-3
DC plasmacytoid	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	4.43e-2
Plasmablast	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	1.33e-3
Plasmablast	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	1.52e-2
Plasmablast	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	4.45e-2
CD34 progenitor	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-2	3.51e-2
CD34 progenitor	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	1.69e-2
CD34 progenitor	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	3.90e-2
T CD4 fh	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-3	2.65e-2
ILC	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-4	2.37e-2
ILC	Medication use	Medication use (agents acting on the renin-angiotensin system)	ETC	Wu Y	2019	62,752	174,778	1.00e-5	1.81e-2
B naive	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	1.31e-2
B naive	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	1.78e-2
T cell dividing	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	3.63e-2
T cell dividing	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	8.69e-3
B mature	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	9.89e-3
B mature	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	2.44e-2
DC 2	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	2.95e-3
Macrophage	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	1.66e-4
Macrophage	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	4.51e-2
Macrophage	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-4	7.89e-3
Macrophage	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	1.78e-2
DC 1	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	1.11e-4
DC 1	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-4	2.77e-2
B Hypermutation	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	4.57e-2
B Hypermutation	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	2.44e-2
Plasmablast	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	4.04e-3
Plasmablast	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	8.69e-3
CD34 progenitor	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-2	1.31e-2
NK dividing	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-3	4.51e-2
NK FCGR3Apos	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-4	4.02e-2
DC activated	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-4	2.77e-2
DC activated	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	6.42e-3
T CD8 MAIT	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	1.09e-2
T CD8 CTL	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	2.84e-2
T CD4 reg	Medication use	Medication use (HMG CoA reductase inhibitors)	ETC	Wu Y	2019	73,475	216,910	1.00e-5	4.40e-2
T CD8 MAIT	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	8.15e-11
T CD8 MAIT	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	3.72e-10
T CD8 MAIT	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	7.68e-11
T CD8 MAIT	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	2.11e-9
NK CD160pos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	4.63e-5
NK CD160pos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	3.36e-4
NK CD160pos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	3.84e-5
NK CD160pos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	7.06e-4
T CD8 activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	4.78e-13
T CD8 activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.83e-10
T CD8 activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	7.68e-11
T CD8 activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	8.81e-10
B naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.37e-3
B naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	2.54e-3
B naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	1.14e-4
B naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	2.31e-4
NK FCGR3Apos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.00e-7
NK FCGR3Apos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	8.66e-5
NK FCGR3Apos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	2.18e-5
NK FCGR3Apos	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	3.72e-5
T CD4 fh	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.43e-13
T CD4 fh	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.83e-10
T CD4 fh	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	3.84e-10
T CD4 fh	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	2.11e-9
T cell dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	3.15e-4
T cell dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.17e-3
T cell dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	4.75e-3
T cell dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	8.19e-3
B mature	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	1.21e-7
B mature	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	5.67e-9
B mature	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	1.82e-9
B mature	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	2.11e-9
T CD8 CTL	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	1.58e-9
T CD8 CTL	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	2.08e-8
T CD8 CTL	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	8.42e-10
T CD8 CTL	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	2.11e-9
T CD4 reg	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	1.74e-15
T CD4 reg	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	5.61e-16
T CD4 reg	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	1.85e-13
T CD4 reg	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	4.69e-13
T CD4 naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.03e-5
T CD4 naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	7.83e-4
T CD4 naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	3.14e-3
T CD4 naive	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	3.27e-3
T CD4 conv	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	1.40e-6
T CD4 conv	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	4.43e-7
T CD4 conv	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	2.18e-5
T CD4 conv	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	1.00e-5
NK dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	8.73e-7
NK dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	4.19e-6
NK dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	1.42e-7
NK dividing	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	1.00e-5
B T doublet	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	3.08e-5
B T doublet	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.39e-6
B T doublet	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	5.44e-7
B T doublet	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	1.00e-5
DC 2	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	1.50e-4
DC 2	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	5.38e-5
DC 2	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	8.31e-4
DC 2	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	1.26e-2
ILC	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	6.38e-4
ILC	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	3.67e-3
ILC	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	2.94e-2
T CD8 gd	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.03e-5
T CD8 gd	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	7.83e-4
T CD8 gd	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	5.17e-4
T CD8 gd	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	1.20e-3
DC 1	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	2.00e-7
DC 1	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	7.90e-7
DC 1	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	1.22e-5
DC 1	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	4.08e-4
B Hypermutation	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	4.32e-2
B Hypermutation	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	3.41e-2
B Hypermutation	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	4.03e-2
DC plasmacytoid	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	6.38e-4
DC plasmacytoid	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.92e-2
DC plasmacytoid	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	7.06e-3
DC plasmacytoid	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	8.19e-3
Plasmablast	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	3.46e-2
Plasmablast	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.92e-2
DC activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-2	8.61e-6
DC activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.39e-6
DC activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-4	3.84e-5
DC activated	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-5	6.97e-5
Macrophage	Medication use	Medication use (thyroid preparations)	ETC	Wu Y	2019	24,832	280,750	1.00e-3	1.41e-2
T CD8 MAIT	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	5.81e-5
T CD8 MAIT	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	2.32e-4
T CD8 MAIT	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.16e-5
T CD8 MAIT	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	2.90e-4
T CD8 MAIT	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	3.78e-4
NK CD160pos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	2.78e-2
NK CD160pos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	2.30e-2
NK CD160pos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	1.28e-2
NK CD160pos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	3.14e-2
T CD8 activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	3.45e-5
T CD8 activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	2.32e-4
T CD8 activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	4.53e-4
T CD8 activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	5.96e-3
T CD8 activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	8.93e-3
B naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	3.75e-2
B naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	1.43e-2
B naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	6.03e-3
B naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	2.90e-4
B naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	3.19e-5
NK FCGR3Apos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	3.43e-3
NK FCGR3Apos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	3.60e-2
NK FCGR3Apos	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	4.87e-2
T CD4 fh	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	4.08e-4
T cell dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	2.30e-3
T cell dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.63e-3
T cell dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.58e-2
B mature	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	2.56e-4
B mature	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.64e-4
B mature	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	6.25e-5
B mature	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	7.95e-6
B mature	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	4.78e-7
T CD8 CTL	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	5.81e-5
T CD8 CTL	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.64e-4
T CD8 CTL	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	1.72e-4
T CD8 CTL	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	2.33e-3
T CD8 CTL	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	3.36e-3
T CD4 reg	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	1.17e-5
T CD4 reg	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.64e-4
T CD4 reg	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	1.13e-3
T CD4 reg	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	3.14e-2
T CD4 reg	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	2.18e-2
T CD4 naive	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	6.42e-4
T CD4 conv	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	6.42e-4
NK dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	7.29e-3
NK dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.63e-3
NK dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	6.03e-3
NK dividing	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	4.89e-2
B T doublet	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	5.04e-3
B T doublet	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	1.60e-3
B T doublet	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.58e-2
B T doublet	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	3.14e-2
B T doublet	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	2.18e-2
DC 2	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	5.04e-3
DC 2	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	3.60e-2
DC 2	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.68e-3
DC 2	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	8.48e-4
DC 2	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	3.78e-4
Macrophage	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	1.04e-2
Macrophage	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	5.06e-3
Macrophage	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.58e-2
Macrophage	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	5.96e-3
Macrophage	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	1.17e-3
T CD8 gd	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	4.08e-4
T CD8 gd	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	2.32e-4
T CD8 gd	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.68e-3
T CD8 gd	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	1.42e-2
T CD8 gd	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	4.89e-2
DC 1	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	2.30e-3
DC 1	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	2.32e-4
DC 1	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	6.80e-7
DC 1	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	5.43e-7
DC 1	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	1.04e-7
Plasma IgM	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	6.42e-4
B Hypermutation	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	1.47e-2
B Hypermutation	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	3.60e-2
Plasma IgG	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	1.53e-3
DC plasmacytoid	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	2.03e-2
DC plasmacytoid	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	3.14e-2
DC plasmacytoid	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	2.18e-2
Plasmablast	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	1.04e-2
DC activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	5.00e-2	7.29e-3
DC activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-2	8.64e-4
DC activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-3	2.25e-6
DC activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-4	2.80e-5
DC activated	Medication use	Medication use (immunosuppressants)	ETC	Wu Y	2019	3,954	268,648	1.00e-5	3.19e-5
T CD8 MAIT	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	7.41e-3
T CD8 MAIT	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	1.34e-2
NK CD160pos	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	3.63e-2
T CD8 activated	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	1.71e-2
B naive	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.22e-2
B naive	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	2.78e-2
T cell dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	3.15e-5
T cell dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	9.71e-4
T cell dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	7.16e-4
B mature	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.85e-2
B mature	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	1.94e-2
T CD8 CTL	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	4.57e-2
T CD4 reg	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.85e-2
T CD4 reg	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	1.57e-3
T CD4 reg	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	1.08e-2
NK dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.95e-3
NK dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	5.99e-3
NK dividing	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	3.31e-4
DC 2	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.95e-3
DC 2	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	3.90e-2
DC 2	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	1.94e-2
DC 1	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	5.24e-4
DC 1	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	2.50e-3
B Hypermutation	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	4.57e-2
B Hypermutation	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	1.94e-2
DC plasmacytoid	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	2.95e-3
DC plasmacytoid	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	5.99e-3
Plasmablast	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	7.41e-3
DC activated	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	3.60e-4
DC activated	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	1.94e-2
DC activated	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	1.94e-2
CD34 progenitor	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	5.00e-2	3.60e-4
CD34 progenitor	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	5.99e-3
B T doublet	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	3.90e-2
Macrophage	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-2	3.90e-2
Macrophage	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	7.16e-4
Macrophage	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-4	9.57e-3
Monocyte	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	3.33e-2
T CD8 gd	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	3.33e-2
Neutrophil	Medication use	Medication use (anti-inflammatory and antirheumatic products, non-steroids)	ETC	Wu Y	2019	74,150	90,370	1.00e-3	1.08e-2
NK CD160pos	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	4.36e-2
B mature	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	3.95e-3
B mature	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	2.02e-3
B mature	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	6.09e-4
B mature	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	2.20e-4
B mature	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	2.01e-5
Monocyte	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	1.06e-2
Monocyte	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	3.26e-2
Monocyte	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	3.60e-3
NK dividing	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	4.36e-2
DC 2	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	1.06e-2
DC 2	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	5.60e-3
DC 2	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	6.09e-4
DC 2	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	9.52e-3
DC 2	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	1.27e-4
ILC	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	3.36e-2
ILC	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	9.00e-3
ILC	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	3.39e-2
DC 1	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	1.73e-4
DC 1	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	2.17e-2
DC 1	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	1.52e-3
DC 1	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	3.00e-3
DC 1	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	7.02e-4
DC plasmacytoid	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	2.56e-2
DC plasmacytoid	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	2.17e-2
DC activated	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	5.00e-2	1.93e-2
DC activated	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	1.42e-2
DC activated	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	8.07e-3
DC activated	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	9.52e-3
DC activated	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	7.02e-4
T CD8 MAIT	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	9.00e-3
T CD8 MAIT	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	3.39e-2
B naive	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	9.00e-3
B naive	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	3.39e-2
B naive	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	3.00e-3
B naive	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	7.02e-4
NK FCGR3Apos	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	3.26e-2
Macrophage	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-2	1.42e-2
Macrophage	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-3	1.70e-2
Macrophage	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-4	3.00e-3
Macrophage	Medication use	Medication use (drugs affecting bone structure and mineralization)	ETC	Wu Y	2019	7,870	207,798	1.00e-5	1.27e-4
T CD8 MAIT	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	4.78e-2
NK CD160pos	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	8.25e-3
NK CD160pos	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	3.29e-2
B naive	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	2.12e-4
B naive	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-4	3.65e-3
B naive	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-5	3.52e-4
NK FCGR3Apos	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	2.38e-2
NK FCGR3Apos	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	2.35e-2
B mature	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	2.47e-3
B mature	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-5	5.75e-3
DC 2	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	2.38e-2
DC 2	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	2.35e-2
DC 2	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-3	2.00e-2
DC 2	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-4	3.65e-3
DC 2	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-5	5.75e-3
Macrophage	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	3.03e-2
Macrophage	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	7.72e-3
DC 1	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	2.81e-5
DC 1	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	1.65e-2
DC plasmacytoid	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	3.39e-3
DC plasmacytoid	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	3.29e-2
DC plasmacytoid	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-3	3.39e-2
DC plasmacytoid	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-4	4.66e-2
CD34 progenitor	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	5.00e-2	3.39e-3
CD34 progenitor	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	7.72e-3
NK dividing	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-2	4.53e-2
NK dividing	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-3	6.21e-3
NK dividing	Medication use	Medication use (opioids)	ETC	Wu Y	2019	22,982	55,826	1.00e-5	1.92e-2
T cell dividing	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	2.16e-2
T cell dividing	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	1.52e-2
T cell dividing	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
DC 2	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	1.20e-2
DC 2	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	1.25e-3
DC 2	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	1.55e-2
DC 2	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
Macrophage	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	8.73e-3
Macrophage	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	1.25e-3
Macrophage	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	6.00e-4
Macrophage	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-4	1.67e-4
Macrophage	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	2.66e-5
DC 1	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	2.16e-2
DC 1	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	3.05e-2
Platelet	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	8.73e-3
Platelet	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
CD34 progenitor	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	3.09e-4
CD34 progenitor	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	2.34e-2
Unknown	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	5.00e-2	3.18e-3
T CD8 MAIT	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	1.52e-2
Monocyte	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-2	3.51e-2
B mature	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	3.05e-2
T CD8 gd	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	3.05e-2
DC activated	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-3	1.47e-3
DC activated	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-4	7.94e-3
DC activated	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	2.66e-5
NK dividing	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
ILC	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
B Hypermutation	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	8.49e-3
Plasmablast	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
Neutrophil	Medication use	Medication use (salicylic acid and derivatives)	ETC	Wu Y	2019	61,583	50,427	1.00e-5	3.87e-2
T CD8 MAIT	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.56e-5
T CD8 MAIT	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.44e-2
T CD8 activated	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	2.01e-2
B naive	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	9.15e-3
B naive	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	1.51e-2
B naive	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	1.48e-5
B naive	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	4.34e-4
B naive	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	1.69e-2
NK FCGR3Apos	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.56e-2
T CD4 fh	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	4.07e-2
T cell dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	5.49e-5
T cell dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	1.95e-2
T cell dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	1.79e-2
B mature	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	2.07e-3
B mature	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	7.54e-5
B mature	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	5.96e-4
B mature	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	9.34e-3
B mature	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	1.69e-2
T CD8 CTL	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.50e-3
T CD4 reg	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	2.07e-3
NK dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	8.20e-5
NK dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	4.43e-6
NK dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	2.81e-6
NK dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	9.99e-4
NK dividing	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.35e-3
DC 2	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	3.24e-2
DC 2	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	4.03e-2
DC 2	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.44e-2
Macrophage	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	9.15e-3
Macrophage	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	1.51e-2
T CD8 gd	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.20e-2
T CD8 gd	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	3.14e-2
DC 1	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	2.01e-2
DC 1	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	4.03e-2
DC 1	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.44e-2
B Hypermutation	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	9.15e-3
B Hypermutation	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	1.95e-2
Platelet	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	4.07e-2
Platelet	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	1.40e-3
Platelet	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	1.15e-3
Platelet	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	2.20e-3
DC plasmacytoid	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	2.60e-4
DC plasmacytoid	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	5.62e-4
DC plasmacytoid	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	4.88e-2
Plasmablast	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.07e-3
Plasmablast	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	3.29e-3
Plasmablast	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	1.15e-3
CD34 progenitor	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	5.00e-2	1.56e-5
CD34 progenitor	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	2.53e-5
CD34 progenitor	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-3	6.88e-3
Plasma IgG	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	2.13e-2
DC activated	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-2	4.03e-2
DC activated	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	3.28e-2
DC activated	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.44e-2
NK CD160pos	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-4	9.34e-3
NK CD160pos	Medication use	Medication use (anilides)	ETC	Wu Y	2019	83,218	96,592	1.00e-5	3.44e-2
NK CD160pos	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	2.37e-2
T cell dividing	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	3.24e-2
Monocyte	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	1.82e-3
Monocyte	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	1.00e-2	2.07e-2
NK dividing	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	2.37e-2
Macrophage	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	5.96e-3
Macrophage	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	1.00e-2	7.37e-3
Macrophage	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	1.00e-3	5.96e-3
ILC	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	1.89e-4
ILC	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	1.00e-2	1.25e-2
B Hypermutation	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	4.88e-4
Plasmablast	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	8.61e-3
CD34 progenitor	Medication use	Medication use (antimigraine preparations)	ETC	Wu Y	2019	5,521	114,323	5.00e-2	8.61e-3
T cell dividing	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	2.67e-2
B mature	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	1.49e-2
NK dividing	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	1.68e-4
NK dividing	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-2	5.66e-4
NK dividing	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-3	4.03e-3
B T doublet	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	3.51e-2
B Hypermutation	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	7.94e-3
B Hypermutation	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-2	1.30e-2
Platelet	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	2.01e-2
Platelet	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-2	8.18e-3
Plasmablast	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	1.09e-2
CD34 progenitor	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	5.00e-2	7.94e-3
B naive	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-2	4.51e-2
B naive	Medication use	Medication use (antidepressants)	ETC	Wu Y	2019	33,757	270,405	1.00e-4	4.87e-3
T CD8 MAIT	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.02e-7
T CD8 MAIT	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.06e-7
T CD8 MAIT	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	4.06e-6
T CD8 MAIT	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	9.54e-5
T CD8 MAIT	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	2.12e-6
NK CD160pos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	5.98e-3
T CD8 activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.65e-7
T CD8 activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.52e-5
T CD8 activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	1.77e-4
T CD8 activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	7.58e-3
T CD8 activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	4.41e-4
B naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	4.90e-2
B naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	4.00e-3
B naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	5.38e-4
B naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	2.16e-5
B naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	5.61e-6
NK FCGR3Apos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.65e-6
NK FCGR3Apos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	2.80e-3
NK FCGR3Apos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.10e-2
NK FCGR3Apos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	4.97e-2
NK FCGR3Apos	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	3.93e-3
T CD4 fh	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	5.46e-4
T CD4 fh	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.93e-3
T CD4 fh	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	9.12e-4
T CD4 fh	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	4.41e-3
T CD4 fh	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	3.93e-3
T cell dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	6.72e-7
T cell dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.04e-4
T cell dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	1.52e-3
B mature	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	4.50e-5
B mature	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	2.50e-5
B mature	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	2.90e-5
B mature	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	4.59e-5
B mature	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	3.56e-5
T CD8 CTL	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	6.72e-7
T CD8 CTL	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	6.11e-7
T CD8 CTL	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	5.40e-5
T CD8 CTL	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	3.81e-4
T CD8 CTL	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	1.44e-5
T CD4 reg	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	2.29e-8
T CD4 reg	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	5.45e-6
T CD4 reg	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	1.53e-5
T CD4 reg	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	2.49e-3
T CD4 reg	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	3.56e-5
T CD4 naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.29e-2
T CD4 naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	3.90e-4
T CD4 naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	9.58e-3
T CD4 naive	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	4.97e-2
T CD4 conv	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	2.58e-3
T CD4 conv	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	2.50e-5
T CD4 conv	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	1.77e-4
T CD4 conv	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	1.37e-3
T CD4 conv	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	1.97e-4
Monocyte	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	2.08e-2
Monocyte	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	4.58e-2
NK dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.06e-6
NK dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.07e-6
NK dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.11e-4
NK dividing	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	1.37e-3
B T doublet	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.01e-2
B T doublet	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	5.92e-4
B T doublet	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.11e-4
B T doublet	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	1.93e-4
B T doublet	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	7.55e-3
DC 2	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	3.06e-5
DC 2	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	8.88e-4
DC 2	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	9.58e-3
DC 2	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	3.93e-3
Macrophage	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	3.06e-5
Macrophage	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	5.92e-4
T CD8 gd	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.37e-4
T CD8 gd	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	4.00e-3
T CD8 gd	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	2.14e-2
T CD8 gd	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	4.97e-2
T CD8 gd	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	2.47e-2
DC 1	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	4.00e-2
DC 1	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.10e-2
DC 1	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	1.27e-2
DC 1	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	1.97e-3
B Hypermutation	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.42e-3
B Hypermutation	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	2.80e-3
B Hypermutation	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.10e-2
Plasmablast	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	3.91e-4
Plasmablast	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	5.66e-3
DC activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	5.00e-2	1.42e-3
DC activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.52e-5
DC activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	2.90e-5
DC activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	7.32e-4
DC activated	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	4.41e-4
ILC	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-2	1.49e-2
ILC	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-3	3.10e-2
ILC	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-4	2.06e-2
ILC	Medication use	Medication use (adrenergics, inhalants)	ETC	Wu Y	2019	28,880	147,565	1.00e-5	1.39e-2
T CD8 MAIT	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	3.51e-7
T CD8 MAIT	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	2.98e-7
T CD8 MAIT	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	9.14e-8
T CD8 MAIT	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	2.77e-8
T CD8 MAIT	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.10e-6
NK CD160pos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	9.03e-3
NK CD160pos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	4.56e-3
NK CD160pos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	5.90e-3
NK CD160pos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	1.35e-2
T CD8 activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.09e-5
T CD8 activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	4.97e-5
T CD8 activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	3.24e-3
T CD8 activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	5.48e-4
T CD8 activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	3.31e-2
B naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.25e-6
B naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	2.28e-6
B naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	1.02e-4
B naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	3.33e-7
B naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.10e-6
NK FCGR3Apos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.09e-5
NK FCGR3Apos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	1.88e-3
NK FCGR3Apos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	2.91e-2
NK FCGR3Apos	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	1.35e-2
T CD4 fh	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.98e-3
T CD4 fh	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	6.92e-3
T CD4 fh	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	1.77e-2
T CD4 fh	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	2.98e-5
T CD4 fh	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	2.85e-3
T cell dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	1.43e-4
T cell dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	2.95e-3
B mature	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	9.50e-5
B mature	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	7.23e-4
B mature	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	4.46e-4
B mature	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	9.79e-8
B mature	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	2.88e-7
T CD8 CTL	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	1.70e-5
T CD8 CTL	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	8.20e-6
T CD8 CTL	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	4.46e-4
T CD8 CTL	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	5.48e-4
T CD8 CTL	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	6.90e-3
T CD4 reg	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	2.65e-5
T CD4 reg	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	1.52e-5
T CD4 reg	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	4.46e-4
T CD4 reg	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	8.24e-5
T CD4 reg	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	4.01e-4
T CD4 naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	2.65e-2
T CD4 naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	2.95e-3
T CD4 naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	3.01e-3
T CD4 naive	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	3.31e-2
T CD4 conv	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.28e-2
T CD4 conv	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	1.03e-2
T CD4 conv	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	4.64e-2
T CD4 conv	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	8.24e-5
T CD4 conv	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	4.01e-4
NK dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	6.62e-4
NK dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	4.56e-3
NK dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	2.91e-2
NK dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	1.35e-2
NK dividing	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.56e-2
B T doublet	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	1.58e-2
B T doublet	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	7.23e-4
B T doublet	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	9.02e-6
B T doublet	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	3.33e-7
B T doublet	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.37e-5
DC 2	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	9.50e-5
DC 2	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	1.51e-2
DC 2	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	5.90e-3
DC 2	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	6.56e-3
DC 2	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.10e-3
Macrophage	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	9.03e-3
Macrophage	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	1.77e-2
Macrophage	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	3.01e-3
Macrophage	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	4.01e-4
T CD8 gd	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	1.35e-3
T CD8 gd	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	4.56e-3
T CD8 gd	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	3.24e-3
T CD8 gd	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	6.56e-3
DC 1	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	6.74e-3
DC 1	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	5.90e-3
DC 1	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	5.48e-4
DC 1	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	4.46e-5
B Hypermutation	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	9.03e-3
Plasmablast	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	6.74e-3
DC activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	5.00e-2	4.58e-4
DC activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-2	2.77e-5
DC activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	8.92e-4
DC activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	2.18e-4
DC activated	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.37e-5
ILC	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-3	4.64e-2
ILC	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	1.35e-2
DC plasmacytoid	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-4	4.89e-2
DC plasmacytoid	Medication use	Medication use (glucocorticoids)	ETC	Wu Y	2019	17,352	188,348	1.00e-5	1.56e-2
T CD8 MAIT	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	8.97e-5
T CD8 MAIT	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	4.72e-3
T CD8 MAIT	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	1.51e-2
NK CD160pos	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.42e-4
NK CD160pos	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	4.48e-4
T CD8 activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.42e-4
T CD8 activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	8.39e-4
B naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	2.23e-4
B naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	2.33e-4
B naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	1.03e-4
B naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	1.54e-5
B naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	9.29e-5
NK FCGR3Apos	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	2.58e-6
NK FCGR3Apos	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	5.86e-5
NK FCGR3Apos	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
T CD4 fh	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.76e-3
T CD4 fh	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	2.73e-3
T CD4 fh	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
T CD4 fh	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	2.89e-2
T CD4 fh	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	2.58e-2
T cell dividing	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	2.57e-2
T cell dividing	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	4.91e-2
T cell dividing	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
B mature	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	4.44e-2
B mature	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	4.91e-2
B mature	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	9.21e-4
B mature	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	4.63e-4
B mature	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	7.48e-4
T CD8 CTL	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	8.97e-5
T CD8 CTL	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	1.18e-4
T CD8 CTL	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	2.51e-3
T CD8 CTL	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	8.39e-3
T CD4 reg	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	2.23e-4
T CD4 reg	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	1.53e-3
T CD4 conv	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.41e-2
T CD4 conv	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	2.09e-2
NK dividing	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.92e-2
B T doublet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.76e-3
B T doublet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	1.18e-4
B T doublet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	1.03e-4
B T doublet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	1.54e-5
B T doublet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	8.18e-7
DC 2	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	8.97e-5
DC 2	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	2.33e-4
DC 2	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	1.03e-4
DC 2	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	4.63e-4
DC 2	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	4.92e-3
Macrophage	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.41e-2
Macrophage	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	4.91e-2
Macrophage	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
Macrophage	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	2.11e-3
Macrophage	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	4.92e-3
T CD8 gd	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	7.98e-4
T CD8 gd	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	8.39e-4
T CD8 gd	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
T CD8 gd	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	2.89e-2
DC 1	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.76e-3
DC 1	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	1.53e-3
DC 1	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	2.42e-6
DC 1	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	3.26e-7
DC 1	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	9.54e-6
Platelet	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	1.03e-2
DC activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	5.00e-2	2.10e-5
DC activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	2.83e-5
DC activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.12e-5
DC activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-4	1.54e-5
DC activated	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-5	7.48e-4
T CD4 naive	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-2	1.31e-2
B Hypermutation	Medication use	Medication use (antihistamines for systemic use)	ETC	Wu Y	2019	13,984	137,652	1.00e-3	3.30e-2
NK CD160pos	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	3.11e-2
NK CD160pos	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-2	3.84e-3
B naive	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	1.27e-2
B naive	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-2	1.05e-2
NK FCGR3Apos	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	1.74e-2
NK FCGR3Apos	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-2	7.04e-4
NK FCGR3Apos	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-3	9.44e-4
B mature	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	3.11e-2
B T doublet	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	4.09e-2
B T doublet	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-2	2.59e-2
Macrophage	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	4.09e-2
Macrophage	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-4	7.94e-3
Macrophage	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	1.00e-5	3.89e-3
DC 1	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	4.09e-2
DC plasmacytoid	Medication use	Medication use (antiglaucoma preparations and miotics)	ETC	Wu Y	2019	5,215	95,653	5.00e-2	4.09e-2
T CD8 MAIT	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	5.60e-3
NK CD160pos	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	5.31e-4
NK CD160pos	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	9.06e-3
T CD8 activated	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	2.16e-3
T CD8 activated	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	1.90e-2
B naive	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	3.70e-2
B naive	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	2.69e-2
B naive	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	2.67e-2
B naive	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-5	1.13e-2
NK FCGR3Apos	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	1.01e-2
NK FCGR3Apos	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-4	1.18e-2
NK FCGR3Apos	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-5	3.12e-2
T cell dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	3.70e-2
T cell dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	1.32e-2
T cell dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	2.67e-2
T CD8 CTL	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	1.09e-3
T CD8 CTL	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	9.06e-3
T CD8 CTL	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	2.67e-2
T CD8 CTL	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-4	5.03e-3
NK dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	5.60e-3
NK dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	2.39e-4
NK dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	1.52e-3
NK dividing	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-4	2.59e-2
Macrophage	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	1.01e-2
Macrophage	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-5	1.13e-2
T CD8 gd	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	4.12e-3
DC 1	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	2.16e-3
Plasma IgG	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	3.70e-2
Plasma IgG	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	1.32e-2
CD34 progenitor	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	5.00e-2	5.60e-3
CD34 progenitor	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	3.74e-2
CD34 progenitor	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	2.67e-2
CD34 progenitor	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-4	2.59e-2
CD34 progenitor	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-5	3.68e-3
Plasma IgM	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	9.06e-3
Plasmablast	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-2	1.32e-2
B Hypermutation	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	9.36e-3
B Hypermutation	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-5	3.12e-2
Platelet	Varicose veins	Varicose veins	ETC	Shadrina AS	2019	10,861	397,594	1.00e-3	9.36e-3
T CD8 MAIT	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	1.11e-2
B naive	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	3.73e-2
B naive	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	4.79e-2
T cell dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	4.84e-3
T cell dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	9.26e-3
T cell dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	1.13e-3
B mature	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	1.02e-3
B mature	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	1.25e-2
NK dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	1.11e-2
NK dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	1.67e-2
NK dividing	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	1.10e-2
Macrophage	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	1.85e-2
Macrophage	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	1.25e-2
Macrophage	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	1.54e-2
Plasma IgM	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	4.63e-2
B Hypermutation	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	5.18e-4
B Hypermutation	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	3.52e-3
B Hypermutation	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	2.55e-3
Plasma IgG	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	1.85e-2
Plasmablast	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-3	2.67e-3
Plasmablast	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-4	2.21e-2
Plasmablast	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	5.45e-3
DC 1	Glomerular filtration rate	Estimated glomerular filtration rate	ETC	Wuttke M	2019	NA	567,460	1.00e-5	2.12e-2
NK FCGR3Apos	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	4.78e-2
T cell dividing	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	7.35e-3
T cell dividing	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	3.26e-2
NK dividing	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	5.61e-3
DC 2	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	3.14e-2
Macrophage	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	9.55e-3
Macrophage	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	4.27e-2
DC 1	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	3.89e-2
B Hypermutation	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	2.00e-2
Plasmablast	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	4.90e-4
Plasmablast	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	9.73e-3
Plasmablast	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-4	2.03e-2
Plasmablast	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-5	4.06e-2
CD34 progenitor	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	5.00e-2	9.45e-4
CD34 progenitor	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	3.26e-2
B naive	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	4.27e-2
T CD4 reg	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	1.34e-2
Plasma IgM	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	1.34e-2
Plasma IgM	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-4	6.77e-3
Plasma IgM	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-5	4.06e-2
Plasma IgG	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-2	1.83e-2
Plasma IgG	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-3	3.78e-2
Plasma IgG	Blood urea nitrogen levels	Blood urea nitrogen levels	ETC	Wuttke M	2019	NA	243,029	1.00e-4	2.03e-2
NK FCGR3Apos	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	1.69e-3
T cell dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	1.50e-6
T cell dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	1.20e-2
T cell dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	4.65e-2
T CD8 CTL	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	4.11e-2
Monocyte	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	2.87e-8
Monocyte	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	3.80e-3
NK dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	9.00e-6
NK dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	4.14e-4
NK dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	4.65e-2
NK dividing	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-5	3.60e-2
DC 2	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	5.61e-3
DC 2	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-5	3.60e-2
Macrophage	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	1.87e-9
Macrophage	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	1.54e-4
Macrophage	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	6.16e-3
T CD8 gd	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	3.30e-2
DC 1	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	3.14e-4
DC 1	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	4.65e-2
DC 1	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-5	1.44e-2
B Hypermutation	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	2.38e-6
B Hypermutation	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	2.38e-2
B Hypermutation	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	4.65e-2
Plasmablast	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	9.00e-6
Plasmablast	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	5.66e-3
Plasmablast	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-5	3.60e-2
DC activated	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	5.61e-3
CD34 progenitor	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	5.00e-2	2.10e-5
CD34 progenitor	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	2.38e-2
CD34 progenitor	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-3	1.07e-2
CD34 progenitor	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-5	1.44e-2
Plasma IgG	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	2.38e-2
Neutrophil	CKD	Chronic kidney disease	ETC	Wuttke M	2019	64,164	561,055	1.00e-2	3.28e-2
T CD8 MAIT	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	3.06e-4
T CD8 MAIT	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	1.74e-4
T CD8 MAIT	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	8.91e-7
T CD8 MAIT	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	3.13e-5
T CD8 MAIT	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	5.22e-4
T CD8 activated	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	3.06e-4
T CD8 activated	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	9.00e-3
T CD8 activated	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	2.39e-2
NK FCGR3Apos	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	8.20e-4
NK FCGR3Apos	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	1.25e-2
NK FCGR3Apos	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	6.29e-3
NK FCGR3Apos	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	1.09e-2
T CD4 fh	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	1.71e-2
T CD4 fh	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	3.07e-2
T CD4 fh	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	3.85e-3
T CD4 fh	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	3.29e-2
T CD4 fh	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	6.72e-3
T CD8 CTL	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	2.75e-3
T CD8 CTL	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	2.15e-3
T CD8 CTL	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	7.69e-4
T CD8 CTL	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	3.29e-2
T CD4 reg	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	8.17e-3
T CD4 reg	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	3.07e-2
T CD4 reg	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	6.29e-3
T CD8 gd	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	1.52e-3
T CD8 gd	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	4.23e-4
T CD8 gd	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	3.29e-2
Plasmablast	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	5.00e-2	1.34e-2
T CD4 naive	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	1.71e-2
T CD4 naive	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	6.29e-3
T CD4 naive	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	2.81e-2
Platelet	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-2	1.71e-2
Platelet	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	1.35e-3
Platelet	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	5.96e-3
Platelet	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	6.72e-3
DC 2	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	3.56e-2
DC 1	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-3	2.39e-2
DC 1	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-4	7.74e-4
DC 1	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	6.72e-3
T CD4 conv	Diverticular disease	Diverticular disease	ETC	Schafmayer C	2019	31,964	419,135	1.00e-5	2.81e-2
T CD8 activated	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	6.28e-4
T CD8 activated	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	1.00e-2	3.79e-2
NK FCGR3Apos	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	2.89e-2
T CD4 fh	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	2.89e-2
T CD8 CTL	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	1.40e-2
T CD4 conv	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	4.04e-2
T CD4 conv	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	1.00e-2	3.79e-2
Monocyte	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	1.40e-2
Monocyte	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	1.00e-2	3.79e-2
Macrophage	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	1.40e-2
T CD8 gd	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	5.00e-2	6.29e-3
T CD4 naive	Renal cell carcinoma	Renal cell carcinoma female	ETC	Laskar RS	2019	1,992	3,095	1.00e-3	3.97e-2
NK dividing	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	5.00e-2	2.74e-2
B T doublet	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	5.00e-2	2.74e-2
B T doublet	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	1.00e-2	2.94e-2
B T doublet	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	1.00e-3	3.94e-3
ILC	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	5.00e-2	6.24e-3
DC 1	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	5.00e-2	9.26e-3
DC 1	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	1.00e-2	4.71e-3
DC plasmacytoid	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	5.00e-2	4.13e-3
Plasma IgG	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	1.00e-3	3.73e-2
Platelet	Renal cell carcinoma	Renal cell carcinoma male	ETC	Laskar RS	2019	3,227	4,916	1.00e-3	3.73e-2
NK CD160pos	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.75e-3
T CD8 activated	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.73e-2
T CD8 activated	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	6.91e-3
NK FCGR3Apos	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.98e-2
NK FCGR3Apos	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.14e-2
T CD4 fh	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.98e-2
Monocyte	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.73e-2
NK dividing	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.92e-3
NK dividing	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.14e-2
DC 2	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.82e-2
Macrophage	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.32e-4
Macrophage	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.18e-3
T CD8 gd	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.83e-4
T CD8 gd	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.52e-2
DC plasmacytoid	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.77e-3
DC plasmacytoid	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	6.91e-3
T CD8 MAIT	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.14e-2
T CD8 CTL	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.14e-2
ILC	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	2.95e-3
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT2)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.14e-2
T CD8 MAIT	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	6.70e-3
T CD8 activated	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.55e-2
NK FCGR3Apos	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	8.96e-4
T CD4 fh	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.61e-2
T CD8 CTL	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.05e-2
T CD4 reg	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.18e-3
T CD4 naive	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.42e-2
T CD4 conv	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	6.70e-3
T CD4 conv	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.44e-2
NK dividing	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.55e-2
B T doublet	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.53e-3
B T doublet	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.44e-2
Platelet	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.55e-2
Monocyte	Periodontal disease	Periodontal disease related phenotype (PCT3)	ETC	Offenbacher S	2016	NA	975	1.00e-2	6.52e-3
B mature	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.15e-2
T CD4 conv	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.94e-2
Monocyte	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.21e-3
DC activated	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.29e-2
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.29e-2
DC 2	Periodontal disease	Periodontal disease related phenotype (PCT4)	ETC	Offenbacher S	2016	NA	975	1.00e-2	4.27e-2
NK CD160pos	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	5.00e-2	7.06e-4
NK CD160pos	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.84e-3
NK dividing	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.36e-3
NK dividing	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	4.52e-3
ILC	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.04e-3
ILC	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	4.55e-2
ILC	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-3	2.59e-2
DC activated	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	5.00e-2	2.00e-2
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	5.00e-2	8.55e-3
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.04e-2
B Hypermutation	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	4.55e-2
DC plasmacytoid	Periodontal disease	Periodontal disease related phenotype (PCT5)	ETC	Offenbacher S	2016	NA	975	1.00e-2	4.55e-2
T CD8 activated	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	3.16e-2
B naive	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.49e-2
B naive	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-3	3.23e-3
B mature	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	6.39e-3
B mature	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-3	1.89e-2
T CD4 reg	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	1.48e-2
T CD4 reg	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.66e-3
Monocyte	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.07e-3
Monocyte	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-2	3.81e-3
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.49e-2
CD34 progenitor	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-3	1.89e-2
Neutrophil	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	5.00e-2	4.49e-2
DC 1	Periodontal disease	Periodontal disease related phenotype (PCT6)	ETC	Offenbacher S	2016	NA	975	1.00e-2	1.71e-2
NK FCGR3Apos	Nonalcoholic Liver disease	Nonalcoholic fatty liver disease	ETC	Namjou B	2019	1,106	8,571	5.00e-2	4.76e-2
DC 2	Nonalcoholic Liver disease	Nonalcoholic fatty liver disease	ETC	Namjou B	2019	1,106	8,571	5.00e-2	3.22e-2
Monocyte	Nonalcoholic Liver disease	Nonalcoholic fatty liver disease	ETC	Namjou B	2019	1,106	8,571	1.00e-3	2.22e-2
DC 1	Nonalcoholic Liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	ETC	Namjou B	2019	NA	235	5.00e-2	1.94e-3
Platelet	Nonalcoholic Liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	ETC	Namjou B	2019	NA	235	5.00e-2	6.02e-4
DC activated	Nonalcoholic Liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	ETC	Namjou B	2019	NA	235	5.00e-2	2.34e-2
CD34 progenitor	Nonalcoholic Liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	ETC	Namjou B	2019	NA	235	5.00e-2	5.67e-3
Unknown	Nonalcoholic Liver disease	Liver fibrosis in non-alcoholic fatty acid liver disease	ETC	Namjou B	2019	NA	235	5.00e-2	3.57e-2
B mature	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	5.00e-2	8.45e-3
T CD4 conv	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	5.00e-2	3.77e-2
T CD8 MAIT	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	1.00e-2	3.34e-2
T CD4 fh	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	1.00e-2	3.34e-2
T CD8 CTL	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	1.00e-2	1.39e-2
T CD4 reg	Nonalcoholic Liver disease	Non-alcoholic fatty liver disease activity score	ETC	Namjou B	2019	NA	235	1.00e-2	1.39e-2
T CD8 MAIT	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	9.88e-4
T CD8 MAIT	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	1.00e-2	9.18e-3
T CD8 activated	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	4.42e-3
T CD8 activated	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	1.00e-2	9.18e-3
NK FCGR3Apos	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	3.55e-2
T cell dividing	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	5.76e-4
T cell dividing	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	1.00e-2	1.87e-2
T CD4 reg	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	3.55e-2
T CD8 gd	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	3.55e-2
DC activated	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	2.44e-2
CD34 progenitor	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	5.00e-2	6.99e-3
NK CD160pos	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	1.00e-2	1.87e-2
Plasma IgG	Autistic traits score	Autistic traits score (Social and Communication Disorders Checklist)	ETC	Massrali A	2019	NA	5,628	1.00e-3	4.80e-2
Monocyte	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	5.00e-2	4.05e-4
DC 2	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	5.00e-2	1.94e-2
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	5.00e-2	2.28e-4
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	1.00e-2	3.76e-2
DC activated	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	1.00e-2	3.76e-2
DC activated	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	2,010	5,145	1.00e-3	4.91e-2
T CD8 activated	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	5.00e-2	2.52e-2
T CD8 activated	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	2.49e-2
T cell dividing	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	5.00e-2	2.52e-2
T cell dividing	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-3	3.59e-2
T CD4 reg	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	5.00e-2	4.24e-4
T CD4 reg	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	3.36e-5
T CD8 MAIT	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	1.29e-2
NK FCGR3Apos	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	2.49e-2
NK FCGR3Apos	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-3	9.50e-3
T CD8 CTL	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	6.36e-3
T CD4 naive	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	1.33e-3
T CD4 conv	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	6.36e-3
CD34 progenitor	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-2	1.29e-2
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	7,834	15,258	1.00e-3	3.59e-2
NK FCGR3Apos	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	5.00e-2	2.57e-2
NK FCGR3Apos	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	4.53e-5
NK FCGR3Apos	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
T CD4 reg	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	5.00e-2	3.69e-2
T CD4 reg	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	4.83e-2
T CD4 reg	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
T CD4 naive	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	5.00e-2	7.63e-3
T CD4 conv	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	5.00e-2	3.69e-2
T CD4 conv	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	5.00e-2	4.89e-3
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	5.45e-3
DC plasmacytoid	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
T CD8 CTL	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	4.83e-2
DC 2	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	2.48e-2
DC 2	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
Macrophage	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	1.20e-2
CD34 progenitor	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-2	4.83e-2
CD34 progenitor	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	6.24e-3
Monocyte	Stress sensitivity	Stress sensitivity (neuroticism score x major depressive disorder status interaction)	ETC	Arnau-Soler A	2018	9,844	20,403	1.00e-3	2.59e-2
B naive	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	6.04e-3
B naive	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-3	8.16e-4
NK FCGR3Apos	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.83e-2
T cell dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.07e-2
T cell dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	4.20e-2
B mature	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	3.82e-2
B mature	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-3	6.86e-3
NK dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	5.90e-5
NK dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-3	2.84e-2
NK dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-4	9.19e-3
NK dividing	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	7.55e-3
DC 2	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.07e-2
DC 2	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	4.20e-2
DC 1	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.33e-4
B Hypermutation	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.72e-3
Platelet	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	4.79e-2
Platelet	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	2.47e-2
DC plasmacytoid	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	2.36e-2
Plasmablast	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.33e-4
Plasmablast	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-3	3.89e-2
Plasmablast	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	1.39e-2
CD34 progenitor	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-2	1.22e-3
CD34 progenitor	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-3	4.62e-3
CD34 progenitor	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-4	9.19e-3
CD34 progenitor	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	2.47e-2
Monocyte	Multisite chronic pain	Multisite chronic pain	ETC	Johnston KJA	2019	NA	387,649	1.00e-5	1.39e-2
T cell dividing	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	1.93e-2
T cell dividing	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-2	3.86e-2
Monocyte	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	2.01e-3
NK dividing	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	1.24e-4
NK dividing	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-2	2.61e-3
Macrophage	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	2.53e-5
Macrophage	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-4	5.36e-3
ILC	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	3.64e-2
ILC	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-2	3.86e-2
DC 1	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	4.54e-3
B Hypermutation	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	9.64e-3
B Hypermutation	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-2	3.86e-2
Platelet	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	2.67e-2
DC plasmacytoid	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	9.64e-3
Plasmablast	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	9.64e-3
Plasmablast	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	1.00e-2	1.45e-2
DC activated	Longevity	Longevity (age >90th survival percentile)	ETC	Deelen J	2019	11,262	25,483	5.00e-2	9.64e-3
B mature	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	2.52e-2
Monocyte	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	4.67e-2
DC 2	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	8.96e-3
ILC	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	3.46e-2
DC 1	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	1.81e-2
B Hypermutation	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	2.52e-2
DC activated	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	5.00e-2	7.49e-4
DC activated	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	1.00e-2	2.23e-2
NK CD160pos	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	1.00e-2	3.63e-2
Plasmablast	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	1.00e-2	3.63e-2
Macrophage	Longevity	Longevity (age >99th survival percentile)	ETC	Deelen J	2019	3,484	25,483	1.00e-4	1.56e-2
B naive	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-2	4.56e-2
B naive	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-3	1.95e-2
T cell dividing	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-2	2.90e-2
NK dividing	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-2	1.78e-2
NK dividing	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-3	2.68e-2
DC plasmacytoid	Urinary sodium excretion	Urinary sodium excretion	ETC	Pazoki R	2019	NA	446,237	1.00e-2	2.90e-2
B naive	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	2.98e-3
B naive	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	4.29e-4
B naive	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-3	3.67e-5
B naive	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	3.01e-4
B naive	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-5	1.90e-3
NK FCGR3Apos	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	1.25e-3
T cell dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	6.68e-3
T cell dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	4.28e-3
T cell dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-3	2.64e-2
T cell dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	4.88e-2
T cell dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-5	4.60e-2
B mature	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	3.40e-2
B mature	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	4.75e-2
B mature	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	4.88e-2
T CD8 CTL	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	1.77e-2
T CD8 CTL	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	4.75e-2
NK dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	1.10e-2
NK dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	1.15e-2
NK dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	1.18e-2
NK dividing	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-5	8.82e-4
Macrophage	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	2.21e-2
Macrophage	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	3.66e-2
Macrophage	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-3	3.81e-2
Macrophage	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	4.88e-2
ILC	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	4.16e-2
ILC	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	4.88e-2
DC 1	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	2.91e-5
DC 1	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	3.66e-2
DC plasmacytoid	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	1.26e-4
DC plasmacytoid	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-2	2.10e-2
DC plasmacytoid	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-3	3.81e-2
Plasmablast	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	1.10e-2
CD34 progenitor	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	5.00e-2	4.88e-4
B Hypermutation	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-4	1.95e-2
B Hypermutation	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-5	2.65e-2
Neutrophil	Urinary potassium excretion	Urinary potassium excretion	ETC	Pazoki R	2019	NA	446,230	1.00e-5	4.60e-2
B naive	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	5.00e-2	7.76e-3
B naive	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	1.38e-2
B naive	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-3	2.70e-3
B naive	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-4	2.22e-2
B mature	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	5.00e-2	4.60e-2
DC 1	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	5.00e-2	6.20e-5
DC 1	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	7.30e-5
DC 1	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-3	7.56e-4
DC 1	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-4	2.22e-2
Plasma IgG	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	5.00e-2	1.15e-2
Plasma IgG	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	1.38e-2
T cell dividing	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	4.26e-2
Monocyte	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	4.26e-2
DC 2	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	7.34e-3
DC 2	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-3	2.51e-2
Macrophage	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	2.47e-2
DC activated	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-2	1.38e-2
DC activated	same-sex sexual behaviour	same-sex sexual behaviour Male	ETC	Ganna A	2019	NA	188,825	1.00e-3	8.71e-3
NK FCGR3Apos	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	5.00e-2	1.79e-2
B mature	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	5.00e-2	5.77e-3
B mature	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	1.00e-2	3.44e-2
B mature	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	1.00e-4	4.37e-2
B Hypermutation	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	5.00e-2	4.77e-2
T CD8 MAIT	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	1.00e-2	3.44e-2
T CD8 MAIT	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	1.00e-3	2.32e-2
B naive	same-sex sexual behaviour	same-sex sexual behaviour Female	ETC	Ganna A	2019	NA	220,170	1.00e-4	4.37e-2
T CD8 MAIT	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	5.00e-2	1.70e-2
T CD8 MAIT	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	2.66e-2
T CD4 reg	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	5.00e-2	3.23e-2
NK dividing	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	5.00e-2	2.82e-4
NK dividing	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	1.22e-5
NK CD160pos	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	4.35e-2
B naive	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	4.35e-2
B naive	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-3	2.79e-2
NK FCGR3Apos	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	2.60e-3
DC 1	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	8.93e-3
DC 1	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-3	3.31e-4
Plasmablast	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	4.90e-3
DC activated	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-2	4.35e-2
DC activated	same-sex sexual behaviour	same-sex sexual behaviour	ETC	Ganna A	2019	NA	408,995	1.00e-3	1.06e-2
T CD8 MAIT	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	5.00e-2	3.93e-3
T CD8 MAIT	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	3.66e-3
T CD8 MAIT	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-3	2.54e-2
B mature	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	5.00e-2	3.08e-2
B mature	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	1.81e-2
B mature	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-3	2.54e-2
Neutrophil	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	5.00e-2	1.17e-2
T CD8 activated	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	4.52e-2
T CD4 conv	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	1.81e-2
B T doublet	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	4.52e-2
B T doublet	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-3	1.11e-2
Macrophage	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-2	2.91e-2
T CD4 reg	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-3	1.11e-2
T CD8 gd	Knee pain	Knee pain	ETC	Meng W	2019	22,204	149,312	1.00e-4	2.11e-2
NK CD160pos	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.48e-3
NK FCGR3Apos	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.98e-2
T cell dividing	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	6.62e-3
T cell dividing	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	3.55e-2
NK dividing	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.48e-3
ILC	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	9.63e-3
Plasma IgM	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.98e-2
Plasma IgM	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	3.55e-2
Plasma IgM	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	1.87e-3
B Hypermutation	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.48e-3
Platelet	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.98e-2
Plasmablast	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	6.62e-3
Plasma IgG	Occipital lobe volume	Occipital lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	5.32e-3
NK CD160pos	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.73e-3
NK CD160pos	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.42e-2
T cell dividing	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.33e-2
T CD4 reg	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.33e-2
NK dividing	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.73e-3
NK dividing	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.42e-2
NK dividing	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	1.24e-2
ILC	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	8.41e-5
DC 1	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.53e-2
Plasma IgM	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	1.20e-2
Plasma IgM	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	4.34e-3
Plasma IgM	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	1.13e-4
Plasma IgM	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	2.58e-2
Platelet	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.53e-2
Platelet	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	4.00e-2
DC plasmacytoid	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	8.25e-3
Plasmablast	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.53e-2
CD34 progenitor	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.33e-2
Plasma IgG	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	4.00e-2
Plasma IgG	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	4.17e-4
Plasma IgG	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	2.58e-2
T CD4 naive	Parietal lobe volume	Parietal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	2.58e-2
NK FCGR3Apos	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.96e-2
T cell dividing	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.96e-2
NK dividing	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.96e-2
DC 2	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	2.11e-2
DC 1	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	7.33e-3
DC 1	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	2.22e-2
B Hypermutation	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.36e-3
B Hypermutation	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	4.01e-3
Plasmablast	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	1.06e-2
Plasmablast	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.29e-2
DC activated	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	2.11e-2
DC activated	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	3.88e-3
NK CD160pos	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	3.83e-2
Plasma IgM	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	7.28e-3
Plasma IgG	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.00e-3
B T doublet	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	1.97e-2
Platelet	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	4.93e-2
Platelet	Temporal lobe volume	Temporal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-4	2.22e-2
B naive	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	1.64e-2
B mature	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	4.29e-4
NK dividing	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	1.65e-3
NK dividing	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.32e-2
B Hypermutation	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	8.08e-3
Plasmablast	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	5.00e-2	3.76e-3
Plasmablast	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-3	2.60e-2
Platelet	Frontal lobe volume	Frontal lobe volume	ETC	van der Lee SJ	2019	NA	15,269	1.00e-2	2.32e-2
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-2	4.78e-3
T CD4 reg	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-2	1.41e-2
DC 1	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-2	4.51e-2
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-2	4.78e-3
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-5	3.33e-2
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-3	3.31e-2
T CD4 fh	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-4	4.41e-2
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-4	4.41e-2
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Female	ETC	Karlsson T	2019	NA	161,168	1.00e-5	2.14e-2
NK CD160pos	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	1.20e-2
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	1.67e-3
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-3	4.45e-2
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-5	4.66e-2
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	8.84e-4
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-3	5.45e-3
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-4	9.59e-3
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-5	2.12e-2
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	4.08e-3
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-3	5.45e-3
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-4	1.74e-3
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-5	8.76e-3
DC 1	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	3.10e-2
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	5.41e-3
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-3	7.62e-3
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-4	1.74e-3
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-5	1.38e-2
Platelet	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	1.20e-2
Plasmablast	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	4.08e-3
Plasmablast	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-3	1.26e-3
Plasmablast	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-4	1.74e-3
Plasmablast	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-5	1.13e-3
DC activated	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	4.76e-2
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-2	2.25e-4
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Male	ETC	Karlsson T	2019	NA	163,984	1.00e-4	2.03e-2
NK CD160pos	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	2.13e-2
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	4.56e-4
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	5.33e-3
NK FCGR3Apos	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	1.13e-2
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	8.62e-4
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	1.67e-2
T cell dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	8.15e-3
T CD4 reg	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	1.34e-2
T CD4 naive	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	4.91e-2
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	1.17e-3
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	3.56e-2
NK dividing	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	2.08e-2
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	2.13e-2
B Hypermutation	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	3.66e-2
Plasmablast	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	3.73e-3
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-3	4.89e-3
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	4.50e-2
CD34 progenitor	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	1.13e-2
T CD8 MAIT	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	4.50e-2
T CD8 MAIT	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-5	2.78e-2
T CD4 fh	Visceral adipose tissue	Predicted visceral adipose tissue Both	ETC	Karlsson T	2019	NA	325,153	1.00e-4	4.50e-2
T CD4 reg	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	5.00e-2	7.25e-3
DC 2	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	5.00e-2	2.59e-2
DC 1	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	5.00e-2	3.44e-2
B Hypermutation	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	5.00e-2	1.92e-2
B Hypermutation	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-2	9.34e-3
B Hypermutation	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-3	6.80e-3
DC activated	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	5.00e-2	4.53e-2
T CD4 fh	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-2	3.57e-2
Platelet	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-2	3.36e-3
Monocyte	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-3	3.47e-2
Monocyte	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-4	4.81e-2
Plasmablast	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-3	3.47e-2
T CD8 gd	Birth	Gestational age at birth (child effect)	ETC	Liu X	2019	NA	84,689	1.00e-4	1.59e-2
T CD8 MAIT	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	1.49e-2
NK CD160pos	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	1.49e-2
NK FCGR3Apos	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	2.13e-2
T cell dividing	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	4.56e-3
T cell dividing	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	1.00e-2	1.20e-2
T CD4 reg	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	2.13e-2
Monocyte	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	1.49e-2
B Hypermutation	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	5.00e-2	1.91e-3
B Hypermutation	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	1.00e-2	6.19e-3
B Hypermutation	Birth	Post-term birth	ETC	Liu X	2019	7,888	60,148	1.00e-3	2.90e-2
T CD8 MAIT	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	1.56e-2
T CD8 activated	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	1.03e-2
NK FCGR3Apos	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	4.80e-2
T CD4 fh	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	9.52e-4
T CD8 CTL	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	1.03e-2
T CD4 reg	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	4.22e-3
T CD4 naive	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	4.22e-3
T CD4 conv	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	5.00e-2	9.52e-4
Platelet	Birth	Early spontaneous preterm birth	ETC	Liu X	2019	1,139	60,148	1.00e-2	1.14e-2
T CD8 activated	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	2.51e-2
Monocyte	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	1.14e-2
DC 2	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	4.76e-3
Plasma IgM	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	3.62e-2
DC activated	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	1.71e-2
DC activated	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	1.00e-2	4.21e-2
Neutrophil	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	5.00e-2	6.71e-5
Neutrophil	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	1.00e-2	2.23e-2
NK dividing	Birth	Spontaneous preterm birth (preterm birth)	ETC	Liu X	2019	4,775	60,148	1.00e-2	4.21e-2
T CD8 activated	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	3.99e-2
NK FCGR3Apos	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	2.02e-2
NK FCGR3Apos	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	2.19e-2
T CD4 fh	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	9.45e-3
T cell dividing	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	1.50e-4
T cell dividing	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	7.61e-5
T cell dividing	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-4	9.57e-3
T CD4 reg	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	1.58e-2
T CD4 reg	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-4	2.15e-2
T CD4 naive	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	3.06e-3
T CD4 naive	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	2.19e-2
NK dividing	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	1.66e-3
NK dividing	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	1.60e-2
B Hypermutation	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	1.58e-2
B Hypermutation	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	1.79e-3
B Hypermutation	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-4	2.15e-2
Plasmablast	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	3.99e-2
CD34 progenitor	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-2	2.55e-2
CD34 progenitor	Alcohol consumption	Alcohol consumption	ETC	Evangelou E	2019	NA	480,842	1.00e-3	3.97e-2
B naive	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.83e-4
B naive	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	1.07e-2
B naive	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-3	2.71e-2
T cell dividing	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.56e-2
B mature	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	2.54e-4
B mature	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	1.07e-2
T CD8 CTL	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	3.76e-2
T CD4 reg	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.56e-2
Monocyte	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.81e-3
Monocyte	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	7.94e-3
NK dividing	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.56e-2
DC 2	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	7.97e-3
DC 2	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	4.11e-2
Macrophage	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	6.72e-6
Macrophage	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	3.03e-3
DC 1	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	9.96e-6
DC 1	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	7.25e-4
B Hypermutation	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	6.60e-4
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	1.20e-3
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	1.47e-4
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-3	2.20e-4
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-4	5.89e-4
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-5	1.41e-2
Plasmablast	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	4.50e-5
Plasmablast	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	7.94e-3
DC activated	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	1.62e-2
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	5.00e-2	6.44e-5
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-2	5.82e-3
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-3	1.32e-2
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-4	1.53e-2
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-5	1.41e-2
Plasma IgM	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-5	4.07e-2
Plasma IgG	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Teumer A	2019	NA	547,361	1.00e-5	2.44e-2
T CD8 MAIT	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	6.96e-8
T CD8 MAIT	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	5.65e-11
T CD8 MAIT	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	3.95e-12
T CD8 MAIT	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	3.54e-13
T CD8 activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	8.85e-5
T CD8 activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.68e-7
T CD8 activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	1.37e-8
T CD8 activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	2.37e-7
B naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.74e-3
B naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.73e-3
B naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	9.54e-3
B naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	2.79e-4
NK FCGR3Apos	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	6.96e-8
NK FCGR3Apos	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	3.66e-5
NK FCGR3Apos	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	8.32e-5
NK FCGR3Apos	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	3.34e-3
T CD4 fh	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	6.10e-4
T CD4 fh	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.05e-4
T CD4 fh	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	2.74e-4
T CD4 fh	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	1.87e-3
T cell dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.33e-4
T cell dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.21e-2
T cell dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	9.54e-3
B mature	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	4.22e-4
B mature	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	2.63e-3
B mature	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	9.54e-3
B mature	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	5.40e-4
T CD8 CTL	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.02e-5
T CD8 CTL	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	4.39e-8
T CD8 CTL	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	3.11e-8
T CD8 CTL	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	1.54e-5
T CD4 reg	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	7.86e-12
T CD4 reg	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.63e-13
T CD4 reg	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	4.30e-10
T CD4 reg	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	3.80e-8
T CD4 naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	8.27e-3
T CD4 naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	2.82e-4
T CD4 naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	4.84e-4
T CD4 naive	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	5.80e-3
T CD4 conv	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	8.27e-3
T CD4 conv	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	3.82e-6
T CD4 conv	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	1.47e-6
T CD4 conv	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	1.54e-5
NK dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.33e-4
NK dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.73e-3
NK dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	3.83e-3
NK dividing	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	5.80e-3
B T doublet	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	3.10e-2
B T doublet	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	1.73e-4
B T doublet	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	1.53e-4
B T doublet	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	2.79e-4
DC 2	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.10e-2
DC 2	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	1.61e-2
Macrophage	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	4.93e-2
T CD8 gd	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	8.27e-3
T CD8 gd	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	2.63e-3
T CD8 gd	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	8.37e-4
T CD8 gd	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	1.87e-3
B Hypermutation	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	1.10e-2
Plasmablast	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	8.27e-3
DC activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-2	2.49e-5
DC activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	4.54e-4
DC activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	1.20e-5
DC activated	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	3.11e-6
ILC	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-3	5.80e-3
ILC	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-4	3.83e-3
ILC	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	5.40e-4
DC 1	Asthma	Asthma	ETC	Zhu Z	2019	46,802	347,481	1.00e-5	2.57e-2
T CD8 MAIT	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	4.84e-9
T CD8 MAIT	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.77e-10
T CD8 MAIT	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.16e-9
T CD8 MAIT	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	3.26e-8
T CD8 MAIT	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	3.67e-4
T CD8 activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	2.29e-5
T CD8 activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.13e-5
T CD8 activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	3.15e-4
T CD8 activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.77e-4
T CD8 activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.49e-2
B naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	3.16e-4
B naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	8.48e-4
B naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	6.94e-3
B naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	2.56e-3
B naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	3.67e-4
NK FCGR3Apos	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.55e-4
NK FCGR3Apos	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.13e-5
NK FCGR3Apos	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	9.55e-5
NK FCGR3Apos	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.37e-3
NK FCGR3Apos	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.49e-2
T CD4 fh	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.55e-4
T CD4 fh	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.13e-5
T CD4 fh	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	9.58e-4
T CD4 fh	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.37e-3
T CD4 fh	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.84e-3
T cell dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.01e-5
T cell dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.54e-6
T cell dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	2.69e-3
T cell dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	2.30e-2
B mature	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	2.23e-4
B mature	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	3.52e-5
B mature	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.62e-3
B mature	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	3.60e-4
B mature	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	8.39e-4
T CD8 CTL	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	5.05e-5
T CD8 CTL	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	8.19e-7
T CD8 CTL	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	5.10e-5
T CD8 CTL	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.77e-4
T CD8 CTL	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	7.78e-3
T CD4 reg	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.08e-4
T CD4 reg	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	3.97e-8
T CD4 reg	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.38e-5
T CD4 reg	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.77e-4
T CD4 reg	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	7.78e-3
T CD4 naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	8.97e-3
T CD4 naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.48e-4
T CD4 naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.08e-2
T CD4 naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	8.16e-3
T CD4 naive	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	2.74e-2
T CD4 conv	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.08e-4
T CD4 conv	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	5.75e-5
T CD4 conv	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.08e-2
T CD4 conv	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.37e-3
T CD4 conv	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	7.78e-3
Monocyte	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	7.40e-5
Monocyte	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	5.58e-4
Monocyte	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.65e-2
Monocyte	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	3.67e-2
NK dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	2.97e-3
NK dividing	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.27e-3
DC 2	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	5.05e-5
DC 2	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	9.28e-5
DC 2	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.08e-2
DC 2	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	1.37e-3
DC 2	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	2.74e-2
Macrophage	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.55e-4
Macrophage	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	8.48e-4
ILC	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	4.57e-2
ILC	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.80e-2
ILC	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	3.67e-2
ILC	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.49e-2
T CD8 gd	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.49e-2
T CD8 gd	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.89e-3
T CD8 gd	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	4.37e-3
T CD8 gd	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	8.16e-3
DC 1	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	1.08e-4
DC 1	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	8.19e-7
DC 1	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	1.08e-2
DC 1	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	8.16e-3
DC 1	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	2.74e-2
B Hypermutation	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	2.39e-2
DC plasmacytoid	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	8.97e-3
DC plasmacytoid	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	2.76e-3
Plasmablast	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	6.88e-3
Plasmablast	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.12e-2
DC activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	5.00e-2	3.16e-4
DC activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	3.63e-4
DC activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-3	6.94e-3
DC activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-4	2.56e-3
DC activated	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.49e-2
B T doublet	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-2	1.12e-2
B T doublet	Asthma	Asthma (childhood onset)	ETC	Zhu Z	2019	9,676	347,481	1.00e-5	1.49e-2
T CD8 MAIT	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	7.26e-6
T CD8 MAIT	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	8.69e-6
T CD8 MAIT	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	7.44e-5
T CD8 MAIT	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	1.63e-5
T CD8 MAIT	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	2.51e-3
T CD8 activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.43e-4
T CD8 activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	4.70e-4
T CD8 activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	5.31e-3
T CD8 activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	5.77e-3
B naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.24e-3
B naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	3.31e-2
B naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	9.61e-3
B naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.60e-2
B naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	2.51e-3
NK FCGR3Apos	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.29e-4
NK FCGR3Apos	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	1.11e-2
NK FCGR3Apos	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	1.68e-2
NK FCGR3Apos	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.60e-2
T cell dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.93e-3
T cell dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	1.26e-3
B mature	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.91e-5
B mature	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	4.91e-3
T CD8 CTL	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.93e-3
T CD8 CTL	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	7.77e-4
T CD8 CTL	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	3.51e-4
T CD8 CTL	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.49e-3
T CD4 reg	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	4.54e-5
T CD4 reg	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	2.79e-4
T CD4 reg	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	2.83e-3
T CD4 reg	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.49e-3
T CD4 conv	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.46e-2
T CD4 conv	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	3.31e-2
Monocyte	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	1.44e-2
Monocyte	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	4.91e-3
NK dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.24e-3
NK dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	1.26e-3
NK dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	1.46e-3
NK dividing	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.49e-3
B T doublet	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.93e-3
B T doublet	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	3.31e-2
B T doublet	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	7.66e-3
DC 2	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	2.46e-2
DC 2	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	2.60e-2
DC 2	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	7.66e-3
Macrophage	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.93e-3
Macrophage	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	7.66e-3
ILC	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	5.93e-3
ILC	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	2.34e-2
T CD8 gd	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	1.08e-2
DC 1	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	1.44e-2
DC 1	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	4.70e-4
DC 1	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	4.60e-2
DC 1	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-5	7.66e-3
DC plasmacytoid	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	1.89e-2
DC plasmacytoid	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	3.31e-2
DC activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	5.00e-2	4.33e-3
DC activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	7.77e-4
DC activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-3	3.51e-4
DC activated	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-4	5.77e-3
T CD4 naive	Asthma	Asthma (adult onset)	ETC	Zhu Z	2019	22,296	347,481	1.00e-2	4.59e-2
T cell dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	4.38e-7
T cell dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	3.26e-4
T cell dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	1.16e-2
T cell dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-5	3.04e-2
NK dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	1.27e-8
NK dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	5.03e-8
NK dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	2.66e-6
NK dividing	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-5	8.83e-4
DC 1	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	4.10e-2
Plasma IgM	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	5.26e-5
Plasma IgM	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	3.35e-3
Plasma IgM	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	1.66e-2
B Hypermutation	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	4.34e-6
B Hypermutation	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	3.26e-4
B Hypermutation	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	5.44e-3
Plasma IgG	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	1.13e-4
Plasma IgG	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	2.34e-3
Plasma IgG	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	1.66e-2
DC plasmacytoid	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	7.57e-3
Plasmablast	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-2	2.79e-6
Plasmablast	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-3	7.74e-6
Plasmablast	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-4	3.85e-4
Plasmablast	Urate	Urate levels	ETC	Tin A	2019	NA	288,649	1.00e-5	9.34e-3
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	3.61e-6
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	1.65e-4
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	2.15e-3
NK CD160pos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	3.81e-3
NK CD160pos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	4.35e-2
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.89e-3
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	2.72e-2
T cell dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.71e-2
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	1.20e-3
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	2.43e-4
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	3.01e-4
T CD4 reg	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.71e-2
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	3.34e-4
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	2.72e-2
DC 2	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	1.74e-2
DC 2	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	4.66e-2
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	8.41e-3
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	7.12e-3
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	4.36e-3
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.89e-3
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	5.29e-3
Plasma IgM	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	1.08e-2
Plasma IgM	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	4.66e-2
B Hypermutation	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	1.74e-2
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.17e-3
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	1.64e-2
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	2.09e-2
DC plasmacytoid	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	3.35e-2
DC plasmacytoid	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	4.66e-2
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	2.18e-2
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-3	1.74e-2
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	1.48e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	1.96e-4
Platelet	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-4	3.46e-2
Platelet	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	379,501	1.00e-5	8.45e-3
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.83e-5
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	2.52e-4
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	1.93e-4
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	2.44e-3
NK CD160pos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	3.09e-2
T cell dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.78e-3
T cell dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	2.44e-2
T cell dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	4.46e-2
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	9.47e-3
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	3.20e-2
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	2.80e-2
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	1.49e-3
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	9.13e-7
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	4.22e-5
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	6.83e-5
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	1.69e-4
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.77e-4
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	1.42e-2
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	1.45e-2
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.22e-2
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	3.92e-3
Plasma IgM	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.22e-2
Plasma IgM	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	3.20e-2
Plasma IgM	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	4.46e-2
B Hypermutation	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	2.39e-3
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	3.09e-2
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	4.15e-2
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	3.13e-2
Platelet	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	1.97e-2
Platelet	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	4.15e-2
Platelet	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	4.46e-2
DC plasmacytoid	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	9.47e-3
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	8.05e-6
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	2.52e-4
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	9.93e-3
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	9.57e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-2	2.39e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	1.26e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	1.30e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	2.44e-3
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-3	4.15e-2
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	1.42e-2
ILC	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-4	3.83e-2
B naive	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	315,284	1.00e-5	3.13e-2
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	6.47e-4
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	1.99e-3
B naive	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	6.66e-3
T CD4 fh	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	3.45e-2
T cell dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	1.11e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	1.21e-3
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	5.03e-4
T CD4 reg	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	2.79e-2
NK dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	8.61e-3
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	6.66e-3
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	3.29e-2
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	2.24e-2
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	2.02e-2
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-4	1.21e-3
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	1.10e-4
DC 2	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	697,734	1.00e-5	3.29e-2
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	4.91e-3
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	1.93e-2
T CD4 fh	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	1.09e-2
T CD4 fh	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	2.52e-2
T cell dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	3.51e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	3.51e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	4.39e-3
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-5	1.52e-3
T CD4 reg	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	2.82e-2
DC 2	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	8.41e-3
DC 2	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	6.03e-3
DC 2	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-5	9.20e-3
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	2.77e-3
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	4.39e-3
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-5	9.20e-3
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	4.33e-2
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	3.26e-2
Plasma IgG	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	3.51e-2
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-3	1.52e-3
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-4	7.72e-4
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	381,152	1.00e-5	2.23e-3
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	4.04e-4
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	4.56e-4
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	1.01e-2
T CD8 MAIT	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-5	4.02e-2
NK FCGR3Apos	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	1.44e-3
NK FCGR3Apos	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	2.98e-3
T cell dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	9.94e-3
T cell dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	1.48e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	1.61e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	4.37e-2
B mature	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	1.46e-2
T CD8 CTL	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	7.72e-3
NK dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	1.94e-3
NK dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	4.56e-4
NK dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	2.07e-2
NK dividing	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-5	2.77e-2
Macrophage	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	4.54e-3
ILC	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	4.76e-2
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	1.94e-3
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	2.98e-3
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	1.01e-2
DC 1	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-5	2.77e-2
B Hypermutation	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	2.54e-2
Plasmablast	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	1.27e-2
Plasmablast	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	4.56e-4
Plasmablast	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	2.88e-2
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-2	9.94e-3
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	2.60e-2
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	1.01e-2
CD34 progenitor	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-5	1.23e-2
B naive	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	2.60e-2
B naive	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	1.01e-2
DC plasmacytoid	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-3	2.60e-2
DC plasmacytoid	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-4	2.88e-2
DC plasmacytoid	Waist to hip ratio	Waist-hip ratio	ETC	Pulit SL	2019	NA	316,772	1.00e-5	4.02e-2
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	1.42e-7
T CD8 MAIT	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	5.00e-6
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	4.05e-3
NK FCGR3Apos	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	4.70e-2
T CD4 fh	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	3.63e-2
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	4.79e-4
B mature	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	1.79e-3
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	8.31e-5
NK dividing	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	2.47e-3
DC 2	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	2.35e-2
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	1.25e-3
Macrophage	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	3.38e-3
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	9.01e-3
DC 1	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	2.34e-2
B Hypermutation	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	2.35e-2
B Hypermutation	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	4.70e-2
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	9.01e-3
Plasma IgG	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	2.34e-2
DC plasmacytoid	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	1.48e-2
DC plasmacytoid	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	2.47e-3
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	2.29e-3
Plasmablast	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	1.29e-3
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-4	4.79e-4
CD34 progenitor	Waist to hip ratio	Waist-to-hip ratio adjusted for BMI	ETC	Pulit SL	2019	NA	694,649	1.00e-5	9.17e-4
T CD8 MAIT	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	6.52e-3
T CD8 MAIT	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	3.60e-2
NK FCGR3Apos	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	6.52e-3
NK FCGR3Apos	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	1.66e-2
NK FCGR3Apos	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-5	1.51e-2
T CD4 fh	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	8.47e-3
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	5.12e-5
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	1.93e-3
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-5	1.10e-2
B mature	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	3.47e-2
B mature	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-5	3.65e-2
NK dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	6.09e-4
NK dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	4.56e-2
NK dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-5	2.75e-2
B Hypermutation	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	2.23e-2
Plasmablast	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	1.15e-3
Plasmablast	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	1.26e-2
Plasmablast	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-5	3.65e-2
CD34 progenitor	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-3	4.98e-3
CD34 progenitor	BMI	Body mass index	ETC	Pulit SL	2019	NA	374,756	1.00e-4	2.17e-2
T CD8 MAIT	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	1.52e-3
T CD8 MAIT	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.84e-2
T CD8 MAIT	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
T CD8 activated	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	2.35e-2
T CD4 fh	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	6.58e-3
T CD4 fh	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.84e-2
B mature	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	4.12e-3
B mature	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
T CD8 CTL	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
T CD8 CTL	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	3.81e-2
T CD8 CTL	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
T CD4 reg	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	1.57e-2
T CD4 reg	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	5.96e-5
T CD4 conv	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	1.57e-2
Monocyte	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	1.03e-2
DC 2	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
DC 2	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.84e-2
DC 2	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
Macrophage	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	1.03e-2
Macrophage	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.38e-3
Macrophage	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
T CD8 gd	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
DC 1	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	8.81e-5
DC 1	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.80e-4
DC 1	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	6.51e-6
Plasma IgM	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	2.35e-2
B Hypermutation	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
Plasma IgG	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
Platelet	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	4.93e-2
DC plasmacytoid	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	6.58e-3
Plasmablast	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	2.35e-2
DC activated	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	2.53e-3
DC activated	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	1.87e-5
DC activated	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	5.77e-4
CD34 progenitor	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	5.00e-2	3.44e-2
B naive	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	3.81e-2
B naive	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	4.01e-3
B T doublet	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-2	3.81e-2
B T doublet	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	4.01e-3
NK CD160pos	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
NK FCGR3Apos	Joint damage	Joint damage in rheumatoid arthritis	ETC	Traylor M	2019	NA	2,527	1.00e-3	2.22e-2
NK FCGR3Apos	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	3.42e-2
NK FCGR3Apos	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	1.32e-2
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	3.42e-2
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	7.15e-3
T cell dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	2.32e-2
B mature	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	1.42e-3
B mature	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	1.23e-2
B mature	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	2.63e-3
T CD4 reg	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	1.46e-2
T CD4 reg	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	3.92e-2
NK dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	2.26e-2
NK dividing	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	2.60e-2
DC 1	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	7.14e-3
DC 1	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	2.05e-2
Platelet	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	2.79e-2
CD34 progenitor	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-3	1.46e-2
CD34 progenitor	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	2.60e-2
CD34 progenitor	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	3.71e-3
B Hypermutation	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	4.11e-2
Plasmablast	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-4	1.59e-2
Plasmablast	BMI	Body mass index	ETC	Pulit SL	2019	NA	434,794	1.00e-5	2.32e-2
DC 2	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	5.00e-2	4.75e-2
Macrophage	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	5.00e-2	1.16e-2
Macrophage	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	1.00e-4	4.37e-2
DC 1	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	5.00e-2	4.75e-2
DC plasmacytoid	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	5.00e-2	7.81e-3
Monocyte	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	1.00e-2	3.36e-2
DC activated	AD	Alzheimer's disease	ETC	Moreno-Grau S	2019	4,120	3,289	1.00e-4	1.85e-3
T CD8 MAIT	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	3.35e-2
T CD8 MAIT	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.85e-3
T CD8 activated	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	1.77e-2
T CD8 activated	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-4	3.58e-2
T CD8 activated	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.00e-2
NK FCGR3Apos	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	7.84e-4
NK FCGR3Apos	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-2	7.60e-3
NK FCGR3Apos	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.00e-2
T CD8 CTL	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	4.19e-3
T CD8 CTL	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-2	1.31e-2
T CD8 CTL	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.00e-2
NK dividing	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	2.81e-3
NK dividing	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-2	2.31e-3
NK dividing	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-3	3.09e-5
NK dividing	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-4	4.47e-3
Macrophage	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	7.84e-4
Macrophage	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-2	7.60e-3
Plasma IgM	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	1.26e-2
B Hypermutation	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	2.46e-2
B Hypermutation	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-3	1.10e-2
Plasma IgG	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	4.19e-3
Plasmablast	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	5.00e-2	1.86e-3
Plasmablast	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-3	1.10e-2
DC 2	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-2	3.55e-2
T cell dividing	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-3	4.75e-2
B mature	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-3	2.37e-2
T CD4 reg	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-4	3.58e-2
T CD4 reg	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	4.37e-2
DC activated	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-4	1.34e-2
DC activated	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.00e-2
Neutrophil	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-4	3.58e-2
Neutrophil	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	4.37e-2
NK CD160pos	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	1.00e-2
T CD8 gd	Body fat percentage	Body fat percentage variance	ETC	Wang H	2019	NA	341,632	1.00e-5	4.37e-2
T CD8 MAIT	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	2.47e-2
T CD8 MAIT	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-3	1.87e-2
T CD8 MAIT	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-4	1.65e-2
T CD8 MAIT	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-5	2.70e-2
NK FCGR3Apos	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	1.40e-2
T cell dividing	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	2.84e-3
B mature	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	2.47e-2
B mature	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	1.94e-2
B mature	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-5	2.70e-2
NK dividing	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	9.58e-4
NK dividing	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	7.31e-4
NK dividing	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-3	1.04e-2
Plasma IgM	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	1.87e-2
Plasma IgM	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	1.94e-2
Plasma IgM	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-4	3.47e-2
Plasma IgG	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	7.66e-3
Plasma IgG	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	1.29e-2
Plasmablast	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	5.00e-2	3.21e-2
Plasmablast	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	4.10e-2
Macrophage	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	4.10e-2
Macrophage	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-3	1.87e-2
Macrophage	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-4	1.65e-2
DC 1	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-2	1.94e-2
T CD8 activated	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-4	3.47e-2
T CD8 CTL	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-4	3.47e-2
T CD8 CTL	Basal metabolic rate	Basal metabolic rate variance	ETC	Wang H	2019	NA	341,584	1.00e-5	2.70e-2
NK FCGR3Apos	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	1.53e-2
T cell dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	5.14e-4
T cell dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-2	7.88e-3
B mature	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	1.70e-4
B mature	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-2	1.14e-2
B mature	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-4	2.00e-2
NK dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	2.24e-5
NK dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-2	1.56e-3
NK dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-3	1.56e-2
NK dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-4	1.47e-3
NK dividing	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-5	3.33e-4
DC 2	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	4.01e-2
DC 1	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	4.99e-2
DC 1	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-4	2.00e-2
Plasma IgM	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	8.92e-3
B Hypermutation	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	1.53e-2
Plasma IgG	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	3.73e-3
Plasmablast	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	5.00e-2	7.32e-4
T CD8 MAIT	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-2	4.23e-2
T CD8 MAIT	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-3	3.77e-2
T CD8 MAIT	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-4	2.00e-2
T CD8 MAIT	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-5	1.77e-2
Macrophage	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-2	3.12e-2
Macrophage	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-4	1.11e-2
Macrophage	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-5	3.37e-2
T CD8 CTL	BMI	Body mass index variance	ETC	Wang H	2019	NA	346,393	1.00e-5	8.86e-3
T CD8 MAIT	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	4.25e-2
T CD8 MAIT	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	3.84e-2
B naive	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	4.25e-2
T cell dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	5.10e-4
B mature	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	4.36e-3
B mature	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-4	3.53e-2
T CD8 CTL	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	2.56e-2
NK dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.56e-3
NK dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	1.87e-2
NK dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-3	1.45e-2
NK dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-4	5.11e-3
NK dividing	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-5	1.18e-3
Macrophage	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.96e-2
Macrophage	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	8.46e-3
Macrophage	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-3	4.77e-3
Macrophage	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-5	1.52e-2
DC 1	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.11e-2
DC 1	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	2.71e-2
Plasma IgM	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	3.32e-2
Plasma IgM	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	2.71e-2
B Hypermutation	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.48e-2
Plasma IgG	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.11e-2
Plasma IgG	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	8.46e-3
DC plasmacytoid	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	3.13e-3
DC plasmacytoid	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	1.38e-3
Plasmablast	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	5.00e-2	1.64e-5
Plasmablast	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-3	2.40e-2
Plasmablast	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-5	3.14e-2
NK FCGR3Apos	Waist circumference	Waist circumference variance	ETC	Wang H	2019	NA	347,158	1.00e-2	2.71e-2
T CD8 MAIT	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	3.25e-2
T CD8 MAIT	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-2	1.22e-2
T CD8 MAIT	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-3	1.93e-2
T CD8 MAIT	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-4	2.49e-2
NK CD160pos	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	1.92e-2
NK FCGR3Apos	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	7.40e-4
NK FCGR3Apos	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-2	1.82e-2
NK FCGR3Apos	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-3	1.10e-2
T cell dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	4.17e-2
B mature	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	5.92e-3
B mature	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-2	1.82e-2
B mature	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-5	4.27e-2
T CD8 CTL	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	8.07e-3
NK dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	3.41e-4
NK dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-2	2.65e-2
NK dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-3	8.34e-5
NK dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-4	6.36e-3
NK dividing	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-5	1.02e-2
DC 2	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	2.51e-2
DC 1	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	2.51e-2
Plasma IgM	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	1.54e-3
Plasma IgG	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	1.54e-3
DC plasmacytoid	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	4.17e-2
Plasmablast	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	5.00e-2	1.45e-2
Macrophage	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-3	1.93e-2
Macrophage	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-4	4.54e-2
Macrophage	Hip circumference	Hip circumference variance	ETC	Wang H	2019	NA	346,781	1.00e-5	2.16e-2
NK CD160pos	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	1.42e-2
B mature	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	4.49e-2
B mature	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	1.00e-2	1.02e-2
Monocyte	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	3.13e-2
Macrophage	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	9.29e-3
DC 1	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	3.13e-2
B Hypermutation	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	9.29e-3
Platelet	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	1.42e-2
Platelet	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	1.00e-3	1.75e-2
DC plasmacytoid	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	3.72e-3
CD34 progenitor	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	5.00e-2	3.13e-2
B naive	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	1.00e-2	3.66e-2
T CD8 CTL	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	1.00e-2	1.98e-2
ILC	Waist to hip ratio	Waist-hip ratio variance	ETC	Wang H	2019	NA	347,134	1.00e-3	1.75e-2
B mature	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	6.75e-3
Monocyte	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	1.19e-4
Monocyte	Height	Height variance	ETC	Wang H	2019	NA	347,086	1.00e-2	2.46e-2
DC 2	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	6.07e-5
DC 2	Height	Height variance	ETC	Wang H	2019	NA	347,086	1.00e-2	1.02e-2
Macrophage	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	1.38e-3
Macrophage	Height	Height variance	ETC	Wang H	2019	NA	347,086	1.00e-2	2.46e-2
DC 1	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	3.04e-5
DC 1	Height	Height variance	ETC	Wang H	2019	NA	347,086	1.00e-2	3.93e-3
Plasma IgM	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	2.65e-2
B Hypermutation	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	2.65e-2
Plasma IgG	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	3.98e-2
DC plasmacytoid	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	2.40e-3
Plasmablast	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	1.09e-2
CD34 progenitor	Height	Height variance	ETC	Wang H	2019	NA	347,086	5.00e-2	3.98e-2
B naive	Height	Height variance	ETC	Wang H	2019	NA	347,086	1.00e-2	1.02e-2
T CD8 MAIT	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	4.55e-2
T CD8 activated	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	3.25e-2
B naive	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	1.56e-2
T cell dividing	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	3.25e-2
B mature	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	4.51e-3
B mature	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	1.00e-2	5.46e-3
T CD8 CTL	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	4.51e-3
T CD4 reg	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	2.27e-2
T CD4 conv	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	6.94e-3
NK dividing	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	3.25e-2
T CD8 gd	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	4.51e-3
T CD8 gd	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	1.00e-2	4.07e-2
DC 1	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	6.94e-3
DC 1	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	1.00e-2	4.07e-2
B Hypermutation	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	3.25e-2
Platelet	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	6.94e-3
Platelet	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	1.00e-3	1.74e-2
DC activated	Lung function	Lung function (forced vital capacity) variance	ETC	Wang H	2019	NA	317,222	5.00e-2	6.94e-3
NK FCGR3Apos	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	9.06e-3
T CD4 fh	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	3.95e-2
B mature	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	9.06e-3
T CD8 gd	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	1.96e-2
T CD8 gd	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-2	4.07e-2
T CD8 gd	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-3	1.55e-2
B Hypermutation	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	1.96e-2
Platelet	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	1.55e-3
CD34 progenitor	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	5.00e-2	3.95e-2
T CD8 MAIT	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-2	1.12e-2
Plasma IgM	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-2	4.07e-2
Plasma IgG	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-2	4.07e-2
Plasmablast	Lung function	Lung function (FEV1) variance	ETC	Wang H	2019	NA	317,285	1.00e-2	1.12e-2
T CD8 MAIT	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	3.11e-2
B naive	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	1.47e-3
B mature	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	4.56e-5
B mature	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	4.03e-2
T CD8 CTL	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	2.24e-2
Monocyte	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	4.24e-2
Monocyte	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	6.48e-3
Monocyte	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-4	1.56e-2
B T doublet	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	2.21e-4
B T doublet	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	3.23e-3
Macrophage	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	2.24e-2
Macrophage	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	2.29e-2
Macrophage	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-3	3.94e-3
Macrophage	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-4	1.56e-2
DC 1	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	5.00e-2	1.11e-2
DC 1	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	4.03e-2
DC 1	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-3	1.07e-3
DC 2	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-2	4.03e-2
DC 2	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-3	1.29e-2
DC 2	Lung function	Lung function (FEV1/FVC) variance	ETC	Wang H	2019	NA	316,614	1.00e-4	3.26e-3
T cell dividing	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	2.65e-2
Monocyte	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	3.74e-2
NK dividing	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	3.59e-3
NK dividing	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	1.00e-2	2.47e-2
DC 2	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	1.42e-3
Macrophage	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	8.72e-4
Plasmablast	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	5.00e-2	1.84e-2
Plasmablast	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	1.00e-2	7.08e-3
B Hypermutation	Heel bone mineral Density	Heel bone mineral density variance	ETC	Wang H	2019	NA	197,261	1.00e-2	2.47e-2
NK CD160pos	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	4.93e-2
NK FCGR3Apos	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	3.61e-2
NK dividing	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	1.84e-2
NK dividing	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	1.00e-2	3.41e-2
DC 2	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	2.60e-2
Macrophage	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	3.93e-3
ILC	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	4.93e-2
ILC	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	1.00e-3	1.23e-2
DC 1	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	8.80e-3
Plasmablast	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	4.93e-2
DC activated	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	5.00e-2	1.84e-2
T cell dividing	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	1.00e-2	3.41e-2
B mature	Birth weight	Birth weight variance	ETC	Wang H	2019	NA	197,758	1.00e-3	4.37e-2
B naive	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	1.28e-2
B naive	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	1.49e-2
B naive	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-3	9.05e-3
B naive	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	5.77e-4
T cell dividing	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	4.20e-5
T cell dividing	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	2.04e-3
T CD4 reg	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	3.66e-2
T CD4 reg	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	2.65e-2
NK dividing	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	1.58e-3
NK dividing	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	2.65e-2
DC 2	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	3.66e-2
DC 2	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	1.49e-2
DC 2	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	2.22e-2
Macrophage	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	2.62e-2
Macrophage	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	4.12e-3
Macrophage	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-3	2.43e-2
Macrophage	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	2.22e-2
DC 1	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	5.82e-3
DC 1	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	2.22e-2
Plasma IgM	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	3.66e-2
B Hypermutation	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	2.19e-4
DC plasmacytoid	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	1.58e-3
DC plasmacytoid	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	7.99e-3
DC plasmacytoid	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-3	9.05e-3
Plasmablast	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	5.00e-2	6.07e-4
B mature	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	4.54e-2
B mature	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-3	9.05e-3
B mature	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	6.75e-5
CD34 progenitor	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-2	7.99e-3
DC activated	Waist to hip ratio	BMI-adjusted waist-hip ratio variance	ETC	Wang H	2019	NA	346,535	1.00e-4	2.22e-2
T CD8 MAIT	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.96e-3
T CD8 MAIT	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	8.53e-4
T CD8 MAIT	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.63e-3
T CD8 MAIT	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	6.03e-4
T CD8 MAIT	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	8.79e-4
NK CD160pos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	2.71e-2
T CD8 activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	5.07e-4
T CD8 activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	8.53e-4
T CD8 activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	4.82e-2
B naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	9.63e-3
B naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	3.06e-3
B naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.03e-5
B naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	4.91e-6
B naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	7.12e-5
NK FCGR3Apos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	5.07e-4
NK FCGR3Apos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	1.64e-3
NK FCGR3Apos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	8.51e-3
NK FCGR3Apos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	2.54e-2
NK FCGR3Apos	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	4.82e-2
T CD4 fh	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	9.63e-3
T CD4 fh	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	2.70e-2
B mature	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.91e-4
B mature	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	1.00e-4
B mature	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	2.03e-8
B mature	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	1.60e-8
B mature	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	4.28e-6
T CD8 CTL	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.91e-4
T CD8 CTL	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	2.09e-5
T CD8 CTL	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	2.50e-4
T CD8 CTL	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	1.99e-4
T CD8 CTL	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	8.79e-4
T CD4 reg	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.15e-4
T CD4 reg	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	4.65e-5
T CD4 reg	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.79e-2
T CD4 reg	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	2.54e-2
T CD4 reg	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	4.82e-2
T CD4 naive	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.95e-2
B T doublet	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	9.63e-3
B T doublet	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	3.06e-3
B T doublet	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.79e-2
B T doublet	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	4.82e-2
DC 2	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	6.62e-3
DC 2	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	3.83e-3
DC 2	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	1.71e-3
DC 2	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	8.79e-4
Macrophage	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	2.98e-3
Macrophage	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	9.69e-3
Macrophage	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.63e-3
Macrophage	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	6.03e-4
Macrophage	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	8.79e-4
T CD8 gd	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	3.99e-6
T CD8 gd	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	1.64e-2
DC 1	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	1.96e-3
DC 1	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	5.53e-3
DC 1	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	1.03e-5
DC 1	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	1.79e-5
DC 1	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	9.46e-7
DC plasmacytoid	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	3.70e-2
DC plasmacytoid	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	1.64e-3
DC plasmacytoid	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	2.50e-4
DC plasmacytoid	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	1.99e-4
DC plasmacytoid	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	2.60e-4
DC activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	3.70e-2
DC activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-2	3.06e-3
DC activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-3	2.50e-4
DC activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-4	6.03e-4
DC activated	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	1.00e-5	2.60e-4
CD34 progenitor	Systemic sclerosis	Systemic sclerosis	ETC	Lopez-Isac E	2019	9,095	17,584	5.00e-2	4.98e-2
T cell dividing	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	3.16e-2
Monocyte	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	4.45e-2
Monocyte	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-2	3.32e-3
NK dividing	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	4.45e-2
Macrophage	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	4.25e-3
Macrophage	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-2	2.66e-4
Macrophage	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-3	5.82e-3
T CD8 gd	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	1.50e-2
T CD8 gd	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-2	4.88e-2
DC 1	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	5.00e-2	4.45e-2
B naive	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-2	4.88e-2
B naive	Macular degeneration	Disease progression in age-related macular degeneration (adjusted for baseline)	ETC	Yan Q	2018	NA	2,721	1.00e-3	5.82e-3
T CD8 MAIT	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	4.73e-4
T CD8 MAIT	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	1.00e-2	4.87e-2
T CD8 activated	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	1.34e-2
T CD4 fh	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	4.91e-2
T CD8 CTL	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	3.64e-2
T CD4 reg	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	4.29e-3
T CD4 reg	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	1.00e-2	4.87e-2
NK dividing	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	1.86e-3
DC 2	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	3.64e-2
T CD8 gd	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	4.29e-3
B Hypermutation	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	5.00e-2	1.34e-2
B mature	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	1.00e-3	1.39e-2
B mature	Uterine fibroids and heavy menstrual bleeding	Uterine fibroids and heavy menstrual bleeding	ETC	Gallagher CS	2019	3,409	199,171	1.00e-4	2.59e-2
B naive	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.06e-2
T cell dividing	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.49e-3
B mature	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.06e-2
B mature	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-2	2.37e-2
B mature	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-4	1.00e-2
NK dividing	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	3.87e-4
ILC	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.50e-2
ILC	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-2	4.53e-3
ILC	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-4	4.37e-2
B Hypermutation	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.50e-2
DC plasmacytoid	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	5.04e-3
DC plasmacytoid	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-3	3.34e-2
Plasmablast	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	1.06e-2
Plasmablast	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-2	2.37e-2
CD34 progenitor	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	5.00e-2	2.09e-2
T CD4 fh	Heavy menstrual bleeding	Heavy menstrual bleeding	ETC	Gallagher CS	2019	9,813	210,946	1.00e-2	3.84e-2
NK FCGR3Apos	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	9.64e-3
T cell dividing	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	1.23e-6
B mature	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	3.44e-2
NK dividing	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	2.49e-4
NK dividing	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-2	3.25e-2
DC 1	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	1.87e-2
B Hypermutation	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	3.47e-5
Plasmablast	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	5.00e-2	5.79e-5
Plasmablast	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-2	2.10e-2
DC activated	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-2	4.88e-2
T CD4 fh	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-3	2.46e-2
T CD4 fh	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-4	3.66e-3
T CD4 fh	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-5	4.75e-4
Platelet	Uterine fibroids	Uterine fibroids	ETC	Gallagher CS	2019	20,406	223,918	1.00e-5	2.30e-2
T CD8 MAIT	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	2.91e-2
T CD8 MAIT	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	2.25e-3
B naive	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	4.06e-2
NK FCGR3Apos	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	1.42e-2
NK FCGR3Apos	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	4.92e-3
T cell dividing	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	4.06e-2
B mature	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	6.44e-3
T CD8 CTL	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	4.22e-3
T CD8 CTL	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	1.02e-2
T CD4 conv	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	1.73e-3
NK dividing	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	1.37e-4
NK dividing	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	4.92e-3
B T doublet	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	9.64e-3
Macrophage	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	2.91e-2
CD34 progenitor	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	6.44e-3
CD34 progenitor	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	6.16e-5
CD34 progenitor	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-3	2.89e-2
Neutrophil	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	5.00e-2	4.06e-2
NK CD160pos	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-2	3.78e-2
NK CD160pos	Cytokine network	Cytokine network levels (multivariate analysis)	ETC	Nath AP	2019	NA	9,263	1.00e-3	8.39e-3
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	4.07e-2
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	1.60e-3
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	4.17e-4
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	7.24e-6
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.87e-6
NK FCGR3Apos	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	5.47e-3
NK FCGR3Apos	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	4.87e-2
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	1.22e-5
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	5.36e-8
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	1.42e-6
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	8.79e-7
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.54e-7
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	1.65e-3
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	5.74e-3
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	8.30e-3
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	7.15e-3
NK dividing	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	4.07e-2
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	5.47e-3
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	1.83e-4
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	6.59e-6
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	5.24e-5
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.67e-4
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	2.21e-2
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	5.74e-3
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	1.24e-2
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	1.79e-3
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.21e-3
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	2.15e-6
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	2.16e-9
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	1.57e-9
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	7.55e-10
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	3.36e-11
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	6.12e-5
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	1.03e-2
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	4.38e-3
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	3.30e-4
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.92e-5
Plasmablast	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	1.13e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	2.21e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	1.03e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	1.41e-3
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	7.24e-6
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	1.87e-6
CD34 progenitor	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	5.00e-2	3.72e-3
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-2	3.01e-2
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	3.23e-2
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	3.41e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-3	3.17e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-4	3.23e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (MPO-ANCA positive)	ETC	Lyons PA	2019	159	6,688	1.00e-5	7.15e-3
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	1.60e-2
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	3.90e-2
NK FCGR3Apos	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.44e-2
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.91e-3
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	3.07e-3
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.44e-2
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	1.96e-3
T CD4 reg	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.44e-2
T CD4 reg	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
T CD4 conv	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	3.22e-2
Monocyte	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	7.40e-3
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	8.04e-4
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	6.19e-3
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	1.96e-3
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	1.60e-2
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
T CD8 gd	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	2.05e-3
T CD8 gd	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	3.20e-3
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	2.65e-6
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.01e-5
B Hypermutation	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	7.40e-3
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.91e-3
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	1.46e-3
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
Plasmablast	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	4.44e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	5.00e-2	2.05e-3
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	1.46e-3
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	1.03e-4
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-2	1.20e-2
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	7.15e-3
T CD8 activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	2.30e-2
Plasma IgM	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	4.75e-4
Plasma IgG	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis (ANCA negative)	ETC	Lyons PA	2019	352	6,688	1.00e-3	1.96e-3
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-2
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	1.87e-3
T CD8 MAIT	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	1.00e-2
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-2
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	2.79e-2
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	6.05e-4
B naive	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	3.63e-7
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	2.01e-3
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	1.53e-3
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	1.82e-4
B mature	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	3.92e-6
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-2
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	2.79e-2
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	5.32e-3
T CD8 CTL	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	1.85e-3
T CD4 reg	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.54e-3
T CD4 reg	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	3.34e-2
T CD4 conv	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	9.64e-3
Monocyte	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.54e-3
NK dividing	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	3.64e-2
NK dividing	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	2.79e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	3.04e-3
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	4.50e-2
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	6.05e-4
B T doublet	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	3.61e-5
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.35e-5
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	5.40e-3
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	3.20e-6
DC 2	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	1.85e-3
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	8.40e-4
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	4.50e-2
Macrophage	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	1.00e-2
T CD8 gd	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	3.64e-2
T CD8 gd	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	4.37e-2
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.35e-5
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	7.72e-4
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	3.20e-6
DC 1	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	2.89e-8
Plasma IgM	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-2
Plasma IgM	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	9.66e-3
B Hypermutation	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.88e-2
Plasma IgG	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-2
Plasma IgG	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	2.92e-3
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	1.37e-6
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	7.72e-4
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	1.82e-4
DC plasmacytoid	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	1.00e-2
Plasmablast	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	4.54e-3
Plasmablast	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	4.50e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	5.00e-2	9.64e-3
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-2	4.50e-2
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	1.87e-3
DC activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	2.89e-8
T CD8 activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-3	1.87e-3
T CD8 activated	Eosinophilic granulomatosis	Eosinophilic granulomatosis with polyangiitis	ETC	Lyons PA	2019	534	6,688	1.00e-4	4.37e-2
Monocyte	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	6.73e-4
Monocyte	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	1.00e-3	3.58e-2
DC 2	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	3.62e-2
Macrophage	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	2.64e-3
Macrophage	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	1.00e-2	3.16e-2
DC 1	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	3.62e-2
DC activated	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	1.30e-2
CD34 progenitor	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	5.00e-2	1.30e-2
Neutrophil	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	1.00e-2	3.16e-2
Neutrophil	BMI at birth	BMI at birth	ETC	Helgeland O	2019	NA	9,286	1.00e-3	3.58e-2
T CD8 MAIT	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	5.82e-3
T CD8 MAIT	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	3.50e-3
NK CD160pos	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	1.85e-2
T CD8 activated	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	1.58e-3
T CD8 activated	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	2.55e-2
T CD8 activated	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-3	1.75e-2
NK FCGR3Apos	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	5.82e-3
NK FCGR3Apos	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	2.55e-2
B mature	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	1.28e-2
B mature	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	1.38e-2
B mature	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-3	1.75e-2
T CD8 CTL	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	2.62e-2
T CD8 CTL	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	2.55e-2
Monocyte	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	1.28e-2
Monocyte	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	4.50e-2
B T doublet	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	8.70e-3
DC 2	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	8.70e-3
DC 2	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	7.47e-4
DC 2	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-3	1.32e-3
Macrophage	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	8.70e-3
Macrophage	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	3.24e-4
Macrophage	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-3	5.13e-3
DC 1	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	9.86e-4
DC 1	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	1.38e-2
Platelet	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	5.00e-2	1.85e-2
B naive	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	1.38e-2
DC activated	BMI by age	BMI at 6 weeks old	ETC	Helgeland O	2019	NA	6,450	1.00e-2	1.38e-2
T CD8 MAIT	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	1.52e-4
T CD8 MAIT	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-4	1.00e-2
T CD8 activated	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	6.70e-4
T CD8 activated	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	4.93e-2
T CD8 activated	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-4	1.00e-2
NK FCGR3Apos	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	3.45e-2
NK FCGR3Apos	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	4.93e-2
T CD8 CTL	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	4.15e-4
T CD8 CTL	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-2	1.57e-2
T CD4 reg	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	3.45e-2
Monocyte	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	1.25e-2
Monocyte	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-2	4.44e-2
Monocyte	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	4.93e-2
DC 2	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	1.25e-2
DC 2	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-2	6.15e-4
DC 2	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	6.69e-4
DC 2	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-4	1.00e-2
Platelet	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	2.50e-2
DC activated	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	5.00e-2	3.45e-2
DC activated	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-2	4.79e-3
Macrophage	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-2	1.57e-2
Macrophage	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	4.93e-2
NK CD160pos	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-3	4.93e-2
NK CD160pos	BMI by age	BMI at 3 months old	ETC	Helgeland O	2019	NA	7,970	1.00e-4	4.37e-2
T CD8 MAIT	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	2.59e-2
T CD8 MAIT	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	1.00e-2	4.11e-2
NK CD160pos	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	3.57e-2
T CD8 activated	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	1.85e-2
B naive	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	2.71e-3
NK FCGR3Apos	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	4.84e-2
NK FCGR3Apos	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	1.00e-2	2.50e-2
B mature	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	3.57e-2
Monocyte	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	6.13e-3
DC 2	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	6.13e-3
CD34 progenitor	BMI by age	BMI at 6 months old	ETC	Helgeland O	2019	NA	8,017	5.00e-2	6.13e-3
Plasma IgM	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	5.00e-2	4.09e-2
T CD8 MAIT	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	1.00e-2	3.33e-2
NK FCGR3Apos	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	1.00e-2	3.33e-2
NK FCGR3Apos	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	1.00e-3	3.35e-2
NK CD160pos	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	1.00e-3	3.35e-2
T CD4 reg	BMI by age	BMI at 8 months old	ETC	Helgeland O	2019	NA	7,197	1.00e-4	4.91e-2
DC 2	BMI by age	BMI at 1 year old	ETC	Helgeland O	2019	NA	6,970	5.00e-2	3.96e-2
ILC	BMI by age	BMI at 1 year old	ETC	Helgeland O	2019	NA	6,970	5.00e-2	3.96e-2
DC 1	BMI by age	BMI at 1 year old	ETC	Helgeland O	2019	NA	6,970	5.00e-2	2.88e-2
B Hypermutation	BMI by age	BMI at 1 year old	ETC	Helgeland O	2019	NA	6,970	5.00e-2	4.64e-3
B Hypermutation	BMI by age	BMI at 1 year old	ETC	Helgeland O	2019	NA	6,970	1.00e-2	2.00e-2
T CD8 MAIT	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	5.00e-2	4.03e-2
B Hypermutation	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	5.00e-2	1.27e-4
B Hypermutation	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-2	4.07e-2
DC plasmacytoid	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	5.00e-2	4.03e-2
Plasmablast	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	5.00e-2	1.40e-3
CD34 progenitor	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	5.00e-2	2.17e-3
CD34 progenitor	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-2	1.41e-2
T CD4 reg	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-2	4.07e-2
B T doublet	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-2	4.07e-2
Monocyte	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-3	2.17e-2
Monocyte	BMI by age	BMI at 1.5 years old	ETC	Helgeland O	2019	NA	6,800	1.00e-4	1.56e-2
T CD8 MAIT	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	4.93e-2
NK FCGR3Apos	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	3.63e-3
T CD4 naive	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	3.58e-2
T CD4 naive	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	1.00e-2	3.28e-2
Macrophage	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	5.56e-3
Macrophage	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	1.00e-2	1.83e-2
Macrophage	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	1.00e-3	1.51e-3
DC plasmacytoid	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	8.35e-3
Plasmablast	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	1.79e-2
CD34 progenitor	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	5.00e-2	2.34e-3
T CD8 CTL	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	1.00e-2	1.83e-2
B T doublet	BMI by age	BMI at 2 years old	ETC	Helgeland O	2019	NA	4,631	1.00e-2	3.28e-2
T CD8 MAIT	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	9.68e-3
NK FCGR3Apos	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	2.07e-2
T CD8 CTL	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	2.07e-2
T CD8 CTL	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	1.00e-2	3.79e-2
Monocyte	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	4.12e-2
NK dividing	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	2.95e-2
Macrophage	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	2.07e-2
Plasmablast	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	9.68e-3
CD34 progenitor	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	5.00e-2	1.71e-3
T CD4 conv	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	1.00e-2	3.79e-2
Plasma IgG	BMI by age	BMI at 3 years old	ETC	Helgeland O	2019	NA	5,069	1.00e-2	3.79e-2
T CD8 activated	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	2.94e-2
B naive	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	4.15e-2
T cell dividing	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	1.39e-2
T CD4 naive	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	2.94e-2
T CD4 conv	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	4.15e-2
NK dividing	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	4.15e-2
B Hypermutation	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	2.94e-2
B Hypermutation	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	1.00e-2	1.72e-2
Plasmablast	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	2.04e-2
DC activated	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	2.94e-2
CD34 progenitor	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	5.00e-2	9.32e-3
B T doublet	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	1.00e-2	3.17e-2
DC plasmacytoid	BMI by age	BMI at 5 years old	ETC	Helgeland O	2019	NA	4,245	1.00e-2	3.17e-2
T CD4 fh	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	9.27e-3
T cell dividing	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	2.87e-2
T CD4 reg	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	1.38e-2
T CD4 naive	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	4.03e-2
T CD4 conv	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	2.87e-2
B Hypermutation	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	5.00e-2	9.27e-3
DC activated	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	1.00e-2	3.39e-2
CD34 progenitor	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	1.00e-2	9.35e-3
CD34 progenitor	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	1.00e-3	1.17e-2
B naive	BMI by age	BMI at 7 years old	ETC	Helgeland O	2019	NA	4,629	1.00e-3	1.17e-2
T CD8 MAIT	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	4.27e-2
T cell dividing	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	2.86e-3
T CD4 reg	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	1.49e-2
NK dividing	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	2.16e-2
DC 2	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	2.16e-2
Macrophage	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	1.01e-2
ILC	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	1.01e-2
ILC	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	1.00e-2	1.52e-2
B Hypermutation	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	5.00e-2	1.01e-2
B Hypermutation	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	1.00e-2	1.52e-2
CD34 progenitor	BMI by age	BMI at 8 years old	ETC	Helgeland O	2019	NA	3,862	1.00e-3	3.46e-2
B naive	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	3.16e-2
T cell dividing	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	9.26e-3
B mature	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	1.42e-2
T CD4 naive	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	4.55e-2
Monocyte	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	1.42e-2
Monocyte	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-2	5.40e-3
Monocyte	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-3	4.92e-3
NK dividing	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	2.14e-2
B Hypermutation	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	2.14e-2
DC plasmacytoid	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	5.00e-2	2.24e-3
DC plasmacytoid	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-2	2.38e-3
DC plasmacytoid	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-3	9.54e-6
DC 2	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-2	2.36e-2
DC 2	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-3	4.92e-3
Platelet	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-2	2.36e-2
DC activated	PD	Parkinson's disease in GBA mutation carriers	ETC	Blauwendraat C	2020	1,588	7,584	1.00e-2	5.40e-3
Monocyte	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	5.00e-2	1.03e-2
Monocyte	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	1.00e-2	2.28e-2
DC 2	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	5.00e-2	1.61e-2
Macrophage	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	5.00e-2	2.45e-2
DC 1	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	5.00e-2	3.64e-2
CD34 progenitor	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	5.00e-2	1.61e-2
NK CD160pos	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	1.00e-2	9.82e-3
Plasma IgM	PD	Parkinson's disease in GBA mutation carriers (age at onset)	ETC	Blauwendraat C	2020	NA	1,353	1.00e-2	2.28e-2
B naive	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	3.33e-2
B naive	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-4	1.75e-2
B naive	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-5	1.50e-3
B mature	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	4.42e-2
B mature	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	2.72e-2
B mature	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-3	4.55e-2
B mature	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-5	8.49e-3
T CD4 reg	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	3.33e-2
T CD4 reg	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-3	1.04e-2
Monocyte	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	1.31e-2
Monocyte	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	2.72e-2
Monocyte	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-3	4.55e-2
DC 2	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	3.12e-3
DC 2	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	2.72e-2
Macrophage	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	6.57e-3
DC 1	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	2.23e-6
DC 1	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	1.72e-2
Plasma IgM	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	2.47e-2
Plasma IgG	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	4.56e-3
Plasma IgG	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	1.06e-2
DC plasmacytoid	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	3.33e-2
DC plasmacytoid	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	4.17e-2
Plasmablast	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	2.47e-2
Plasmablast	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	6.38e-3
Plasmablast	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-3	4.55e-2
DC activated	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	9.26e-4
DC activated	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	4.17e-2
CD34 progenitor	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	5.00e-2	1.81e-2
CD34 progenitor	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	3.72e-3
CD34 progenitor	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-3	4.55e-2
T cell dividing	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	1.06e-2
NK dividing	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	4.17e-2
B Hypermutation	Left ventricular	Left ventricular mass to end-diastolic volume ratio	ETC	Aung N	2019	NA	16,884	1.00e-2	2.72e-2
T cell dividing	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	4.81e-3
B mature	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	4.33e-2
NK dividing	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	4.33e-2
DC 1	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	4.81e-3
DC 1	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	1.39e-2
DC 1	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	1.23e-2
DC 1	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-4	6.58e-3
B Hypermutation	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	1.03e-3
B Hypermutation	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	8.48e-3
B Hypermutation	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	2.61e-2
Plasmablast	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	6.84e-3
CD34 progenitor	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	6.83e-4
CD34 progenitor	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	3.42e-2
B naive	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-4	1.98e-2
T CD4 reg	Left ventricular	Left ventricular end-systolic volume	ETC	Aung N	2019	NA	16,920	1.00e-5	3.41e-2
NK FCGR3Apos	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	5.00e-2	4.53e-2
T cell dividing	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	5.00e-2	2.42e-2
NK dividing	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	5.00e-2	8.36e-3
DC 1	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	5.00e-2	3.81e-3
DC 1	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	1.00e-2	4.62e-3
B Hypermutation	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	5.00e-2	4.09e-4
B Hypermutation	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	1.00e-2	2.47e-2
ILC	Left ventricular	Left ventricular ejection fraction	ETC	Aung N	2019	NA	16,923	1.00e-4	4.80e-2
T CD8 MAIT	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	5.00e-2	2.60e-2
T CD8 MAIT	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	1.00e-2	2.17e-2
B mature	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	5.00e-2	9.90e-3
Monocyte	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	1.00e-2	2.37e-3
DC 1	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	1.00e-2	7.62e-3
CD34 progenitor	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	1.00e-3	4.30e-2
CD34 progenitor	Left ventricular	Left ventricular mass	ETC	Aung N	2019	NA	16,920	1.00e-4	1.35e-2
B naive	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	1.07e-2
B naive	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	3.59e-2
T cell dividing	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	1.48e-2
B mature	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	1.07e-2
B mature	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	9.02e-3
T CD4 reg	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	2.72e-2
DC 1	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	1.15e-3
DC 1	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	1.78e-3
DC 1	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	6.56e-5
DC 1	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-4	2.30e-2
Plasma IgM	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	7.59e-3
B Hypermutation	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	5.34e-3
Plasma IgG	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	2.72e-2
Plasma IgG	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	3.98e-2
Plasmablast	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	3.70e-3
Plasmablast	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	3.59e-2
DC activated	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	5.00e-2	4.77e-2
DC 2	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	1.47e-2
DC 2	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	1.93e-2
DC plasmacytoid	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-2	1.78e-3
T CD8 MAIT	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-3	3.98e-2
T CD8 activated	Left ventricular	Left ventricular end-diastolic volume	ETC	Aung N	2019	NA	16,920	1.00e-4	2.30e-2
NK FCGR3Apos	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	4.31e-2
ILC	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	1.05e-3
ILC	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	3.81e-2
B Hypermutation	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	4.85e-3
B Hypermutation	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	2.57e-2
B Hypermutation	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-3	3.37e-2
B Hypermutation	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-4	4.40e-2
DC activated	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	2.46e-2
CD34 progenitor	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	1.57e-3
CD34 progenitor	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	1.09e-2
Unknown	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	5.00e-2	4.31e-2
T cell dividing	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	1.69e-2
T cell dividing	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-4	1.93e-2
T CD4 naive	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	2.57e-2
Macrophage	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-2	1.69e-2
NK dividing	Optic cup area	Optic cup area	ETC	Bonnemaijer PWM	2019	NA	24,493	1.00e-4	4.40e-2
T CD8 MAIT	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	7.49e-3
B naive	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	2.68e-2
B naive	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-2	3.40e-2
NK FCGR3Apos	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	3.56e-2
T CD4 conv	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	7.49e-3
DC 2	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	3.56e-2
DC 2	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-2	2.22e-2
Macrophage	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	3.56e-2
Macrophage	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-2	2.22e-2
Macrophage	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-3	3.24e-2
Platelet	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	4.68e-2
DC plasmacytoid	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	3.67e-3
DC activated	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	4.68e-2
DC activated	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-2	8.80e-3
CD34 progenitor	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	5.00e-2	5.28e-3
Monocyte	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-3	3.24e-2
Neutrophil	Optic disc area	Optic disc area	ETC	Bonnemaijer PWM	2019	NA	24,509	1.00e-3	1.70e-2
NK FCGR3Apos	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	1.15e-3
ILC	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	1.92e-2
ILC	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	1.00e-3	5.56e-3
ILC	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	1.00e-4	5.57e-3
DC 1	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	3.42e-2
B Hypermutation	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	1.92e-2
B Hypermutation	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	1.00e-2	2.65e-3
B Hypermutation	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	1.00e-5	4.93e-2
DC activated	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	1.71e-3
CD34 progenitor	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	5.00e-2	1.15e-3
Monocyte	Vertical cup to disc ratio	Vertical cup-disc ratio	ETC	Bonnemaijer PWM	2019	NA	25,180	1.00e-5	4.93e-2
NK CD160pos	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	1.53e-3
T CD8 activated	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	4.70e-3
NK FCGR3Apos	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	2.25e-3
NK FCGR3Apos	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	1.44e-3
T cell dividing	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	1.03e-3
T cell dividing	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	4.56e-2
T CD8 CTL	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	2.38e-2
T CD4 reg	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	1.29e-2
T CD4 naive	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	1.76e-2
NK dividing	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	2.88e-4
NK dividing	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	4.41e-3
DC 2	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	2.38e-2
DC 2	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	4.56e-2
Macrophage	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	6.80e-4
Macrophage	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	2.76e-5
Macrophage	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	1.89e-3
Macrophage	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-4	4.02e-4
T CD8 gd	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	2.38e-2
Plasmablast	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	3.17e-2
Plasmablast	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	3.37e-2
DC activated	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	3.17e-2
DC activated	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	7.42e-3
DC activated	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	3.37e-2
CD34 progenitor	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	5.00e-2	3.17e-2
CD34 progenitor	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	1.22e-2
Plasma IgM	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	4.56e-2
Plasma IgM	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	4.20e-3
Plasma IgM	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-4	3.86e-3
DC plasmacytoid	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-2	1.44e-3
DC plasmacytoid	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	3.33e-4
DC plasmacytoid	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-4	2.63e-2
Plasma IgG	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-3	8.86e-3
Plasma IgG	Intraocular pressure	Intraocular pressure	ETC	Bonnemaijer PWM	2019	NA	31,269	1.00e-4	2.63e-2
T cell dividing	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	3.94e-4
T cell dividing	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	9.03e-3
T cell dividing	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-3	4.34e-2
T CD8 CTL	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	1.99e-2
T CD8 CTL	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	2.59e-2
T CD8 CTL	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-3	4.34e-2
T CD8 CTL	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-4	2.97e-2
T CD8 CTL	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-5	2.70e-2
T CD4 reg	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	1.99e-2
T CD4 reg	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	2.59e-2
T CD4 reg	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-4	2.97e-2
NK dividing	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	9.37e-3
Plasma IgM	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	6.52e-4
Plasma IgM	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	9.03e-3
Plasma IgM	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-5	2.70e-2
B Hypermutation	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	1.99e-2
Plasma IgG	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	4.13e-3
Plasma IgG	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	4.17e-2
DC plasmacytoid	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	1.70e-3
DC plasmacytoid	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	1.45e-3
DC plasmacytoid	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-4	2.97e-2
DC plasmacytoid	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-5	9.52e-3
Plasmablast	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	1.06e-3
CD34 progenitor	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	5.00e-2	3.92e-2
T CD8 MAIT	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-2	4.17e-2
NK FCGR3Apos	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-3	1.10e-2
NK FCGR3Apos	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-4	1.21e-2
NK FCGR3Apos	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-5	9.52e-3
T CD8 gd	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-3	4.34e-2
NK CD160pos	Central corneal thickness	Central corneal thickness	ETC	Bonnemaijer PWM	2019	NA	16,204	1.00e-5	9.52e-3
T CD8 MAIT	Temporale grey matter volume	Right planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,039	5.00e-2	4.51e-2
T cell dividing	Temporale grey matter volume	Right planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,039	5.00e-2	3.49e-2
Plasmablast	Temporale grey matter volume	Right planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,039	1.00e-4	2.80e-2
B mature	Temporale grey matter volume	Right planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,039	1.00e-5	1.79e-2
T CD8 gd	Temporale grey matter volume	Right planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,039	1.00e-5	1.79e-2
B mature	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	4.01e-2
NK dividing	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	4.01e-2
NK dividing	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	1.00e-4	3.41e-2
DC 2	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	1.44e-2
DC 1	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	9.90e-3
Platelet	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	4.45e-3
Platelet	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	1.00e-2	4.57e-2
DC plasmacytoid	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	1.18e-3
DC activated	Temporale asymmetry	Planum temporale asymmetry index	ETC	Carrion-Castillo A	2020	NA	18,049	5.00e-2	9.90e-3
T cell dividing	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	2.33e-2
NK dividing	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	3.33e-3
DC 2	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	2.33e-2
Macrophage	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	1.28e-2
DC 1	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	8.13e-5
B Hypermutation	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	2.33e-2
Platelet	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	7.19e-4
Platelet	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-2	1.65e-2
DC plasmacytoid	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	9.30e-3
Plasmablast	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	1.28e-2
Plasmablast	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-4	8.71e-3
CD34 progenitor	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	5.00e-2	4.76e-4
CD34 progenitor	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-2	3.72e-2
B mature	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-2	3.72e-2
B mature	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-3	2.02e-2
T CD4 conv	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-2	2.51e-2
T CD8 gd	Temporale grey matter volume	Left planum temporale grey matter volume	ETC	Carrion-Castillo A	2020	NA	18,037	1.00e-5	2.58e-2
T CD8 MAIT	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-2	1.63e-2
T CD8 MAIT	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	3.22e-2
B naive	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-2	3.37e-3
B naive	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	2.45e-2
NK FCGR3Apos	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-2	3.99e-2
NK FCGR3Apos	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	7.31e-3
B mature	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-2	3.22e-2
NK dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-2	5.88e-3
NK dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	3.73e-3
NK dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	6.98e-3
NK dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	1.02e-2
T cell dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	3.22e-2
T cell dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	6.98e-3
T cell dividing	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	6.52e-3
Plasmablast	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	4.18e-2
Plasmablast	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	3.06e-3
Plasmablast	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	2.48e-3
CD34 progenitor	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-3	3.22e-2
CD34 progenitor	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	1.49e-2
CD34 progenitor	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	4.99e-2
T CD4 reg	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	2.12e-2
B Hypermutation	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-4	4.09e-2
B Hypermutation	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	3.47e-2
Plasma IgM	Refractive error	Refractive error (age-at-onset of spectacle wearing-inferred)	ETC	Ghorbani Mojarrad N	2020	NA	287,448	1.00e-5	3.47e-2
B naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	1.42e-3
B naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	1.90e-4
B naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	1.51e-4
B naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-5	3.46e-2
NK FCGR3Apos	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	2.09e-2
NK FCGR3Apos	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	3.27e-3
NK FCGR3Apos	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	6.39e-3
NK FCGR3Apos	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-5	1.53e-2
T cell dividing	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	1.66e-2
B mature	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	2.05e-5
B mature	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	2.89e-5
B mature	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	4.23e-3
T CD4 reg	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	3.46e-3
T CD4 reg	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	1.74e-2
T CD4 reg	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	1.98e-2
T CD4 naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	4.95e-2
T CD4 naive	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	1.27e-2
NK dividing	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	4.58e-3
NK dividing	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	2.26e-3
NK dividing	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	8.80e-5
NK dividing	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-5	2.40e-4
Macrophage	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	3.46e-3
B Hypermutation	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	1.01e-2
B Hypermutation	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	4.23e-3
B Hypermutation	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-5	6.20e-3
DC plasmacytoid	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	1.01e-2
Plasmablast	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	2.09e-2
Plasmablast	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-4	2.79e-2
CD34 progenitor	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-2	1.01e-2
NK CD160pos	Refractive error	Refractive error (autorefraction measured)	ETC	Ghorbani Mojarrad N	2020	NA	95,619	1.00e-3	4.07e-2
T CD8 MAIT	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	4.10e-4
T CD8 MAIT	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-2	3.39e-3
T CD8 MAIT	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-3	3.07e-2
B naive	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	3.13e-2
B naive	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-4	9.21e-4
B naive	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-5	3.90e-4
NK FCGR3Apos	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	4.71e-2
NK FCGR3Apos	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-2	6.74e-3
NK FCGR3Apos	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-3	6.25e-3
NK dividing	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	5.94e-3
DC 1	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	3.86e-2
B Hypermutation	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	4.95e-5
B Hypermutation	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-2	2.31e-2
Plasmablast	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	2.94e-4
DC activated	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	1.61e-2
DC activated	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-4	4.09e-2
CD34 progenitor	Household income	Household income	ETC	Hill WD	2019	NA	286,301	5.00e-2	7.70e-3
T CD8 CTL	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-3	4.34e-2
B mature	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-4	5.59e-3
B mature	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-5	1.56e-2
Macrophage	Household income	Household income	ETC	Hill WD	2019	NA	286,301	1.00e-5	2.85e-2
NK dividing	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-2	3.42e-2
B Hypermutation	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-2	5.71e-3
Plasmablast	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-2	2.72e-2
CD34 progenitor	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-2	4.27e-3
B naive	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-3	3.73e-2
B naive	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-4	1.94e-2
B naive	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-5	1.26e-3
B mature	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-4	2.85e-2
B mature	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-5	7.10e-3
T CD8 MAIT	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-5	4.74e-2
DC 2	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-5	4.74e-2
DC 1	Household income (MTAG)	Household income (MTAG)	ETC	Hill WD	2019	NA	505,541	1.00e-5	4.74e-2
T CD8 MAIT	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	8.80e-3
B mature	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	1.19e-2
T CD4 reg	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	2.77e-2
Macrophage	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	7.79e-4
ILC	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	1.19e-2
ILC	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	1.00e-2	8.37e-3
DC plasmacytoid	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	6.43e-3
DC plasmacytoid	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	1.00e-4	8.71e-3
DC plasmacytoid	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	1.00e-5	4.37e-2
Plasmablast	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	6.43e-5
CD34 progenitor	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	5.00e-2	3.32e-3
CD34 progenitor	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	1.00e-2	1.29e-2
T cell dividing	Heart failure	Heart failure	ETC	Shah S	2020	47,309	930,014	1.00e-2	2.87e-2
B mature	CCL19	CCL19 levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.46e-2
B mature	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.64e-2
T CD4 reg	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.38e-2
Monocyte	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.91e-2
DC 2	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	9.83e-3
Macrophage	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.91e-2
DC 1	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.60e-2
T CD4 fh	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.48e-2
Platelet	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.94e-2
Platelet	IL 6	Interleukin-6 receptor subunit alpha levels	ETC	Enroth S	2014	NA	653	1.00e-5	2.98e-2
T CD4 fh	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.57e-2
T CD4 conv	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.36e-2
T CD8 gd	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.99e-2
Platelet	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.02e-2
Platelet	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	1.00e-5	4.64e-2
Monocyte	C-X-C chmokine	C-X-C motif chemokine 10 levels	ETC	Enroth S	2014	NA	653	1.00e-5	4.64e-2
Platelet	CCL24	CCL24 levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.93e-2
Platelet	CCL24	CCL24 levels	ETC	Enroth S	2014	NA	653	1.00e-5	3.81e-2
CD34 progenitor	CCL24	CCL24 levels	ETC	Enroth S	2014	NA	653	5.00e-2	7.84e-3
Neutrophil	CCL24	CCL24 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.75e-2
ILC	CCL24	CCL24 levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.07e-2
T CD8 MAIT	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.42e-2
B naive	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.37e-3
B naive	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	3.38e-2
NK FCGR3Apos	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.59e-3
B mature	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.41e-4
T CD8 CTL	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	9.84e-4
Monocyte	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	9.84e-4
Monocyte	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.73e-2
Monocyte	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-3	4.10e-3
DC 2	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	7.65e-5
DC 2	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.44e-2
Macrophage	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	5.14e-5
Macrophage	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	8.17e-5
Macrophage	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-3	7.33e-3
T CD8 gd	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	8.32e-3
DC 1	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	7.01e-4
DC 1	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	8.17e-5
DC 1	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.13e-2
Platelet	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.09e-2
Platelet	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.21e-2
Platelet	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-4	3.24e-2
Platelet	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-5	7.79e-3
DC plasmacytoid	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.26e-5
DC plasmacytoid	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.00e-3
DC activated	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.72e-3
DC activated	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	3.74e-3
CD34 progenitor	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.83e-2
CD34 progenitor	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-3	3.46e-2
Plasma IgM	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	8.31e-3
Plasma IgG	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-2	3.38e-2
T CD4 reg	MHC class I	MHC class I polypeptide-related sequence A levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.13e-2
T CD4 fh	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.54e-2
T CD4 reg	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	5.00e-2	8.23e-3
T CD4 reg	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.01e-2
T CD4 reg	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.39e-3
T CD4 reg	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-4	2.19e-3
T CD4 reg	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-5	4.66e-2
Monocyte	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.75e-2
T CD8 gd	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	5.00e-2	5.91e-3
T CD8 gd	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-2	3.56e-2
T CD8 gd	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-3	9.69e-3
T CD8 gd	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-4	4.64e-2
Platelet	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-2	3.56e-2
CD34 progenitor	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.39e-2
T CD4 conv	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-3	3.28e-2
T CD4 conv	CD40	CD40 ligand levels	ETC	Enroth S	2014	NA	653	1.00e-4	4.64e-2
T CD4 fh	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.32e-2
T cell dividing	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.40e-2
T CD4 reg	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.40e-2
Monocyte	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.40e-2
Macrophage	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.47e-2
B Hypermutation	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.32e-2
Platelet	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.17e-3
Platelet	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.55e-2
Platelet	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.76e-2
Platelet	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-4	1.05e-2
Platelet	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-5	1.51e-2
T CD4 conv	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.55e-2
ILC	CXCL5	CXCL5 levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.59e-2
ILC	Kallikrein11	kallikrein-11 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.12e-2
Plasma IgM	Kallikrein11	kallikrein-11 levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.52e-2
Platelet	Kallikrein11	kallikrein-11 levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.20e-2
Plasmablast	Kallikrein11	kallikrein-11 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.12e-2
T cell dividing	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.93e-3
NK dividing	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.88e-2
T CD8 gd	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.49e-2
Platelet	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.88e-2
DC plasmacytoid	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.49e-2
Plasmablast	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.49e-2
CD34 progenitor	Epithelial	epithelial cell adhesion molecule levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.68e-2
T CD4 reg	IL 17	interleukin 17 receptor B levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.23e-2
Monocyte	IL 17	interleukin 17 receptor B levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.58e-2
Platelet	IL 17	interleukin 17 receptor B levels	ETC	Enroth S	2014	NA	653	1.00e-5	4.89e-2
T CD8 CTL	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	5.00e-2	2.74e-3
T CD4 conv	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.08e-2
T CD4 conv	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.98e-2
Monocyte	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.55e-2
Monocyte	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.94e-2
Platelet	IL 12	interleukin 12 receptor subunit beta-1 levels	ETC	Enroth S	2014	NA	653	1.00e-5	3.95e-2
T CD8 CTL	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.57e-2
T CD4 reg	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	7.43e-3
Monocyte	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	5.41e-4
Monocyte	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.81e-2
Monocyte	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-3	5.13e-4
Macrophage	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	7.43e-3
Macrophage	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.07e-2
Macrophage	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-3	2.54e-2
ILC	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.09e-2
T CD8 gd	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.09e-2
T CD8 gd	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.81e-2
DC 1	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.24e-2
CD34 progenitor	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	5.00e-2	5.41e-4
T CD4 naive	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.65e-2
Platelet	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.65e-2
Neutrophil	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.65e-2
Neutrophil	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-3	4.71e-2
DC 2	Endothelial	vascular endothelial growth factor D levels	ETC	Enroth S	2014	NA	653	1.00e-3	4.71e-2
Monocyte	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.39e-2
Macrophage	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.80e-4
Macrophage	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	1.00e-2	9.32e-3
T CD4 fh	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	1.00e-2	4.38e-2
T CD4 conv	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	1.00e-3	4.00e-2
Platelet	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	1.00e-4	3.30e-2
Platelet	E-selectin	E-selectin levels	ETC	Enroth S	2014	NA	653	1.00e-5	4.17e-2
T CD4 reg	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.02e-2
Macrophage	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	4.09e-2
Plasma IgM	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.52e-3
Plasma IgM	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	1.00e-2	1.66e-2
Plasma IgG	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.10e-2
Plasma IgG	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	1.00e-2	2.64e-2
DC activated	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	1.52e-3
Neutrophil	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	5.00e-2	3.02e-2
T CD8 MAIT	Melanoma	melanoma-derived growth regulatory protein levels	ETC	Enroth S	2014	NA	653	1.00e-3	1.87e-2
T CD8 MAIT	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	1.62e-2
T CD8 MAIT	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	7.99e-3
T CD8 MAIT	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	3.19e-2
T CD8 MAIT	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-5	3.60e-2
T cell dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	2.31e-3
T cell dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	3.90e-3
T cell dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	1.64e-3
T cell dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-5	2.32e-2
B mature	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	1.62e-2
B mature	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	1.12e-2
T CD4 naive	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	4.11e-2
NK dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	1.62e-2
NK dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	2.86e-2
NK dividing	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	1.51e-2
Macrophage	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	1.23e-3
Macrophage	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	1.32e-4
Macrophage	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	1.23e-6
Macrophage	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-5	1.43e-5
DC 1	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	5.61e-3
DC 1	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	2.86e-2
Plasma IgM	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	1.62e-2
B Hypermutation	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	3.13e-3
B Hypermutation	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	3.90e-3
B Hypermutation	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	1.64e-3
Plasma IgG	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	4.21e-3
DC plasmacytoid	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	5.61e-3
Plasmablast	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-2	2.10e-5
Plasmablast	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-3	3.32e-4
Plasmablast	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	2.66e-3
DC 2	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-4	3.19e-2
DC 2	Metabolic syndrome	Metabolic syndrome	ETC	Lind L	2019	NA	291,107	1.00e-5	2.32e-2
T CD8 MAIT	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	3.01e-2
B naive	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	2.57e-4
NK FCGR3Apos	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	4.82e-2
B mature	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	1.04e-2
Macrophage	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	2.24e-3
Macrophage	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-3	7.22e-3
DC 1	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	3.77e-4
B Hypermutation	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	1.38e-2
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	2.24e-3
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-4	1.82e-2
DC plasmacytoid	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-5	2.58e-2
Plasmablast	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-2	5.80e-3
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-4	4.17e-2
CD34 progenitor	Albumin to creatinine ratio	Urinary albumin-to-creatinine ratio	ETC	Casanova F	2019	NA	437,027	1.00e-5	8.60e-3
NK FCGR3Apos	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	4.89e-2
T cell dividing	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	3.40e-2
B mature	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	4.89e-2
B mature	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	7.75e-3
B mature	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	1.50e-3
DC 2	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	2.31e-2
DC 2	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	8.49e-3
Macrophage	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	3.40e-2
Macrophage	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	7.75e-3
Macrophage	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	2.19e-4
ILC	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	4.79e-4
DC 1	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	4.79e-4
DC 1	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	3.44e-2
DC 1	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	8.49e-3
CD34 progenitor	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	6.34e-3
Unknown	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	5.00e-2	3.95e-3
Unknown	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	3.44e-2
B naive	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	1.36e-3
B naive	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	2.19e-4
DC activated	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-2	3.44e-2
DC activated	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	1.50e-3
B T doublet	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	8.49e-3
DC plasmacytoid	Steroid sensitive nephrotic syndrome	Childhood steroid-sensitive nephrotic syndrome	ETC	Debiec H	2018	132	2,000	1.00e-3	8.49e-3
T CD8 MAIT	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.70e-5
T CD8 MAIT	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	5.89e-5
T CD8 MAIT	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	8.17e-4
T CD8 MAIT	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	2.49e-3
T CD8 MAIT	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	1.51e-2
NK CD160pos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	3.20e-6
NK CD160pos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	2.29e-4
NK CD160pos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	1.35e-3
NK CD160pos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	1.37e-3
NK CD160pos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	8.37e-3
B naive	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.17e-2
NK FCGR3Apos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.29e-7
NK FCGR3Apos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	2.87e-6
NK FCGR3Apos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	1.61e-4
NK FCGR3Apos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	1.37e-3
NK FCGR3Apos	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	2.63e-2
T CD4 fh	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	3.05e-3
T CD4 fh	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	4.25e-2
T CD4 fh	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	3.89e-2
T cell dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	4.72e-4
T cell dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	1.00e-2
T CD4 reg	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	3.36e-4
T CD4 reg	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	3.26e-2
T CD4 conv	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	9.09e-3
NK dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	4.92e-6
NK dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	2.29e-4
NK dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	2.74e-2
NK dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	7.58e-3
NK dividing	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	4.40e-2
B T doublet	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	4.54e-2
Macrophage	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	3.36e-4
Macrophage	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	2.29e-4
Macrophage	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	4.98e-5
Macrophage	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	1.37e-3
Macrophage	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	4.40e-2
ILC	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	9.07e-4
DC 1	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.17e-2
DC 1	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	3.26e-2
DC 1	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	1.89e-2
B Hypermutation	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.24e-3
B Hypermutation	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	4.25e-2
Platelet	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	1.16e-4
Platelet	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	1.37e-2
Platelet	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	4.40e-2
Plasmablast	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	4.54e-2
CD34 progenitor	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	5.00e-2	5.35e-3
CD34 progenitor	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	5.17e-3
CD34 progenitor	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	2.20e-3
CD34 progenitor	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	4.41e-3
CD34 progenitor	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	1.51e-2
T CD8 CTL	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	2.47e-2
T CD8 CTL	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	4.97e-2
T CD8 CTL	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	2.63e-2
T CD8 gd	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-2	3.26e-2
T CD8 gd	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	7.58e-3
T CD8 gd	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-5	2.63e-2
DC 2	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-3	3.89e-2
T CD8 activated	Glaucoma (MTAG)	Glaucoma (multi-trait analysis)	ETC	Craig JE	2020	119,318	232,378	1.00e-4	4.97e-2
B naive	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	3.64e-3
T CD4 fh	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	3.64e-3
T CD4 fh	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-2	6.10e-3
T cell dividing	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	1.29e-4
T cell dividing	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-2	1.52e-2
B mature	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	1.98e-2
T CD4 reg	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	1.29e-4
T CD4 reg	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-2	3.35e-4
T CD4 reg	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-3	1.21e-2
T CD4 reg	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-4	2.81e-2
NK dividing	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	1.98e-2
NK dividing	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-2	4.40e-2
Macrophage	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	1.26e-2
ILC	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	3.01e-2
DC 1	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	3.01e-2
B Hypermutation	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	3.12e-5
Plasmablast	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	2.78e-3
CD34 progenitor	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	5.00e-2	4.47e-2
CD34 progenitor	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-3	3.70e-2
CD34 progenitor	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-4	2.81e-2
T CD4 naive	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-2	4.40e-2
T CD4 naive	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-3	2.60e-2
NK FCGR3Apos	Snoring	Snoring main	ETC	Campos AI	2020	152,302	256,015	1.00e-3	3.70e-2
B naive	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	2.72e-2
T CD4 fh	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	1.75e-2
T CD4 fh	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	9.30e-3
T CD4 fh	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.83e-2
T cell dividing	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	2.94e-3
B mature	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	4.12e-2
T CD4 reg	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	1.38e-2
T CD4 reg	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	3.08e-2
T CD4 reg	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	7.48e-3
NK dividing	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	8.50e-3
Macrophage	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	3.36e-2
ILC	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	2.19e-2
ILC	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.65e-3
ILC	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-4	4.44e-2
Plasma IgM	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	4.12e-2
Plasma IgM	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.65e-3
Plasma IgM	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-5	4.69e-2
B Hypermutation	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	6.59e-3
B Hypermutation	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	4.03e-2
Plasmablast	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	1.23e-3
Plasmablast	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	2.33e-2
Plasmablast	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.83e-2
CD34 progenitor	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	5.00e-2	1.23e-3
CD34 progenitor	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	3.33e-3
CD34 progenitor	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.83e-2
NK FCGR3Apos	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-2	4.03e-2
NK CD160pos	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	1.83e-2
NK CD160pos	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-4	2.69e-2
NK CD160pos	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-5	4.69e-2
Plasma IgG	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-3	7.48e-3
DC plasmacytoid	Snoring	Snoring adjusted BMI	ETC	Campos AI	2020	151,836	255,230	1.00e-5	4.69e-2
B naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	4.00e-2
T CD4 fh	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	2.99e-3
T CD4 fh	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	2.62e-2
T cell dividing	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	1.85e-2
T CD8 CTL	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	4.00e-2
T CD8 CTL	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	2.62e-2
T CD8 CTL	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	1.35e-2
T CD4 reg	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	1.50e-3
T CD4 reg	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	1.18e-3
T CD4 reg	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	1.35e-2
T CD4 reg	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-5	3.16e-2
T CD4 naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	1.05e-2
T CD4 naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	1.20e-2
T CD4 naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	2.47e-2
T CD4 naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-4	3.34e-2
T CD4 naive	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-5	3.16e-2
Monocyte	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	2.42e-2
DC 2	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	5.72e-3
Macrophage	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	4.16e-3
Macrophage	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	2.62e-2
Macrophage	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	2.47e-2
T CD8 gd	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	2.99e-3
T CD8 gd	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	2.62e-2
T CD8 gd	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	1.35e-2
B Hypermutation	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	2.13e-3
Plasmablast	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	5.00e-2	2.42e-2
NK FCGR3Apos	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-2	3.77e-2
NK FCGR3Apos	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-3	7.08e-3
T CD8 activated	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-4	3.34e-2
T CD8 activated	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-5	3.16e-2
DC activated	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-4	3.34e-2
CD34 progenitor	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-4	1.39e-2
CD34 progenitor	Snoring	Snoring male	ETC	Campos AI	2020	90,806	99,165	1.00e-5	3.16e-2
T CD8 MAIT	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	5.52e-4
T CD8 activated	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	2.41e-2
NK FCGR3Apos	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	2.41e-2
NK FCGR3Apos	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	1.59e-2
T CD4 fh	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	2.41e-2
T cell dividing	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	5.52e-4
T cell dividing	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	1.13e-2
B mature	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	3.04e-2
B mature	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	3.72e-3
T CD4 reg	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	1.08e-3
T CD4 reg	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	5.47e-3
Monocyte	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	5.52e-4
Monocyte	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	5.47e-3
NK dividing	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	3.90e-4
NK dividing	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	2.21e-2
DC 2	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	1.48e-2
Macrophage	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	1.08e-3
ILC	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	2.41e-2
DC 1	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	5.03e-3
B Hypermutation	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	2.73e-4
B Hypermutation	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	5.47e-3
Plasmablast	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	3.04e-2
CD34 progenitor	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	5.00e-2	8.77e-3
CD34 progenitor	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	3.72e-3
T CD8 CTL	Snoring	Snoring Female	ETC	Campos AI	2020	61,792	156,554	1.00e-2	3.02e-2
T cell dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	2.73e-7
T cell dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	3.57e-5
T cell dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	3.14e-3
T cell dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-5	2.28e-2
B mature	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	1.83e-3
B mature	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	4.75e-2
Monocyte	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	3.05e-2
NK dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	1.89e-4
NK dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	1.49e-4
NK dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	1.39e-2
NK dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-4	3.52e-2
NK dividing	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-5	2.28e-2
T CD8 gd	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	2.45e-2
DC 1	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	3.05e-2
DC 1	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	1.39e-2
B Hypermutation	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	1.67e-6
B Hypermutation	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	2.34e-4
B Hypermutation	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	2.17e-2
B Hypermutation	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-4	1.97e-2
B Hypermutation	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-5	4.89e-2
Plasma IgG	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	2.45e-2
Platelet	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	4.31e-3
Platelet	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	7.92e-3
DC plasmacytoid	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	7.35e-3
DC plasmacytoid	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	4.91e-2
Plasmablast	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	3.97e-8
Plasmablast	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	3.57e-5
Plasmablast	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	5.28e-3
Plasmablast	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-4	3.52e-2
Plasmablast	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-5	2.28e-2
DC activated	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	7.24e-4
CD34 progenitor	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	5.00e-2	4.61e-2
T CD4 reg	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-2	2.75e-2
T CD4 reg	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-4	3.52e-2
Macrophage	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-3	1.39e-2
Macrophage	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-4	1.97e-2
T CD4 fh	Parental lifespan	Parental lifespan	ETC	Timmers PR	2019	NA	500,193	1.00e-5	4.89e-2
T CD8 MAIT	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	3.49e-2
NK FCGR3Apos	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	1.98e-2
T cell dividing	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	8.53e-4
NK dividing	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	5.52e-3
DC 1	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	1.07e-2
DC 1	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-5	2.58e-2
B Hypermutation	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	1.41e-5
B Hypermutation	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-2	9.70e-3
B Hypermutation	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-4	2.43e-2
B Hypermutation	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-5	2.58e-2
Platelet	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	2.93e-6
Platelet	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-2	5.58e-4
Platelet	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-3	1.70e-2
Plasmablast	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	3.89e-3
CD34 progenitor	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	5.00e-2	1.87e-3
CD34 progenitor	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-2	1.58e-2
B mature	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-2	2.51e-2
Macrophage	Retinal detachment	Retinal detachment or retinal break	ETC	Boutin TS	2020	6148	59546	1.00e-2	2.51e-2
T CD8 MAIT	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	2.12e-4
T CD8 MAIT	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	1.00e-2	1.35e-5
T CD8 activated	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	1.86e-2
T CD8 activated	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	1.00e-2	4.64e-2
T CD8 CTL	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	1.16e-4
T CD8 CTL	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	1.00e-2	3.35e-4
T CD8 CTL	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	1.00e-3	3.23e-2
T CD4 reg	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	5.03e-3
Monocyte	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	3.98e-2
NK dividing	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	2.75e-2
Macrophage	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	1.86e-2
DC activated	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	5.00e-2	2.75e-2
T CD8 gd	COVID-19 Host Genetics	hospitalized covid vs. not hospitalized covid (EA)	ETC	covid19hg	2020	928	2028	1.00e-2	2.37e-2
T CD8 MAIT	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	1.10e-2
NK CD160pos	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	1.69e-2
NK FCGR3Apos	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	1.10e-2
T CD4 reg	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	1.54e-3
T CD4 reg	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-3	4.58e-3
Monocyte	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	3.77e-2
DC 2	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	4.30e-3
ILC	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	1.69e-2
T CD8 gd	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	5.00e-2	3.77e-2
T CD4 fh	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	7.32e-3
T CD4 fh	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-3	4.58e-3
T cell dividing	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	4.85e-4
T cell dividing	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-3	2.03e-2
T CD4 conv	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	3.29e-2
T CD4 conv	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-3	4.58e-3
B T doublet	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	3.29e-2
B T doublet	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-3	4.58e-3
B Hypermutation	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	3.29e-2
Plasmablast	COVID-19 Host Genetics	predicted covid from self-reported symptoms vs. predicted or self-reported non-covid (EA)	ETC	covid19hg	2020	1865	29174	1.00e-2	1.60e-2
NK CD160pos	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	1.63e-2
NK CD160pos	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-3	3.89e-3
T CD8 activated	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	7.30e-3
T CD8 activated	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-2	2.20e-2
T CD4 reg	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	1.10e-2
T CD4 reg	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-2	1.12e-2
NK dividing	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	1.63e-2
T CD8 gd	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	3.38e-2
B Hypermutation	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	1.90e-3
CD34 progenitor	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	5.00e-2	3.38e-2
CD34 progenitor	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-3	1.55e-2
T CD8 MAIT	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-2	5.46e-3
B T doublet	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-2	4.07e-2
ILC	COVID-19	Severe COVID-19 infection with respiratory failure (analysis I)	ETC	Ellinghaus D	2020	1610	2205	1.00e-3	1.56e-4
NK CD160pos	COVID-19	Severe COVID-19 infection with respiratory failure (analysis II)	ETC	Ellinghaus D	2020	1610	2180	5.00e-2	1.78e-2
CD34 progenitor	COVID-19	Severe COVID-19 infection with respiratory failure (analysis II)	ETC	Ellinghaus D	2020	1610	2180	5.00e-2	8.03e-4
CD34 progenitor	COVID-19	Severe COVID-19 infection with respiratory failure (analysis II)	ETC	Ellinghaus D	2020	1610	2180	1.00e-2	3.57e-3
T CD8 activated	COVID-19	Severe COVID-19 infection with respiratory failure (analysis II)	ETC	Ellinghaus D	2020	1610	2180	1.00e-3	3.16e-2
T CD8 MAIT	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	1.93e-2
T CD8 MAIT	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-2	2.17e-2
B mature	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	1.93e-2
B mature	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	1.92e-2
B mature	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	1.13e-2
Monocyte	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	1.93e-3
Monocyte	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	1.92e-2
Monocyte	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	1.08e-3
NK dividing	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	5.56e-3
DC 2	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	3.95e-3
DC 2	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-2	2.17e-2
DC 2	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	9.95e-4
DC 2	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	2.60e-6
DC 2	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	5.91e-7
Macrophage	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	1.70e-5
Macrophage	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-2	3.28e-2
Macrophage	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	9.79e-3
Macrophage	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	3.57e-5
Macrophage	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	5.91e-7
DC 1	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	6.08e-4
DC 1	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	3.52e-2
DC 1	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	1.14e-3
DC 1	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	2.86e-4
B Hypermutation	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	1.33e-3
DC plasmacytoid	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	5.00e-2	7.72e-3
DC plasmacytoid	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-2	1.41e-2
DC plasmacytoid	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	9.79e-3
DC plasmacytoid	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	1.92e-2
ILC	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	3.52e-2
ILC	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	4.22e-2
DC activated	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-3	4.23e-4
DC activated	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-4	1.21e-4
DC activated	Alzheimer's disease (late onset)	late-onset Alzheimers disease	ETC	Kunkle BW	2019	21982	41944	1.00e-5	3.14e-6
T CD8 MAIT	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	3.20e-2
NK FCGR3Apos	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	2.25e-2
NK FCGR3Apos	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-2	1.06e-2
T CD4 reg	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	3.20e-2
Monocyte	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	6.95e-3
Monocyte	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-2	1.06e-2
B T doublet	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	1.55e-2
DC 2	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	4.06e-4
DC 2	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-2	2.64e-3
Macrophage	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	7.74e-5
Macrophage	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-2	1.24e-3
Plasma IgG	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	1.05e-2
Plasmablast	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	1.55e-2
Plasmablast	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-2	1.97e-2
DC activated	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	5.00e-2	2.25e-2
DC plasmacytoid	COVID-19	COVID-19 UKBB EUR tested (Mixed Population)	ETC	GRASP	2020	1,291	5,455	1.00e-3	3.20e-2
T CD4 reg	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	1.80e-2
Monocyte	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	2.60e-2
Macrophage	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	1.80e-2
Macrophage	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	1.00e-3	1.44e-2
Plasma IgM	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	3.67e-2
Plasma IgG	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	2.22e-3
Plasma IgG	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	1.00e-2	2.27e-2
DC plasmacytoid	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	3.67e-2
Plasmablast	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	5.00e-2	1.23e-2
Plasmablast	COVID-19	COVID-19 UKBB EUR (Mixed Population)	ETC	GRASP	2020	1,291	457,959	1.00e-2	2.27e-2

* If the number of cases is 0/NA, it means the phenotype is a continuous data type and the number of controls is the total number of samples.